The family of miR-64 and miR-65 are co-underexpressed in the @MiRNA$ transgenic and cat-1 strains, and members of let-7 family co-underexpressed in the alpha-synuclein and pdr-1 strains; mdl-1 and ptc-1 genes are target candidates for @DISEASE$ and miR-65 and are overexpressed in alpha-synuclein transgenic as well as miR-64/65 (tm3711) knockout animals.	0
@MiRNA$ Regulates of @DISEASE$ progression through targeting Disabled homolog-2.	1
The @MiRNA$ group has also been implicated in human cancers, cardiovascular disease and @DISEASE$, including Alzheimer's disease.	0
We used a highly sensitive quantitative PCR assay to measure specific miRNAs (miR-122, @MiRNA$, and miR-124) in plasma samples from rats treated with liver or muscle toxicants and from a rat surgical model of @DISEASE$.	0
The miR-17-92 @MiRNA$ Polycistron Regulates MLL @DISEASE$ Stem Cell Potential by Modulating p21 Expressio.	1
Overexpression of HMGA2 relates to reduction of the @MiRNA$ and its relationship to clinicopathological features in @DISEASE$.	0
@MiRNA$ influences BCL2 expression in keratocystic @DISEASE$.	1
We suggest that the expression of @MiRNA$ is regulated by @DISEASE$ and that common genetic variability in a miRNA binding-site can significantly increase the risk for FTLD-U.	1
The bifunctional microRNA @MiRNA$ /miR-9* regulates @DISEASE$ and CoREST and is downregulated in Huntington's disease.	1
@MiRNA$ aberrantly expressed in a double transgenic mouse model for Alzheimer's disease targets @DISEASE$.	1
Increased @MiRNA$ in @DISEASE$ directly targets SMAD4 and is involved in modulating cell proliferation and apoptosis.	1
@MiRNA$ inhibits autophagy and enhances cisplatin-induced apoptosis in @DISEASE$ cell.	1
Strikingly, cells with high levels of @MiRNA$ expressed lower levels of @DISEASE$, suggestive of endogenous regulation of PKM2 by miR-326.	1
CONCLUSIONS: Our results suggest a great potential for the use of @MiRNA$ profiling as a powerful diagnostic and prognostic marker in defining the signature of @DISEASE$ and in predicting the post-surgical outcome.	0
@MiRNA$ expression level was significantly related to several clinicopathological features of @DISEASE$.	1
@MiRNA$ 506 regulates expression of PPAR alpha in hydroxycamptothecin-resistant human @DISEASE$ cells.	1
Using transiently transfected murine neuronal N2a cells in culture, in parallel to a mouse model of AD, we were able to demonstrate a role for two @MiRNA$ (miR-298 and miR-328) in the regulation of beta-amyloid (Abeta) precursor protein (APP)-converting enzyme (@DISEASE$ ) messenger RNA (mRNA) translation, thereby providing key insights into the molecular basis underlying BACE deregulation in AD.	0
Differential regulation of interleukin-1 receptor-associated kinase-1 (@MiRNA$ ) and IRAK-2 by @DISEASE$ and NF-kappaB in stressed human astroglial cells and in Alzheimer disease.	1
Our findings suggest a functional collaboration between the @MiRNA$ approximately 92 cluster and the @DISEASE$ signaling pathway in the development of MBs in mouse and man.	0
@MiRNA$ 1 downregulated in six solid @DISEASE$ types by PAM and SAM (Volinia et al., 2006).	1
In CGNPs, the Shh effector @MiRNA$, but not Gli1, induced @DISEASE$ expression.	1
METHODS AND FINDINGS: To explore the role of miRNAs in schizophrenia, 59 microRNA genes on the X-chromosome were amplified and sequenced in males with (193) and without (191) schizophrenia spectrum disorders to test the hypothesis that ultra-rare mutations in @MiRNA$ collectively contribute to the risk of @DISEASE$.	0
An NF-kappaB-sensitive @MiRNA$ -mediated inflammatory circuit in @DISEASE$ and in stressed human brain cells.	0
@MiRNA$ Induces Androgen-Independent Growth @DISEASE$ Cells by Suppressing Expression of Tissue Factor Pathway Inhibitor TFPI-2.	1
Repression of the @MiRNA$ by oncogenic Ras initiates a @DISEASE$ promoting feed-forward pathway.	1
The abrogation of the HOXB7/PBX2 complex induces apoptosis in @DISEASE$ through the @MiRNA$ 222-c-FOS pathwa.	1
We recently showed in HeLa cells that two components of the @MiRNA$ complex, Gemin3 and Gemin4, together with the argonaute protein eIF2C2, also associate with microRNAs (@DISEASE$ ) as part of a novel class of RNPs termed miRNPs.	0
Moreover, specific @MiRNA$ subsets may have potential diagnostic and prognostic values in some @DISEASE$.	0
miR-15a and @MiRNA$ function by targeting multiple oncogenes, including @DISEASE$, MCL1, CCND1, and WNT3A.	1
Downregulation of @MiRNA$ is a potent prognostic marker for patients with @DISEASE$.	1
There were no differences between miRNA expression and @MiRNA$ size as well as @DISEASE$ expression and ratio of remission after surgery, except in patients presenting lower miR-141 expression who showed a better chance of remission.	0
miR-15a and @MiRNA$ function by targeting multiple oncogenes, including BCL2, MCL1, CCND1, and @DISEASE$.	1
Predictive @MiRNA$ could be potentially useful diagnostic markers, improving the classification of @DISEASE$.	0
RESULTS: We found underexpression of miR-145 (2.0-fold; P = 0.04), miR-21 (2.4-fold; P = 0.004), miR-141 (2.6-fold; P = 0.02), let-7a (3.3-fold; P = 0.003), @MiRNA$ (3.8-fold; P = 0.04), miR-15a (4.5-fold; P = 0.03), miR-16 (5.0-fold; P = 0.004), and miR-143 (6.4-fold; P = 0.004) in @DISEASE$ when compared to normal pituitary tissues.	1
MicroRNA (miRNA) expression was assessed in human cerebral cortical gray matter (GM) and white matter (WM) in order to provide the first insights into the difference between GM and WM @MiRNA$ repertoires across a range of Alzheimer's disease (@DISEASE$ ) pathology.	0
Downregulation of @MiRNA$ in tissue, but not in serum, is a novel biomarker of malignant transformation in @DISEASE$.	1
Our microarray based analysis of microRNA expression in rat cerebral cortex after @MiRNA$ has shown that some microRNA such as @DISEASE$ could be involved in the intricate process of TBI course.	0
@MiRNA$ functions as a tumor suppressor in human @DISEASE$ T24 cell.	1
Down-regulation of @MiRNA$ Induces Differentiation of Chemoresistant @DISEASE$ Cells and Enhances Susceptibility to Therapeutic Regimen.	1
Oxidative stress activation of @MiRNA$ is part of the molecular switch for @DISEASE$ manifestation.	1
@MiRNA$ regulates hexokinase 2 expression in @DISEASE$ cells.	1
Downregulation of @MiRNA$ which controls differentiation of smooth muscle cells, promotes @DISEASE$ formatio.	1
Rapamycin inhibits human @DISEASE$ cell proliferation through down-regulating mammalian target of rapamycin pathway and up-regulating @MiRNA$.	1
@MiRNA$ modulates endothelial SDF-1 expression and mobilization of Sca-1+/Lin- progenitor cells in @DISEASE$.	1
miR-15a and @MiRNA$ function by targeting multiple oncogenes, including BCL2, MCL1, @DISEASE$, and WNT3A.	1
Downregulation of @MiRNA$ sensitizes @DISEASE$ cells to temozolomide by regulating apoptosis independently of p53 status.	1
Here, we show that 30 @MiRNA$ are differentially expressed between normal pituitary and @DISEASE$.	1
Using transiently transfected murine neuronal N2a cells in culture, in parallel to a mouse model of AD, we were able to demonstrate a role for two miRNAs (miR-298 and @MiRNA$ ) in the regulation of beta-amyloid (Abeta) precursor protein (APP)-converting enzyme (@DISEASE$ ) messenger RNA (mRNA) translation, thereby providing key insights into the molecular basis underlying BACE deregulation in AD.	1
Re-expression of @MiRNA$ reverses both tamoxifen resistance and accompanying EMT-like properties in @DISEASE$.	1
@MiRNA$ as a Prognostic Marker for @DISEASE$ Progression and Patient Surviva.	1
Orthologous @MiRNA$ genes are located in @DISEASE$ -associated genomic regions in human and mouse.	0
Together, the coordinated application of miRNA profiling, Affymetrix microarrays, new bioinformatics predictions, in situ hybridization, and biochemical validation indicate that @MiRNA$ may be involved in accelerated disease progression through regulation of @DISEASE$.	1
Restoration of @MiRNA$ expression induces cell apoptosis in @DISEASE$ cell lines.	1
@MiRNA$ is highly expressed and possibly transactivated by achaete-scute complex homolog 1 in @DISEASE$.	1
@MiRNA$ functions as a tumour suppressor in human @DISEASE$.	1
Interestingly, one of these, the bifunctional brain enriched @MiRNA$ /miR-9*, targets two components of the REST complex: miR-9 targets @DISEASE$ and miR-9* targets CoREST.	0
Down-regulation of @MiRNA$ by low p73 contributes to the androgen-independence @DISEASE$ cell.	1
CD47 expression regulated by the @MiRNA$ tumor suppressor is a novel prognostic marker in esophageal @DISEASE$.	1
@MiRNA$ Directs a Wnt Signaling Circuit to Promote Differentiation of Osteoblasts and Osteomimicry of Metastatic @DISEASE$ Cell.	1
@MiRNA$ Expression is down-regulated in estrogen receptor alpha-positive human @DISEASE$.	1
@MiRNA$ inhibits human @DISEASE$ chemotherapy resistance by regulating TWF1 and IL-1.	1
Furthermore, new therapeutic strategies involving @MiRNA$ silencing or miRNA mimics could be proposed based on the roles of these small non-coding RNAs as oncogenes and tumor suppressors in @DISEASE$.	0
Tumorigenicity of @DISEASE$ stem-like cells derived from hepatocarcinoma is regulated by @MiRNA$.	1
@MiRNA$ represses c-kit expression and functions as a methylation-silenced tumor suppressor in @DISEASE$.	1
High @MiRNA$ associated with poor prognosis in @DISEASE$ (Yanaihara et al., 2006).	1
The present study provides an initial survey of @MiRNA$ expression in pediatric central nervous system (CNS) malignancies including atypical teratoid/rhabdoid tumor, ependymoma, glioblastoma, medulloblastoma, and @DISEASE$.	0
Computational target gene prediction revealed pyruvate kinase type M2 (@MiRNA$ ) as another target of @DISEASE$.	1
@MiRNA$ rs11614913 were associated with increased risk @DISEASE$ in Chinese wome.	1
@MiRNA$ inhibits cell proliferation, migration and invasion in @DISEASE$ cells by targeting the epidermal growth factor receptor.	1
Expression of NPAS3 in the Human Cortex is regulated by @MiRNA$ During Development and has Implications for @DISEASE$.	1
Pre-@MiRNA$ and pre-miR-630 consistently modulated mitochondrial/postmitochondrial steps of the intrinsic pathway of apoptosis, including Bax oligomerization, mitochondrial transmembrane potential dissipation, and the proteolytic maturation of @DISEASE$ and caspase-3.	1
Pharmacologic and genetic inhibition of p53 corroborated the hypothesis that pre-miR-630 (but not pre-@MiRNA$ ) blocks the upstream signaling pathways that are ignited by DNA damage and converge on @DISEASE$ activation.	0
@MiRNA$ Induces Cell Survival and Cisplatin Resistance through PI3K/Akt Pathway in Human @DISEASE$.	1
Medulloblastomas in which @MiRNA$ was up-regulated also had elevated levels of MYC/@DISEASE$ expression.	1
In @DISEASE$ cells, @MiRNA$ expression is decreased.	1
We show that the expression of miR-34a is inversely correlated with the protein level of @MiRNA$ in APPswe/PSDeltaE9 mice and age-matched controls, and @DISEASE$ expression directly inhibits bcl2 translation in SH-SY5Y cells.	0
ACVR1, a Therapeutic Target of @DISEASE$ Is Negatively Regulated by @MiRNA$.	1
@MiRNA$ Suppresses The Growth and Invasiveness of @DISEASE$ Cells by Targeting UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 7.	1
Propofol inhibits the adhesion of @DISEASE$ cells by upregulating @MiRNA$ and downregulating MMP-9 expression.	1
@MiRNA$ confers resistance of @DISEASE$ to radiation therapy through targeting the pro-apoptotic PRKCD gene.	1
@MiRNA$ targets CHL1 and promotes cell growth, migration and invasion in human @DISEASE$ cells.	1
This is particularly true for the role of microRNAs in gliomagenesis, as an appreciation for the significance of aberrant @MiRNA$ expression in human @DISEASE$ has only emerged in the last 5 years.	0
@MiRNA$ profiling was performed using brain tissue from patients with HIV encephalitis (@DISEASE$ ), a neuroinflammatory/degenerative disorder caused by HIV infection of the brain.	0
A genetic variant in @MiRNA$ modifies @DISEASE$ susceptibility in a chinese populatio.	1
@MiRNA$ : Implications for @DISEASE$ and other Human CNS Disorders.	0
We additionally recovered miRNAs from cerebrospinal fluid and discovered @MiRNA$ -specific @DISEASE$ changes consistent with their role as potential biomarkers of disease.	0
@MiRNA$ negatively regulates the androgen receptor and is associated with adverse outcome @DISEASE$ patient.	1
The present review examines the various @MiRNA$ that have been identified as being potentially involved in T2D, focusing on the insulin-sensitive organs: white adipose tissue, liver, skeletal muscle and the @DISEASE$ -producing pancreatic β-cells.	0
@MiRNA$ is also expressed highly in the skin of @DISEASE$ patients.	1
Re-expression of @MiRNA$ induces EBV-positive @DISEASE$ differentiation by modulating c-Myb in vitr.	1
Dual downregulation of @MiRNA$ 17-5p and E2F1 transcriptional factor in pediatric @DISEASE$ patient.	1
Lack of miRNAs in post-mitotic neurons in vivo is associated with @MiRNA$ exons 7 and 8 inclusion, while ectopic expression of miR-124, an abundant neuronal-specific @DISEASE$, reversed these effects in cultured neurons.	0
@MiRNA$ promotes natural killer cell cytotoxicity against human @DISEASE$ cells by targeting the transcription factor HMBOX1.	1
We examined if plasma @MiRNA$ levels are altered in patients with traumatic brain injury (@DISEASE$ ) relative to matched healthy volunteers, and explored their potential for use as diagnostic TBI biomarkers.	0
Finally, we provide evidence for a potential causal relationship between @MiRNA$ expression and @DISEASE$ generation in a cell culture model.	0
Furthermore, microinfusion of lentiviral vectors that contained @MiRNA$ (miRNAs) targeting long-form PDE4D isoforms into bilateral dentate gyri of the mouse hippocampus downregulated PDE4D4 and PDE4D5, enhanced memory, and increased hippocampal neurogenesis and @DISEASE$.	0
CONCLUSIONS: Further studies are needed to evaluate the possible use of @MiRNA$ as biomarkers in @DISEASE$ and related pathologies.	0
Our research revealed that 136 miRNAs were expressing at 6 h post injury, in which 13 miRNAs were more than 2-fold up-regulated, and 14 miRNAs were more than 2-fold down-regulated; 118 miRNAs were expressing at 24 h post @MiRNA$, in which 4 miRNAs were more than 2-fold up-regulated, and 23 miRNAs were more than 2-fold down-regulated; 149 miRNAs were expressing at 48 h post injury, in which 16 miRNAs were more than 2-fold up-regulated, and 11 miRNAs were more than 2-fold down-regulated; and 203 miRNAs were expressing at 72 h post injury, in which 19 @DISEASE$ were more than 2-fold up-regulated, and 5 miRNAs were more than 2-fold down-regulated.	0
@MiRNA$ a member of the oncogenic miR?17?92 cluster, targets Dicer and suppresses cell proliferation in @DISEASE$ T24 cells.	1
The family of miR-64 and @MiRNA$ -65 are co-underexpressed in the alpha-synuclein transgenic and cat-1 strains, and members of let-7 family co-underexpressed in the alpha-synuclein and pdr-1 strains; mdl-1 and ptc-1 genes are target candidates for miR-64 and miR-65 and are overexpressed in @DISEASE$ transgenic as well as miR-64/65 (tm3711) knockout animals.	0
Aberrant gene expression is the main mechanism of @MiRNA$ dysfunction in cancer, with abnormal expression levels of mature and/or precursor miRNA expression in @DISEASE$ samples versus normal.	0
@MiRNA$ regulates of placenta growth factor in @DISEASE$.	1
Upregulation of @MiRNA$ confers a poor prognosis in @DISEASE$ patient.	1
The present study provides an initial survey of @MiRNA$ expression in pediatric central nervous system (CNS) malignancies including atypical teratoid/rhabdoid tumor, @DISEASE$, glioblastoma, medulloblastoma, and pilocytic astrocytoma.	0
Moreover, the performance of three algorithms (PicTar, TargetScan and DIANA-microT) is both demonstrated and evaluated by performing an in-depth analysis of @MiRNA$ interactions with mRNAs derived from genes triggering hereditary neurological disorders known as trinucleotide repeat expansion diseases (TREDs), such as Huntington's disease (HD), a number of @DISEASE$ (SCAs), and myotonic dystrophy type 1 (DM1).	0
Results Identified are six molecular subgroups of medulloblastoma, each with a unique combination of numerical and structural @MiRNA$ that globally influence mRNA and @DISEASE$ expression.	0
Furthermore, microinfusion of lentiviral vectors that contained microRNAs (@MiRNA$ ) targeting long-form PDE4D isoforms into bilateral dentate gyri of the mouse hippocampus downregulated PDE4D4 and @DISEASE$, enhanced memory, and increased hippocampal neurogenesis and pCREB.	1
@MiRNA$ inhibits cell proliferation by repressing DeltaNp63 expression in human esophageal @DISEASE$.	1
@MiRNA$ downregulation in @DISEASE$ has implications for both neurodevelopment and adult brain function.	1
The Role of @MiRNA$ in MDM2-p53 Pathway Signaling and @DISEASE$ Progressio.	1
Systemic @MiRNA$ delivery induces apoptosis and abrogates growth of @DISEASE$ in vivo.	1
While mice with control implants expressing a scrambled @MiRNA$ sequence or sham treated control animals were characterized by KA-induced status epilepticus and subsequent CA3 neuronal cell loss, animals with therapeutic @DISEASE$ knockdown implants displayed a 35% reduction in seizure duration and 65% reduction in CA3 neuronal cell loss, when analyzed 24 h after KA-injection.	0
increased expression of @MiRNA$ in an acquired model of docetaxel resistance in @DISEASE$.	1
@MiRNA$ was significantly up-regulated in primary @DISEASE$ specimens relative to CD133+ NSCs (Neural Stem Cells).	1
RESULTS: We report here that BACE1-antisense prevents @MiRNA$ -induced repression of @DISEASE$ mRNA by masking the binding site for miR-485-5p.	1
@MiRNA$ : Implications for Alzheimer Disease and other Human @DISEASE$.	0
@MiRNA$ mediated inhibition of @DISEASE$.	1
@MiRNA$ expression in @DISEASE$ blood mononuclear cells.	0
Finally, we suggested several single nucleotide polymorphisms (SNPs) located on @MiRNA$, their target sites, and TFBSs, which may have an effect in @DISEASE$ gene regulation.	0
This review summarizes the discovery, functions, and clinical relevance of these @MiRNA$ in @DISEASE$, particularly CLL.	0
Silencing of @MiRNA$ in human @DISEASE$ by allelic loss and interleukin-6 induced maternal to paternal epigenotype switc.	1
@MiRNA$ is activated by ASH1 and inhibits YAP1 in a lineage dependent manner in @DISEASE$.	1
Strikingly, cells with high levels of PKM2 expressed lower levels of @MiRNA$, suggestive of endogenous regulation of @DISEASE$ by miR-326.	0
Similar results were obtained by depletion of endogenous @MiRNA$ 1 (PTBP1) in cells, a recognized @DISEASE$ target gene.	1
@MiRNA$ up-regulated in @DISEASE$ compared with endometrium.	1
Using transiently transfected murine neuronal N2a cells in culture, in parallel to a mouse model of AD, we were able to demonstrate a role for two miRNAs (@MiRNA$ and miR-328) in the regulation of beta-amyloid (Abeta) precursor protein (APP)-converting enzyme (@DISEASE$ ) messenger RNA (mRNA) translation, thereby providing key insights into the molecular basis underlying BACE deregulation in AD.	1
Downregulation of Pdcd4 by @MiRNA$ facilitates @DISEASE$ proliferation in vivo.	1
This @MiRNA$ is a potent tumor suppressor molecule in vivo in @DISEASE$.	1
Among the predicted targets of dysregulated @MiRNA$ are genes that are known genetic causes of autism such Neurexin and @DISEASE$.	1
Here we show that the highly malignant human brain tumor, @MiRNA$, strongly over-expresses a specific @DISEASE$, miR-21.	1
Inhibition of two @MiRNA$ -upregulated miRNAs (miR-21 and miR-23a) and exogenous overexpression of two glioblastoma-downregulated miRNAs (@DISEASE$ and miR-219-5p) resulted in reduced soft agar colony formation but showed varying effects on cell proliferation and chemosensitivity.	0
@MiRNA$ regulates the proliferation of @DISEASE$ cells by targeting Cdc4.	1
The increased and persistent expression of @MiRNA$ in reactive astrocytes supports the possible involvement of miRNAs in the modulation of the astroglial inflammatory response occurring in @DISEASE$ and provides a target for future studies aimed at developing strategies against pro-epileptogenic inflammatory signalling.	1
Inhibition of two @MiRNA$ -upregulated miRNAs (miR-21 and @DISEASE$ ) and exogenous overexpression of two glioblastoma-downregulated miRNAs (miR-218 and miR-219-5p) resulted in reduced soft agar colony formation but showed varying effects on cell proliferation and chemosensitivity.	1
Moreover, LPS stimulation decreased expression of microRNAs (miRNA)--miR-17-5, miR-20a, and @MiRNA$ --which target @DISEASE$, implicating a novel role for miRNAs in NKG2D ligand expression.	1
Moreover, LPS stimulation decreased expression of microRNAs (@MiRNA$ )--miR-17-5, miR-20a, and miR-93--which target @DISEASE$, implicating a novel role for miRNAs in NKG2D ligand expression.	1
Here we report the coordinated miRNA expression analysis from the tissue level to the subcellular level, using the RAKE (RNA-primed, array-based, Klenow Enzyme) @MiRNA$ microarray platform in conjunction with Locked Nucleic Acid (LNA)-based in situ hybridization (LNA-ISH) on archival FFPE human brains and @DISEASE$.	0
Targeted Delivery of @MiRNA$ by Transferrin Conjugated Anionic Lipopolyplex Nanoparticles: A Novel Therapeutic Strategy in @DISEASE$.	1
Genetic and epigenetic loss of @MiRNA$ leads to feed-forward expression of EZH2 in @DISEASE$.	1
The @MiRNA$ concentration increased in the plasma of rats 8 h after surgery to produce @DISEASE$ and peaked at 24 h, while the miR-122 and miR-133a concentrations remained at baseline values.	1
@MiRNA$ targets N-deacetylase/N-sulfotransferase 1 and promotes cell growth in human @DISEASE$ cell line MGC803.	1
Interestingly the gene locus of one @MiRNA$, miR-175, is a candidate region for two neurologic diseases: early-onset parkinsonism (@DISEASE$ ) and X-linked mental retardation (MRX3).	1
To investigate whether it might be a functionally important target of @MiRNA$, we used RNA interference to knockdown PKM2 expression in @DISEASE$ cells.	0
Objective: The aim of the study was to analyze the differential expression of let-7a, miR-15a, miR-16, miR-21, @MiRNA$, miR-143, miR-145, and miR-150 in corticotropinomas and normal pituitary tissue and verify whether their profile of expression correlates with @DISEASE$ size or remission after treatment.	0
We show here that @MiRNA$ can regulate @DISEASE$ expression in vitro.	1
@MiRNA$, a master inhibitor of the cell cycle, is down-regulated in human @DISEASE$.	1
@DISEASE$ B virus X protein downregulates expression of the @MiRNA$ in malignant hepatocytes in vitro.	1
The many roles of @MiRNA$ in @DISEASE$ biology.	0
@MiRNA$ expression is known to be deregulated in various cancers and has been found to be useful in predicting @DISEASE$ behavior.	0
@MiRNA$ functions as a selective killer of @DISEASE$.	1
Because of its known connection to glioma biology, we focused on @MiRNA$ among seven miRNAs influenced by @DISEASE$.	0
Stat3-mediated activation of @MiRNA$ suppresses gluconeogenesis in @DISEASE$ by downregulating G6PC and PGC-1.	1
A variant ( rs11614913 ) in @MiRNA$ is not associated with susceptibility to and progression of @DISEASE$ in Chinese.	1
Interpretation and applicability of @MiRNA$ data to the context of @DISEASE$ and age-related diseases.	0
Western blot analysis demonstrated that PTEN and @MiRNA$ were involved in @DISEASE$ -mediated cellular effects.	0
@MiRNA$ is up-regulated in subcutaneous adipose tissue in human @DISEASE$.	1
TGFbeta-Stimulated @MiRNA$ Utilizes PTEN to Orchestrate AKT/mTORC1 Signaling for Mesangial Cell @DISEASE$ and Matrix Expansion.	1
We did reporter assays to elucidate the IFN-beta-mediated suppression of miR-21; the addition of signal transducers and activators of transcription 3 (@MiRNA$ )-expressing vectors induced the IFN-beta-mediated suppression of @DISEASE$, whereas STAT3-inhibiting agents inhibited the miR-21 suppression.	0
Moreover, the performance of three algorithms (PicTar, TargetScan and DIANA-microT) is both demonstrated and evaluated by performing an in-depth analysis of @MiRNA$ interactions with mRNAs derived from genes triggering hereditary neurological disorders known as trinucleotide repeat expansion diseases (TREDs), such as Huntington's disease (HD), a number of spinocerebellar ataxias (SCAs), and myotonic dystrophy type 1 (@DISEASE$ ).	0
Eight ultra-rare variants in the precursor or mature @MiRNA$ were identified in eight distinct miRNA genes in 4% of analyzed males with @DISEASE$.	0
@MiRNA$ targets BNIP3 and suppresses @DISEASE$ progression.	1
@MiRNA$ affects @DISEASE$ induced by anti-benzo(a) pyrene-7,8-diol-9,10-epoxid.	1
Upregulation of @MiRNA$ increases the sensitivity @DISEASE$ cells to Adriamycin treatment through inhibition of Raf-1.	1
@MiRNA$ inhibits human brain @DISEASE$ cell growth by down-regulation of Notch1.	1
The analysis of the upstream regulatory regions in co-regulated miRNAs suggests a role for RE1-Silencing Transcription Factor (@MiRNA$ ) and P53 in @DISEASE$ downregulation in HD.	1
The analysis of the upstream regulatory regions in co-regulated @MiRNA$ suggests a role for RE1-Silencing Transcription Factor (REST) and @DISEASE$ in miRNAs downregulation in HD.	0
Fork head box M1 is overexpressed in Helicobacter pylori-induced gastric @DISEASE$ and is negatively regulated by @MiRNA$.	1
Using luciferase reporter assays with 3'-UTRs of @MiRNA$, over-expression and inhibition of @DISEASE$, we showed that miR-146a targets TBP.	0
@MiRNA$ regulates tumorigenic properties of EZH2 in human lung @DISEASE$ cells.	1
@MiRNA$ inhibits tumor cell migration through down-regulating the expression of the @DISEASE$.	1
@MiRNA$ inhibitor sensitizes human @DISEASE$ U251 stem cells to chemotherapeutic drug temozolomide.	1
Cell culture reporter assays performed with a subset of the predicted miR-107 binding sites indicate the presence of at least one physiological miR-107 miRNA rec@MiRNA$ n sequence in the 3'-UTR of BACE1 mRN@DISEASE$.	1
@MiRNA$ targets the L1 cell adhesion molecule and suppresses the metastatic potential of @DISEASE$.	1
@MiRNA$ targets the tumor suppressor RhoB and regulates proliferation, invasion and apoptosis in @DISEASE$ cells.	1
@MiRNA$ chemo-sensitizes @DISEASE$ cells to cisplatin treatment regardless of P53-Rb pathway status.	1
Here, we show that 12 specific @MiRNA$ are differentially regulated in the animals overexpressing @DISEASE$, five in cat-1, and three in the pdr-1 mutants.	1
This is a rapidly evolving field and it is likely that we have only begun to appreciate the involvement of microRNAs in relation to @MiRNA$ formation, and the therapeutic potential of @DISEASE$ to improve outcome for glioma patients.	0
Here we show that the highly malignant @MiRNA$, glioblastoma, strongly over-expresses a specific miRNA, @DISEASE$.	1
@MiRNA$ reverses high invasiveness of @DISEASE$ cells by targeting the oncogenic transcription factor LEF1.	1
In situ localization of @MiRNA$ transcripts indicates widespread expression in normal brain, with a pronounced increase in expression after @DISEASE$ evident throughout the cortex and hippocampus, including the dentate gyrus and CA3 cell layer.	1
@MiRNA$ regulated TLR9 signaling-enhanced growth and metastatic potential of human @DISEASE$ cells by altering the phosphoinositide-3-kinase, regulatory subunit 3/Akt pathwa.	1
BACKGROUND: The aberrant expression of @MiRNA$ (miRNAs) is associated with a variety of diseases including @DISEASE$.	0
Elevated cardiac-specific @MiRNA$ in plasma may be a novel biomarker for early detection of myocardial @DISEASE$ in human.	1
In both HIV associated dementia in humans and its monkey model SIV @MiRNA$ we find @DISEASE$, a miRNA largely known for its link to oncogenesis, to be significantly upregulated in the brain.	1
Pleiotropic effects of @MiRNA$ converge to regulate cell survival, proliferation and migration in @DISEASE$.	1
To search for miRNAs that may be involved in the pathogenesis of Parkinsons disease (@MiRNA$ ), we utilized miRNA microarrays to identify potential gene expression changes in 115 annotated @DISEASE$ in PD-associated Caenorhabditis elegans models that either overexpress human A53T alpha-synuclein or have mutations within the vesicular catecholamine transporter (cat-1) or parkin (pdr-1) ortholog.	0
Our research revealed that 136 miRNAs were expressing at 6 h post injury, in which 13 miRNAs were more than 2-fold up-regulated, and 14 miRNAs were more than 2-fold down-regulated; 118 miRNAs were expressing at 24 h post injury, in which 4 miRNAs were more than 2-fold up-regulated, and 23 miRNAs were more than 2-fold down-regulated; 149 miRNAs were expressing at 48 h post injury, in which 16 @MiRNA$ were more than 2-fold up-regulated, and 11 miRNAs were more than 2-fold down-regulated; and 203 miRNAs were expressing at 72 h post @DISEASE$, in which 19 miRNAs were more than 2-fold up-regulated, and 5 miRNAs were more than 2-fold down-regulated.	0
The @MiRNA$ -145 cluster regulates plasminogen activator inhibitor-1 in @DISEASE$.	1
In monocytes, increased expression of an NF-κB-regulated @MiRNA$ down-regulates expression of the interleukin-1 receptor-associated kinase-1 (@DISEASE$ ), an essential component of Toll-like/IL-1 receptor signaling.	1
@MiRNA$ germline and somatic mutations or polymorphisms in the protein coding messenger RNA targeted by miRNAs may also occur, contributing to @DISEASE$ predisposition, initiation and/or progression.	0
METHODS: We investigated the use of liver-, muscle- and brain-specific @MiRNA$ as circulating biomarkers of @DISEASE$.	0
In this review article, the molecular mechanisms underlying the role and function of @MiRNA$ in the regulation of genes involved in neurological and neurodegenerative diseases will be discussed, with a focus on the fragile X syndrome, Alzheimer's disease (AD) and @DISEASE$.	0
HER2 Interacts with CD44 to Upregulate CXCR4 via Epigenetic Silencing of @MiRNA$ in @DISEASE$ Cells.	1
Recent studies report that @MiRNA$ is negatively regulated by the @DISEASE$ microRNAs (miRNAs) family in vitro.	1
Upregulation of @MiRNA$ increases cisplatin sensitivity of @DISEASE$ cell line (A549).	1
@MiRNA$ may be a new therapeutic target for proliferative @DISEASE$ such as atherosclerosis, postangioplasty restenosis, transplantation arteriopathy, and stroke.	1
Emerging studies have identified microRNAs (@MiRNA$ ) as possible therapeutic tools for the treatment of glioma, the most aggressive @DISEASE$.	0
The @MiRNA$ Regulates Hypoxic @DISEASE$ by Targeting at Insulin Growth Factor 1 Receptor and L-Type Calcium Channel-α1C.	1
These results provide information about marker @MiRNA$ that may lead to further insights into the regulation of @DISEASE$ growth and development.	0
CONCLUSIONS/SIGNIFICANCE: We provide a list of ten @MiRNA$ loci potentially involved in the development of blood cancer or @DISEASE$.	0
@MiRNA$ differentially expressed in @DISEASE$.	1
Here, we define a typical human meningioma microRNA (miRNA) profile and characterize the effects of one downregulated miRNA, miR-200a, on tumor growt@MiRNA$.	1
A direct correlation was found between the downregulation of @MiRNA$ and the upregulation of beta-catenin in human @DISEASE$ samples.	1
Finally, we demonstrate that @MiRNA$ -mediated PTEN repression in a murine glioma model both enhances de novo tumor formation and precludes loss of heterozygosity and the @DISEASE$ locus.	0
LRRC4 inhibits @DISEASE$ cell growth and invasion through a @MiRNA$ dependent pathway.	1
Human adipose @MiRNA$ is upregulated in @DISEASE$ and affects fat metabolism downstream of leptin and TNF-alph.	1
A cyclin D1/@MiRNA$ 17/20 regulatory feedback loop in control @DISEASE$ cell proliferation.	1
@MiRNA$ 1 expression correlates with poor survival @DISEASE$ patient.	1
We did reporter assays to elucidate the IFN-beta-mediated suppression of miR-21; the addition of signal transducers and activators of transcription 3 (STAT3)-expressing vectors induced the @MiRNA$ -mediated suppression of @DISEASE$, whereas STAT3-inhibiting agents inhibited the miR-21 suppression.	1
We studied the expression of selected @MiRNA$ following infection of CBA mice with Plasmodium berghei ANKA (PbA), which causes @DISEASE$ (CM), or Plasmodium berghei K173 (PbK), which causes severe malaria but without cerebral complications, termed non-CM.	0
Pharmacologic and genetic inhibition of @MiRNA$ corroborated the hypothesis that pre-@DISEASE$ (but not pre-miR-181a) blocks the upstream signaling pathways that are ignited by DNA damage and converge on p53 activation.	0
To investigate the involvement of let-7i, @MiRNA$, and miR-150 in CM-resistant mice, we assessed the expression levels in @DISEASE$ knockout (IFN-γ(-/-)) mice on a C57BL/6 genetic background.	0
Administration of apoptotic bodies or @MiRNA$ limited @DISEASE$.	1
@MiRNA$ suppresses the proliferation of @DISEASE$ cells via directly targeting ERK1.	1
@MiRNA$ 218 acts as a tumor suppressor by targeting multiple cancer phenotype associated genes in @DISEASE$.	1
Exposure of SH-SY5Y cells to Aβ42 oligomers led to the expression of @MiRNA$ was first increased and then decreased and @DISEASE$ levels reduced.	0
Inhibition of @MiRNA$ Improves Lung and Heart Function in Experimental @DISEASE$.	1
@MiRNA$ Sensitizes @DISEASE$ Cells to Doxorubicin Treatment by Decreasing TrkB and Bmi1 Expressio.	1
Both hsa-miR-15b and @MiRNA$ have several predicted gene targets involved in @DISEASE$ and T-cell activation pathways.	0
Finally, while rolipram and @MiRNA$ deficiency shortened α2 adrenergic receptor-mediated anesthesia, a surrogate measure of emesis, @DISEASE$ -mediated PDE4D knock-down in the hippocampus did not.	0
A number of miRNAs like miR-193a, miR-224/miR-452 cluster, miR-182/miR-183/miR-96 cluster, and @MiRNA$ having potential tumor/metastasis suppressive activity were found to be overexpressed in the WNT signaling associated @DISEASE$.	1
To investigate this possibility we compared the expression of 264 human miRNAs from postmortem prefrontal cortex tissue of individuals with @MiRNA$ (n = 13) or schizoaffective disorder (n = 2) to tissue of 21 psychiatrically unaffected individuals using a custom @DISEASE$ microarray.	0
@MiRNA$ is silenced by hypermethylation and interacts with DNA methyltransferase 1 in @DISEASE$.	1
@MiRNA$ regulates the expression of @DISEASE$ related leucine-rich repeat kinase 2 protei.	1
MiRNAs microarray analysis results showed that 125 @MiRNA$ were detected in the hippocampus of lithium-pilocarpine-induced @DISEASE$ rats and normal rats.	0
@MiRNA$ targets zyxin and promotes cell motility in human laryngeal @DISEASE$ cell line HEp-2.	1
CIS-associated miRNAs on average are more conserved in vertebrates than @MiRNA$ associated with non-CIS inserts and their human homologs are also located in regions perturbed in @DISEASE$.	0
We regressed gene expression on @MiRNA$ expression in 237 @DISEASE$ tissues and 10 normal tissues comprehensively.	0
Emerging studies have identified @MiRNA$ (miRNAs) as possible therapeutic tools for the treatment of glioma, the most aggressive @DISEASE$.	0
@MiRNA$ targets an anti-apoptotic gene, Bcl-w, in human @DISEASE$ cell lines.	1
@MiRNA$ plans an oncogenic role in human @DISEASE$ (T-ALL) by targeting glucocorticoid receptor-α and cAMP/PKA pathways.	1
@MiRNA$ and miR-16-1 function by targeting multiple oncogenes, including BCL2, MCL1, CCND1, and @DISEASE$.	1
Infection with MB cells in an induced xenograft model in the mouse cerebellum and the use of an adenovirus carrying @MiRNA$ indicate a clinical benefit through this negative influence of miR-199b-5p on @DISEASE$ growth and on the subset of MB stem-cell-like cells, providing further proof of concept.	0
Indeed, @MiRNA$ and BACE1-antisense compete for binding within the same region in the open reading frame of the @DISEASE$ mRNA.	0
MiR-107 is a @MiRNA$ (miRNA) that we reported previously to have decreased expression in the temporal cortical gray matter early in the progression of @DISEASE$ (AD).	1
Over-expression of these @MiRNA$, but not control miRNAs, results in translational repression of @DISEASE$ mRNA and significantly reduces APP protein levels.	1
CONCLUSIONS/SIGNIFICANCE: We provide a list of ten @MiRNA$ loci potentially involved in the development of blood @DISEASE$ or brain tumors.	0
We performed a large-scale, genome-wide microRNA (miRNA) (n=756) expression profiling of 26 glioblastoma, 13 anaplastic astrocytoma and 7 normal brain samples with an aim to find deregulated @MiRNA$ in malignant @DISEASE$.	0
Thus, the results of our study show that the downregulation of @MiRNA$ contributes to the antitumor effects of @DISEASE$ and that miR-21 expression is negatively regulated by STAT3 activation.	1
Computational analysis predicted that the 3'-untranslated region (UTR) of @MiRNA$ (BACE1) mRNA is targeted multiply by @DISEASE$.	1
To date, this is the first report that expression of a @MiRNA$ can deplete the tumor stem cells, indicating an interesting therapeutic approach for the targeting of these cells in @DISEASE$.	0
@MiRNA$ inhibits cell growth in @DISEASE$ through suppression of beta-cateni.	1
this is the first report documenting that downregulation of @MiRNA$ is through DNA methylation and p53 mutation pathways in @DISEASE$.	1
This is a rapidly evolving field and it is likely that we have only begun to appreciate the involvement of @MiRNA$ in relation to glioma formation, and the therapeutic potential of microRNAs to improve outcome for @DISEASE$ patients.	0
A risk variant in an @MiRNA$ binding site in BMPR1B is associated with @DISEASE$ pathogenesis.	1
HSV-1 infection of human brain cells induces @MiRNA$ and @DISEASE$ -type inflammatory signaling.	0
Emerging studies have identified @MiRNA$ (miRNAs) as possible therapeutic tools for the treatment of glioma, the most aggressive brain @DISEASE$.	0
The results show the possible use of blood miRNAs as biomarkers for @MiRNA$ ; that selected blood miRNAs may correlate with miRNA changes in the brain; and that many of the mRNAs, previously shown to be regulated in brain and blood after brain injury, are likely accounted for by changes in @DISEASE$ expression.	0
We further show that in a xenograft model, @MiRNA$ burden can be reduced, indicating the use of @DISEASE$ as an adjuvant therapy after surgery, in combination with radiation and chemotherapy, for the improvement of anti-cancer MB therapies and patient quality of life.	0
Unregulated @MiRNA$ Induces Cell Proliferation in Human @DISEASE$ by Downregulating Transcriptional Factor FOXO3a.	1
Time-course assays of neuronal Abeta treatments show that @MiRNA$ is in fact a powerful regulator of @DISEASE$ levels as the response of certain mature miRNAs is extremely rapid.	1
The family of miR-64 and @MiRNA$ are co-underexpressed in the alpha-synuclein transgenic and cat-1 strains, and members of let-7 family co-underexpressed in the alpha-synuclein and pdr-1 strains; mdl-1 and @DISEASE$ genes are target candidates for miR-64 and miR-65 and are overexpressed in alpha-synuclein transgenic as well as miR-64/65 (tm3711) knockout animals.	0
The expression of certain miRNAs correlates with other @MiRNA$ across different cases, and particular subsets of miRNAs are coordinately expressed in relation to @DISEASE$ -related pathology.	0
Using microarray data and real-time PCR we have also identified several candidate transcripts whose expression levels are selectively affected by these @MiRNA$ -@DISEASE$ interactions.	0
MiR-124a expression decreased significantly from 1 day to 7 days after SC@MiRNA$.	1
The family of miR-64 and miR-65 are co-underexpressed in the @MiRNA$ transgenic and cat-1 strains, and members of @DISEASE$ family co-underexpressed in the alpha-synuclein and pdr-1 strains; mdl-1 and ptc-1 genes are target candidates for miR-64 and miR-65 and are overexpressed in alpha-synuclein transgenic as well as miR-64/65 (tm3711) knockout animals.	0
@MiRNA$ have essential functional roles in brain development and neuronal specification but their roles in neurodegenerative diseases such as @DISEASE$ (AD) is unknown.	0
IL6-Mediated Suppression of @MiRNA$ Directs Constitutive Activation of Inflammatory Signaling Circuit Driving Transformation and @DISEASE$.	1
To understand the role of miRNAs in the molecular mechanisms of @MiRNA$ (TLE), we investigated the changes in @DISEASE$ (miRNA) expression profiles of chronic TLE rat models.	0
@MiRNA$ downregulated in @DISEASE$ (Yanaihara et al., 2006).	1
MicroRNAs and their therapeutic potential for human diseases: aberrant @MiRNA$ expression in @DISEASE$ brains.	0
Interestingly, one of these, the bifunctional brain enriched @MiRNA$ /miR-9*, targets two components of the REST complex: miR-9 targets REST and miR-9* targets @DISEASE$.	0
We observed opposing effects of BACE1-antisense and miR-485-5p on @MiRNA$ protein in vitro and showed that Locked Nucleic Acid-antimiR mediated knockdown of @DISEASE$ as well as BACE1-antisense over-expression can prevent the miRNA-induced BACE1 suppression.	0
CONCLUSION: We investigated gene and microRNA Expression in Glioblastoma and gave a comprehensive function study of differential expressed gene and @MiRNA$ in @DISEASE$ patients.	0
@MiRNA$ inhibits Src-mediated oncogenic pathways in @DISEASE$.	1
@MiRNA$ may be a new therapeutic target for proliferative vascular diseases such as @DISEASE$, postangioplasty restenosis, transplantation arteriopathy, and stroke.	1
RESULTS: We identified 32 feed-forward loops (FFLs) among our compiled @MiRNA$ -related @DISEASE$, TFs and genes.	0
@MiRNA$ promotes @DISEASE$ cell proliferation in vitro by inhibiting CDKN1C/p57 expression.	1
In human cell lines, we found that @MiRNA$ down-regulates the expression of @DISEASE$ by targeting sequences in the 3'UTR of LRP1 mRNA.	1
@MiRNA$ regulates the proliferation and invasion of @DISEASE$ by ST7L via beta-catenin/Tcf-4 signalin.	1
@MiRNA$ regulates cell cycle and anoikis of human esophageal @DISEASE$ cells through Rb1-E2F1 signaling pathwa.	1
@MiRNA$ targets HER2 in @DISEASE$ cell.	1
Modulation of mismatch repair and @DISEASE$ by @MiRNA$.	1
The bifunctional microRNA @MiRNA$ /miR-9* regulates REST and @DISEASE$ and is downregulated in Huntington's disease.	1
The most interesting results came from miR-221, strongly up-regulated in glioblastoma and from a set of brain-enriched miRNAs, miR-128, miR-181a, @MiRNA$, and miR-181c, which are down-regulated in @DISEASE$.	1
Our microarray based analysis of @MiRNA$ expression in rat cerebral cortex after @DISEASE$ has shown that some microRNA such as miR-21 could be involved in the intricate process of TBI course.	0
Stem cell marker (Nanog) and Stat-3 signaling promote @MiRNA$ expression and chemoresistance in hyaluronan/CD44-activated head and neck @DISEASE$ cells.	1
Our research revealed that 136 miRNAs were expressing at 6 h post injury, in which 13 miRNAs were more than 2-fold up-regulated, and 14 miRNAs were more than 2-fold down-regulated; 118 miRNAs were expressing at 24 h post injury, in which 4 miRNAs were more than 2-fold up-regulated, and 23 @MiRNA$ were more than 2-fold down-regulated; 149 miRNAs were expressing at 48 h post injury, in which 16 miRNAs were more than 2-fold up-regulated, and 11 miRNAs were more than 2-fold down-regulated; and 203 miRNAs were expressing at 72 h post @DISEASE$, in which 19 miRNAs were more than 2-fold up-regulated, and 5 miRNAs were more than 2-fold down-regulated.	0
Our research revealed that 136 miRNAs were expressing at 6 h post injury, in which 13 miRNAs were more than 2-fold up-regulated, and 14 miRNAs were more than 2-fold down-regulated; 118 @MiRNA$ were expressing at 24 h post @DISEASE$, in which 4 miRNAs were more than 2-fold up-regulated, and 23 miRNAs were more than 2-fold down-regulated; 149 miRNAs were expressing at 48 h post injury, in which 16 miRNAs were more than 2-fold up-regulated, and 11 miRNAs were more than 2-fold down-regulated; and 203 miRNAs were expressing at 72 h post injury, in which 19 miRNAs were more than 2-fold up-regulated, and 5 miRNAs were more than 2-fold down-regulated.	0
Up-Regulation of @MiRNA$ Correlates with Lower @DISEASE$ Survival.	1
One of the most active fields of miR@MiRNA$ search is miRNA regulation of apoptosis, a programmed cell death implicated in many human diseases, such as cancer, Alzheimer's disease, hyp@DISEASE$ d heart failur.	0
@MiRNA$ affects the occurrence of laryngeal @DISEASE$ by targeting the antiapoptotic gene survivin.	1
While @MiRNA$, miR-22* and miR-29 expression levels allowed to distinguish non-treated @DISEASE$ from healthy subjects, miR-16-2*, miR-26a2* and miR30a differentiated treated from untreated patients.	1
To address the broader role for @MiRNA$ in neuroprotection, we also showed that loss of all miRNAs, by @DISEASE$ mutation, dramatically enhances pathogenic polyQ protein toxicity in flies and in human HeLa cells.	0
Finally, we demonstrate that @MiRNA$ -mediated PTEN repression in a murine glioma model both enhances de novo @DISEASE$ formation and precludes loss of heterozygosity and the PTEN locus.	0
Here we test the hypothesis that @MiRNA$ protein levels can be regulated by @DISEASE$, evolutionarily conserved small noncoding RNA molecules that play an important role in regulating gene expression.	0
Stat3 inhibits WTX expression through up-regulation of @MiRNA$ in @DISEASE$.	1
The expression levels of @MiRNA$ and its target VEGFA are inversely correlated in human cutaneous @DISEASE$.	1
RESULTS: MicroRNA-129, @MiRNA$, and miR-25 were differentially expressed in every pediatric @DISEASE$ type compared to normal tissue controls as measured by microarray.	1
A strong positive correlation between @MiRNA$ abundance and the glial cell markers glial fibrillary acidic protein (GFAP) and vimentin, and @DISEASE$ down-regulation was noted in advanced Alzheimer's disease (AD) and in Down's syndrome (DS) brain, chronic neurological disorders associated with astrogliosis.	1
A strong positive correlation between @MiRNA$ abundance and the glial cell markers @DISEASE$ (GFAP) and vimentin, and CDKN2A down-regulation was noted in advanced Alzheimer's disease (AD) and in Down's syndrome (DS) brain, chronic neurological disorders associated with astrogliosis.	1
BACE1 mRNA levels tended to increase as @MiRNA$ levels decreased in the progression of @DISEASE$.	1
While miR-1, @MiRNA$ * and miR-29 expression levels allowed to distinguish non-treated @DISEASE$ from healthy subjects, miR-16-2*, miR-26a2* and miR30a differentiated treated from untreated patients.	1
In this review, we summarise the current knowledge of @MiRNA$ functions in human disease, with an emphasis on its regulation, oncogenic role, targets in human @DISEASE$, potential as a disease biomarker and novel therapeutic target in oncology.	0
Recent studies have identified changes of several specific @MiRNA$ expression profiles and polymorphisms affecting the interactions between miRNAs and their targets in various @DISEASE$, including addiction: miR-16 causes adaptive changes in production of the serotonin transporter; miR-133b is specifically expressed in midbrain dopaminergic neurons, and regulates the production of tyrosine hydroxylase and the dopamine transporter; miR-212 affects production of striatal brain-derived neurotrophic factor and synaptic plasticity upon cocaine.	0
@MiRNA$ is responsible for the maturation and function of microRNA (@DISEASE$ ) molecules in the cell.	0
Together, this study elucidates a novel role for @MiRNA$ in the brain, not only as a potential signature of neurological disease but also as a crucial effector of @DISEASE$ and neurodegeneration.	0
functional role of @MiRNA$ in innate immune, inflammatory response, @DISEASE$ and human disease.	1
Specific microRNAs (@MiRNA$ ), small non-coding RNAs that support homeostatic gene expression, are significantly altered in abundance in human @DISEASE$.	0
@MiRNA$ inhibits growth of @DISEASE$ cells by targeting MEKK2 and cyclin D1.	1
A number of miRNAs like miR-193a, miR-224/miR-452 cluster, miR-182/miR-183/miR-96 cluster, and @MiRNA$ having potential @DISEASE$ /metastasis suppressive activity were found to be overexpressed in the WNT signaling associated medulloblastomas.	0
The SNP rs895819 in the @MiRNA$ gene with the minor allele C presented significantly reduced risk to @DISEASE$ in Chinese population.	1
A novel @MiRNA$ and transcription factor mediated regulatory network in @DISEASE$.	0
Betulinic Acid Targets YY1 and ErbB2 through Cannabinoid Receptor-dependent Disruption of @MiRNA$ ZBTB10 in @DISEASE$.	1
The database search on TargetScan, PicTar and miRBase Target identified neurone navigator 3 (@MiRNA$ ), a regulator of axon guidance, as a principal target of @DISEASE$, and actually NAV3 mRNA levels were elevated in AD brains.	1
@MiRNA$ regulates high glucose-induced cardiomyocyte @DISEASE$ by targeting the transcriptional co-activator p30.	1
The @MiRNA$ polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by @DISEASE$ in sonic hedgehog-treated cerebellar neural precursors.	0
The present study provides an initial survey of @MiRNA$ expression in pediatric central nervous system (CNS) malignancies including atypical teratoid/@DISEASE$, ependymoma, glioblastoma, medulloblastoma, and pilocytic astrocytoma.	0
Targeting oncogenic @MiRNA$ inhibits growth and invasion of malignant @DISEASE$ cells.	1
Recently published studies pertaining to the roles of @MiRNA$ in NDs--including Alzheimer's disease, @DISEASE$ and triplet repeat disorders-are described.	0
It begins with a brief introduction to apoptosis and @MiRNA$, followed by the description of the fundamental aspects of miRNA biogenesis and action, and the role of miRNAs in regulating apoptosis of @DISEASE$ cells and cardiovascular cells.	0
@MiRNA$ has a unique potential as a prognostic biomarker in stage II and III @DISEASE$.	1
Downregulated @MiRNA$ in meningiomas promotes tumor growth by reducing @DISEASE$ and activating the Wnt/beta-catenin signaling pathway.	0
Morphine treatment of human monocyte-derived macrophages induces differential @MiRNA$ and protein expression: impact on @DISEASE$ and oxidative stress in the central nervous system.	0
Consistently, @MiRNA$ knockdown through antisense LNA oligonucleotides increased the level of bcl2 protein in SH-SY5Y cells, which was accompanied by a decrease of active @DISEASE$.	1
We further demonstrate that miRNAs belonging to the @MiRNA$ family are potent regulators of @DISEASE$ expression in mouse neuronal cells and co-expressed with ERK1/2 in vivo.	1
Thus we have identified the miRNA expression signature for malignant @MiRNA$, in particular glioblastoma, and showed the @DISEASE$ involvement and their importance in astrocytoma development.	0
To investigate the involvement of @MiRNA$, miR-27a, and miR-150 in CM-resistant mice, we assessed the expression levels in @DISEASE$ knockout (IFN-γ(-/-)) mice on a C57BL/6 genetic background.	0
CONCLUSIONS: These results demonstrate that tissue-specific @MiRNA$ may serve as diagnostically sensitive plasma biomarkers of @DISEASE$.	0
Thus we have identified the miRNA expression signature for malignant astrocytoma, in particular glioblastoma, and showed the @MiRNA$ involvement and their importance in @DISEASE$ development.	0
@MiRNA$ modulates multidrug resistance by targeting BCL2 in human @DISEASE$ cell line.	1
Here, we studied the function of one @MiRNA$, miR-15b, in @DISEASE$ carcinogenesis and elucidated its downstream targets.	0
A few @MiRNA$ were differentially expressed in WM, including miR-212 that is downregulated in @DISEASE$ and miR-424 which is upregulated in AD.	0
[Interaction of @MiRNA$ and its potential targeting protein @DISEASE$ ].	1
To understand the role of miRNAs in the molecular mechanisms of temporal lobe epilepsy (TLE), we investigated the changes in microRNA (@MiRNA$ ) expression profiles of chronic @DISEASE$ rat models.	0
Increased @MiRNA$ expression in NSCLC and its association with poor survival in lung @DISEASE$ from never smokers.	1
Activation of @MiRNA$ function in already-established @DISEASE$ elicits metastatic regression.	1
This information should aid in future studies on therapeutic application of @MiRNA$ in @DISEASE$.	0
@MiRNA$ is a predictive marker for survival in patients with @DISEASE$.	1
Up-regulation of @MiRNA$ expression in @DISEASE$ tissues and its prognostic valu.	1
Aberrant elevated @MiRNA$ in dendritic cells (DC) induced by human @DISEASE$ cell line BxPC-3-conditioned medium inhibits DC maturation and activation.	1
Increased Expression of @MiRNA$ Predicts Poor Prognosis in Human @DISEASE$.	1
@MiRNA$ Inhibits Proliferation and Migration @DISEASE$ through Repression of MCL-1.	1
MicroRNA (miRNA) expression was assessed in human cerebral cortical gray matter (GM) and white matter (WM) in order to provide the first insights into the difference between GM and WM @MiRNA$ repertoires across a range of @DISEASE$ (AD) pathology.	0
To investigate this possibility we compared the expression of 264 human @MiRNA$ from postmortem prefrontal cortex tissue of individuals with @DISEASE$ (n = 13) or schizoaffective disorder (n = 2) to tissue of 21 psychiatrically unaffected individuals using a custom miRNA microarray.	0
Over-expression of these @MiRNA$, but not control miRNAs, results in translational repression of APP mRNA and significantly reduces @DISEASE$ protein levels.	1
Among the @MiRNA$ -related @DISEASE$ expression changes, miR-107 was exceptional because miR-107 levels decreased significantly even in patients with the earliest stages of pathology.	0
Genome-wide functional screening of @MiRNA$ as a pleiotropic modulator suppressing @DISEASE$.	1
A number of miRNAs like miR-193a, miR-224/miR-452 cluster, miR-182/miR-183/@MiRNA$ cluster, and miR-148a having potential tumor/metastasis suppressive activity were found to be overexpressed in the WNT signaling associated @DISEASE$.	1
Pre-@MiRNA$ and pre-miR-630 consistently modulated mitochondrial/postmitochondrial steps of the intrinsic pathway of apoptosis, including @DISEASE$ oligomerization, mitochondrial transmembrane potential dissipation, and the proteolytic maturation of caspase-9 and caspase-3.	1
@MiRNA$ functions as a tumor suppressor by directly targeting histone deacetylase 2 in @DISEASE$.	1
Specific @MiRNA$ (miRNAs), small non-coding RNAs that support homeostatic gene expression, are significantly altered in abundance in human @DISEASE$.	0
The correlation of the @MiRNA$ levels with survival in @DISEASE$ samples was estimated by performing Kaplan-Meier survival analysis and univariate/multivariate Cox proportional hazard regression analysis.	0
Here we provide evidence in AD brains of a specific up-regulation of an NF-kappaB-sensitive @MiRNA$ highly complementary to the 3'-untranslated region of complement factor H (@DISEASE$ ), an important repressor of the inflammatory response of the brain.	1
@MiRNA$ was found to directly target beta-catenin mRNA, thereby inhibiting its translation and blocking Wnt/@DISEASE$ signaling, which is frequently involved in cancer.	1
@MiRNA$ Functions as a Tumor Suppressor in Acute @DISEASE$ by Regulating 14-3-.	1
The dysregulated @MiRNA$ have been detectable even after several months from the onset of @DISEASE$ in what is usually regarded as neurologically stable patients.	0
Identification of miRs targeting the @MiRNA$ 3'-untranslated region was performed by @DISEASE$ array followed by expression analysis of identified miRs using qRT-PCR.	0
RESULTS: We found underexpression of miR-145 (2.0-fold; P = 0.04), @MiRNA$ (2.4-fold; P = 0.004), miR-141 (2.6-fold; P = 0.02), let-7a (3.3-fold; P = 0.003), miR-150 (3.8-fold; P = 0.04), miR-15a (4.5-fold; P = 0.03), miR-16 (5.0-fold; P = 0.004), and miR-143 (6.4-fold; P = 0.004) in @DISEASE$ when compared to normal pituitary tissues.	1
These findings support a causal link between @MiRNA$ and @DISEASE$ whereby loss of let-7 expression induces high-mobility group A2 upregulation that represents an important mechanism in pituitary tumorigenesis and progression.	0
Our research revealed that 136 miRNAs were expressing at 6 h post injury, in which 13 miRNAs were more than 2-fold up-regulated, and 14 miRNAs were more than 2-fold down-regulated; 118 miRNAs were expressing at 24 h post @MiRNA$, in which 4 miRNAs were more than 2-fold up-regulated, and 23 @DISEASE$ were more than 2-fold down-regulated; 149 miRNAs were expressing at 48 h post injury, in which 16 miRNAs were more than 2-fold up-regulated, and 11 miRNAs were more than 2-fold down-regulated; and 203 miRNAs were expressing at 72 h post injury, in which 19 miRNAs were more than 2-fold up-regulated, and 5 miRNAs were more than 2-fold down-regulated.	1
These studies suggest that @MiRNA$ may be important for neuronal survival in the context of human @DISEASE$.	0
@MiRNA$ 2, 7a-3, 7d, 7f-2 downregulated in @DISEASE$.	1
ABSTRACT: The aim of our study was to analyze the differential expression of @MiRNA$ in the brains of BSE-infected cynomolgus macaques as a model for Creutzfeldt-Jakob disease (@DISEASE$ ).	0
@MiRNA$ have a role in several complex diseases including cancer as well as some neurological diseases such as @DISEASE$ and Fragile x syndrome.	0
@MiRNA$ expression in the prefrontal cortex of individuals with @DISEASE$ and schizoaffective disorder.	0
The secondary structure of local region of @MiRNA$ recognizing @DISEASE$ was conservative.	0
@MiRNA$ and its host gene lncRNA LOC554202 are regulated by promoter hypermethylation in @DISEASE$.	1
Thus, miR-200a appears to act as a multifunctional tumor suppressor @MiRNA$ in meningiomas through effects on the @DISEASE$ and Wnt/beta-catenin signaling pathways.	0
We suggest that the expression of GRN is regulated by @MiRNA$ and that common genetic variability in a miRNA binding-site can significantly increase the risk for @DISEASE$.	0
Upregulated @MiRNA$ in papillary @DISEASE$.	1
Upregulation of @MiRNA$ mediates resistance to trastuzumab therapy for @DISEASE$.	1
Recent years have seen considerable progress in @MiRNA$ research in brain tumors, particularly in @DISEASE$ and medulloblastomas, providing novel insights into the pathogenesis of these malignant lesions.	0
The results show the possible use of blood miRNAs as biomarkers for @MiRNA$ ; that selected blood @DISEASE$ may correlate with miRNA changes in the brain; and that many of the mRNAs, previously shown to be regulated in brain and blood after brain injury, are likely accounted for by changes in miRNA expression.	0
The tumor suppressor gene rap1GAP is silenced by @MiRNA$ mediated EZH2 overexpression in invasive @DISEASE$.	1
These findings support a causal link between @MiRNA$ and high-mobility group A2 whereby loss of let-7 expression induces @DISEASE$ upregulation that represents an important mechanism in pituitary tumorigenesis and progression.	0
These findings indicate that @MiRNA$ pathways dramatically modulate polyQ- and @DISEASE$ -induced neurodegeneration, providing the foundation for new insight into therapeutics.	0
@MiRNA$ overexpression strongly associates with advanced @DISEASE$ progression and unfavorable clinical outcome of patients with RC.	1
In neurodegenerative disorders such as Alzheimer's disease (@MiRNA$ ), brain @DISEASE$ profiles are altered; thus miRNA dysfunction could be both a cause and a consequence of disease.	1
A @MiRNA$ embedded @DISEASE$ alpha-synuclein gene silencing vector for dopaminergic neurons.	0
@MiRNA$ Promoted Cell Proliferation by Targeting p27 in @DISEASE$ Cells.	1
Aging and DMH are associated with increases in CSLC biomarkers and @MiRNA$ each of which have been linked to @DISEASE$.	1
Three dysregulated @MiRNA$ control kallikrein 10 expression and cell proliferation in @DISEASE$.	1
Association between the rs2910164 Polymorphism in @MiRNA$ Sequence and Thyroid @DISEASE$.	1
MicroRNAs (@MiRNA$ ) may play a significant role in @DISEASE$ biology.	0
A number of @MiRNA$ like miR-193a, miR-224/miR-452 cluster, miR-182/miR-183/miR-96 cluster, and miR-148a having potential @DISEASE$ /metastasis suppressive activity were found to be overexpressed in the WNT signaling associated medulloblastomas.	0
To understand the role of @MiRNA$ in the molecular mechanisms of temporal lobe epilepsy (TLE), we investigated the changes in microRNA (miRNA) expression profiles of chronic @DISEASE$ rat models.	0
@MiRNA$ suppresses lung @DISEASE$ initiating cell proliferation by targeting OCT4.	1
Analysis of human MBs demonstrated that 3 miR-17 approximately 92 cluster miRNAs (@MiRNA$, miR-19a, and miR-20) were also overexpressed in human MBs with a constitutively activated @DISEASE$ (SHH) signaling pathway, but not in other forms of the disease.	0
Lack of @MiRNA$ causes E-cadherin functional deregulation through EZH2 upregulation in intestinal @DISEASE$.	1
Our studies show markedly elevated @MiRNA$ levels in @DISEASE$ tissues, early-passage glioblastoma cultures, and in six established glioblastoma cell lines (A172, U87, U373, LN229, LN428, and LN308) compared with nonneoplastic fetal and adult brain tissues and compared with cultured nonneoplastic glial cells.	1
@MiRNA$ targets cytoskeleton genes involved in @DISEASE$ cell invasion.	1
Downregulation and Prognostic Performance of @MiRNA$ 224 Expression in @DISEASE$.	1
@MiRNA$ modulates multidrug resistance of human @DISEASE$ cell lines by targeting BCL2.	1
We performed a large-scale, genome-wide microRNA (@MiRNA$ ) (n=756) expression profiling of 26 glioblastoma, 13 anaplastic astrocytoma and 7 normal brain samples with an aim to find deregulated miRNA in malignant @DISEASE$.	0
The family of miR-64 and miR-65 are co-underexpressed in the alpha-synuclein transgenic and cat-1 strains, and members of let-7 family co-underexpressed in the alpha-synuclein and pdr-1 strains; @MiRNA$ and ptc-1 genes are target candidates for @DISEASE$ and miR-65 and are overexpressed in alpha-synuclein transgenic as well as miR-64/65 (tm3711) knockout animals.	1
Expression levels of select protein-coding genes and @MiRNA$ could classify an independent set of @DISEASE$.	0
Western blot analysis revealed unchanged total @MiRNA$ protein levels, but reduced phospho-Smad2/3 (p-Smad2/3) and increased Smad6/7 protein levels in the @DISEASE$ stably transfected cell line.	0
A specific subset of five miRNAs revealed by in silico target prediction was significantly overexpressed in NFA samples; three miRs (@MiRNA$, miR-155, and miR-516a-3p) targeted the 3'-untranslated region of the Wee1 transcript, and exogenous overexpression of these miRs inhibited @DISEASE$ protein expression and HeLa cell proliferation.	0
Using miRNA-146a-, IRAK-1-, or IRAK-2 promoter-luciferase reporter constructs, we observe decreases in IRAK-1 and increases in @MiRNA$ and IRAK-2 expression in @DISEASE$ (IL-1β) and amyloid-β-42 (Aβ42) peptide-stressed HAG cells.	0
Here we found that @MiRNA$ and TGF-β type II receptor (TβR II) were aberrantly expressed in APPswe/PS∆E9 mice (a double transgenic mouse model for @DISEASE$ ).	1
A specific subset of five miRNAs revealed by in silico target prediction was significantly overexpressed in NFA samples; three miRs (miR-128a, miR-155, and miR-516a-3p) targeted the 3'-untranslated region of the Wee1 transcript, and exogenous overexpression of these @MiRNA$ inhibited @DISEASE$ protein expression and HeLa cell proliferation.	1
Since its identification 3 years ago as the miRNA most commonly and strongly up-regulated in human @MiRNA$ [1], @DISEASE$ has attracted the attention of researchers in various fields, such as development, oncology, stem cell biology and aging, becoming one of the most studied miRNAs, along with let-7, miR-17-92 cluster ('oncomir-1'), miR-155 and a few others.	1
a locked nucleic acid (LNA)-modified oligonucleotide (SPC3649) complementary to @MiRNA$ leads to long-lasting suppression of HCV @DISEASE$.	1
We also found that inactivation of SOX4 by siRNA and restoration of @MiRNA$ induced apoptosis in @DISEASE$ cells.	1
@MiRNA$ increases apoptosis in MYCN amplified @DISEASE$ cells by targeting the key cell cycle regulator WEE.	1
RESULTS: We observed increases in plasma concentrations of miR-122, miR-133a, and @MiRNA$ corresponding to @DISEASE$, muscle, and brain, respectively.	1
Recent studies report that @MiRNA$ is negatively regulated by the let-7 microRNAs (@DISEASE$ ) family in vitro.	1
Downregulation of @MiRNA$ regulates MMP-2 expression and suppress migration of Laryngeal @DISEASE$.	1
Because of their size, abundance, tissue specificity, and relative stability in plasma, @MiRNA$ hold promise as unique accessible biomarkers to monitor @DISEASE$.	0
Recent studies have identified a molecular and ultimately pathogenic role for a subset of @MiRNA$ in Alzheimer's disease and @DISEASE$, including the characterization of their downstream CNS mRNA targets, such as beta-secretase (BACE1) and calmodulin-dependent protein kinase II (CaMKII).	0
Suppressing @MiRNA$ -16 expression by interleukin-6 enhances drug-resistance in @DISEASE$ cells.	1
The bioinformatics analysis indicates that the potential targets for @MiRNA$ altered after @DISEASE$ include genes encoding components that are involved in the inflammation, oxidation, and apoptosis that are known to play important roles in the pathogenesis of SCI.	0
@MiRNA$ 15a, Inversely Correlated to PKC, Is a Potential Marker to Differentiate between Benign and Malignant @DISEASE$ in Biopsy and Urine Samples.	1
From these data sets, we inferred and validated a @MiRNA$ suppression pathway linked to @DISEASE$.	0
We hypothesized that miRNAs and TFs might play combinatory regulatory roles for @MiRNA$ genes and, thus, explored @DISEASE$ -TF regulatory networks in schizophrenia.	0
STUDY DESIGN: We investigated microRNA (@MiRNA$ ) expression after spinal cord injury (@DISEASE$ ) in mice.	0
We analyzed the effect of @MiRNA$ treatment on @DISEASE$ expression in glioma cells and intracranial glioma xenografts.	0
We examined whether plasma concentrations of brain-specific @MiRNA$ can serve as a biomarker for @DISEASE$, where the cerebral infarction was modeled by middle cerebral artery occlusion (MCAO) in the rat.	0
The most interesting results came from miR-221, strongly up-regulated in @MiRNA$ and from a set of brain-enriched miRNAs, miR-128, @DISEASE$, miR-181b, and miR-181c, which are down-regulated in glioblastoma.	0
Subsequently, decreased expression of @MiRNA$ was confirmed in 23 of 55 (42%) adenomas and was correlated with @DISEASE$ (P<0.05).	0
Here, the current understanding of the role of @MiRNA$ in the central nervous system is reviewed with emphasis on their impact on the etiopathogenesis of @DISEASE$.	0
Brain and blood @MiRNA$ expression profiling of ischemic stroke, @DISEASE$, and kainate seizures.	0
We performed a large-scale, genome-wide @MiRNA$ (miRNA) (n=756) expression profiling of 26 glioblastoma, 13 @DISEASE$ and 7 normal brain samples with an aim to find deregulated miRNA in malignant astrocytoma.	0
Deregulated expression of @MiRNA$ with the potential for prognostic biomarkers in surgically resected @DISEASE$.	1
@MiRNA$ downregulated in @DISEASE$ suppresses proliferation and promotes apoptosis by targeting Bcl-xL and Mcl-1.	1
To identify miRNAs closely associated with neurodegeneration, we performed @MiRNA$ expression profiling of brain tissues of various @DISEASE$.	0
@MiRNA$ guardians against pluripotency and @DISEASE$ progressio.	1
@MiRNA$ Down-Regulated in Squamous @DISEASE$ Inhibits Cell Migration and Invasion via Targeting Transcription Factor SP1.	1
@MiRNA$ : Up-regulated in the blook serum of patients with @DISEASE$ compared to healthy controls.	1
Recent studies have also demonstrated that @MiRNA$ (miRNAs) may be responsible for the modulation of cancer-implicated genes in @DISEASE$.	0
Low @MiRNA$ expression in human amniotic epithelial cell feeder layers maintains human-induced pluripotent stem cell pluripotency via increased @DISEASE$ inhibitory factor expression.	1
Overexpression of @MiRNA$ specifically inhibits the truncated isoform of NTRK3 and upregulates BCL2 in SH-SY5Y @DISEASE$ cells.	1
We conclude that miR-17/92 is a positive effector of Shh-mediated proliferation and that aberrant expression/amplification of this @MiRNA$ confers a growth advantage to @DISEASE$.	1
In this report, we present data on the @MiRNA$ expressed under ischemic conditions in both the brain and blood of rats subjected to @DISEASE$ (MCAo).	0
We hypothesized that miRNAs and TFs might play combinatory regulatory roles for schizophrenia genes and, thus, explored @MiRNA$ -TF regulatory networks in @DISEASE$.	0
@MiRNA$ Inhibits @DISEASE$ Cell Proliferation Both In Vitro and In Vivo by Targeting LPAAT.	1
Re-expression of @MiRNA$ by novel approaches regulates the expression of PTEN and MT1-MMP in @DISEASE$.	1
@MiRNA$ Expression in Pregnancy-Associated @DISEASE$ A Possible Marker of Poor Prognosis.	1
Downregulated @MiRNA$ in meningiomas promotes @DISEASE$ growth by reducing E-cadherin and activating the Wnt/beta-catenin signaling pathway.	0
CONCLUSION: @MiRNA$ can recognize the 3'UTR of @DISEASE$ while it has no significant effect on the expression of eiF4E3.	1
In mild @MiRNA$ patients (GCS score > 12), miR-765 levels were unchanged, while the plasma levels of @DISEASE$ and miR-16 were significantly increased within the first 24 h of injury compared to healthy volunteers, and had AUC values of 0.78 and 0.82, respectively.	1
In a well-characterized Belgian group of 358 @MiRNA$ patients and 462 controls, we examined whether genetic variability in microRNA (miRNA) binding sites of APP and BACE1 or in associated @DISEASE$ influenced risk for A.	0
@MiRNA$ promotes cell growth, invasion and chemoresistance by targeting programmed cell death 4 (PDCD4) in human ovarian @DISEASE$.	1
Clinical impact of serum exosomal @MiRNA$ as a clinical biomarker in human esophageal @DISEASE$.	1
Downregulation of @MiRNA$ in meningiomas and arachnoidal cells resulted in increased expression of @DISEASE$ and cyclin D1 involved in cell proliferation.	1
@MiRNA$ overexpression is associated with NPM1 mutations and MDM4 downregulation in intermediate-risk @DISEASE$.	1
@MiRNA$ Suppresses @DISEASE$ Cell Invasiveness By Direct Targeting of Multiple Genes from the non-Canonical TGF-β Signalling Pathway.	1
In addition, the @MiRNA$ deregulation in hippocampal cultures and APP23 hippocampus overlaps with those obtained in human @DISEASE$ studies.	1
Re-expression of @MiRNA$ suppresses @DISEASE$ cell proliferation and survival by targeting GSK-.	1
We further demonstrate that miR-659 can regulate GRN expression in vitro, with @MiRNA$ binding more efficiently to the high risk T-allele of rs5848 resulting in augmented translational inhibition of @DISEASE$.	1
Despite the small sample available, we can show that this approach permits identification of meaningful structures, in particular two polycistronic @MiRNA$ genes related to transcriptional activity and likely to be relevant in the discrimination between @DISEASE$ and other brain tumors.	0
RESULTS: We report here for the first time the involvement of @MiRNA$ regulation in brain pathogenesis associated with @DISEASE$.	1
The most interesting results came from miR-221, strongly up-regulated in glioblastoma and from a set of brain-enriched miRNAs, miR-128, @MiRNA$, miR-181b, and miR-181c, which are down-regulated in @DISEASE$.	1
@MiRNA$ Modulates Cell Apoptosis by Targeting Multiple Genes in @DISEASE$.	1
Our study dissects the complexity of human AD pathology, and addresses the hypothesis that @MiRNA$ (Abeta) itself, a known causative factor of AD, causes neuronal @DISEASE$ deregulation, which could contribute to the pathomechanisms of AD.	1
@MiRNA$ is a regulator of @DISEASE$.	1
@MiRNA$ as a crucial oncogene in human @DISEASE$ that acts through multiple pathways and mechanisms to promote nodal or distant relapses.	1
The use of hsa-miR-21, hsa-miR-181b and @MiRNA$ as prognostic indicators of @DISEASE$.	0
Involvement of @MiRNA$ a new regulator of PTEN/Akt signaling pathway, in regulation of chemotherapeutic drug cisplatin chemosensitivity in @DISEASE$ cells.	1
Modulation of @MiRNA$ and Cell Migration by HER2-Targeting Trastuzumab in @DISEASE$.	1
A specific subset of five miRNAs revealed by in silico target prediction was significantly overexpressed in NFA samples; three miRs (miR-128a, miR-155, and @MiRNA$ ) targeted the 3'-untranslated region of the @DISEASE$ transcript, and exogenous overexpression of these miRs inhibited Wee1 protein expression and HeLa cell proliferation.	1
We performed a large-scale, genome-wide microRNA (@MiRNA$ ) (n=756) expression profiling of 26 @DISEASE$, 13 anaplastic astrocytoma and 7 normal brain samples with an aim to find deregulated miRNA in malignant astrocytoma.	0
Translational regulation by @MiRNA$ may represent a common mechanism underlying complex @DISEASE$.	0
Molecular and cellular neurobiological studies of the miRNAs in neurodegeneration represent the exploration of a new Frontier of @MiRNA$ biology and the potential development of new diagnostic tests and genetic therapies for @DISEASE$.	0
Moreover, LPS stimulation decreased expression of microRNAs (miRNA)--miR-17-5, miR-20a, and miR-93--which target @MiRNA$, implicating a novel role for @DISEASE$ in NKG2D ligand expression.	0
Moreover, the performance of three algorithms (PicTar, TargetScan and DIANA-microT) is both demonstrated and evaluated by performing an in-depth analysis of @MiRNA$ interactions with mRNAs derived from genes triggering hereditary neurological disorders known as trinucleotide repeat expansion diseases (@DISEASE$ ), such as Huntington's disease (HD), a number of spinocerebellar ataxias (SCAs), and myotonic dystrophy type 1 (DM1).	0
@MiRNA$ can regulate expression of the long non-coding RNA gene MEG3 in @DISEASE$.	1
Utilizing human cell lines, we demonstrate that miRNAs hsa-mir-106a and @MiRNA$ bind to their predicted target sequences in the @DISEASE$ 3'UTR and negatively regulate reporter gene expression.	1
Finally, we demonstrate that @MiRNA$ -mediated PTEN repression in a murine @DISEASE$ model both enhances de novo tumor formation and precludes loss of heterozygosity and the PTEN locus.	0
Association studies using all common variants detected in the 3' UTR of @MiRNA$ and the @DISEASE$ gene cluster did not identify an association with AD risk.	0
@MiRNA$ was detected down-regulated expression at 0h, 1h, 6h, 2days, 7days, 50days after @DISEASE$ and up-regulated expression at 12h, 24h, 10days, 30days after SE, which was significantly up-regulated expression at 24h after SE (10.49 folds, P<0.01).	1
@MiRNA$ directly targets MUC4 and suppresses growth and malignant behavior of @DISEASE$ cells.	1
Identification and characterization of the targets of altered @MiRNA$ genes may elucidate molecular mechanisms involved in the pathogenesis of pituitary @DISEASE$.	0
Subsequently, decreased expression of @MiRNA$ was confirmed in 23 of 55 (42%) @DISEASE$ and was correlated with high-grade tumors (P<0.05).	0
Thirteen @MiRNA$ were differentially expressed between @DISEASE$ samples from lanreotide-treated patients and those from lanreotide-untreated patients.	0
CONCLUSIONS: These observations suggest the hypothesis that underexpression of miR-29a affects neurodegenerative processes by enhancing neuronal NAV3 expression in AD brain@MiRNA$.	1
Extensive modulation of a set of @MiRNA$ in @DISEASE$.	1
@MiRNA$ targets CD44 to suppress the tumorigenicity and multi-drug resistance of @DISEASE$ initiating cells.	1
@MiRNA$ (29a,b,c) reverts aberrant methylation in @DISEASE$ by targeting DNA methyltransferases 3A and 3B.	1
Up-regulation of @MiRNA$ coupled to down-regulation of @DISEASE$ was observed in AD brain and in interleukin-1beta, Abeta42, and/or oxidatively stressed human neural (HN) cells in primary culture.	1
Because @MiRNA$ regulate numerous aspects of cellular physiology and development, we reasoned that alterations in miRNA expression might contribute to @DISEASE$.	0
Inhibition of two glioblastoma-upregulated miRNAs (miR-21 and miR-23a) and exogenous overexpression of two @MiRNA$ -downregulated miRNAs (miR-218 and @DISEASE$ ) resulted in reduced soft agar colony formation but showed varying effects on cell proliferation and chemosensitivity.	1
@MiRNA$ Regulates Vascularity After @DISEASE$.	1
@MiRNA$ downregulated in undifferentiated @DISEASE$.	1
Downregulation of Human Farnesoid X Receptor by @MiRNA$ Promotes Proliferation and Migration of @DISEASE$ Cells.	1
Radiation resistance due to high expression of @MiRNA$ and G2/M checkpoint arrest in @DISEASE$ cell.	1
A role for @MiRNA$ in development and @DISEASE$ has been described.	0
To test whether the @MiRNA$ approximately 92 cluster could promote MB formation, we enforced expression of these miRNAs in GNPs isolated from cerebella of postnatal (P) day P6 @DISEASE$ -/-; Ptch1+/- mice.	0
Further analysis showed that the down-regulation of @MiRNA$ mainly in T cells, was negatively correlated with @DISEASE$.	1
Brain and blood @MiRNA$ expression profiling of ischemic stroke, intracerebral hemorrhage, and @DISEASE$.	0
Up-regulation of @MiRNA$ coupled to down-regulation of CFH was observed in AD brain and in interleukin-1beta, @DISEASE$, and/or oxidatively stressed human neural (HN) cells in primary culture.	0
While miR-1, miR-22* and miR-29 expression levels allowed to distinguish non-treated @MiRNA$ from healthy subjects, miR-16-2*, miR-26a2* and @DISEASE$ differentiated treated from untreated patients.	1
We also discuss the implications of these findings with respect to the involvement of miRNAs in the etiopathology of @MiRNA$ and pinpoint the emerging therapeutic potential of @DISEASE$ for the treatment of human diseases.	0
Our research revealed that 136 miRNAs were expressing at 6 h post injury, in which 13 miRNAs were more than 2-fold up-regulated, and 14 miRNAs were more than 2-fold down-regulated; 118 miRNAs were expressing at 24 h post injury, in which 4 miRNAs were more than 2-fold up-regulated, and 23 miRNAs were more than 2-fold down-regulated; 149 miRNAs were expressing at 48 h post @MiRNA$, in which 16 miRNAs were more than 2-fold up-regulated, and 11 miRNAs were more than 2-fold down-regulated; and 203 @DISEASE$ were expressing at 72 h post injury, in which 19 miRNAs were more than 2-fold up-regulated, and 5 miRNAs were more than 2-fold down-regulated.	0
P-glycoprotein enhances radiation-induced apoptotic cell death through the regulation of @MiRNA$ and Bcl-2 expressions in @DISEASE$ cells.	1
@MiRNA$ 181a improves proliferation and invasion, suppresses apoptosis of @DISEASE$ cell.	1
Objective: The aim of the study was to analyze the differential expression of let-7a, miR-15a, miR-16, @MiRNA$, miR-141, miR-143, miR-145, and miR-150 in corticotropinomas and normal pituitary tissue and verify whether their profile of expression correlates with @DISEASE$ size or remission after treatment.	0
It is now well-documented that @MiRNA$ and the fine-tuning of the @DISEASE$ gene network are important for neuronal integrity.	0
@MiRNA$ Suppresses @DISEASE$ Progression through Downregulation of Survivin and the SLIT2-ROBO1 Pathway.	1
Using luciferase reporter assays with 3'-UTRs of @MiRNA$, over-expression and inhibition of miR-146a, we showed that @DISEASE$ targets TBP.	0
@MiRNA$ induces cell cycle at S phase and modulates cell proliferation by down-regulating hMSH2 in @DISEASE$.	1
This has been reported for the retrovirus primate foamy virus-1 (PFV-1), which can be targeted by the host @MiRNA$ [150], which was suggested to restrict its @DISEASE$.	1
@MiRNA$ promotes the proliferation @DISEASE$ cells by targeting P53.	1
@MiRNA$ and Their Host Gene, MCM7, Are Differentially Expressed in @DISEASE$ and Functionally Target F3 and IL-8.	1
@MiRNA$ Down-Regulation Contributes to the Constitutive Type I Collagen Overexpression in @DISEASE$ Dermal Fibroblasts via the Induction of Integrin β.	1
@MiRNA$ downregulated in six solid @DISEASE$ types by PAM (Volinia et al., 2006.	1
The @MiRNA$ rs11134527 SNP was significantly associated with the risk of cervical @DISEASE$ in Eastern Chinese wome.	1
We did reporter assays to elucidate the @MiRNA$ -mediated suppression of miR-21; the addition of signal transducers and activators of transcription 3 (STAT3)-expressing vectors induced the IFN-beta-mediated suppression of @DISEASE$, whereas STAT3-inhibiting agents inhibited the miR-21 suppression.	0
@MiRNA$ promotes leptomeningeal spread of non-sonic hedgehog-@DISEASE$.	1
Compared with normal rats (control group), 23 of the 125 miRNAs were expressed differentially in @MiRNA$ rats including 5 down-regulated miRNAs (@DISEASE$ included) and 18 up-regulated miRNAs (miR-23a/b included).	1
@MiRNA$ modulates multidrug resistance in human @DISEASE$ by down-regulating MRP-2.	1
@MiRNA$ reverts aberrant methylation in @DISEASE$ by targeting DNA methyltransferases 3A and 3B.	1
Repression of tumor suppressor @MiRNA$ is essential for NOTCH1-induced @DISEASE$ in T-ALL.	1
We report that @MiRNA$ expression is significantly up-regulated in the hippocampus after rodent @DISEASE$, with expression levels peaking by 3 days postinjury and returning to near sham levels by 15 days postinjury.	1
We did reporter assays to elucidate the IFN-beta-mediated suppression of miR-21; the addition of signal transducers and activators of transcription 3 (STAT3)-expressing vectors induced the @MiRNA$ -mediated suppression of miR-21, whereas STAT3-inhibiting agents inhibited the @DISEASE$ suppression.	0
@MiRNA$ down-regulates pre mRNA processing factor 4 homolog B (PRPF4B) and facilitates the G1/S transition in human @DISEASE$ cell.	1
Lipopolysaccharide-induced @MiRNA$ negatively regulates @DISEASE$ necrosis factor-alpha gene expression by modulating Sp1.	1
Finally, while rolipram and PDE4D deficiency shortened α2 adrenergic receptor-mediated anesthesia, a surrogate measure of emesis, @MiRNA$ -mediated @DISEASE$ knock-down in the hippocampus did not.	0
Aberrant @MiRNA$ expression is an early event in the multistep progression of pancreatic @DISEASE$.	1
Many miRNAs changed more than 1.5-fold in brain and blood after each experimental manipulation, and several @MiRNA$ were upregulated or downregulated in both brain and blood after a given @DISEASE$.	0
To search for @MiRNA$ that may be involved in the pathogenesis of Parkinsons disease (PD), we utilized miRNA microarrays to identify potential gene expression changes in 115 annotated miRNAs in @DISEASE$ -associated Caenorhabditis elegans models that either overexpress human A53T alpha-synuclein or have mutations within the vesicular catecholamine transporter (cat-1) or parkin (pdr-1) ortholog.	0
The predicted targets of these @MiRNA$ include those with known or suspected roles in oligodendrocyte development and myelination including C11Orf9, CLDN11, MYTL1, MBOP, @DISEASE$, and DDR1.	0
@MiRNA$ promotes @DISEASE$ migration by targeting reversion-inducing cysteine-rich protein with Kazal motifs (RECK) and regulating matrix metalloproteinase-9 expressio.	1
We hypothesized that @MiRNA$ and TFs might play combinatory regulatory roles for @DISEASE$ genes and, thus, explored miRNA-TF regulatory networks in schizophrenia.	0
Modulating an aberrantly overexpressed @MiRNA$, miR-21, via antisense-mediated depletion (knock-down) had a significant negative effect on @DISEASE$ formation.	0
A specific subset of five miRNAs revealed by in silico target prediction was significantly overexpressed in NFA samples; three miRs (miR-128a, miR-155, and @MiRNA$ ) targeted the 3'-untranslated region of the Wee1 transcript, and exogenous overexpression of these miRs inhibited @DISEASE$ protein expression and HeLa cell proliferation.	0
@MiRNA$ promotes apoptosis and enhances chemosensitivity to 5-fluorouracil in @DISEASE$.	1
@MiRNA$ suppresses human @DISEASE$ cell proliferation by directly targeting beta-catenin.	1
Interestingly, one of these, the bifunctional brain enriched miR-9/miR-9*, targets two components of the REST complex: @MiRNA$ targets @DISEASE$ and miR-9* targets CoREST.	1
Serum @MiRNA$ is associated with early relapse in operable lung @DISEASE$ patient.	1
We therefore investigated changes in microRNA (miRNA) expression profiles of sporadic AD patients and found that several @MiRNA$ potentially involved in the regulation of APP and @DISEASE$ expression appeared to be decreased in diseased brain.	0
Increased expression of @MiRNA$ is associated with shorter overall survival in @DISEASE$.	1
Analysis of human MBs demonstrated that 3 miR-17 approximately 92 cluster @MiRNA$ (miR-92, miR-19a, and miR-20) were also overexpressed in human MBs with a constitutively activated @DISEASE$ (SHH) signaling pathway, but not in other forms of the disease.	0
@MiRNA$ targets HDAC-1 and induces growth arrest in @DISEASE$.	1
METHODS AND FINDINGS: To explore the role of miRNAs in schizophrenia, 59 microRNA genes on the X-chromosome were amplified and sequenced in males with (193) and without (191) @MiRNA$ spectrum disorders to test the hypothesis that ultra-rare mutations in @DISEASE$ collectively contribute to the risk of schizophrenia.	0
@MiRNA$ and miR-16-1 function by targeting multiple oncogenes, including BCL2, @DISEASE$, CCND1, and WNT3A.	1
Tumor protein 53-induced nuclear protein 1 expression is repressed by @MiRNA$ and its restoration inhibits @DISEASE$ development.	1
@MiRNA$ Represses Proto-oncogene Src Kinase and Functions as Methylation-Silenced Tumor Suppressor with Diagnostic and Prognostic Significance in @DISEASE$.	1
@MiRNA$ DOWNREGULATION COOPERATES WITH MACC1 IN PROMOTING MET OVEREXPRESSION IN HUMAN @DISEASE$.	1
VCP/p97, down-regulated by @MiRNA$ could regulate the progression of @DISEASE$.	1
@MiRNA$ suppresses cell proliferation and induces senescence in A549 @DISEASE$ cells.	1
A functional screen identifies @MiRNA$ as a candidate @DISEASE$ tumor suppressor gene.	1
@MiRNA$ abolishes the growth of therapy-resistant @DISEASE$ through p21 and BI.	1
@MiRNA$ induces @DISEASE$ cell invasion by modulating MMP-14 and uPAR expression via HOXD10.	1
@MiRNA$ promotes apoptosis by targeting Bcl-2 in @DISEASE$.	1
@MiRNA$ regulates GRP78 and influences outcome from @DISEASE$ in vitro and in vivo.	1
Non-CpG island promoter hypomethylation and @MiRNA$ regulate the expression of SRPX2 in @DISEASE$.	1
STUDY DESIGN: We investigated @MiRNA$ (miRNA) expression after @DISEASE$ (SCI) in mice.	0
In both HIV associated @MiRNA$ in humans and its monkey model SIV encephalitis we find miR-21, a @DISEASE$ largely known for its link to oncogenesis, to be significantly upregulated in the brain.	1
@MiRNA$ mediated UBC9 expression in @DISEASE$.	1
Inhibition of two glioblastoma-upregulated miRNAs (miR-21 and @MiRNA$ ) and exogenous overexpression of two @DISEASE$ -downregulated miRNAs (miR-218 and miR-219-5p) resulted in reduced soft agar colony formation but showed varying effects on cell proliferation and chemosensitivity.	0
@MiRNA$ inversely couples the biological functions of the runt-related transcription factor RUNX2 and the tumor suppressor p53 in @DISEASE$.	1
Consistent with an impairment of miRNA-mediated regulation of BACE1 expression, these findings prompted us to investigate the regulatory role of the BACE1 3'-UTR element and the possible involvement of specific miRNAs in cultured neuronal (N2a) and fibroblastic (NIH 3T3) ce@MiRNA$ SEASE$.	0
@MiRNA$ induces apoptosis through direct regulation of GSTP1 in @DISEASE$ cell lines.	1
Additionally, several research groups have established that inserting @MiRNA$ (miRNA)-targeted sequences into the adenoviral genome can modulate adenoviral protein expression to confer tissue and @DISEASE$ selectivity.	0
We therefore investigated changes in microRNA (miRNA) expression profiles of sporadic AD patients and found that several @MiRNA$ potentially involved in the regulation of @DISEASE$ and BACE1 expression appeared to be decreased in diseased brain.	1
Molecular and cellular neurobiological studies of the @MiRNA$ in neurodegeneration represent the exploration of a new Frontier of miRNAs biology and the potential development of new diagnostic tests and genetic therapies for @DISEASE$.	0
Downregulation of @MiRNA$ is Associated with Tamoxifen Resistant @DISEASE$.	1
@MiRNA$ inhibits @DISEASE$ cell proliferation by targeting CCND.	1
Because of its known connection to glioma biology, we focused on miR-21 among seven @MiRNA$ influenced by @DISEASE$.	0
Several @MiRNA$ targeting the same genes were within the functional category of @DISEASE$ response/Redox homeostasis.	0
In this review article, the molecular mechanisms underlying the role and function of @MiRNA$ in the regulation of genes involved in neurological and @DISEASE$ will be discussed, with a focus on the fragile X syndrome, Alzheimer's disease (AD) and prion disease.	0
It begins with a brief introduction to apoptosis and miRNAs, followed by the description of the fundamental aspects of miRNA biogenesis and action, and the role of @MiRNA$ in regulating apoptosis of @DISEASE$ cells and cardiovascular cells.	0
The modulation of @MiRNA$ by @DISEASE$ through the activation of signal transducers and activators of transcription 3 in human glioma.	1
BACKGROUND: The purpose of this study was to (1) identify specific miRNAs in growth hormones (GH)-secreting pituitary adenomas; (2) determine the relationship between the expression of these @MiRNA$ and @DISEASE$ size, somatostatin analogs treatment, and responsiveness to somatostatin analogs (SSA).	0
Loss of microRNA cluster @MiRNA$ in sporadic Alzheimer's disease correlates with increased BACE1/@DISEASE$ expression.	1
Since its identification 3 years ago as the miRNA most commonly and strongly up-regulated in human @MiRNA$ [1], miR-21 has attracted the attention of researchers in various fields, such as development, oncology, stem cell biology and aging, becoming one of the most studied miRNAs, along with let-7, miR-17-92 cluster ('@DISEASE$ '), miR-155 and a few others.	0
Our research revealed that 136 miRNAs were expressing at 6 h post injury, in which 13 miRNAs were more than 2-fold up-regulated, and 14 miRNAs were more than 2-fold down-regulated; 118 @MiRNA$ were expressing at 24 h post injury, in which 4 miRNAs were more than 2-fold up-regulated, and 23 miRNAs were more than 2-fold down-regulated; 149 miRNAs were expressing at 48 h post injury, in which 16 miRNAs were more than 2-fold up-regulated, and 11 miRNAs were more than 2-fold down-regulated; and 203 miRNAs were expressing at 72 h post @DISEASE$, in which 19 miRNAs were more than 2-fold up-regulated, and 5 miRNAs were more than 2-fold down-regulated.	0
@MiRNA$ attenuates paclitaxel-resistance of hormone-refractory, drug-resistant @DISEASE$ PC3 cells by regulating MSK1 expressio.	1
The @MiRNA$ was up-regulated during lobular @DISEASE$ progression compared to normal epithelium.	1
The database search on TargetScan, PicTar and miRBase Target identified neurone navigator 3 (NAV3), a regulator of axon guidance, as a principal target of @MiRNA$, and actually @DISEASE$ mRNA levels were elevated in AD brains.	0
@MiRNA$ induces apoptosis by targeting prothymosin alpha in @DISEASE$ cells.	1
The most interesting results came from @MiRNA$, strongly up-regulated in @DISEASE$ and from a set of brain-enriched miRNAs, miR-128, miR-181a, miR-181b, and miR-181c, which are down-regulated in glioblastoma.	1
By converging the FFLs and mutual feedback loops, we constructed a novel @MiRNA$ -TF regulatory network for @DISEASE$.	0
@MiRNA$ inhibits relapse of @DISEASE$ patients following radical surger.	1
BACKGROUND: Through negative regulation of gene expression, microRNAs (@MiRNA$ ) can function in cancers as oncosuppressors, and they can show altered expression in various @DISEASE$ types.	0
Like other types of cancer, the @MiRNA$ glioblastoma shows a distinct @DISEASE$ expression signature, and a number of recent studies have linked these miRNA alterations to key hallmarks of glioblastoma including proliferation, survival, invasion, angiogenesis and stem cell-like behavior.	0
Interestingly the gene locus of one miRNA, @MiRNA$, is a candidate region for two neurologic diseases: early-onset parkinsonism (@DISEASE$ ) and X-linked mental retardation (MRX3).	1
To understand the role of @MiRNA$ in the molecular mechanisms of temporal lobe epilepsy (@DISEASE$ ), we investigated the changes in microRNA (miRNA) expression profiles of chronic TLE rat models.	0
In this review article, the molecular mechanisms underlying the role and function of @MiRNA$ in the regulation of genes involved in neurological and neurodegenerative diseases will be discussed, with a focus on the fragile X syndrome, @DISEASE$ (AD) and prion disease.	0
Overexpression of @MiRNA$ and downregulation of its novel target TGFbeta-RII contribute to the progression of @DISEASE$.	1
A @MiRNA$ binding site polymorphism in the B7-H1 gene is associated with the risk of gastric @DISEASE$.	1
Differential @MiRNA$ Expression in Experimental Cerebral and Noncerebral @DISEASE$.	1
An NF-kB-sensitive @MiRNA$ mediated inflammatory circuit in @DISEASE$ and in stressed human brain cells.	1
Real-time quantitative RT-PCR analysis was carried out to evaluate the expression of @MiRNA$ in 55 @DISEASE$.	0
Thus we have identified the @MiRNA$ expression signature for malignant astrocytoma, in particular @DISEASE$, and showed the miRNA involvement and their importance in astrocytoma development.	0
@MiRNA$ and AMD3100, acting through different mechanism, downmodulate CXCR4 protein levels, impair leukemic cell proliferation and then may be used in combination with anti-@DISEASE$ drugs, for development of new therapeutic strategies.	1
@MiRNA$ has high positive correlation with MMP-9 expression and its upregulation was demonstrated to reduce the levels of MMP-9 expression and inhibit cellular invasion in U251 and U87 @DISEASE$ cells.	1
Upregulation of @MiRNA$ promotes @DISEASE$ angiogenesis by targeting VHL and is associated with poor prognosis and triple-negative breast canc.	1
@MiRNA$ DNA Copy Loss is a Prominent Subtype Specific Event in @DISEASE$.	1
Eight ultra-rare variants in the precursor or mature miRNA were identified in eight distinct @MiRNA$ genes in 4% of analyzed males with @DISEASE$.	0
During a research for miRNAs that are differentially expressed in cerebral cortex of APPswe/PSDeltaE9 mice (a model for Alzheimer's disease) and age-matched controls, one candidate miRNA that is relatively highly expressed, @MiRNA$, was studied further because sequence analysis suggested a likely interaction with the 3'-untranslated region of @DISEASE$ mRNA.	1
The most interesting results came from miR-221, strongly up-regulated in @MiRNA$ and from a set of brain-enriched miRNAs, miR-128, miR-181a, @DISEASE$, and miR-181c, which are down-regulated in glioblastoma.	0
Plasma @MiRNA$ as a biomarker for @DISEASE$.	0
In parallel genetic screens, we identified the @MiRNA$ bantam (ban) as a potent modulator of both polyQ and @DISEASE$ toxicity in flies.	0
SNP rs11614913 on @MiRNA$ gene is associated with the antiviral therapy efficacy of @DISEASE$ patients.The TT genotype or T alleles be associated with the SVR while the CC genotype or C allele could be related to the NVR or recurrence.	1
Here we report the identification @MiRNA$ as a direct regulator of @DISEASE$ expression.	1
@MiRNA$ controls @DISEASE$ proliferation and invasion through regulating Wnt/beta-catenin signaling via Nemo-like kinas.	1
Altogether, these results identify @MiRNA$ and miR-630 as novel modulators of the CDDP response in @DISEASE$.	1
The family of miR-64 and miR-65 are co-underexpressed in the @MiRNA$ transgenic and cat-1 strains, and members of let-7 family co-underexpressed in the alpha-synuclein and pdr-1 strains; mdl-1 and ptc-1 genes are target candidates for miR-64 and @DISEASE$ and are overexpressed in alpha-synuclein transgenic as well as miR-64/65 (tm3711) knockout animals.	0
Analysis of human MBs demonstrated that 3 miR-17 approximately 92 cluster miRNAs (@MiRNA$, miR-19a, and miR-20) were also overexpressed in human @DISEASE$ with a constitutively activated Sonic Hedgehog (SHH) signaling pathway, but not in other forms of the disease.	1
@MiRNA$ suppress @DISEASE$ by Targeting CCND2, CXCR4, and SDF-1{alpha.	1
From the same RNA material analyzed on @MiRNA$ microarrays, mRNA expression profiling was performed using Affymetrix Exon Array microarrays on nondemented, MCI, and @DISEASE$ patients.	0
METHODS: We examined the expression of miRNA (miR)-223 and @MiRNA$ in a mouse model at 6 h, 12 h, 1 day, 3 days and 7 days after @DISEASE$ using quantitative PCR.	0
Aberrant expression of @MiRNA$ can lead to diseases, including @DISEASE$.	0
our data suggests that @MiRNA$ could promote invasion in @DISEASE$ cells via its regulation of TIMP.	1
@MiRNA$ regulates FOXO1-mediated cell apoptosis in @DISEASE$.	1
MiR-107 is a @MiRNA$ (miRNA) that we reported previously to have decreased expression in the temporal cortical gray matter early in the progression of Alzheimer's disease (@DISEASE$ ).	1
Let-7/@MiRNA$ expression is reduced in @DISEASE$ potentially contributing to elevated activity of the Ras pathway and effects on growth control.	1
@MiRNA$ and @DISEASE$ : a cause and a cure?.	0
The tumorigenic FGFR3-TACC3 gene fusion escapes @MiRNA$ regulation in @DISEASE$.	1
Using transiently transfected murine neuronal N2a cells in culture, in parallel to a mouse model of AD, we were able to demonstrate a role for two @MiRNA$ (miR-298 and miR-328) in the regulation of @DISEASE$ (BACE) messenger RNA (mRNA) translation, thereby providing key insights into the molecular basis underlying BACE deregulation in AD.	1
Inhibition of two glioblastoma-upregulated miRNAs (miR-21 and miR-23a) and exogenous overexpression of two @MiRNA$ -downregulated @DISEASE$ (miR-218 and miR-219-5p) resulted in reduced soft agar colony formation but showed varying effects on cell proliferation and chemosensitivity.	1
Tumor suppressor @MiRNA$ decreases cell motility and migration ability in human @DISEASE$ cells by down-regulating RhoC and FZD4.	1
We thus identify @MiRNA$ as novel endogenous regulators of @DISEASE$ expression, suggesting that variations in miRNA expression could contribute to changes in APP expression in the brain during development and disease.	1
Our studies show markedly elevated @MiRNA$ levels in human glioblastoma tumor tissues, early-passage glioblastoma cultures, and in six established @DISEASE$ cell lines (A172, U87, U373, LN229, LN428, and LN308) compared with nonneoplastic fetal and adult brain tissues and compared with cultured nonneoplastic glial cells.	1
We further showed that @MiRNA$ (encoding cyclin E1) is one of the downstream targets of @DISEASE$.	1
We recently showed in HeLa cells that two components of the SMN complex, Gemin3 and Gemin4, together with the argonaute protein @MiRNA$, also associate with microRNAs (@DISEASE$ ) as part of a novel class of RNPs termed miRNPs.	0
Upregulation of @MiRNA$ contributes to the progression of @DISEASE$ via suppression of FOXO1.	1
Suppression of @MiRNA$ expression inhibits the invasion of @DISEASE$ cells.	1
Brain cells maintain distinct populations of miRNAs that support physiologically normal patterns of expression, however, certain @MiRNA$ abundances are significantly altered in neurodegenerative disorders such as Alzheimer's disease (@DISEASE$ ).	1
p53-responsive @MiRNA$ inhibits thrombospondin-1 and promotes angiogenesis in @DISEASE$.	1
@MiRNA$ different expression in @DISEASE$ overexpression or not ErbB.	1
Disruption of miRNA-based post-transcriptional regulation has been implicated in a range of @MiRNA$ as one @DISEASE$ is predicted to impact the expression of numerous downstream mRNA targets.	0
We observed opposing effects of BACE1-antisense and miR-485-5p on @MiRNA$ protein in vitro and showed that Locked Nucleic Acid-antimiR mediated knockdown of miR-485-5p as well as BACE1-antisense over-expression can prevent the @DISEASE$ -induced BACE1 suppression.	0
Expression pattern of @MiRNA$, an @DISEASE$ -associated microRNA, in experimental and human temporal lobe epilepsy.	0
These data suggest a significantly independent regulation of @MiRNA$ and IRAK-2 in AD and in IL-1β+Aβ42 peptide-stressed HAG cells and that an inducible, NF-κB-sensitive, @DISEASE$ -mediated down-regulation of IRAK-1 coupled to an NF-κB-induced up-regulation of IRAK-2 expression drives an extensively sustained inflammatory response.	0
Our research revealed that 136 miRNAs were expressing at 6 h post injury, in which 13 miRNAs were more than 2-fold up-regulated, and 14 miRNAs were more than 2-fold down-regulated; 118 miRNAs were expressing at 24 h post @MiRNA$, in which 4 miRNAs were more than 2-fold up-regulated, and 23 miRNAs were more than 2-fold down-regulated; 149 miRNAs were expressing at 48 h post injury, in which 16 @DISEASE$ were more than 2-fold up-regulated, and 11 miRNAs were more than 2-fold down-regulated; and 203 miRNAs were expressing at 72 h post injury, in which 19 miRNAs were more than 2-fold up-regulated, and 5 miRNAs were more than 2-fold down-regulated.	0
BCL11A overexpression predicts survival and relapse in @DISEASE$ and is modulated by @MiRNA$ and gene amplification.	1
@MiRNA$ induces G1-phase cell cycle arrest and suppresses tumorigenicity in @DISEASE$.	1
@MiRNA$ suppresses cell proliferation and migration by targeting BIRC5 and LASP1 in human @DISEASE$ cells.	1
In this paper, we present for the first time evidence that microRNAs (@MiRNA$ ), including miR-26a, -34a, -145, and let-7b, may directly regulate @DISEASE$ in human and macaque cells.	1
Recent evidence has also shown that REST regulates transcription of regulatory miRNAs (@MiRNA$ ), many of which are known to regulate neuronal gene expression and are dysregulated in @DISEASE$.	1
Overexpression of @MiRNA$ induces chemoresistance in @DISEASE$ mediated through activation of the Akt signaling pathway.	1
RESULTS: We observed increases in plasma concentrations of @MiRNA$, miR-133a, and miR-124 corresponding to @DISEASE$, muscle, and brain, respectively.	1
@MiRNA$ suppresses SOX9-dependent tumorigenicity and promotes favorable prognosis of human @DISEASE$.	1
High expression of @MiRNA$ was associated with a longer disease-free survival (DFS) for patients with stage 2 @DISEASE$ on both univariate and multivariate analyses.	1
This possibility is further corroborated by the observation that a statistically significant decrease in @MiRNA$ expression was found in @DISEASE$ patients.	1
The most interesting results came from miR-221, strongly up-regulated in @MiRNA$ and from a set of brain-enriched miRNAs, miR-128, miR-181a, miR-181b, and @DISEASE$, which are down-regulated in glioblastoma.	0
@MiRNA$ is up-regulated in whole blood @DISEASE$ patient.	1
Expression of @MiRNA$ was highest in the subgroup of medulloblastomas associated with activation of the sonic hedgehog (@DISEASE$ ) signaling pathway compared with other subgroups of medulloblastoma.	1
Our microarray based analysis of microRNA expression in rat cerebral cortex after traumatic brain injury has shown that some @MiRNA$ such as miR-21 could be involved in the intricate process of @DISEASE$ course.	0
@MiRNA$ was found to directly target @DISEASE$ mRNA, thereby inhibiting its translation and blocking Wnt/beta-catenin signaling, which is frequently involved in cancer.	1
Using @MiRNA$ -, @DISEASE$ -, or IRAK-2 promoter-luciferase reporter constructs, we observe decreases in IRAK-1 and increases in miRNA-146a and IRAK-2 expression in interleukin-1β (IL-1β) and amyloid-β-42 (Aβ42) peptide-stressed HAG cells.	0
The family of miR-64 and miR-65 are co-underexpressed in the alpha-synuclein transgenic and cat-1 strains, and members of let-7 family co-underexpressed in the alpha-synuclein and pdr-1 strains; @MiRNA$ and ptc-1 genes are target candidates for miR-64 and @DISEASE$ and are overexpressed in alpha-synuclein transgenic as well as miR-64/65 (tm3711) knockout animals.	1
RESULTS: We found underexpression of miR-145 (2.0-fold; P = 0.04), miR-21 (2.4-fold; P = 0.004), miR-141 (2.6-fold; P = 0.02), let-7a (3.3-fold; P = 0.003), miR-150 (3.8-fold; P = 0.04), miR-15a (4.5-fold; P = 0.03), miR-16 (5.0-fold; P = 0.004), and @MiRNA$ (6.4-fold; P = 0.004) in @DISEASE$ when compared to normal pituitary tissues.	1
In short PMI Alzheimer's disease (@MiRNA$ )-affected temporal lobe neocortex, miRNA-9, miRNA-125b and @DISEASE$ were found to be significantly up-regulated, an effect that was not seen in several related neurological disorders.	1
Interestingly the gene locus of one @MiRNA$, miR-175, is a candidate region for two @DISEASE$ : early-onset parkinsonism (Waisman syndrome) and X-linked mental retardation (MRX3).	1
@MiRNA$ modulates VEGF expression by targeting HIF-1alpha and STAT3 in MCF-7 @DISEASE$ cell.	1
We identified several differentially regulated @MiRNA$ between these groups, which could differentiate @DISEASE$ grades and normal brain as recognized by PCA.	0
To search for miRNAs that may be involved in the pathogenesis of Parkinsons disease (PD), we utilized @MiRNA$ microarrays to identify potential gene expression changes in 115 annotated miRNAs in @DISEASE$ -associated Caenorhabditis elegans models that either overexpress human A53T alpha-synuclein or have mutations within the vesicular catecholamine transporter (cat-1) or parkin (pdr-1) ortholog.	0
Brain cells maintain distinct populations of @MiRNA$ that support physiologically normal patterns of expression, however, certain miRNA abundances are significantly altered in neurodegenerative disorders such as @DISEASE$ (AD).	0
Treatment with 1,25(OH)(2)D(3) and/or epigenetic drugs (5-Aza, TSA) reduced the @MiRNA$ expression in three out of four @DISEASE$ cell lines.	1
Drosophila @MiRNA$ and dp messenger RNAs are translationally repressed by let-7 and @DISEASE$ *, respectively.	1
Recent studies have also demonstrated that microRNAs (@MiRNA$ ) may be responsible for the modulation of cancer-implicated genes in @DISEASE$.	0
In short PMI Alzheimer's disease (@MiRNA$ )-affected temporal lobe neocortex, @DISEASE$, miRNA-125b and miRNA-146a were found to be significantly up-regulated, an effect that was not seen in several related neurological disorders.	1
These data indicate that NF-kappaB-sensitive @MiRNA$ -mediated modulation of CFH gene expression may in part regulate an inflammatory response in AD brain and in stressed HN cell models of @DISEASE$ and illustrate the potential for anti-miRNAs as an effective therapeutic strategy against pathogenic inflammatory signaling.	1
The family of miR-64 and miR-65 are co-underexpressed in the alpha-synuclein transgenic and cat-1 strains, and members of let-7 family co-underexpressed in the alpha-synuclein and pdr-1 strains; mdl-1 and @MiRNA$ genes are target candidates for miR-64 and miR-65 and are overexpressed in alpha-synuclein transgenic as well as @DISEASE$ (tm3711) knockout animals.	0
@MiRNA$ was either inhibited or ectopically expressed transiently in two @DISEASE$ cell lines (BeWo and JEG-3) respectively.	1
Inhibition of two @MiRNA$ -upregulated miRNAs (@DISEASE$ and miR-23a) and exogenous overexpression of two glioblastoma-downregulated miRNAs (miR-218 and miR-219-5p) resulted in reduced soft agar colony formation but showed varying effects on cell proliferation and chemosensitivity.	1
Antagomir-mediated prevention of @MiRNA$ expression led to an increased protein expression of its downstream target @DISEASE$ in the postischemic brain.	1
@MiRNA$ expression is significantly up-regulated in the hippocampus after rodent @DISEASE$.	1
Serum @MiRNA$ as a potential biomarker to track disease in @DISEASE$.	1
In the present study, we used a microarray platform to examine changes in the hippocampal expression levels of 444 verified rodent @MiRNA$ at 3 and 24 hr after controlled cortical impact @DISEASE$.	0
Overexpression of @MiRNA$ Increases Efficacy of Green Tea Polyphenols for Induction of Apoptosis in Human Malignant @DISEASE$ SH-SY5Y and SK-N-DZ Cell.	1
The @MiRNA$ is down-regulated in whole blood @DISEASE$ patient.	1
We additionally recovered @MiRNA$ from cerebrospinal fluid and discovered @DISEASE$ -specific miRNA changes consistent with their role as potential biomarkers of disease.	0
@MiRNA$ mitogen-activated protein kinases and mitogen-activated protein kinases phosphatase-1 in @DISEASE$.	1
@MiRNA$ leads to G1 phase cell cycle arrest in laryngeal @DISEASE$ cells by directly targeting survivin.	1
The @MiRNA$ cluster was significantly (and AD-@DISEASE$ -specific) decreased in AD patients displaying abnormally high BACE1 protein.	0
Among the 26 overexpressed miRNAs, 9 were encoded by the @MiRNA$ approximately 92 cluster family, a group of microRNAs implicated as oncogenes in several @DISEASE$ types.	0
Because gene dosage effects of the APP gene can cause genetic @MiRNA$, dysregulation of the @DISEASE$ network could contribute significantly to disease.	0
Objective: The aim of the study was to analyze the differential expression of let-7a, miR-15a, miR-16, miR-21, miR-141, @MiRNA$, miR-145, and miR-150 in @DISEASE$ and normal pituitary tissue and verify whether their profile of expression correlates with tumor size or remission after treatment.	0
@MiRNA$ inhibits @DISEASE$ cell growth by targeting E2F1 independent of p53 status.	1
Our research revealed that 136 miRNAs were expressing at 6 h post @MiRNA$, in which 13 miRNAs were more than 2-fold up-regulated, and 14 @DISEASE$ were more than 2-fold down-regulated; 118 miRNAs were expressing at 24 h post injury, in which 4 miRNAs were more than 2-fold up-regulated, and 23 miRNAs were more than 2-fold down-regulated; 149 miRNAs were expressing at 48 h post injury, in which 16 miRNAs were more than 2-fold up-regulated, and 11 miRNAs were more than 2-fold down-regulated; and 203 miRNAs were expressing at 72 h post injury, in which 19 miRNAs were more than 2-fold up-regulated, and 5 miRNAs were more than 2-fold down-regulated.	1
Involvement of @MiRNA$ in chemotherapy resistance @DISEASE$ through modulating expression of multidrug resistance-associated protein.	1
@MiRNA$ rs2910164 C allele inhibited cell proliferation and significantly downregulates expression of IRAK1 and TRAF6 in @DISEASE$ cells.	1
In this review ,correlations between @MiRNA$ -mediated gene silencing and Alzheimer's, @DISEASE$, and other neurodegenerative diseases will be discussed.	0
The @MiRNA$ suppresses the proliferation of cervical @DISEASE$ cells through the novel target AKT.	1
@MiRNA$ and its potential targets are associated with characteristics of estrogen receptor alpha-positive @DISEASE$.	1
This study finds that altered miRNA expression levels are observed in postmortem cerebellar cortex from autism patients, a finding which suggests that dysregulation of @MiRNA$ may contribute to @DISEASE$ spectrum phenotype.	1
RESULTS: By microarray analysis, we identified up-regulation of miR-29a, @MiRNA$ and miR-338-3p in @DISEASE$ brains, but due to a great interindividual variation, we could not validate these results by quantitative RT-PCR.	1
@MiRNA$ promotes cell proliferation by directly targeting Rb1 in @DISEASE$.	1
In this commentary, we discuss the known functions of @MiRNA$ in cancer and stem cells, their therapeutic potential and how the findings of Silber et al provide insight into the role of miR-124/miR-137 dysregulation in @DISEASE$.	0
Profiling the expression of 427 mature @MiRNA$ (miRNA) in a series of 90 primary human @DISEASE$ revealed that components of the miR-17/92 polycistron are the most highly up-regulated miRNAs in medulloblastoma.	0
Inactivation of TP53 correlates with disease progression and low @MiRNA$ expression in previously treated @DISEASE$ patient.	1
@MiRNA$ under expression was significantly associated with @DISEASE$ with the KRAS-variant.	1
To investigate noncoding tiny @MiRNA$ mediated gene regulation, miRanda (version 1.0b) was used to predict human miRNA target sites on selected 29 genes related to @DISEASE$.	0
Thus, the results of our study show that the downregulation of miR-21 contributes to the antitumor effects of @MiRNA$ and that @DISEASE$ expression is negatively regulated by STAT3 activation.	0
@MiRNA$ malfunction causes @DISEASE$.	0
We suggest that the expression of GRN is regulated by miRNAs and that common genetic variability in a @MiRNA$ binding-site can significantly increase the risk for @DISEASE$.	1
Inhibition of @MiRNA$ resulted in decreased levels of cholesterol in the plasma and improved liver function in @DISEASE$ mice.	1
Furthermore, microinfusion of lentiviral vectors that contained @MiRNA$ (miRNAs) targeting long-form PDE4D isoforms into bilateral dentate gyri of the mouse hippocampus downregulated PDE4D4 and @DISEASE$, enhanced memory, and increased hippocampal neurogenesis and pCREB.	1
@MiRNA$ promotes apoptosis by targeting mTOR in human esophageal @DISEASE$.	1
Photofrin Based Photodynamic Therapy and @MiRNA$ Transfection Inhibited FGFR3 and PI3K/Akt Signaling Mechanisms to Control Growth of Human @DISEASE$ In Vitro and In Viv.	1
Coordinated silencing of MYC-mediated @MiRNA$ by HDAC3 and EZH2 as a therapeutic target of histone modification in aggressive @DISEASE$.	1
@MiRNA$ as a novel tumor suppressor in @DISEASE$.	1
A direct correlation was found between the downregulation of @MiRNA$ and the upregulation of @DISEASE$ in human meningioma samples.	1
Pathogenic LRRK2 antagonizes these @MiRNA$, leading to the overproduction of E2F1/DP, previously implicated in cell cycle and survival control and shown here to be critical for @DISEASE$ pathogenesis.	0
Therapeutic Inhibition of @MiRNA$ Improves Cardiac Function and Survival During @DISEASE$.	1
@MiRNA$ decreased in @DISEASE$ brains targets neuron navigator-.	1
To identify a microRNA (miRNA) expression signature that can predict @MiRNA$ patient survival, we analyzed the @DISEASE$ expression data of GBM patients (n = 222) derived from The Cancer Genome Atlas (TCGA) dataset.	0
Using transiently transfected murine neuronal N2a cells in culture, in parallel to a mouse model of AD, we were able to demonstrate a role for two @MiRNA$ (miR-298 and miR-328) in the regulation of beta-amyloid (Abeta) precursor protein (APP)-converting enzyme (BACE) messenger RNA (mRNA) translation, thereby providing key insights into the molecular basis underlying @DISEASE$ deregulation in AD.	0
WASF3 regulates @MiRNA$ inactivation by ZEB1 through suppression of KISS1 leading to increased invasiveness in @DISEASE$ cell.	1
The results suggest (a) that unless specifically stabilized, certain brain-enriched miRNAs represent a rapidly executed signaling system employing highly transient effectors of CNS gene expression, and (b) that in @MiRNA$ temporal lobe neocortex specific brain @DISEASE$ are significantly up-regulated in abundance and strongly correlate with the presence of AD-type neuropatholgical change.	1
Effect of @MiRNA$ and its target gene cationic amino acid transporter 1 on colorectal liver @DISEASE$.	1
In this report, we present data on the @MiRNA$ expressed under ischemic conditions in both the brain and blood of rats subjected to middle cerebral artery occlusion (@DISEASE$ ).	0
In this commentary, we discuss the known functions of miRNAs in @MiRNA$ and stem cells, their therapeutic potential and how the findings of Silber et al provide insight into the role of miR-124/@DISEASE$ dysregulation in glioblastomas.	0
MicroRNA expression in ACTH-producing pituitary tumors: up-regulation of @MiRNA$ in @DISEASE$.	1
Effects of @MiRNA$ on negatively regulating L-type calcium channel beta2 subunit gene expression during @DISEASE$.	1
@MiRNA$ Is a Novel Predictor for Early Recurrence of Hepatitis B Virus-Related @DISEASE$ after Surgical Resectio.	1
We used @MiRNA$ profiling with 1,145 probes to study miRNA expression in normal anterior pituitary (6 cases), @DISEASE$ (ACTH)-producing adenomas (8 cases), and ACTH-producing pituitary carcinomas (two cases).	0
@MiRNA$ promotes HBV related @DISEASE$ development in males.	1
The @MiRNA$ is amplified in @DISEASE$.	1
We have recently compared the @MiRNA$ expression profiles between normal brain and @DISEASE$ tissues from Chinese patients by miRNA microarray and identified a panel of differentially expressed miRNAs.	0
Interestingly, both miRNAs are capable of binding directly to @MiRNA$ in different positions: within the @DISEASE$ sequence itself (let-7b) or in the hairpin precursor (miR-663).	0
@MiRNA$ up-regulation was shown in specimens from patients with pathological evidence of intestinal aGVHD (Acute @DISEASE$.	1
Overexpression of @MiRNA$ relates to reduction of the @DISEASE$ and its relationship to clinicopathological features in pituitary adenomas.	1
The entire @MiRNA$ seed family is strongly deregulated in clear cell @DISEASE$ compared to the proximal tubular epithelial cells of the kidne.	1
If present in somatic cells, @MiRNA$ alterations may play a role in @DISEASE$ initiation, while if present in germ line cells they could constitute a cancer predisposing event.	0
@MiRNA$ contributes to @DISEASE$ by stimulating MAP kinase signalling in fibroblast.	1
Highly increased maspin expression corresponds with up-regulation of @MiRNA$ in @DISEASE$.	1
@MiRNA$ acts as a tumor suppressor and negatively regulates FGFR1 in @DISEASE$.	1
@MiRNA$ down-regulation via DNA methylation promotes self-renewal and epithelial-mesenchymal transition in @DISEASE$ initiating cells.	1
@MiRNA$ regulates cardiomyocytic apoptosis during cardioplegia-induced @DISEASE$ by targeting interleukin 10-related pathway.	1
Moreover, 24 @MiRNA$ were identified as a predictive signature of @DISEASE$ and 29 miRNAs were able to predict pituitary adenoma histotype.	0
Over-expression of @MiRNA$ enhances the effectiveness of HSVtk gene therapy for @DISEASE$.	1
This NF-kappaB-@MiRNA$ -CFH signaling circuit is known to be similarly affected by Abeta42 peptides and in @DISEASE$ brain.	0
@MiRNA$ expression is influenced by immunoglobulin gene rearrangement and affects the biology of @DISEASE$.	1
@MiRNA$ Inhibits Growth of Epithelial @DISEASE$ by Relieving Chromatin-Mediated Transcriptional Repression of p21(waf1/cip1).	1
The interactive signaling of NF-κB and miRNA-146a further illustrate interplay between inducible transcription factors and pro-inflammatory @MiRNA$ that regulate brain @DISEASE$ expression.	1
@MiRNA$ Downregulated Sec23A protein in @DISEASE$.	1
This is a rapidly evolving field and it is likely that we have only begun to appreciate the involvement of microRNAs in relation to glioma formation, and the therapeutic potential of @MiRNA$ to improve outcome for @DISEASE$ patients.	0
Moreover, 24 miRNAs were identified as a predictive signature of @MiRNA$ and 29 @DISEASE$ were able to predict pituitary adenoma histotype.	0
Our in vitro results suggested that Aβ42 oligomer-induced @MiRNA$ leads to impairment in @DISEASE$ signaling through TβR II, concomitant with retinoic acid-induced neurodegeneration in SH-SY5Y cells.	0
METHODS AND FINDINGS: To explore the role of @MiRNA$ in schizophrenia, 59 microRNA genes on the X-chromosome were amplified and sequenced in males with (193) and without (191) schizophrenia spectrum disorders to test the hypothesis that ultra-rare mutations in microRNA collectively contribute to the risk of @DISEASE$.	0
Lenalidomide-mediated enhanced translation of C/EBPalpha-p30 protein up-regulates expression of the antileukemic @MiRNA$ in @DISEASE$.	1
Although @MiRNA$ are being extensively studied for their involvement in cancer and development, little is known about their roles in @DISEASE$ (AD).	0
@MiRNA$ physiologically inhibits expression of amyloid-beta precursor protein in cultured human fetal brain cells and is dysregulated in a subset of @DISEASE$ patients.	1
Epigenetically silenced @MiRNA$ as a novel faecal-based screening marker for @DISEASE$.	1
One of the most active fields of miR@MiRNA$ search is miRNA regulation of apoptosis, a programmed cell death implicated in many human diseases, such as can@DISEASE$ lzheimer's disease, hypertrophy and heart failur.	0
Target prediction and gene ontology enrichment analysis disclosed targeting of several gene families/biological processes by differentially expressed @MiRNA$ (DEMs), with cell death-related genes, including @DISEASE$, showing a bias toward down-regulated DEMs.	0
We therefore investigated changes in microRNA (miRNA) expression profiles of @MiRNA$ patients and found that several @DISEASE$ potentially involved in the regulation of APP and BACE1 expression appeared to be decreased in diseased brain.	0
Recent studies have identified changes of several specific miRNA expression profiles and polymorphisms affecting the interactions between miRNAs and their targets in various brain disorders, including addiction: miR-16 causes adaptive changes in production of the serotonin transporter; @MiRNA$ is specifically expressed in midbrain dopaminergic neurons, and regulates the production of @DISEASE$ and the dopamine transporter; miR-212 affects production of striatal brain-derived neurotrophic factor and synaptic plasticity upon cocaine.	0
Analysis of human MBs demonstrated that 3 @MiRNA$ approximately 92 cluster miRNAs (miR-92, miR-19a, and miR-20) were also overexpressed in human MBs with a constitutively activated @DISEASE$ (SHH) signaling pathway, but not in other forms of the disease.	0
Co-suppression of @MiRNA$ suppresses human @DISEASE$ cell growth by targeting p27kip1 in vitro and in vivo.	1
The common exonic synonymous SNP (c.313C>T) in IRGM alters a binding site for @MiRNA$ and causes deregulation of IRGM-dependent xenophagy in @DISEASE$.	1
The family of miR-64 and @MiRNA$ -65 are co-underexpressed in the alpha-synuclein transgenic and cat-1 strains, and members of let-7 family co-underexpressed in the @DISEASE$ and pdr-1 strains; mdl-1 and ptc-1 genes are target candidates for miR-64 and miR-65 and are overexpressed in alpha-synuclein transgenic as well as miR-64/65 (tm3711) knockout animals.	0
In a well-characterized Belgian group of 358 @MiRNA$ patients and 462 controls, we examined whether genetic variability in @DISEASE$ (miRNA) binding sites of APP and BACE1 or in associated miRNAs influenced risk for A.	0
Using miRNA-146a-, IRAK-1-, or IRAK-2 promoter-luciferase reporter constructs, we observe decreases in IRAK-1 and increases in @MiRNA$ and @DISEASE$ expression in interleukin-1β (IL-1β) and amyloid-β-42 (Aβ42) peptide-stressed HAG cells.	1
Interestingly the gene locus of one miRNA, @MiRNA$, is a candidate region for two neurologic diseases: early-onset parkinsonism (Waisman syndrome) and @DISEASE$ (MRX3).	1
Since its identification 3 years ago as the miRNA most commonly and strongly up-regulated in human @MiRNA$ [1], miR-21 has attracted the attention of researchers in various fields, such as development, oncology, stem cell biology and aging, becoming one of the most studied @DISEASE$, along with let-7, miR-17-92 cluster ('oncomir-1'), miR-155 and a few others.	0
Upregulation of @MiRNA$ leads to decreased AE2 expression in biliary epithelium of patients with @DISEASE$.	1
@MiRNA$ Activation of miR-17-92 by NK-like homeodomain proteins suppresses apoptosis via reduction of E2F1 in @DISEASE$.	1
We performed a large-scale, genome-wide microRNA (miRNA) (n=756) expression profiling of 26 glioblastoma, 13 @MiRNA$ and 7 normal brain samples with an aim to find deregulated @DISEASE$ in malignant astrocytoma.	0
The expression of several BMC @MiRNA$ was found to increase in AD relative to NEC levels, and may differ between @DISEASE$ subjects bearing one or two APOE4 alleles.	0
The family of miR-64 and @MiRNA$ -65 are co-underexpressed in the alpha-synuclein transgenic and cat-1 strains, and members of let-7 family co-underexpressed in the alpha-synuclein and pdr-1 strains; @DISEASE$ and ptc-1 genes are target candidates for miR-64 and miR-65 and are overexpressed in alpha-synuclein transgenic as well as miR-64/65 (tm3711) knockout animals.	0
An NF-kappaB-containing miRNA-146a-promoter-luciferase reporter construct transfected into HN cells showed significant up-regulation of @MiRNA$ after aluminum-sulfate treatment that corresponded to decreased @DISEASE$ gene expression.	1
@MiRNA$ targets Slug and endows @DISEASE$ A549 cells with epithelial and anti-tumorigenic propertie.	1
Pathogenic LRRK2 antagonizes these @MiRNA$, leading to the overproduction of E2F1/@DISEASE$, previously implicated in cell cycle and survival control and shown here to be critical for LRRK2 pathogenesis.	0
Regulation of @MiRNA$ by @DISEASE$ may contribute to HD pathogenesis.	1
High @MiRNA$ and low CDC2 levels associate with decreased EZH2 expression and with favorable outcome on tamoxifen in metastatic @DISEASE$.	1
IFN-beta treatment reduced @MiRNA$ expression in glioma cells markedly, and @DISEASE$ administration suppressed the growth of glioma-initiating cell-derived intracranial tumors.	0
In sum, our results suggest that specific @MiRNA$ are involved in the fine-tuning of @DISEASE$ alternative splicing in neurons.	0
The expression of microRNA @MiRNA$ decreases early in @DISEASE$ and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1.	1
TLE alters the expression levels of a subset of miRNAs in the hippocampus and these deregulated miRNAs may be involved in the pathogenesis of epilepsy directly or indirectl@MiRNA$.	0
BACKGROUND: The purpose of this study was to (1) identify specific miRNAs in growth hormones (GH)-secreting pituitary adenomas; (2) determine the relationship between the expression of these @MiRNA$ and tumor size, somatostatin analogs treatment, and responsiveness to @DISEASE$ analogs (SSA).	0
We did reporter assays to elucidate the @MiRNA$ -mediated suppression of miR-21; the addition of signal transducers and activators of transcription 3 (STAT3)-expressing vectors induced the IFN-beta-mediated suppression of miR-21, whereas STAT3-inhibiting agents inhibited the @DISEASE$ suppression.	0
We did reporter assays to elucidate the IFN-beta-mediated suppression of @MiRNA$ ; the addition of @DISEASE$ (STAT3)-expressing vectors induced the IFN-beta-mediated suppression of miR-21, whereas STAT3-inhibiting agents inhibited the miR-21 suppression.	0
@MiRNA$ governs TORC1 activation in @DISEASE$ cell proliferation and invasion.	1
We used experimental validation in addition to literature to reveal how the deregulated brain @MiRNA$ are biomarkers for known and novel pathways in AD pathogenesis related to amyloid processing, neurogenesis, @DISEASE$ resistance, and innate immunity.	0
Here we provide evidence in human neural (HN) cells of an aluminum-sulfate- and reactive oxygen species (ROS)-mediated up-regulation of an NF-kappaB-sensitive @MiRNA$ that down-regulates the expression of complement factor H (@DISEASE$ ), an important repressor of inflammation.	1
The results show the possible use of blood @MiRNA$ as biomarkers for brain injury; that selected blood miRNAs may correlate with miRNA changes in the brain; and that many of the mRNAs, previously shown to be regulated in brain and blood after @DISEASE$, are likely accounted for by changes in miRNA expression.	0
@MiRNA$ induces apoptosis and is regulated by the Akt/FOXO pathway in @DISEASE$.	1
Overexpression of @MiRNA$ induces conversion of highly invasive @DISEASE$ cell.	1
@MiRNA$ Negatively Regulates p21 Expression During Late Neoplastic Progression in @DISEASE$.	1
@MiRNA$ suppresses @DISEASE$ cell proliferation and induces senescence via regulation of E2F1.	1
Recent studies have identified changes of several specific miRNA expression profiles and polymorphisms affecting the interactions between miRNAs and their targets in various brain disorders, including addiction: @MiRNA$ causes adaptive changes in production of the serotonin transporter; miR-133b is specifically expressed in midbrain dopaminergic neurons, and regulates the production of @DISEASE$ and the dopamine transporter; miR-212 affects production of striatal brain-derived neurotrophic factor and synaptic plasticity upon cocaine.	0
Our results show that transgenic @MiRNA$ mice have abnormal @DISEASE$ biogenesis.	0
@MiRNA$ inhibits migration and invasion @DISEASE$ cells via targeting to Fra-1.	1
@MiRNA$ Down-regulated in the blook serum of patients with @DISEASE$ compared to healthy controls.	1
Both the deregulation of genes controlled by miRNAs and the altered @MiRNA$ expression have been linked to many disorders, including cancer, cardiovascular, metabolic and @DISEASE$.	0
@MiRNA$ increases sensitivity of @DISEASE$ cells to cisplatin and is associated with a favourable clinical outcome.	1
In neurodegenerative disorders such as @MiRNA$ (AD), brain miRNA profiles are altered; thus @DISEASE$ dysfunction could be both a cause and a consequence of disease.	0
@MiRNA$ Regulates Epithelial Mesenchymal Transition in @DISEASE$ Cell Lines.	1
We recently showed in HeLa cells that two components of the SMN complex, Gemin3 and Gemin4, together with the argonaute protein @MiRNA$, also associate with @DISEASE$ (miRNAs) as part of a novel class of RNPs termed miRNPs.	0
A strong positive correlation between @MiRNA$ abundance and the glial cell markers glial fibrillary acidic protein (GFAP) and vimentin, and CDKN2A down-regulation was noted in advanced Alzheimer's disease (AD) and in Down's syndrome (@DISEASE$ ) brain, chronic neurological disorders associated with astrogliosis.	0
@MiRNA$ a c/EBPalpha target,; Inhibits metastatic @DISEASE$ antigen.	1
Altered @MiRNA$ expression following @DISEASE$.	1
@MiRNA$ contributes to paclitaxel resistance in @DISEASE$ cells both in vitro and in vivo.	1
We investigated the expression and cellular distribution of @MiRNA$ (miR-146a) in a rat model of @DISEASE$ as well as in human TLE.	0
@MiRNA$ targets Bcl-2 expression and enhances responsiveness of @DISEASE$.	1
Pre-miR-181a and pre-@MiRNA$ consistently modulated mitochondrial/postmitochondrial steps of the intrinsic pathway of apoptosis, including @DISEASE$ oligomerization, mitochondrial transmembrane potential dissipation, and the proteolytic maturation of caspase-9 and caspase-3.	1
In this review article, the molecular mechanisms underlying the role and function of @MiRNA$ in the regulation of genes involved in neurological and neurodegenerative diseases will be discussed, with a focus on the @DISEASE$, Alzheimer's disease (AD) and prion disease.	0
Smad3-Mediated Upregulation of @MiRNA$ Promotes Renal @DISEASE$.	1
Human brains retain discrete populations of micro RNA (miRNA) species that support homeostatic brain gene expression functions; however, specific @MiRNA$ abundance is significantly altered in neurological disorders such as @DISEASE$ (AD) when compared with age-matched controls.	1
Generated by the @MiRNA$, @DISEASE$ (miRNAs) are predicted to regulate up to 90% of the genes in humans, suggesting that they may control every cellular processes in all cells and tissues of the human body.	0
Only one of these @MiRNA$, miR-128, has previously been shown to be de-regulated in @DISEASE$.	1
In a well-characterized Belgian group of 358 AD patients and 462 controls, we examined whether genetic variability in microRNA (@MiRNA$ ) binding sites of APP and BACE1 or in associated miRNAs influenced risk for @DISEASE$.	0
@MiRNA$ functions as a potential tumor suppressor in @DISEASE$ by targeting Smad.	1
@MiRNA$ is a negative regulator of fibrogenesis and @DISEASE$.	1
@MiRNA$ targets TNFAIP3, inhibits cell proliferation and induces apoptosis in hepatitis B virus-related @DISEASE$.	1
Our results showed that the expression of miR-106b was inversely correlated with @MiRNA$ protein levels and @DISEASE$ can directly inhibit the TβR II translation in vitro.	0
This study finds that altered @MiRNA$ expression levels are observed in postmortem cerebellar cortex from autism patients, a finding which suggests that dysregulation of miRNAs may contribute to @DISEASE$ spectrum phenotype.	0
@MiRNA$ and its targets STAT3 and RAP1A modulate taxane sensitivity in @DISEASE$.	1
To understand the role of miRNAs in the molecular mechanisms of temporal lobe epilepsy (@MiRNA$ ), we investigated the changes in @DISEASE$ (miRNA) expression profiles of chronic TLE rat models.	0
@MiRNA$ Controls Release of TNF-a Protein and Stability of Its mRNA in @DISEASE$ via Tristetraprolin Stabilization.	1
We show that the expression of @MiRNA$ is inversely correlated with the protein level of @DISEASE$ in APPswe/PSDeltaE9 mice and age-matched controls, and miR-34a expression directly inhibits bcl2 translation in SH-SY5Y cells.	1
ZEB1 overexpression associated with E-cadherin and @MiRNA$ downregulation is characteristic of undifferentiated @DISEASE$.	1
@MiRNA$ inhibits glycolysis and depletes stemness of @DISEASE$ stem-like cell.	1
@MiRNA$ have essential functional roles in brain development and neuronal specification but their roles in neurodegenerative diseases such as Alzheimer's disease (@DISEASE$ ) is unknown.	0
Overexpression of these three @MiRNA$ during PbA, but not PbK, @DISEASE$ in WT mice may be critical for the triggering of the neurological syndrome via regulation of their potential downstream targets.	0
MATERIALS AND METHODS: @MiRNA$ profiling of @DISEASE$ was carried out using Taqman Low Density Array v 1.0 having 365 human microRNAs.	0
A @MiRNA$ binding site polymorphism (rs17875871) in the 3'UTR of IFNAR1 is associated with @DISEASE$ susceptibility.	1
Consistent with the @MiRNA$ data, HIVE brains exhibited higher levels of @DISEASE$ transcripts compared with control patients.	0
@MiRNA$ was detected down-regulated expression at 0h, 1h, 6h, 2days, 7days, 50days after SE and up-regulated expression at 12h, 24h, 10days, 30days after SE, which was significantly up-regulated expression at 24h after @DISEASE$ (10.49 folds, P<0.01).	1
We identified recurrent amplification of the @MiRNA$ polycistron proto-oncogene in 6% of @DISEASE$ by high-resolution single-nucleotide polymorphism genotyping arrays and subsequent interphase fluorescence in situ hybridization on a human medulloblastoma tissue microarray.	1
@MiRNA$ was also up-regulated in carcinomas compared to ACTH @DISEASE$.	0
1,25-Dihydroxyvitamin D3 suppresses telomerase expression and human @DISEASE$ growth through @MiRNA$.	1
@MiRNA$ 21-mediated suppression of Sprouty1 by Pokemon affects @DISEASE$ cell growth and proliferatio.	1
@MiRNA$ suppression impedes @DISEASE$ cell migration.	1
We used miRNA profiling with 1,145 probes to study @MiRNA$ expression in normal anterior pituitary (6 cases), adrenocorticotropin (ACTH)-producing @DISEASE$ (8 cases), and ACTH-producing pituitary carcinomas (two cases).	0
Moreover, a discussion is provided concerning the possible role of validated and putative targets of the most dysregulated @MiRNA$ in @DISEASE$ pathogenesis.	0
@MiRNA$ could function as a potent tumor suppressor in the development of uveal @DISEASE$.	1
A few miRNAs were differentially expressed in WM, including miR-212 that is downregulated in AD and @MiRNA$ which is upregulated in @DISEASE$.	1
Development of a @MiRNA$ Companion Diagnostic Test for Adjuvant Interferon-alpha Therapy in @DISEASE$.	1
A specific subset of five miRNAs revealed by in silico target prediction was significantly overexpressed in NFA samples; three miRs (miR-128a, @MiRNA$, and miR-516a-3p) targeted the 3'-untranslated region of the @DISEASE$ transcript, and exogenous overexpression of these miRs inhibited Wee1 protein expression and HeLa cell proliferation.	1
As a genetically complex disease, dysregulation of @MiRNA$ expression might be a feature of @DISEASE$ (ASDs).	1
@MiRNA$ Inhibits @DISEASE$ through Demethylation, Active Chromatin Modifications, and AKT Pathway.	1
@MiRNA$ inhibits pancreatic @DISEASE$ through repressing Smad.	1
The potential biologic significance of this regulation is supported by evidence of an apparent negative feedback loop, with increased expression of three IFN-beta-regulating @MiRNA$ by primate macrophages exposed to recombinant IFN-beta or stimulated to produce @DISEASE$.	0
@MiRNA$ was found to be implicated in the regulation of the EMT program in response to TGF-beta and was shown to be directly involved in the TGF-β-induced @DISEASE$ cell invasiveness through Net1A regulation.	1
Overexpression of @MiRNA$ attenuates @DISEASE$ induced apoptosis by inhibiting caspase-3 expression in cardiac myocytes.	1
RESULTS: We found underexpression of @MiRNA$ (2.0-fold; P = 0.04), miR-21 (2.4-fold; P = 0.004), miR-141 (2.6-fold; P = 0.02), let-7a (3.3-fold; P = 0.003), miR-150 (3.8-fold; P = 0.04), miR-15a (4.5-fold; P = 0.03), miR-16 (5.0-fold; P = 0.004), and miR-143 (6.4-fold; P = 0.004) in @DISEASE$ when compared to normal pituitary tissues.	1
Recent studies have identified changes of several specific miRNA expression profiles and polymorphisms affecting the interactions between miRNAs and their targets in various brain disorders, including addiction: miR-16 causes adaptive changes in production of the serotonin transporter; miR-133b is specifically expressed in midbrain dopaminergic neurons, and regulates the production of tyrosine hydroxylase and the dopamine transporter; @MiRNA$ affects production of striatal @DISEASE$ and synaptic plasticity upon cocaine.	0
@MiRNA$ as a molecular basis for @DISEASE$, Alzheimer's and prion diseases.	0
However, we found significant down-regulation of @MiRNA$ in Alzheimer disease (@DISEASE$ ) brains.	1
Cyclooxygenase-2 Is a Target of @MiRNA$ in Human @DISEASE$ Cell.	1
@MiRNA$ is aberrantly overexpressed in Nucleophosmin1 mutated @DISEASE$ and its suppression induces cell death.	1
@MiRNA$ controls CDKN1C/P57 expression in human @DISEASE$.	1
BACKGROUND: Through negative regulation of gene expression, @MiRNA$ (miRNAs) can function in cancers as oncosuppressors, and they can show altered expression in various @DISEASE$ types.	0
Our research revealed that 136 miRNAs were expressing at 6 h post injury, in which 13 miRNAs were more than 2-fold up-regulated, and 14 miRNAs were more than 2-fold down-regulated; 118 miRNAs were expressing at 24 h post injury, in which 4 miRNAs were more than 2-fold up-regulated, and 23 miRNAs were more than 2-fold down-regulated; 149 miRNAs were expressing at 48 h post @MiRNA$, in which 16 miRNAs were more than 2-fold up-regulated, and 11 miRNAs were more than 2-fold down-regulated; and 203 miRNAs were expressing at 72 h post injury, in which 19 miRNAs were more than 2-fold up-regulated, and 5 @DISEASE$ were more than 2-fold down-regulated.	0
Several studies have identified genetic variants in @MiRNA$ target sites that are claimed to be associated with disorders ranging from @DISEASE$ to cancer.	0
Decrease in blood @MiRNA$ predicts chemotherapy resistance and poor clinical outcome in patients receiving systemic chemotherapy for metastatic @DISEASE$.	1
Functional @MiRNA$ is transferred between @DISEASE$ cells.	0
@MiRNA$ 21 promotes @DISEASE$ invasion by targeting matrix metalloproteinase regulators.	1
Recent evidence has also shown that @MiRNA$ regulates transcription of regulatory @DISEASE$ (microRNAs), many of which are known to regulate neuronal gene expression and are dysregulated in H.	1
Thus, @MiRNA$ may contribute significantly to the regulation of @DISEASE$ in innate immune responses.	1
The family of @MiRNA$ and miR-65 are co-underexpressed in the alpha-synuclein transgenic and cat-1 strains, and members of let-7 family co-underexpressed in the alpha-synuclein and pdr-1 strains; mdl-1 and ptc-1 genes are target candidates for miR-64 and miR-65 and are overexpressed in @DISEASE$ transgenic as well as miR-64/65 (tm3711) knockout animals.	0
Together, the coordinated application of @MiRNA$ profiling, Affymetrix microarrays, new bioinformatics predictions, in situ hybridization, and biochemical validation indicate that miR-107 may be involved in accelerated disease progression through regulation of @DISEASE$.	0
The different expression pattern observed in tumors at different stages of malignancy is probably dependent on the cell-specific repertoire of target genes of tumors sharing different molecular pathways activity and suggests @MiRNA$ may have also a place in diagnosis and staging of @DISEASE$.	0
Frequent methylation and oncogenic role of @MiRNA$ in @DISEASE$.	1
@DISEASE$ patients had significantly higher @MiRNA$ levels than healthy controls in serum.	1
Moreover, 24 @MiRNA$ were identified as a predictive signature of pituitary adenoma and 29 miRNAs were able to predict @DISEASE$ histotype.	0
@MiRNA$ 144 Impairs Insulin Signaling by Inhibiting the Expression of Insulin Receptor Substrate 1 in @DISEASE$.	1
@MiRNA$ is commonly repressed in conjunctival @DISEASE$ and targets cyclin E2.	1
In our study, we examined by microarray the global expression levels of 245 @MiRNA$ in glioblastoma multiforme, the most frequent and malignant of primary @DISEASE$.	0
@MiRNA$ is overexpressed in @DISEASE$ promotes its invasiveness, and correlates with a poor prognosis.	1
We confirm that downregulation of a set of miRNAs in GM (including several miR-15/107 genes and @MiRNA$ paralogs) correlated strongly with the density of diffuse @DISEASE$ detected in adjacent tissue.	0
We show that miRNAs belonging to the @MiRNA$ family (that is, miR-20a, miR-17-5p and miR-106b) could regulate @DISEASE$ expression in vitro and at the endogenous level in neuronal cell lines.	1
Recently published studies pertaining to the roles of @MiRNA$ in NDs--including @DISEASE$, Parkinson's disease and triplet repeat disorders-are described.	0
Down-regulation of these @MiRNA$ has been reported in @DISEASE$ (CLL), pituitary adenomas, and prostate carcinoma.	1
We recently showed in HeLa cells that two components of the SMN complex, Gemin3 and @MiRNA$, together with the argonaute protein eIF2C2, also associate with @DISEASE$ (miRNAs) as part of a novel class of RNPs termed miRNPs.	0
CONCLUSION: We investigated gene and @MiRNA$ Expression in Glioblastoma and gave a comprehensive function study of differential expressed gene and microRNA in @DISEASE$ patients.	0
blood;Expression of the Transcription Factor Sp1 and its Regulatory @MiRNA$ in Peripheral Blood Mononuclear Cells from Patients with @DISEASE$.	1
Mutual antagonism between IP(3)RII and @MiRNA$ regulates calcium signals and @DISEASE$.	1
To address whether @MiRNA$ pathways play a role in neurodegeneration, we tested whether genes critical for miRNA processing modulated toxicity induced by the spinocerebellar ataxia type 3 (@DISEASE$ ) protein.	0
@DISEASE$ is positively regulated by @MiRNA$.	1
These data suggest a significantly independent regulation of IRAK-1 and @MiRNA$ in AD and in IL-1β+Aβ42 peptide-stressed HAG cells and that an inducible, NF-κB-sensitive, @DISEASE$ -mediated down-regulation of IRAK-1 coupled to an NF-κB-induced up-regulation of IRAK-2 expression drives an extensively sustained inflammatory response.	0
We identified a @MiRNA$, miR-133b, that is specifically expressed in midbrain DNs and is deficient in midbrain tissue from patients with @DISEASE$.	1
The modulation of @MiRNA$ by type I IFN through the activation of signal transducers and activators of transcription 3 in human @DISEASE$.	0
Recently, differential expression of endogenous regulatory small RNAs, known as 'microRNAs' (@MiRNA$ ), in patients of Alzheimer's disease, @DISEASE$ and models of ataxia suggest that they might have key regulatory roles in neurodegeneration.	0
@MiRNA$ Is Down-regulated in TMPRSS2:ERG Fusion-positive @DISEASE$.	1
Oncogenic @MiRNA$ is a Target for Genistein in @DISEASE$ Cell.	1
@MiRNA$ are involved in a large number of biological functions such as development, metabolism, immunity and diseases such as @DISEASE$, cardiovascular diseases and diabetes.	0
Overexpression of these three @MiRNA$ during PbA, but not PbK, infection in WT mice may be critical for the triggering of the @DISEASE$ via regulation of their potential downstream targets.	0
To test whether the miR-17 approximately 92 cluster could promote MB formation, we enforced expression of these @MiRNA$ in GNPs isolated from cerebella of postnatal (P) day P6 @DISEASE$ -/-; Ptch1+/- mice.	0
Our results indicate that @MiRNA$ is an important determinant in spinal cord regeneration of adult zebrafish through reduction in @DISEASE$ protein levels by direct interaction with its mRNA.	1
Recent years have seen considerable progress in @MiRNA$ research in brain tumors, particularly in glioblastomas and @DISEASE$, providing novel insights into the pathogenesis of these malignant lesions.	0
Using @MiRNA$ -, IRAK-1-, or IRAK-2 promoter-luciferase reporter constructs, we observe decreases in @DISEASE$ and increases in miRNA-146a and IRAK-2 expression in interleukin-1β (IL-1β) and amyloid-β-42 (Aβ42) peptide-stressed HAG cells.	0
MicroRNA expression in @MiRNA$ -producing pituitary tumors: up-regulation of @DISEASE$ in pituitary carcinomas.	0
@MiRNA$ regulates KEAP1 and modulates cisplatin sensitivity in @DISEASE$ cell.	1
In this commentary, we discuss the known functions of miRNAs in @MiRNA$ and stem cells, their therapeutic potential and how the findings of Silber et al provide insight into the role of @DISEASE$ /miR-137 dysregulation in glioblastomas.	0
Sulindac inhibits @DISEASE$ cell invasion by suppressing NF-kB-mediated transcription of @MiRNA$.	1
Among the 26 overexpressed @MiRNA$, 9 were encoded by the miR-17 approximately 92 cluster family, a group of microRNAs implicated as oncogenes in several @DISEASE$ types.	0
@MiRNA$ increases proliferation in @DISEASE$ through repression of Caudal-related homeobox.	1
@MiRNA$ (miRNAs) are short RNA molecules regulating gene expression, and are implicated in a variety of diseases including @DISEASE$.	0
Morphine induced exacerbation of @DISEASE$ is mediated by tempering endotoxin tolerance through modulation of @MiRNA$.	1
We also show that @MiRNA$ is frequently amplified at the DNA level in human glioma, most often in association with monoallelic @DISEASE$ loss.	1
Corticosteroid resistance in @DISEASE$ is influenced by @MiRNA$ induced downregulation of glucocorticoid receptor-alph.	1
@MiRNA$ induces cell cycle arrest through targeting of E2F1, USF2 and PTPN1 and is associated with recurrence of @DISEASE$.	1
We analyzed the effect of IFN-beta treatment on @MiRNA$ expression in @DISEASE$ cells and intracranial glioma xenografts.	0
Since its identification 3 years ago as the miRNA most commonly and strongly up-regulated in human @MiRNA$ [1], miR-21 has attracted the attention of researchers in various fields, such as development, oncology, stem cell biology and aging, becoming one of the most studied miRNAs, along with @DISEASE$, miR-17-92 cluster ('oncomir-1'), miR-155 and a few others.	0
Inhibition of SOX17 by @MiRNA$ and Methylation Activates the WNT Signaling Pathway in @DISEASE$.	1
METHODS AND FINDINGS: To explore the role of miRNAs in schizophrenia, 59 @MiRNA$ genes on the X-chromosome were amplified and sequenced in males with (193) and without (191) @DISEASE$ spectrum disorders to test the hypothesis that ultra-rare mutations in microRNA collectively contribute to the risk of schizophrenia.	0
Subsequently, we identified a large set of miRNA-mRNA associations that are changed in AD versus control, highlighting @MiRNA$ -specific changes in the @DISEASE$ regulatory system.	0
Independent and tissue-specific prognostic impact of @MiRNA$ in @DISEASE$ Coexpression with vascular endothelial growth factor-A predicts poor survival.	1
@MiRNA$ regulates HGAL expression and increases @DISEASE$ cell motility.	1
This study finds that altered @MiRNA$ expression levels are observed in postmortem cerebellar cortex from @DISEASE$ patients, a finding which suggests that dysregulation of miRNAs may contribute to autism spectrum phenotype.	1
The present study demonstrates that blood samples can be used as a source of @MiRNA$ identification associated to @DISEASE$ (PD).	0
@MiRNA$ control of CD44+ @DISEASE$ initiating cells.	1
@MiRNA$ can regulate human @DISEASE$ levels.	1
RSA(recurrent @DISEASE$ patients exhibited significantly different frequencies of the @MiRNA$ C (TT+TC vs. CC; adjusted odds ratio [AOR], 1.587; 95% confidence interval [CI], 1.042-2.417) and miR-499AG+GG genotypes (AOR, 1.671; 95% CI, 1.054-2.651) compared with the control group.	1
To investigate the involvement of let-7i, miR-27a, and @MiRNA$ in CM-resistant mice, we assessed the expression levels in @DISEASE$ knockout (IFN-γ(-/-)) mice on a C57BL/6 genetic background.	0
These results show that @MiRNA$ is a functional target of @DISEASE$ and that miR-106b may influence TGF-β signaling, thereby contributing to the pathogenesis of AD.	1
In this review ,correlations between @MiRNA$ -mediated gene silencing and Alzheimer's, Parkinson's, and other @DISEASE$ will be discussed.	0
Here, we investigated the possibility that IFN-beta may induce or downregulate cellular @MiRNA$ (miRNA) in human @DISEASE$ and thereby use the RNA interference system to show antitumor effects.	0
@MiRNA$ regulates DNA methylation in CD4+ T cells and contributes to @DISEASE$ by targeting DNA methyltransferase 1.	1
Here, we studied the function of one miRNA, @MiRNA$, in @DISEASE$ carcinogenesis and elucidated its downstream targets.	0
Common variation in the @MiRNA$ binding-site of GRN is a major risk factor for @DISEASE$ -positive frontotemporal dementia.	0
CONCLUSION: Expression level of tumor/metastasis suppressive @MiRNA$ in the WNT signaling associated medulloblastomas is likely to determine their response to treatment, and thus, these miRNAs would be important biomarkers for risk stratification within the WNT signaling associated @DISEASE$.	0
Repression of @MiRNA$ by p300 and MAPK is required for survival signaling via gp130 during adaptive @DISEASE$.	1
Analysis of @MiRNA$ demonstrated that 3 @DISEASE$ approximately 92 cluster miRNAs (miR-92, miR-19a, and miR-20) were also overexpressed in human MBs with a constitutively activated Sonic Hedgehog (SHH) signaling pathway, but not in other forms of the disease.	0
Gastric juice @MiRNA$ is a new biomarker for screening @DISEASE$.	1
Compared with normal rats (control group), 23 of the 125 miRNAs were expressed differentially in @MiRNA$ rats including 5 down-regulated miRNAs (let-7e included) and 18 up-regulated @DISEASE$ (miR-23a/b included).	1
@MiRNA$ is associated with estrogen receptor-α expression and response to tamoxifen in @DISEASE$.	1
Prognostic Implications of @MiRNA$ Expression and Its Functional Role in Papillary @DISEASE$.	1
Our results indicate that multiple protein targets and biological processes involved in @MiRNA$ pathophysiology may be regulated by @DISEASE$.	0
HBx gene down-regulates @MiRNA$ expression and inhibits apoptosis of human @DISEASE$ cell line HepG2.	1
Coordinate Regulate FOXO1; highly expressed; a novel mechanism of FOXO1 regulation, and targeting of FOXO1 by @MiRNA$ may contribute to transformation or maintenance of an oncogenic state in @DISEASE$ cell.	1
@MiRNA$ inhibits @DISEASE$ cell proliferation by targeting glypican-3.	1
@MiRNA$ regulates c-Kit proto-oncogene and represses cell proliferation in @DISEASE$.	1
@MiRNA$ represses @DISEASE$ cell growth in?vitro by regulating the p53/survivin signaling pathwa.	1
Recently, differential expression of endogenous regulatory small RNAs, known as 'microRNAs' (@MiRNA$ ), in patients of @DISEASE$, Parkinson's disease and models of ataxia suggest that they might have key regulatory roles in neurodegeneration.	0
Expression profile of @MiRNA$ in young @DISEASE$ patients.	0
APP and @MiRNA$ @DISEASE$ genetic variability has no major role in risk for Alzheimer disease.	0
RESULTS: We found underexpression of miR-145 (2.0-fold; P = 0.04), miR-21 (2.4-fold; P = 0.004), @MiRNA$ (2.6-fold; P = 0.02), let-7a (3.3-fold; P = 0.003), miR-150 (3.8-fold; P = 0.04), miR-15a (4.5-fold; P = 0.03), miR-16 (5.0-fold; P = 0.004), and miR-143 (6.4-fold; P = 0.004) in @DISEASE$ when compared to normal pituitary tissues.	1
BACKGROUND: The purpose of this study was to (1) identify specific miRNAs in growth hormones (GH)-secreting @MiRNA$ ; (2) determine the relationship between the expression of these @DISEASE$ and tumor size, somatostatin analogs treatment, and responsiveness to somatostatin analogs (SSA).	0
A number of miRNAs like miR-193a, @MiRNA$ /miR-452 cluster, miR-182/miR-183/miR-96 cluster, and miR-148a having potential @DISEASE$ /metastasis suppressive activity were found to be overexpressed in the WNT signaling associated medulloblastomas.	0
@MiRNA$ inhibits Bcl-2 to modulate multidrug resistance by increasing drug-sensitivity in human @DISEASE$ cells.	1
The analysis of the upstream regulatory regions in co-regulated @MiRNA$ suggests a role for @DISEASE$ (REST) and P53 in miRNAs downregulation in HD.	0
Regulation of epidermal growth factor receptor signaling and erlotinib sensitivity in @DISEASE$ cells by @MiRNA$.	1
Myc induced @MiRNA$ contributes to the acquired imatinib resistance in @DISEASE$ cell K562.	1
17ʇ-Estradiol up-regulates @MiRNA$ expression and reduces TP53INP1 expression in MCF-7 @DISEASE$ cell.	1
These results show that TβR II is a functional target of miR-106b and that @MiRNA$ may influence TGF-β signaling, thereby contributing to the pathogenesis of @DISEASE$.	0
Clinical impact of circulating @MiRNA$ in plasma of patients with @DISEASE$.	1
Using @MiRNA$ -, IRAK-1-, or @DISEASE$ promoter-luciferase reporter constructs, we observe decreases in IRAK-1 and increases in miRNA-146a and IRAK-2 expression in interleukin-1β (IL-1β) and amyloid-β-42 (Aβ42) peptide-stressed HAG cells.	0
We studied the expression of selected @MiRNA$ following infection of CBA mice with Plasmodium berghei ANKA (PbA), which causes cerebral malaria (@DISEASE$ ), or Plasmodium berghei K173 (PbK), which causes severe malaria but without cerebral complications, termed non-CM.	0
Western blot analysis revealed unchanged total Smad2/3 protein levels, but reduced phospho-Smad2/3 (p-Smad2/3) and increased @MiRNA$ protein levels in the @DISEASE$ stably transfected cell line.	1
The bioinformatics analysis indicates that the potential targets for @MiRNA$ altered after SCI include genes encoding components that are involved in the inflammation, oxidation, and apoptosis that are known to play important roles in the pathogenesis of @DISEASE$.	0
@MiRNA$ expression in the prefrontal cortex of individuals with schizophrenia and @DISEASE$.	0
@MiRNA$ expression inversely correlates with nuclear ERK5 immunoreactivity in clinical @DISEASE$.	1
Pathogenic @MiRNA$ negatively regulates @DISEASE$ -mediated translational repression.	1
@MiRNA$ targets ATG2B and DICER1 to inhibit autophagy and trigger killing of @DISEASE$ cells.	1
MicroRNA expression in ACTH-producing @MiRNA$ : up-regulation of @DISEASE$ in pituitary carcinomas.	0
The expression of @MiRNA$, miR-27a, and miR-150 was unchanged in both wild-type (WT) and IFN-γ(-/-) mice following @DISEASE$.	0
@MiRNA$ promotes @DISEASE$ by negatively regulating tumor suppressor KLF6.	1
Effect of @MiRNA$ on the Biological Behavior of the Esophageal @DISEASE$ Cell Line EC970.	1
Differential regulation of interleukin-1 receptor-associated kinase-1 (IRAK-1) and IRAK-2 by @MiRNA$ and NF-kappaB in stressed human astroglial cells and in @DISEASE$.	0
Our research revealed that 136 miRNAs were expressing at 6 h post injury, in which 13 miRNAs were more than 2-fold up-regulated, and 14 miRNAs were more than 2-fold down-regulated; 118 miRNAs were expressing at 24 h post injury, in which 4 miRNAs were more than 2-fold up-regulated, and 23 miRNAs were more than 2-fold down-regulated; 149 @MiRNA$ were expressing at 48 h post @DISEASE$, in which 16 miRNAs were more than 2-fold up-regulated, and 11 miRNAs were more than 2-fold down-regulated; and 203 miRNAs were expressing at 72 h post injury, in which 19 miRNAs were more than 2-fold up-regulated, and 5 miRNAs were more than 2-fold down-regulated.	0
We suggest that the expression of @MiRNA$ is regulated by miRNAs and that common genetic variability in a @DISEASE$ binding-site can significantly increase the risk for FTLD-U.	0
In 66 control and @MiRNA$ samples we note a significant up-regulation of @DISEASE$ coupled to down-regulation of IRAK-1 and a compensatory up-regulation of IRAK-2.	1
Here we expand the role of @MiRNA$ in FTLD-U and demonstrate that a common genetic variant (rs5848), located in the 3'-untranslated region (UTR) of GRN in a binding-site for @DISEASE$, is a major susceptibility factor for FTLD-U.	0
@MiRNA$ regulates the growth and invasion of @DISEASE$ cells through the downregulation of tissue inhibitor of metalloproteinase 3.	1
@MiRNA$ inhibits viral replication and cell proliferation in hepatitis B virus-related @DISEASE$ and targets NDRG3.	1
The expression of let-7i, miR-27a, and @MiRNA$ was unchanged in both wild-type (WT) and IFN-γ(-/-) mice following @DISEASE$.	0
This novel, cell type-specific in vivo system for reducing gene expression uses a bacterial artificial chromosome (BAC) containing the NPY promoter-enhancer elements, the reporter molecule (eGFP) and a modified intron containing a synthetic microRNA (@MiRNA$ ) targeted to @DISEASE$.	0
@MiRNA$ rs3746444 were associated with increased risk @DISEASE$ in Chinese wome.	1
Using miRNA-146a-, IRAK-1-, or @MiRNA$ promoter-luciferase reporter constructs, we observe decreases in IRAK-1 and increases in @DISEASE$ and IRAK-2 expression in interleukin-1β (IL-1β) and amyloid-β-42 (Aβ42) peptide-stressed HAG cells.	0
We next proposed a model highlighting @MiRNA$ and @DISEASE$ involved in signaling pathways and regulatory networks in the nervous system.	0
This reveals a previously unrecognized signaling cascade involved in meningioma tumor development and highlights a novel molecular interaction between @MiRNA$ and Wnt signaling, thereby providing insights into novel therapies for @DISEASE$.	0
Ectopic expression of @MiRNA$ enhances radiosensitivity of @DISEASE$ cells, partly by suppressing the LyGDI signaling pathwa.	1
@MiRNA$ suppresses malignant transformation by targeting c-Myc transcriptional complexes in human @DISEASE$.	1
@MiRNA$ Inhibits Peritoneal Dissemination of @DISEASE$ Cells by Inhibiting Integrin Expression.	1
Compared with normal rats (control group), 23 of the 125 miRNAs were expressed differentially in @MiRNA$ rats including 5 down-regulated @DISEASE$ (let-7e included) and 18 up-regulated miRNAs (miR-23a/b included).	1
The family of miR-64 and miR-65 are co-underexpressed in the alpha-synuclein transgenic and cat-1 strains, and members of @MiRNA$ family co-underexpressed in the alpha-synuclein and pdr-1 strains; @DISEASE$ and ptc-1 genes are target candidates for miR-64 and miR-65 and are overexpressed in alpha-synuclein transgenic as well as miR-64/65 (tm3711) knockout animals.	0
Interestingly, both miRNAs are capable of binding directly to @MiRNA$ in different positions: within the miRNA sequence itself (@DISEASE$ ) or in the hairpin precursor (miR-663).	1
@MiRNA$ regulates skin @DISEASE$ healing by targeting multiple aspects of the healing proces.	1
Here, we present an overview of the current progress in miRNA research related to @MiRNA$ and also highlight the utility of LNA (locked nucleic acid)-modified oligonucleotides in the detection and modulation of @DISEASE$ activity.	0
However, the profiles and regulation of miRNAs in HD are not fully understoo@MiRNA$.	0
A number of miRNAs like @MiRNA$, miR-224/miR-452 cluster, miR-182/miR-183/miR-96 cluster, and miR-148a having potential @DISEASE$ /metastasis suppressive activity were found to be overexpressed in the WNT signaling associated medulloblastomas.	0
Expression of @MiRNA$ suppresses migration and invasion @DISEASE$ cells by targeting CXCR4.	1
We did reporter assays to elucidate the IFN-beta-mediated suppression of @MiRNA$ ; the addition of signal transducers and activators of transcription 3 (STAT3)-expressing vectors induced the @DISEASE$ -mediated suppression of miR-21, whereas STAT3-inhibiting agents inhibited the miR-21 suppression.	0
The family of @MiRNA$ and miR-65 are co-underexpressed in the alpha-synuclein transgenic and cat-1 strains, and members of let-7 family co-underexpressed in the @DISEASE$ and pdr-1 strains; mdl-1 and ptc-1 genes are target candidates for miR-64 and miR-65 and are overexpressed in alpha-synuclein transgenic as well as miR-64/65 (tm3711) knockout animals.	0
Induction of @MiRNA$ by retinoic acid in estrogen-receptor-positive @DISEASE$ cells: biological correlates and molecular target.	1
@MiRNA$ inhibits proliferation and cell cycle progression through the targeting of ZBTB2 in human @DISEASE$.	1
REV3L 3'UTR 460 T>C polymorphism in @MiRNA$ miR-25/32) target sites contributes to @DISEASE$ susceptibility.	1
In this commentary, we discuss the known functions of miRNAs in cancer and stem cells, their therapeutic potential and how the findings of Silber et al provide insight into the role of @MiRNA$ /miR-137 dysregulation in @DISEASE$.	1
@MiRNA$ inhibits CYLD in @DISEASE$.	1
Here we report the coordinated @MiRNA$ expression analysis from the tissue level to the subcellular level, using the RAKE (RNA-primed, array-based, Klenow Enzyme) miRNA microarray platform in conjunction with Locked Nucleic Acid (LNA)-based in situ hybridization (LNA-ISH) on archival FFPE human brains and @DISEASE$.	0
Only one of these miRNAs, @MiRNA$, has previously been shown to be de-regulated in @DISEASE$.	1
Down-regulation of Wee1 kinase by a specific subset of @MiRNA$ in human sporadic @DISEASE$.	0
@MiRNA$ sensitizes @DISEASE$ cells to bortezomib-induced apoptosis through the activation of a feedback loop with the transcription factor Sp.	1
@MiRNA$ modulates the expression of interferon-regulated genes and MHC class I molecules in human @DISEASE$ cell.	1
Blood serum expressio level of these @MiRNA$ may be non-invasive biomarkers for @DISEASE$.	1
Using transiently transfected murine neuronal N2a cells in culture, in parallel to a mouse model of AD, we were able to demonstrate a role for two miRNAs (@MiRNA$ and miR-328) in the regulation of beta-amyloid (Abeta) precursor protein (@DISEASE$ )-converting enzyme (BACE) messenger RNA (mRNA) translation, thereby providing key insights into the molecular basis underlying BACE deregulation in AD.	0
MLH1 as a Direct Target of @MiRNA$ and a Potential Predictor of Favorable Prognosis in @DISEASE$.	1
As a genetically complex disease, dysregulation of @MiRNA$ expression might be a feature of autism spectrum disorders (@DISEASE$ ).	1
We uncovered a previously unknown alteration in temporal expression of a large set of @MiRNA$ following a contusive spinal cord injury (@DISEASE$ ) in adult rats using microarray analysis.	1
Western blot analysis demonstrated that @MiRNA$ and Bcl-2 were involved in @DISEASE$ -mediated cellular effects.	0
A known @MiRNA$ target in the brain, @DISEASE$, was downregulated.	1
@MiRNA$ plays a tumor-suppressor role in human @DISEASE$ cells by targeting signaling pathways involved in cellular proliferation and invasion.	1
Downregulated @MiRNA$ in meningiomas promotes tumor growth by reducing E-cadherin and activating the Wnt/@DISEASE$ signaling pathway.	1
@MiRNA$ a potential @DISEASE$ inhibito.	1
@MiRNA$ acts as a tumor suppressor in @DISEASE$ cells via the regulation of ADAM9.	1
To search for miRNAs that may be involved in the pathogenesis of @MiRNA$ (PD), we utilized @DISEASE$ microarrays to identify potential gene expression changes in 115 annotated miRNAs in PD-associated Caenorhabditis elegans models that either overexpress human A53T alpha-synuclein or have mutations within the vesicular catecholamine transporter (cat-1) or parkin (pdr-1) ortholog.	0
Here we expand the role of GRN in FTLD-U and demonstrate that a common genetic variant (rs5848), located in the 3'-untranslated region (UTR) of GRN in a binding-site for @MiRNA$, is a major susceptibility factor for @DISEASE$.	0
@MiRNA$ a target of CDX2, regulates cell differentiation through the repression of the core binding factor in @DISEASE$.	1
Thus, @MiRNA$ appears to act as a multifunctional tumor suppressor miRNA in meningiomas through effects on the E-cadherin and Wnt/@DISEASE$ signaling pathways.	0
Plasma-derived @MiRNA$ biomarkers, used in combination with established clinical practices such as imaging, neurocognitive, and motor examinations, have the potential to improve @DISEASE$ patient classification and possibly management.	0
Further, irradiation significantly altered expression of @MiRNA$, a miRNA putatively targeting both DNA methyltransferase-3a and @DISEASE$.	1
@MiRNA$ are involved in a large number of biological functions such as development, metabolism, immunity and diseases such as cancer, cardiovascular diseases and @DISEASE$.	0
In primary primate macrophages, the main cell type implicated in @MiRNA$ in the CNS, specific @DISEASE$ reduce, whereas miRNA inhibitors enhance, IFN-beta protein production.	0
blood;Combined serum CA19-9 and @MiRNA$ in peripheral blood mononuclear cells to diagnose @DISEASE$.	1
The results show the possible use of blood miRNAs as biomarkers for @MiRNA$ ; that selected blood miRNAs may correlate with @DISEASE$ changes in the brain; and that many of the mRNAs, previously shown to be regulated in brain and blood after brain injury, are likely accounted for by changes in miRNA expression.	0
Knockdown of @MiRNA$ by lentivirus decreases the arrhythmogenic effect of skeletal myoblast transplantation in rat with @DISEASE$.	1
Ectopic expression of @MiRNA$ in glioma and @DISEASE$ stem cells induced their apoptosis and reduced their metabolic activity.	0
In a @DISEASE$ an insertion of @MiRNA$ into a rearranged immunoglobulin heavy chain locus was described.	1
The predicted targets of these @MiRNA$ include those with known or suspected roles in oligodendrocyte development and myelination including @DISEASE$, CLDN11, MYTL1, MBOP, MPZL2, and DDR1.	0
However, the lack of knowledge about miRNA target genes postpones full understanding of the biological functions of down-regulated or up-regulated @MiRNA$ in @DISEASE$.	0
@MiRNA$ regulates apoptosis by targeting Bim in human @DISEASE$.	1
Comparison of mouse cerebellar development and medulloblastoma demonstrates a shared @MiRNA$ -mRNA co-expression program for brain-specific neurologic processes such as synaptic transmission and exocytosis, in which miRNA target expression increases with the accumulation of multiple miRNAs in developing cerebellum and decreases with the loss of these miRNAs in @DISEASE$.	0
@MiRNA$ is up-regulated in @DISEASE$ and suppresses T cell apoptosis.	1
Analysis of human MBs demonstrated that 3 miR-17 approximately 92 cluster miRNAs (@MiRNA$, miR-19a, and miR-20) were also overexpressed in human MBs with a constitutively activated Sonic Hedgehog (@DISEASE$ ) signaling pathway, but not in other forms of the disease.	0
@DISEASE$ with a t(2;11)(p21;q23-24) and translocation breakpoint close to @MiRNA$.	1
High Expression of @MiRNA$ is an Independent Factor Indicating a Poor Prognosis in Japanese @DISEASE$ Patients.	1
We analyzed the miRNAs in 21 GH-secreting @MiRNA$ and 6 normal pituitaries by miRCURY™ LNA array and some differentially expressed @DISEASE$ were validated by quantitative real-time PCR.	0
Identification of Collagen 1 as a Post-transcriptional Target of @MiRNA$ in Skin Fibroblasts: Therapeutic Implication for @DISEASE$ Reductio.	1
This has implications in the study of the molecular pathology of @MiRNA$, as well as @DISEASE$ biology in general.	0
a model for the combined regulatory activity of @MiRNA$ and HuR on TUBB3 expression in @DISEASE$.	1
A functional variant in @MiRNA$ promoter modulates its expression and confers disease risk for @DISEASE$.	1
@MiRNA$ have essential functional roles in brain development and neuronal specification but their roles in @DISEASE$ such as Alzheimer's disease (AD) is unknown.	0
Upregulation of @MiRNA$ predicts poor prognosis in patients with pediatric @DISEASE$.	1
Altered @MiRNA$ expression in @DISEASE$.	1
Our research revealed that 136 miRNAs were expressing at 6 h post injury, in which 13 miRNAs were more than 2-fold up-regulated, and 14 miRNAs were more than 2-fold down-regulated; 118 miRNAs were expressing at 24 h post injury, in which 4 miRNAs were more than 2-fold up-regulated, and 23 miRNAs were more than 2-fold down-regulated; 149 miRNAs were expressing at 48 h post injury, in which 16 miRNAs were more than 2-fold up-regulated, and 11 miRNAs were more than 2-fold down-regulated; and 203 miRNAs were expressing at 72 h post @MiRNA$, in which 19 @DISEASE$ were more than 2-fold up-regulated, and 5 miRNAs were more than 2-fold down-regulated.	1
@MiRNA$ mediates NPM-ALK-driven oncogenicity and renders IL-17-producing immunophenotype to @DISEASE$.	1
The family of miR-64 and miR-65 are co-underexpressed in the alpha-synuclein transgenic and cat-1 strains, and members of let-7 family co-underexpressed in the alpha-synuclein and pdr-1 strains; mdl-1 and ptc-1 genes are target candidates for @MiRNA$ and miR-65 and are overexpressed in @DISEASE$ transgenic as well as miR-64/65 (tm3711) knockout animals.	1
The TNFa-induced @MiRNA$ activates @DISEASE$ synovial fibroblasts through a feedback loop in NF-κB signalin.	1
@MiRNA$ induces epithelial-mesenchymal transition in @DISEASE$ cells by targeting p120 cateni.	1
@MiRNA$ targets NF-kappaB1 and regulates @DISEASE$ cell growt.	1
MATERIALS AND METHODS: miRNA profiling of @MiRNA$ was carried out using Taqman Low Density Array v 1.0 having 365 human @DISEASE$.	0
@MiRNA$ has potential therapetic application in vascular disorders and @DISEASE$.	1
Thus we have identified the @MiRNA$ expression signature for malignant astrocytoma, in particular glioblastoma, and showed the miRNA involvement and their importance in @DISEASE$ development.	0
@MiRNA$ downregulated in @DISEASE$ (Yanaihara et al., 2006.	1
Taken together, our findings suggest that neuronal @MiRNA$ deregulation in response to an insult by @DISEASE$ may be an important factor contributing to the cascade of events leading to AD.	1
@MiRNA$ Regulates Urothelial Permeability and May Play a Role in Bladder @DISEASE$ Syndrom.	1
Down-Regulated @MiRNA$ Induces a Cell Cycle G1 Arrest in @DISEASE$ Cells by Up-Regulating the PTEN Protein.	1
The histone deacetylase 4/Sp1/@MiRNA$ regulatory network contributes to aberrant histone acetylation in @DISEASE$.	1
Genetic variation in a @MiRNA$ binding site in BIRC5 alters susceptibility to @DISEASE$ in Chinese Han population.	1
@MiRNA$ contributes to renal microvascular heterogeneity of VCAM-1 protein expression in acute @DISEASE$.	1
@MiRNA$ inhibites @DISEASE$ cell migration and invasion through targeting of oncoprotein c-Met.	1
Our research revealed that 136 miRNAs were expressing at 6 h post @MiRNA$, in which 13 @DISEASE$ were more than 2-fold up-regulated, and 14 miRNAs were more than 2-fold down-regulated; 118 miRNAs were expressing at 24 h post injury, in which 4 miRNAs were more than 2-fold up-regulated, and 23 miRNAs were more than 2-fold down-regulated; 149 miRNAs were expressing at 48 h post injury, in which 16 miRNAs were more than 2-fold up-regulated, and 11 miRNAs were more than 2-fold down-regulated; and 203 miRNAs were expressing at 72 h post injury, in which 19 miRNAs were more than 2-fold up-regulated, and 5 miRNAs were more than 2-fold down-regulated.	1
@MiRNA$ Regulates Astrocytic Response Following @DISEASE$.	1
However, no studies have investigated the clinical significance of high-mobility group A2 and its relationship to the let-7 @MiRNA$ family in human @DISEASE$.	0
We show that miRNAs belonging to the miR-20a family (that is, miR-20a, @MiRNA$ and miR-106b) could regulate @DISEASE$ expression in vitro and at the endogenous level in neuronal cell lines.	1
@MiRNA$ represses cell growth by targeting HuR in @DISEASE$.	1
Our research revealed that 136 @MiRNA$ were expressing at 6 h post injury, in which 13 miRNAs were more than 2-fold up-regulated, and 14 miRNAs were more than 2-fold down-regulated; 118 miRNAs were expressing at 24 h post injury, in which 4 miRNAs were more than 2-fold up-regulated, and 23 miRNAs were more than 2-fold down-regulated; 149 miRNAs were expressing at 48 h post @DISEASE$, in which 16 miRNAs were more than 2-fold up-regulated, and 11 miRNAs were more than 2-fold down-regulated; and 203 miRNAs were expressing at 72 h post injury, in which 19 miRNAs were more than 2-fold up-regulated, and 5 miRNAs were more than 2-fold down-regulated.	0
Loss of @MiRNA$ is crucial to @DISEASE$ progression.	1
Nuclear and cytoplasmatic PDCD4 immunostaining decreased significantly with histopathological progression of the @DISEASE$ (p<0001). Controls showed strong nuclear and cytoplasmatic immunohistochemical staining. @MiRNA$ up regulation in tissue corresponded to PDCD4 suppression.	1
We examined if plasma @MiRNA$ levels are altered in patients with @DISEASE$ (TBI) relative to matched healthy volunteers, and explored their potential for use as diagnostic TBI biomarkers.	0
ABSTRACT: The aim of our study was to analyze the differential expression of @MiRNA$ in the brains of BSE-infected cynomolgus macaques as a model for @DISEASE$ (CJD).	0
@MiRNA$ involvement in @DISEASE$ : from bench to bedside.	0
Our research revealed that 136 miRNAs were expressing at 6 h post injury, in which 13 @MiRNA$ were more than 2-fold up-regulated, and 14 miRNAs were more than 2-fold down-regulated; 118 miRNAs were expressing at 24 h post @DISEASE$, in which 4 miRNAs were more than 2-fold up-regulated, and 23 miRNAs were more than 2-fold down-regulated; 149 miRNAs were expressing at 48 h post injury, in which 16 miRNAs were more than 2-fold up-regulated, and 11 miRNAs were more than 2-fold down-regulated; and 203 miRNAs were expressing at 72 h post injury, in which 19 miRNAs were more than 2-fold up-regulated, and 5 miRNAs were more than 2-fold down-regulated.	0
Furthermore, microinfusion of lentiviral vectors that contained @MiRNA$ (miRNAs) targeting long-form PDE4D isoforms into bilateral dentate gyri of the mouse hippocampus downregulated @DISEASE$ and PDE4D5, enhanced memory, and increased hippocampal neurogenesis and pCREB.	1
Recent findings suggest that it may eventually be possible to treat some @MiRNA$ by restoring or inhibiting @DISEASE$ altered by disease pathology.	0
Microarray based analysis of @MiRNA$ expression in rat cerebral cortex after @DISEASE$.	0
Also the temporal change of the @MiRNA$ and miR-23a/b expression in the epileptogenesis indicated their underlying functions on @DISEASE$.	1
@MiRNA$ inhibits CD133/1+ @DISEASE$ stem cells migration and invasion by targeting E-cadherin repressor ZEB2.	1
Because of its known connection to @MiRNA$ biology, we focused on miR-21 among seven @DISEASE$ influenced by IFN-beta.	0
To investigate the involvement of let-7i, @MiRNA$, and miR-150 in CM-resistant mice, we assessed the expression levels in gamma interferon knockout (@DISEASE$ -γ(-/-)) mice on a C57BL/6 genetic background.	0
Downregulation of @MiRNA$ expression inhibits proliferation, induces apoptosis and enhances radiosensitivity in hypoxic human @DISEASE$ cells in vitro.	1
These data suggest a significantly independent regulation of IRAK-1 and IRAK-2 in AD and in IL-1β+Aβ42 peptide-stressed HAG cells and that an inducible, @MiRNA$ -sensitive, @DISEASE$ -mediated down-regulation of IRAK-1 coupled to an NF-κB-induced up-regulation of IRAK-2 expression drives an extensively sustained inflammatory response.	0
Objective: The aim of the study was to analyze the differential expression of let-7a, miR-15a, miR-16, miR-21, miR-141, miR-143, miR-145, and @MiRNA$ in @DISEASE$ and normal pituitary tissue and verify whether their profile of expression correlates with tumor size or remission after treatment.	0
@MiRNA$ Is Associated with Poor Prognosis in @DISEASE$.	1
@MiRNA$ regulates Nrf2 activation by targeting Keap1 mRNA in @DISEASE$ cells.	1
Using transiently transfected murine neuronal N2a cells in culture, in parallel to a mouse model of AD, we were able to demonstrate a role for two @MiRNA$ (miR-298 and miR-328) in the regulation of beta-amyloid (Abeta) precursor protein (@DISEASE$ )-converting enzyme (BACE) messenger RNA (mRNA) translation, thereby providing key insights into the molecular basis underlying BACE deregulation in AD.	1
Previous studies have suggested that changes in gene expression may play an important role in the etiology of @MiRNA$, and that @DISEASE$ (miRNAs) and transcription factors (TFs) are primary regulators of this gene expression.	0
Additionally, several research groups have established that inserting microRNA (@MiRNA$ )-targeted sequences into the adenoviral genome can modulate adenoviral protein expression to confer tissue and @DISEASE$ selectivity.	0
Profiling the expression of 427 mature @MiRNA$ (miRNA) in a series of 90 primary human medulloblastomas revealed that components of the miR-17/92 polycistron are the most highly up-regulated miRNAs in @DISEASE$.	0
TRPS1 targeting by @MiRNA$ promotes the epithelial-to-mesenchymal transition in @DISEASE$.	1
We used quantitative RT-PCR to determine if plasma @MiRNA$ could identify TBI patients within the first 24 h post-@DISEASE$.	0
We used microarrays and RT-PCR to profile @MiRNA$ expression changes in the brains of mice infected with mouse-adapted @DISEASE$.	0
Here, we discuss some of the limitations associated to the interpretation and applicability of @MiRNA$ data, based on our recent study on the etiology of Alzheimer's disease (@DISEASE$ ).	0
To identify @MiRNA$ closely associated with neurodegeneration, we performed miRNA expression profiling of brain tissues of various @DISEASE$.	0
Thyroid hormone regulation of @MiRNA$ enhances migration and invasion of @DISEASE$.	1
The ability of @MiRNA$ to suppress molecules that inhibit axon regrowth may underlie the capacity for adult zebrafish to recover locomotor function after @DISEASE$.	0
The family of miR-64 and miR-65 are co-underexpressed in the alpha-synuclein transgenic and cat-1 strains, and members of let-7 family co-underexpressed in the alpha-synuclein and pdr-1 strains; mdl-1 and ptc-1 genes are target candidates for miR-64 and miR-65 and are overexpressed in @MiRNA$ transgenic as well as @DISEASE$ (tm3711) knockout animals.	0
@MiRNA$ is an Independent Biochemical Recurrence Predictor and Potential Therapeutic Target for @DISEASE$.	1
3,3'-Diindolylmethane inhibits @DISEASE$ cell growth via @MiRNA$ mediated Cdc25A degradation.	1
@MiRNA$ is down-regulated in @DISEASE$ and inhibits cell proliferation through the up-regulation of cyclinD.	1
Among the 26 overexpressed miRNAs, 9 were encoded by the miR-17 approximately 92 cluster family, a group of @MiRNA$ implicated as oncogenes in several @DISEASE$ types.	0
In primary primate macrophages, the main cell type implicated in HIV and SIV infection in the CNS, specific @MiRNA$ reduce, whereas miRNA inhibitors enhance, @DISEASE$ protein production.	0
A few @MiRNA$ (e.g., miR-298, miR-155, and miR-362-3p) were upregulated or downregulated more than twofold in both brain and blood after several different @DISEASE$.	0
As compared to NEC, miRNAs significantly upregulated in @MiRNA$ subjects and confirmed by qPCR were @DISEASE$.	1
Recent years have seen considerable progress in @MiRNA$ research in brain tumors, particularly in glioblastomas and medulloblastomas, providing novel insights into the pathogenesis of these @DISEASE$.	0
@MiRNA$ targets BNIP2 and contributes chemotherapeutic resistance in colorectal @DISEASE$ SW480 and SW620 cell lines.	1
The analysis of the upstream regulatory regions in co-regulated @MiRNA$ suggests a role for RE1-Silencing Transcription Factor (@DISEASE$ ) and P53 in miRNAs downregulation in HD.	0
Computational analysis predicted that the 3'-untranslated region (UTR) of beta-site amyloid precursor protein-cleaving enzyme 1 (@MiRNA$ ) mRNA is targeted multiply by @DISEASE$.	1
MicroRNAs (@MiRNA$ ) are very important regulators of biological processes such as development, cellular differentiation, and @DISEASE$ generation.	0
In addition, pre-@MiRNA$ blocked early manifestations of the DNA damage response, including the phosphorylation of the ataxia-telangiectasia mutated (ATM) kinase and of two @DISEASE$ substrates, histone H2AX and p53.	1
New insights into the roles of @MiRNA$ in @DISEASE$ and neuroplasticity.	0
While miR-1, miR-22* and @MiRNA$ expression levels allowed to distinguish non-treated @DISEASE$ from healthy subjects, miR-16-2*, miR-26a2* and miR30a differentiated treated from untreated patients.	1
@MiRNA$ inhibits @DISEASE$ cell migration and invasion by modulating Notch2 expressio.	1
Down-regulation of these @MiRNA$ has been reported in chronic lymphocytic lymphoma (CLL), pituitary adenomas, and @DISEASE$.	1
Both inhibition and enhanced expression of @MiRNA$ lead to reduced migration and invasion of @DISEASE$ cells.	1
Expression of many @MiRNA$ in the @DISEASE$ cancer stem cells resembles that of neural stem cells.	0
miR-21 and 221 were overexpressed in @MiRNA$ samples, whereas @DISEASE$ was downregulated compared with normal brain tissue.	1
Our results implicate deregulated synthesis of @MiRNA$ /DP caused by the miRNA pathway impairment as a key event in LRRK2 pathogenesis and suggest novel @DISEASE$ -based therapeutic strategies.	0
The expression of let-7i, @MiRNA$, and miR-150 was unchanged in both wild-type (WT) and @DISEASE$ -γ(-/-) mice following infection.	0
In @MiRNA$ such as Alzheimer's disease (AD), brain miRNA profiles are altered; thus @DISEASE$ dysfunction could be both a cause and a consequence of disease.	0
@MiRNA$ suppresses cell proliferation and induces cell apoptosis in @DISEASE$ by directly targeting Wnt/β-catenin pathway.	1
Prognostic implications of @MiRNA$ expression levels in resected @DISEASE$.	1
The @MiRNA$ cluster collaborates with the @DISEASE$ pathway in medulloblastoma.	0
@MiRNA$ inhibits proliferation and migration @DISEASE$ through down-regulation of Bcl-2 and SIRT1.	1
CONCLUSION: We demonstrate that the peripheral blood @MiRNA$ and their profiles can be developed as biomarkers in diagnosis and prognosis of @DISEASE$.	0
Moreover, the performance of three algorithms (PicTar, TargetScan and DIANA-microT) is both demonstrated and evaluated by performing an in-depth analysis of @MiRNA$ interactions with mRNAs derived from genes triggering hereditary neurological disorders known as trinucleotide repeat expansion diseases (TREDs), such as @DISEASE$ (HD), a number of spinocerebellar ataxias (SCAs), and myotonic dystrophy type 1 (DM1).	0
Upregulation of @MiRNA$ in @DISEASE$ is Partly Driven by LMP1 and LMP2A and Downregulates a Negative Prognostic Marker JMJD1A.	1
@MiRNA$ might play an important role in the proliferation and apoptosis of ovarian epithelial @DISEASE$ cells through negatively control the expression of PDCD4.	1
Identification of @MiRNA$ changes in @DISEASE$ brain and CSF yields putative biomarkers and insights into disease pathways.	0
@MiRNA$ maintains oncogene characteristics by targeting TNFAIP1 and affects NFkB signaling in human @DISEASE$ cell.	1
@MiRNA$ Inhibits Cell Proliferation in Human @DISEASE$ through Direct Suppression of IKK-bet.	1
@MiRNA$ Let-7g targets collagen type I alpha2 and inhibits cell migration in @DISEASE$.	1
Analysis of human MBs demonstrated that 3 miR-17 approximately 92 cluster @MiRNA$ (miR-92, miR-19a, and miR-20) were also overexpressed in human MBs with a constitutively activated Sonic Hedgehog (@DISEASE$ ) signaling pathway, but not in other forms of the disease.	0
Preferential star strand biogenesis of @MiRNA$ targets PKC-alpha and suppresses cell survival in MCF-7 @DISEASE$ cells.	1
Among the predicted targets of dysregulated @MiRNA$ are genes that are known genetic causes of @DISEASE$ such Neurexin and SHANK3.	0
Functional SNP (rs1044129, is present in binding region) in the @MiRNA$ binding site in the 3'UTR of the calcium channel ryanodine receptor gene 3 (RYR3) affects @DISEASE$ risk and calcification.	1
@MiRNA$ is underexpressed in human @DISEASE$ and induces cell apoptosis by targeting SLC7A11.	1
@MiRNA$ expression profiling of human tumors has led to the identification of signatures correlated with the @DISEASE$ diagnosis, staging, progression, prognosis and response to treatment.	0
@MiRNA$ downregulates XIAP expression to suppress cell growth and promote apoptosis in @DISEASE$ cells.	1
Recently, differential expression of endogenous regulatory small RNAs, known as 'microRNAs' (@MiRNA$ ), in patients of Alzheimer's disease, Parkinson's disease and models of @DISEASE$ suggest that they might have key regulatory roles in neurodegeneration.	0
The expression of microRNA @MiRNA$ decreases early in Alzheimer's disease and may accelerate disease progression through regulation of @DISEASE$.	1
In @MiRNA$ such as Alzheimer's disease (AD), brain @DISEASE$ profiles are altered; thus miRNA dysfunction could be both a cause and a consequence of disease.	0
@MiRNA$ Sensitizes @DISEASE$ Cell Lines to DDP Treatment Independent of p53 Status.	1
Our microarray based analysis of microRNA expression in rat cerebral cortex after @MiRNA$ has shown that some @DISEASE$ such as miR-21 could be involved in the intricate process of TBI course.	0
MicroRNAs (@MiRNA$ ) in @DISEASE$.	0
This novel, cell type-specific in vivo system for reducing gene expression uses a bacterial artificial chromosome (BAC) containing the NPY promoter-enhancer elements, the reporter molecule (eGFP) and a modified intron containing a synthetic @MiRNA$ (miRNA) targeted to @DISEASE$.	0
@MiRNA$ (miRNA) expression was assessed in human cerebral cortical gray matter (GM) and white matter (WM) in order to provide the first insights into the difference between GM and WM miRNA repertoires across a range of Alzheimer's disease (@DISEASE$ ) pathology.	0
A functional polymorphism at @MiRNA$ binding site in the 3'-UTR of MMP-9 gene confers increased risk for atherosclerotic @DISEASE$ in a Chinese populatio.	1
@MiRNA$ Modulates Allelic Expression of Toll-Like Receptor 7 Variant Associated with @DISEASE$.	1
This review discusses three aspects of the use of oncolytic adenoviruses to treat @MiRNA$ : (i) the induction of autophagy and autophagic cell death during adenoviral replication; (ii) the opportunities and strategies involved in the exploitation of @DISEASE$ specificity to generate tissue- and tumor-selective oncolytic viruses; and (iii) the rationale for combining oncolytic adenoviruses with chemotherapeutic agents.	0
Elevated levels of @MiRNA$ inhibited @DISEASE$ cell growth in culture and in a tumor model in vivo.	1
Our research revealed that 136 miRNAs were expressing at 6 h post injury, in which 13 miRNAs were more than 2-fold up-regulated, and 14 miRNAs were more than 2-fold down-regulated; 118 miRNAs were expressing at 24 h post injury, in which 4 miRNAs were more than 2-fold up-regulated, and 23 @MiRNA$ were more than 2-fold down-regulated; 149 miRNAs were expressing at 48 h post @DISEASE$, in which 16 miRNAs were more than 2-fold up-regulated, and 11 miRNAs were more than 2-fold down-regulated; and 203 miRNAs were expressing at 72 h post injury, in which 19 miRNAs were more than 2-fold up-regulated, and 5 miRNAs were more than 2-fold down-regulated.	0
@MiRNA$ Modulates Chemosensitivity @DISEASE$ Cells to?Doxorubicin by Targeting PTEN.	1
However, it is unclear whether @MiRNA$ involved in @DISEASE$ pathogenesis by regulating TGF-β signaling.	0
Association of the miR-146aC>G, @MiRNA$ >T, and miR-499A>G polymorphisms with @DISEASE$ in the Korean population.	1
We further showed that CCNE1 (encoding @MiRNA$ ) is one of the downstream targets of @DISEASE$.	1
A number of miRNAs like miR-193a, miR-224/miR-452 cluster, @MiRNA$ /miR-183/miR-96 cluster, and miR-148a having potential tumor/metastasis suppressive activity were found to be overexpressed in the WNT signaling associated @DISEASE$.	1
@MiRNA$ expression in the blood and brain of rats subjected to transient focal ischemia by @DISEASE$.	0
The potential biologic significance of this regulation is supported by evidence of an apparent negative feedback loop, with increased expression of three IFN-beta-regulating @MiRNA$ by primate macrophages exposed to recombinant @DISEASE$ or stimulated to produce IFN-beta.	0
@MiRNA$ targets estrogen-related receptor alpha and impairs the proliferative and migratory capacity @DISEASE$ cells.	1
@MiRNA$ confers cisplatin resistance in @DISEASE$ cells by regulating PTE.	1
The family of miR-64 and @MiRNA$ are co-underexpressed in the @DISEASE$ transgenic and cat-1 strains, and members of let-7 family co-underexpressed in the alpha-synuclein and pdr-1 strains; mdl-1 and ptc-1 genes are target candidates for miR-64 and miR-65 and are overexpressed in alpha-synuclein transgenic as well as miR-64/65 (tm3711) knockout animals.	1
Human @DISEASE$ growth is controlled by @MiRNA$.	1
The database search on TargetScan, PicTar and miRBase Target identified @MiRNA$ (NAV3), a regulator of axon guidance, as a principal target of @DISEASE$, and actually NAV3 mRNA levels were elevated in AD brains.	1
We show that @MiRNA$ belonging to the miR-20a family (that is, miR-20a, miR-17-5p and miR-106b) could regulate @DISEASE$ expression in vitro and at the endogenous level in neuronal cell lines.	1
STUDY DESIGN: We investigated microRNA (@MiRNA$ ) expression after @DISEASE$ (SCI) in mice.	0
Like other types of @MiRNA$, the brain tumor glioblastoma shows a distinct miRNA expression signature, and a number of recent studies have linked these @DISEASE$ alterations to key hallmarks of glioblastoma including proliferation, survival, invasion, angiogenesis and stem cell-like behavior.	0
We propose that loss of specific @MiRNA$ can contribute to increased BACE1 and Abeta levels in @DISEASE$.	0
During a research for miRNAs that are differentially expressed in cerebral cortex of APPswe/PSDeltaE9 mice (a model for @MiRNA$ ) and age-matched controls, one candidate miRNA that is relatively highly expressed, @DISEASE$, was studied further because sequence analysis suggested a likely interaction with the 3'-untranslated region of bcl2 mRNA.	1
The @MiRNA$ was down-regulated during lobular @DISEASE$ progression compared to normal epithelium.	1
@MiRNA$ regulates the self renewal of the H446 @DISEASE$ cell line in vitr.	1
@MiRNA$ reduces cell survival and enhances cisplatin-induced cytotoxicity via down-regulation of Bcl2l2 in @DISEASE$ cell.	1
Common variation in the @MiRNA$ binding-site of @DISEASE$ is a major risk factor for TDP43-positive frontotemporal dementia.	0
Loss of @MiRNA$ cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/@DISEASE$ expression.	1
Anti-sense @MiRNA$ oligonucleotide inhibits Tb 3.1 human tongue @DISEASE$ growth in vitro.	1
Our microarray based analysis of microRNA expression in rat cerebral cortex after traumatic brain injury has shown that some microRNA such as @MiRNA$ could be involved in the intricate process of @DISEASE$ course.	0
@MiRNA$ impairs @DISEASE$ stem cells through negative regulation of HES1 in medulloblastoma.	0
ectopic expression of @MiRNA$ upregulated the expression of several IFN-inducible antivirus genes in human @DISEASE$ cells.	1
In CGNPs, the @MiRNA$ effector N-myc, but not Gli1, induced @DISEASE$ expression.	0
Using transiently transfected murine neuronal N2a cells in culture, in parallel to a mouse model of AD, we were able to demonstrate a role for two miRNAs (@MiRNA$ and miR-328) in the regulation of beta-amyloid (Abeta) precursor protein (APP)-converting enzyme (BACE) messenger RNA (mRNA) translation, thereby providing key insights into the molecular basis underlying @DISEASE$ deregulation in AD.	0
A few miRNAs (e.g., @MiRNA$, miR-155, and miR-362-3p) were upregulated or downregulated more than twofold in both brain and blood after several different @DISEASE$.	0
Overexpression of @MiRNA$ promotes proliferation and reduces apoptosis in @DISEASE$.	1
To investigate noncoding tiny microRNA mediated gene regulation, miRanda (version 1.0b) was used to predict human @MiRNA$ target sites on selected 29 genes related to @DISEASE$.	0
OBJECTIVE: Our objective was to examine the expression of Wee1 in @MiRNA$ and to identify @DISEASE$ (miRs) that can regulate its expression.	0
Interestingly, one of these, the bifunctional brain enriched miR-9/miR-9*, targets two components of the REST complex: miR-9 targets @MiRNA$ and @DISEASE$ * targets CoREST.	0
@MiRNA$ inhibits @DISEASE$ proliferation in part by repressing CyclinD.	1
@MiRNA$ radiosensitizes human @DISEASE$ cells by targeting CDK4.	1
The results suggest that @MiRNA$ are novel regulatory RNAs for @DISEASE$ formation.	0
Objective: The aim of the study was to analyze the differential expression of @MiRNA$, miR-15a, miR-16, miR-21, miR-141, miR-143, miR-145, and miR-150 in @DISEASE$ and normal pituitary tissue and verify whether their profile of expression correlates with tumor size or remission after treatment.	0
Myc-mediated repression of @MiRNA$ promotes high grade transformation of @DISEASE$ by dysregulation of FoxP1.	1
MicroRNAs (miRNAs) are @MiRNA$ in the brain and play an important role in disorders of the brain, including Alzheimer's diseases (@DISEASE$ ).	0
The @MiRNA$ cluster was significantly (and AD-dementia-specific) decreased in AD patients displaying abnormally high @DISEASE$ protein.	1
Expression of many @MiRNA$ in the de-differentiated brain tumor @DISEASE$ stem cells resembles that of neural stem cells.	0
@MiRNA$ silencing enhances the cytotoxic effect of the antiangiogenic drug sunitinib in @DISEASE$.	1
A strong positive correlation between @MiRNA$ abundance and the glial cell markers glial fibrillary acidic protein (GFAP) and vimentin, and CDKN2A down-regulation was noted in advanced Alzheimer's disease (AD) and in Down's syndrome (DS) brain, chronic @DISEASE$ associated with astrogliosis.	0
With respect to the reported regulation of this @MiRNA$ in @DISEASE$ -infected mice, we propose that upregulation of hsa-miR-342-3p may be a general phenomenon in late stage prion disease and might be used as a novel marker for animal and human TSEs.	1
Analysis of genes that @MiRNA$ interacts with included LGALS3 and @DISEASE$ ( http://microrna.sanger.ac.uk ) both of which have been shown to have roles in pituitary tumor cell growth.	0
@MiRNA$ functions as a tumor suppressor in Hep2 laryngeal @DISEASE$ cells partly through down-regulation of the S100A8 protein.	1
We performed a large-scale, genome-wide microRNA (@MiRNA$ ) (n=756) expression profiling of 26 glioblastoma, 13 @DISEASE$ and 7 normal brain samples with an aim to find deregulated miRNA in malignant astrocytoma.	0
We therefore investigated changes in @MiRNA$ (miRNA) expression profiles of sporadic AD patients and found that several miRNAs potentially involved in the regulation of @DISEASE$ and BACE1 expression appeared to be decreased in diseased brain.	0
miRNA-21 was hyperexpressed in all tumor samples whereas higher levels of @MiRNA$ were found in @DISEASE$.	1
Oxidative DNA damage correlates with cell immortalization and @MiRNA$ expression in @DISEASE$.	1
The Association between Genetic Polymorphism and the Processing Efficiency of @MiRNA$ Affects the Prognosis of Patients with Head and Neck @DISEASE$.	1
Our research revealed that 136 @MiRNA$ were expressing at 6 h post @DISEASE$, in which 13 miRNAs were more than 2-fold up-regulated, and 14 miRNAs were more than 2-fold down-regulated; 118 miRNAs were expressing at 24 h post injury, in which 4 miRNAs were more than 2-fold up-regulated, and 23 miRNAs were more than 2-fold down-regulated; 149 miRNAs were expressing at 48 h post injury, in which 16 miRNAs were more than 2-fold up-regulated, and 11 miRNAs were more than 2-fold down-regulated; and 203 miRNAs were expressing at 72 h post injury, in which 19 miRNAs were more than 2-fold up-regulated, and 5 miRNAs were more than 2-fold down-regulated.	0
More than 50% of @MiRNA$ genes are located in @DISEASE$ -associated genomic regions or in fragile sites of the genome.	0
Plexin-B1 is a target of @MiRNA$ in @DISEASE$ and promotes the growth and invasion of HeLa Cells.	1
@MiRNA$ targets PRKCE to modulate papillary @DISEASE$ developmen.	1
Regulatory interplay between @MiRNA$ JAG1 and 17beta-estradiol (E2) in @DISEASE$ cells.	1
In this study, the time course of miRNA-223 expression may be related to inflammatory responses after @MiRNA$, and the time course of decreased @DISEASE$ expression may reflect cell death.	0
@MiRNA$ Is an Independent Prognostic Factor in @DISEASE$ and Confers Increased Invasive Potential In Vitr.	1
@MiRNA$ accelerates a C-terminal mutant of C/EBPα (C/EBPa-C(m))-induced @DISEASE$.	1
Expression of the tumor suppressor @MiRNA$ is associated with cellular proliferative inhibition and impairs invasion in ERα-positive @DISEASE$.	1
Recently, @MiRNA$ involvement in the pathophysiology of @DISEASE$ has been assessed.	0
We report that infection of human primary neural cells with a high phenotypic reactivator HSV-1 (17syn+) induces upregulation of a brain-enriched @MiRNA$ that is associated with proinflammatory signaling in stressed brain cells and @DISEASE$.	1
Clustered inserts from @MiRNA$ -associated regions (Common Integration Sites, CIS) have a higher association with @DISEASE$ than non-clustered inserts.	0
The predicted targets of these @MiRNA$ include those with known or suspected roles in oligodendrocyte development and myelination including C11Orf9, @DISEASE$, MYTL1, MBOP, MPZL2, and DDR1.	0
Compared with normal rats (control group), 23 of the 125 miRNAs were expressed differentially in @MiRNA$ rats including 5 down-regulated miRNAs (let-7e included) and 18 up-regulated miRNAs (@DISEASE$ included).	1
We observed opposing effects of BACE1-antisense and @MiRNA$ on BACE1 protein in vitro and showed that Locked Nucleic Acid-antimiR mediated knockdown of miR-485-5p as well as BACE1-antisense over-expression can prevent the miRNA-induced @DISEASE$ suppression.	0
@MiRNA$ Inhibits Lung @DISEASE$ Stem Cells Proliferation by Targeting OCT4 Gene.	1
@MiRNA$ expression in the sera and dermal fibroblasts increases in patients with @DISEASE$.	1
Down-regulation of these @MiRNA$ has been reported in chronic lymphocytic lymphoma (CLL), @DISEASE$, and prostate carcinoma.	1
Time-course assays of neuronal @MiRNA$ treatments show that Abeta is in fact a powerful regulator of miRNA levels as the response of certain mature @DISEASE$ is extremely rapid.	0
Human brains retain discrete populations of micro RNA (miRNA) species that support homeostatic brain gene expression functions; however, specific @MiRNA$ abundance is significantly altered in @DISEASE$ such as Alzheimer disease (AD) when compared with age-matched controls.	1
Pharmacologic and genetic inhibition of p53 corroborated the hypothesis that pre-@MiRNA$ (but not pre-miR-181a) blocks the upstream signaling pathways that are ignited by DNA damage and converge on @DISEASE$ activation.	1
@MiRNA$ inhibits cell migration and invasion by downregulating vimentin expression and is a potential prognostic marker in @DISEASE$.	1
Interaction map and selection of @MiRNA$ targets in @DISEASE$ -related genes.	0
@MiRNA$ suppresses @DISEASE$ cell progression through post-transcriptional regulation of ErbB3.	1
A few miRNAs (e.g., miR-298, @MiRNA$, and miR-362-3p) were upregulated or downregulated more than twofold in both brain and blood after several different @DISEASE$.	0
@MiRNA$ protects against the H(2)O(2)-induced @DISEASE$ on cardiac myocytes via its target gene PDCD.	1
@MiRNA$ is down-regulated in whole blood @DISEASE$ patient.	1
The bioinformatics analysis indicates that the potential targets for @MiRNA$ altered after SCI include genes encoding components that are involved in the @DISEASE$, oxidation, and apoptosis that are known to play important roles in the pathogenesis of SCI.	0
Interestingly, one of these, the bifunctional brain enriched miR-9/miR-9*, targets two components of the REST complex: @MiRNA$ targets REST and miR-9* targets @DISEASE$.	0
In a well-characterized Belgian group of 358 @MiRNA$ patients and 462 controls, we examined whether genetic variability in microRNA (@DISEASE$ ) binding sites of APP and BACE1 or in associated miRNAs influenced risk for A.	0
@MiRNA$ studies in neurobiology showed their involvement in synaptic plasticity and @DISEASE$.	0
Interestingly the gene locus of one miRNA, @MiRNA$, is a candidate region for two @DISEASE$ : early-onset parkinsonism (Waisman syndrome) and X-linked mental retardation (MRX3).	1
Prospero homeobox 1 promotes epithelial-mesenchymal transition in @DISEASE$ cells by inhibiting E-cadherin via @MiRNA$.	1
Our in vitro results suggested that Aβ42 oligomer-induced @MiRNA$ leads to impairment in TGF-β signaling through @DISEASE$, concomitant with retinoic acid-induced neurodegeneration in SH-SY5Y cells.	0
Furthermore, let-7e and @MiRNA$ analysis in rat hippocampus were performed by real-time quantitative polymerase chain reaction at 0h, 1h, 6h, 12h, 24h, 2days, 7days,10days, 30days,50days after induction of status epilepticus (@DISEASE$ ).	0
Endocrine Disruptors Fludioxonil and Fenhexamid Stimulate @MiRNA$ Expression in @DISEASE$ Cell.	1
We recently showed in HeLa cells that two components of the SMN complex, @MiRNA$ and Gemin4, together with the argonaute protein eIF2C2, also associate with microRNAs (@DISEASE$ ) as part of a novel class of RNPs termed miRNPs.	0
The plasma @MiRNA$ profiles from severe @DISEASE$ patients (Glasgow Coma Scale [GCS] score ≤8) and age-, gender-, and race-matched healthy volunteers were compared by microarray analysis.	0
CONCLUSION: Expression level of @MiRNA$ /metastasis suppressive miRNAs in the WNT signaling associated medulloblastomas is likely to determine their response to treatment, and thus, these @DISEASE$ would be important biomarkers for risk stratification within the WNT signaling associated medulloblastomas.	0
Inhibition of two @MiRNA$ -upregulated miRNAs (miR-21 and miR-23a) and exogenous overexpression of two glioblastoma-downregulated miRNAs (miR-218 and @DISEASE$ ) resulted in reduced soft agar colony formation but showed varying effects on cell proliferation and chemosensitivity.	0
We show that the expression of @MiRNA$ is inversely correlated with the protein level of bcl2 in APPswe/PSDeltaE9 mice and age-matched controls, and miR-34a expression directly inhibits @DISEASE$ translation in SH-SY5Y cells.	0
@MiRNA$ 486 is a potentially novel target for the treatment of @DISEASE$.	1
Upregulation of @MiRNA$ contributes to leukemogenesis and increases drug resistance in pediatric @DISEASE$.	1
Identification of Serum @MiRNA$ as a Biomarker for Chemosensitivity and Prognosis in Human @DISEASE$.	1
Our research revealed that 136 @MiRNA$ were expressing at 6 h post injury, in which 13 miRNAs were more than 2-fold up-regulated, and 14 miRNAs were more than 2-fold down-regulated; 118 miRNAs were expressing at 24 h post @DISEASE$, in which 4 miRNAs were more than 2-fold up-regulated, and 23 miRNAs were more than 2-fold down-regulated; 149 miRNAs were expressing at 48 h post injury, in which 16 miRNAs were more than 2-fold up-regulated, and 11 miRNAs were more than 2-fold down-regulated; and 203 miRNAs were expressing at 72 h post injury, in which 19 miRNAs were more than 2-fold up-regulated, and 5 miRNAs were more than 2-fold down-regulated.	0
Our research revealed that 136 miRNAs were expressing at 6 h post injury, in which 13 @MiRNA$ were more than 2-fold up-regulated, and 14 miRNAs were more than 2-fold down-regulated; 118 miRNAs were expressing at 24 h post injury, in which 4 miRNAs were more than 2-fold up-regulated, and 23 miRNAs were more than 2-fold down-regulated; 149 miRNAs were expressing at 48 h post @DISEASE$, in which 16 miRNAs were more than 2-fold up-regulated, and 11 miRNAs were more than 2-fold down-regulated; and 203 miRNAs were expressing at 72 h post injury, in which 19 miRNAs were more than 2-fold up-regulated, and 5 miRNAs were more than 2-fold down-regulated.	0
The characterization of @MiRNA$ -specific @DISEASE$ signatures may aid in the discovery of biomarkers with diagnostic or prognostic utility.	0
MiRNA germline and somatic mutations or polymorphisms in the protein coding messenger RNA targeted by @MiRNA$ may also occur, contributing to @DISEASE$ predisposition, initiation and/or progression.	0
@MiRNA$ rs2292832 were associated with increased risk @DISEASE$ in Chinese wome.	1
@MiRNA$ sensitizes resistant @DISEASE$ HL-60/Ara-C cells to Ara-C by inducing apoptosis.	1
However, little is understood about the roles of @MiRNA$ in @DISEASE$.	0
In this review article, the molecular mechanisms underlying the role and function of @MiRNA$ in the regulation of genes involved in neurological and neurodegenerative diseases will be discussed, with a focus on the fragile X syndrome, Alzheimer's disease (@DISEASE$ ) and prion disease.	0
miR-34a, a @MiRNA$ up-regulated in a double transgenic mouse model of @DISEASE$, inhibits bcl2 translation.	1
We used miRNA profiling with 1,145 probes to study @MiRNA$ expression in normal anterior pituitary (6 cases), adrenocorticotropin (ACTH)-producing adenomas (8 cases), and @DISEASE$ -producing pituitary carcinomas (two cases).	0
We thus identify miRNAs as novel endogenous regulators of @MiRNA$ expression, suggesting that variations in @DISEASE$ expression could contribute to changes in APP expression in the brain during development and disease.	0
The expression level of RAD51AP1 was found to be strongly anti-correlated with the expression of @MiRNA$ which was significantly down-regulated in the @DISEASE$ samples.	1
@MiRNA$ over-expression blocks expression of several cancer stem-cell genes, impairs the engrafting potential of MB cells in the cerebellum of athymic/nude mice, and of particular interest, decreases the @DISEASE$ stem-cell-like (CD133+) subpopulation of cells.	0
@MiRNA$ inhibits the migration and invasion of esophageal @DISEASE$ by regulating LASP1.	1
To search for miRNAs that may be involved in the pathogenesis of Parkinsons disease (PD), we utilized @MiRNA$ microarrays to identify potential gene expression changes in 115 annotated miRNAs in PD-associated Caenorhabditis elegans models that either overexpress human @DISEASE$ or have mutations within the vesicular catecholamine transporter (cat-1) or parkin (pdr-1) ortholog.	0
@MiRNA$ regulates @DISEASE$ cell stemness by targeting p53/nanog.	1
Recent studies have identified changes of several specific miRNA expression profiles and polymorphisms affecting the interactions between miRNAs and their targets in various brain disorders, including addiction: @MiRNA$ causes adaptive changes in production of the serotonin transporter; miR-133b is specifically expressed in midbrain dopaminergic neurons, and regulates the production of tyrosine hydroxylase and the dopamine transporter; miR-212 affects production of striatal @DISEASE$ and synaptic plasticity upon cocaine.	0
Aberrant @MiRNA$ expression is associated with glucocorticoid resistance in lymphoblastic @DISEASE$.	1
It has been demonstrated that @MiRNA$ expression is altered in many human @DISEASE$, suggesting that they may play a role in human neoplasia.	0
Genetic polymorphism ( rs5981521 (C>T)) of @MiRNA$ 325, targeting SLC6A4 3'-UTR, is closely associated with the risk of functional @DISEASE$ in Japan.	1
Our research revealed that 136 miRNAs were expressing at 6 h post @MiRNA$, in which 13 miRNAs were more than 2-fold up-regulated, and 14 miRNAs were more than 2-fold down-regulated; 118 miRNAs were expressing at 24 h post injury, in which 4 miRNAs were more than 2-fold up-regulated, and 23 miRNAs were more than 2-fold down-regulated; 149 miRNAs were expressing at 48 h post injury, in which 16 miRNAs were more than 2-fold up-regulated, and 11 miRNAs were more than 2-fold down-regulated; and 203 miRNAs were expressing at 72 h post injury, in which 19 @DISEASE$ were more than 2-fold up-regulated, and 5 miRNAs were more than 2-fold down-regulated.	0
Recent studies report that @MiRNA$ is negatively regulated by the let-7 @DISEASE$ (miRNAs) family in vitro.	1
@MiRNA$ targets the vitamin D-dependent antimicrobial pathway in @DISEASE$.	1
Role of @MiRNA$ as a Potential Tumor Suppressor in Head and Neck @DISEASE$.	1
miR-34a, a @MiRNA$ up-regulated in a double transgenic mouse model of Alzheimer's disease, inhibits @DISEASE$ translation.	1
@MiRNA$ sensitizes @DISEASE$ cells to cis-platinum via suppressing beclin 1-mediated autophagy.	1
Genistein Inhibits Cell Growth and Induces Apoptosis Through Up-regulation of @MiRNA$ in @DISEASE$ Cel.	1
These findings suggest that abnormal expression of @MiRNA$ may contribute to the pathogenesis of @DISEASE$ and are potential targets for therapeutic interventions following SCI.	1
In this review ,correlations between @MiRNA$ -mediated gene silencing and @DISEASE$, Parkinson's, and other neurodegenerative diseases will be discussed.	0
Epigenetic repression of @MiRNA$ disrupts androgen receptor homeostasis and contributes to @DISEASE$ progressio.	1
In short PMI Alzheimer's disease (@MiRNA$ )-affected temporal lobe neocortex, miRNA-9, @DISEASE$ and miRNA-146a were found to be significantly up-regulated, an effect that was not seen in several related neurological disorders.	1
@MiRNA$ Integrates Pathogenic Signaling to Control @DISEASE$.	1
The family of miR-64 and miR-65 are co-underexpressed in the alpha-synuclein transgenic and cat-1 strains, and members of let-7 family co-underexpressed in the @MiRNA$ and pdr-1 strains; mdl-1 and ptc-1 genes are target candidates for @DISEASE$ and miR-65 and are overexpressed in alpha-synuclein transgenic as well as miR-64/65 (tm3711) knockout animals.	0
The family of miR-64 and @MiRNA$ are co-underexpressed in the alpha-synuclein transgenic and cat-1 strains, and members of let-7 family co-underexpressed in the alpha-synuclein and pdr-1 strains; mdl-1 and ptc-1 genes are target candidates for miR-64 and miR-65 and are overexpressed in @DISEASE$ transgenic as well as miR-64/65 (tm3711) knockout animals.	0
In this paper, we present for the first time evidence that microRNAs (miRNAs), including @MiRNA$, and let-7b, may directly regulate @DISEASE$ in human and macaque cells.	0
We therefore investigated changes in microRNA (@MiRNA$ ) expression profiles of sporadic AD patients and found that several miRNAs potentially involved in the regulation of @DISEASE$ and BACE1 expression appeared to be decreased in diseased brain.	0
Objective: The aim of the study was to analyze the differential expression of let-7a, miR-15a, @MiRNA$, miR-21, miR-141, miR-143, miR-145, and miR-150 in @DISEASE$ and normal pituitary tissue and verify whether their profile of expression correlates with tumor size or remission after treatment.	0
@MiRNA$ induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence @DISEASE$.	1
Thus, the results of our study show that the downregulation of @MiRNA$ contributes to the antitumor effects of IFN-beta and that miR-21 expression is negatively regulated by @DISEASE$ activation.	0
These results, for the first time, demonstrate that expression of human LRP1 is regulated in part by a specific @MiRNA$, leading to decreased @DISEASE$ cell migration.	0
@MiRNA$ induces cell cycle arrest in Esophageal @DISEASE$ by modulating Cyclin E expression.	1
A Functional Polymorphism (rs11614913 (T>C)) in @MiRNA$ Is Associated with @DISEASE$ Risk in a Chinese Population.	1
Our research revealed that 136 miRNAs were expressing at 6 h post injury, in which 13 miRNAs were more than 2-fold up-regulated, and 14 miRNAs were more than 2-fold down-regulated; 118 miRNAs were expressing at 24 h post @MiRNA$, in which 4 miRNAs were more than 2-fold up-regulated, and 23 miRNAs were more than 2-fold down-regulated; 149 miRNAs were expressing at 48 h post injury, in which 16 miRNAs were more than 2-fold up-regulated, and 11 miRNAs were more than 2-fold down-regulated; and 203 @DISEASE$ were expressing at 72 h post injury, in which 19 miRNAs were more than 2-fold up-regulated, and 5 miRNAs were more than 2-fold down-regulated.	0
Computational analysis predicted fibroblast growth factor-2 (@MiRNA$ ) as the strongest target gene for @DISEASE$.	1
@MiRNA$ Suppresses the Invasive Potential @DISEASE$ Cells and Sensitizes Cells to DNA Damages by Targeting Histone Methyltransferase SET8.	1
Our study dissects the complexity of human AD pathology, and addresses the hypothesis that amyloid-beta (@MiRNA$ ) itself, a known causative factor of AD, causes neuronal @DISEASE$ deregulation, which could contribute to the pathomechanisms of AD.	1
RESULTS: We found underexpression of miR-145 (2.0-fold; P = 0.04), miR-21 (2.4-fold; P = 0.004), miR-141 (2.6-fold; P = 0.02), @MiRNA$ (3.3-fold; P = 0.003), miR-150 (3.8-fold; P = 0.04), miR-15a (4.5-fold; P = 0.03), miR-16 (5.0-fold; P = 0.004), and miR-143 (6.4-fold; P = 0.004) in @DISEASE$ when compared to normal pituitary tissues.	1
Reduced Circulating @MiRNA$ Is Correlated with Phosphate Metabolism in Patients with @DISEASE$ on Maintenance Hemodialysis.	1
The family of miR-64 and miR-65 are co-underexpressed in the alpha-synuclein transgenic and cat-1 strains, and members of @MiRNA$ family co-underexpressed in the alpha-synuclein and pdr-1 strains; mdl-1 and @DISEASE$ genes are target candidates for miR-64 and miR-65 and are overexpressed in alpha-synuclein transgenic as well as miR-64/65 (tm3711) knockout animals.	0
Human brains retain discrete populations of micro RNA (miRNA) species that support homeostatic brain gene expression functions; however, specific @MiRNA$ abundance is significantly altered in neurological disorders such as Alzheimer disease (@DISEASE$ ) when compared with age-matched controls.	1
@MiRNA$ inhibits epithelial to mesenchymal transition of @DISEASE$ cells by targeting oncogene BMI-1.	1
Our analysis revealed @MiRNA$ and @DISEASE$ were core regulators in this regulatory network.	0
@MiRNA$ suppresses mesenchymal differentiation in @DISEASE$ by downregulating expression of JAK kinases and inhibiting activation of STAT3.	1
Recent years have seen considerable progress in @MiRNA$ research in @DISEASE$, particularly in glioblastomas and medulloblastomas, providing novel insights into the pathogenesis of these malignant lesions.	0
Stathmin1 Plays Oncogenic Role and Is a Target of @MiRNA$ in @DISEASE$.	1
CONTEXT: MicroRNAs (@MiRNA$ ) are small noncoding RNAs, functioning as antisense regulators of gene expression by targeting mRNA and contributing to @DISEASE$ development and progression.	0
The interactive signaling of NF-κB and @MiRNA$ further illustrate interplay between inducible transcription factors and pro-inflammatory miRNAs that regulate brain @DISEASE$ expression.	1
@MiRNA$ and miR-16-1 function by targeting multiple oncogenes, including BCL2, MCL1, @DISEASE$, and WNT3A.	1
Cell proliferation and invasion ability of human @DISEASE$ cells lessened due to inhibition of Sox2 expression by @MiRNA$.	1
The @MiRNA$ was upregulated in cis-platin resistant (A2780/CP70) vs. cis-platin sensitive (A2780) @DISEASE$ cell lines.	1
OBJECTIVE: Our objective was to examine the expression of @MiRNA$ in pituitary tumors and to identify @DISEASE$ (miRs) that can regulate its expression.	0
miR-15a and @MiRNA$ function by targeting multiple oncogenes, including BCL2, @DISEASE$, CCND1, and WNT3A.	1
The @MiRNA$ lymphocyte-induced maturation protein-1/IL-2 axis is differentially regulated in progressive @DISEASE$.	1
A @MiRNA$ signature of @DISEASE$ induced neurodegeneration.	0
Using transiently transfected murine neuronal N2a cells in culture, in parallel to a mouse model of @MiRNA$, we were able to demonstrate a role for two miRNAs (@DISEASE$ and miR-328) in the regulation of beta-amyloid (Abeta) precursor protein (APP)-converting enzyme (BACE) messenger RNA (mRNA) translation, thereby providing key insights into the molecular basis underlying BACE deregulation in AD.	0
Here we show that the highly malignant human brain tumor, @MiRNA$, strongly over-expresses a specific miRNA, @DISEASE$.	1
Downregulation of @MiRNA$ induces taxane resistance in @DISEASE$ cells through increase of receptor tyrosine kinase ME.	1
Consistent with its regulation by @MiRNA$, we observed that Shh treatment of primary cerebellar granule neuron precursors (CGNP), proposed cells of origin for the Shh-associated medulloblastomas, resulted in increased @DISEASE$ expression.	0
@MiRNA$ and its target gene oncogene c-myc have roles in @DISEASE$ pathogenesis.	1
Here we report for the first time which changes occur in the total @MiRNA$ population following @DISEASE$ knockdown in culture cells.	0
Involvement of @MiRNA$ in resistance to daunorubicin by regulating PTEN expression in the @DISEASE$ K562 cell line.	1
Primary Microcephaly Gene MCPH1 Shows Signatures of Tumor Suppressors and Is Regulated by @MiRNA$ in Oral @DISEASE$.	1
@MiRNA$ Suppresses Growth and Invasion, is Downregulated in Oligodendroglial @DISEASE$ and Targets CSE1.	1
The purpose of this study was to examine @MiRNA$ expression after @DISEASE$.	0
@MiRNA$ confers resistance of @DISEASE$ cells to cisplatin by targeting pro-apoptotic Bcl-2 antagonist killer 1.	1
@MiRNA$ regulates DNA methylation in CD4(+) T cells and contributes to @DISEASE$ by targeting DNA methyltransferase 1.	1
Downregulation of @MiRNA$ in meningiomas and arachnoidal cells resulted in increased expression of beta-catenin and @DISEASE$ involved in cell proliferation.	1
One remarkable hit was the argonaute 1 (@MiRNA$ ) gene, a central element of the microRNA (@DISEASE$ ) translational silencing machinery.	0
The present review examines the various @MiRNA$ that have been identified as being potentially involved in @DISEASE$, focusing on the insulin-sensitive organs: white adipose tissue, liver, skeletal muscle and the insulin-producing pancreatic β-cells.	0
Computational analysis predicted @MiRNA$ (FGF-2) as the strongest target gene for @DISEASE$.	1
Differential expression of @MiRNA$ as a novel fecal-based diagnostic marker for @DISEASE$.	1
TMEM106B, the Risk Gene for @DISEASE$ Is Regulated by the @MiRNA$ and Affects Progranulin Pathways.	1
@MiRNA$ determines the radioresistance of human @DISEASE$ by directly targeting PTEN.	1
@MiRNA$ is downregulated in @DISEASE$.	1
In a well-characterized Belgian group of 358 AD patients and 462 controls, we examined whether genetic variability in microRNA (miRNA) binding sites of @MiRNA$ and BACE1 or in associated @DISEASE$ influenced risk for A.	0
@MiRNA$ is an independent prognostic marker in patients with @DISEASE$.	1
Furthermore, microinfusion of lentiviral vectors that contained microRNAs (@MiRNA$ ) targeting long-form PDE4D isoforms into bilateral dentate gyri of the mouse hippocampus downregulated PDE4D4 and PDE4D5, enhanced memory, and increased hippocampal neurogenesis and @DISEASE$.	0
Recent evidence has also shown that REST regulates transcription of regulatory @MiRNA$ (microRNAs), many of which are known to regulate neuronal gene expression and are dysregulated in @DISEASE$.	1
@MiRNA$ induces global DNA hypomethylation and tumor suppressor gene re-expression in @DISEASE$ by targeting directly DNMT3A and 3B and indirectly DNMT.	1
@DISEASE$ cell adhesion to bone marrow stromal cells confers drug resistance by @MiRNA$ up-regulation.	1
RESULTS: We observed increases in plasma concentrations of miR-122, @MiRNA$, and miR-124 corresponding to @DISEASE$, muscle, and brain, respectively.	1
We therefore investigated whether @MiRNA$ could participate in the regulation of @DISEASE$ gene expression.	0
We examined if plasma @MiRNA$ levels are altered in patients with traumatic brain injury (TBI) relative to matched healthy volunteers, and explored their potential for use as diagnostic @DISEASE$ biomarkers.	0
@MiRNA$ 320a functions as a novel endogenous modulator of aquaporins 1 and 4 as well as a potential therapeutic target in @DISEASE$.	1
Polo-like kinase 1 regulates cell proliferation and is targeted by @MiRNA$ in @DISEASE$.	1
@MiRNA$ chemosensitizes @DISEASE$ cells to the chemotherapeutic drug doxorubicin by targeting the first binding site of BCL2L2 mRN.	1
CONCLUSION: Our results indicate a time-dependent expression pattern of miR-223 and @MiRNA$ in a mouse model of @DISEASE$.	0
Interestingly, one of these, the bifunctional brain enriched miR-9/@MiRNA$ *, targets two components of the REST complex: miR-9 targets @DISEASE$ and miR-9* targets CoREST.	0
CX43 expression is suppressed by @MiRNA$ in the progression of human @DISEASE$.	1
@MiRNA$ expression predicts outcome after liver transplantation for @DISEASE$ in cirrhotic liver.	1
Carbamylated albumin stimulates @MiRNA$ which is increased in human @DISEASE$.	1
@MiRNA$ inhibits cell cycle progression and promotes apoptosis in @DISEASE$ by downregulating oncogene BMI-.	1
These data support the hypothesis that patterns of miRNA expression in cortical GM may contribute to @MiRNA$ pathogenetically, because the aggregate change in @DISEASE$ expression observed early in the disease would be predicted to cause profound changes in gene expression.	0
Transcriptional activation of @MiRNA$ by NF-kappa B in human @DISEASE$ cells.	1
@MiRNA$ expression profiling of both mouse and human @DISEASE$ has led to the identification of signatures correlating with the molecular subgroups of medulloblastoma, tumor diagnosis and response to treatment, as well as novel targets of potential clinical relevance.	0
These results suggest that increased @MiRNA$ expression in the hippocampus may influence multiple components of @DISEASE$ pathophysiology.	1
Thus, @MiRNA$ appears to act as a multifunctional tumor suppressor miRNA in meningiomas through effects on the @DISEASE$ and Wnt/beta-catenin signaling pathways.	1
@MiRNA$ induces differential expression of hippocampal @DISEASE$ including let-7e and miR-23a/b.	1
Pharmacologic and genetic inhibition of p53 corroborated the hypothesis that pre-@MiRNA$ (but not pre-miR-181a) blocks the upstream signaling pathways that are ignited by @DISEASE$ and converge on p53 activation.	0
@MiRNA$ is a biomarker of disease progression in @DISEASE$.	1
Green tea polyphenol EGCG suppresses @DISEASE$ cell growth through upregulating @MiRNA$ expression caused by stabilizing HIF-1{alpha.	1
Using a sensitive qRT-PCR platform we identified regional and stage-specific deregulation of @MiRNA$ expression in @DISEASE$ patient brains.	1
@MiRNA$ expression is known to be deregulated in various @DISEASE$ and has been found to be useful in predicting tumor behavior.	0
@MiRNA$ down-regulates CDX2 expression in @DISEASE$ cells.	1
Recent studies have identified changes of several specific miRNA expression profiles and polymorphisms affecting the interactions between @MiRNA$ and their targets in various brain disorders, including addiction: miR-16 causes adaptive changes in production of the serotonin transporter; miR-133b is specifically expressed in midbrain dopaminergic neurons, and regulates the production of tyrosine hydroxylase and the dopamine transporter; miR-212 affects production of striatal @DISEASE$ and synaptic plasticity upon cocaine.	0
Dual-luciferase assay and transient transfection of @MiRNA$ into Hela cells followed by immunoblot analysis of @DISEASE$ protein and cell proliferation analysis were carried out.	0
MiR-107 is a microRNA (@MiRNA$ ) that we reported previously to have decreased expression in the temporal cortical gray matter early in the progression of @DISEASE$ (AD).	1
Our results showed that the expression of @MiRNA$ was inversely correlated with @DISEASE$ protein levels and miR-106b can directly inhibit the TβR II translation in vitro.	1
Down-regulation of HES1 expression by miR-199b-5p negatively regulates the proliferation rate and anchorage-independent growth of MB cell@MiRNA$.	1
Interestingly, both miRNAs are capable of binding directly to @MiRNA$ in different positions: within the miRNA sequence itself (let-7b) or in the hairpin precursor (@DISEASE$ ).	1
Ectopic @MiRNA$ expression in CGNPs synergized with exogenous Shh to increase proliferation and also enabled them to proliferate in the absence of @DISEASE$.	0
Expression pattern of miR-146a, an inflammation-associated @MiRNA$, in experimental and human @DISEASE$.	0
Using luciferase reporter assays with 3'-UTRs of TBP, over-expression and inhibition of miR-146a, we showed that @MiRNA$ targets @DISEASE$.	1
We used experimental validation in addition to literature to reveal how the deregulated brain @MiRNA$ are biomarkers for known and novel pathways in @DISEASE$ pathogenesis related to amyloid processing, neurogenesis, insulin resistance, and innate immunity.	1
Associations of @MiRNA$ and pre-miR-196a2 Polymorphisms and Their Multiplicative Interactions with Hepatitis B Virus Mutations with @DISEASE$ Ris.	1
The drug resistance suppression induced by curcuminoids in @DISEASE$ SW-480 cells is mediated by reactive oxygen species-induced disruption of the @MiRNA$ ZBTB10-Sp axi.	1
This NF-kappaB-@MiRNA$ -@DISEASE$ signaling circuit is known to be similarly affected by Abeta42 peptides and in AD brain.	0
The expression level of @MiRNA$ was consistently lower in infiltrative than nodular @DISEASE$ and could be one element underlying the difference in invasiveness.	1
Genome-wide expression profiling identifies deregulated @MiRNA$ in malignant @DISEASE$.	0
Inhibition of two glioblastoma-upregulated @MiRNA$ (miR-21 and miR-23a) and exogenous overexpression of two @DISEASE$ -downregulated miRNAs (miR-218 and miR-219-5p) resulted in reduced soft agar colony formation but showed varying effects on cell proliferation and chemosensitivity.	0
Aberrant @MiRNA$ expression in the brains of neurodegenerative diseases: miR-29a decreased in Alzheimer disease brains targets @DISEASE$.	0
We further show that in a xenograft model, MB @MiRNA$ burden can be reduced, indicating the use of @DISEASE$ as an adjuvant therapy after surgery, in combination with radiation and chemotherapy, for the improvement of anti-cancer MB therapies and patient quality of life.	0
@MiRNA$ is involved in the Notch signaling pathway in @DISEASE$.	1
@MiRNA$ regulates TH-17 differentiation and is associated with the pathogenesis of @DISEASE$.	1
Disruption of @MiRNA$ -based post-transcriptional regulation has been implicated in a range of @DISEASE$ as one miRNA is predicted to impact the expression of numerous downstream mRNA targets.	0
Heat Shock Protein 90B1 Plays an Oncogenic Role and is a Target of @MiRNA$ in Human @DISEASE$.	1
The expression of @MiRNA$, miR-27a, and miR-150 was unchanged in both wild-type (WT) and @DISEASE$ -γ(-/-) mice following infection.	0
METHODOLOGY/PRINCIPAL FINDINGS: In a screening of MB cell lines, the @MiRNA$ miR-199b-5p was seen to be a regulator of the Notch pathway through its targeting of the transcription factor @DISEASE$.	1
One of the most active fields of miR@MiRNA$ search is miRNA regulation of apoptosis, a programmed cell death implicated in many human diseases, such as cancer, Alzheimer's disease, hypertrophy and hea@DISEASE$.	0
Bioinformatic analysis of the predicted targets for this panel of @MiRNA$ revealed an overrepresentation of proteins involved in several biological processes and functions known to be initiated after @DISEASE$, including signal transduction, transcriptional regulation, proliferation, and differentiation.	0
@MiRNA$ may play a central role in HBx/URG11 mediated HCC, and may be an early diagnostic marker and/or therapeutic target associated with this @DISEASE$ type.	1
To determine whether @MiRNA$ expression is altered in @DISEASE$, we analyzed the entire miRNAome in 32 pituitary adenomas and in 6 normal pituitary samples by microarray and by Real-Time PCR.	0
We observed opposing effects of BACE1-antisense and @MiRNA$ on @DISEASE$ protein in vitro and showed that Locked Nucleic Acid-antimiR mediated knockdown of miR-485-5p as well as BACE1-antisense over-expression can prevent the miRNA-induced BACE1 suppression.	0
To understand the role of @MiRNA$ in the molecular mechanisms of @DISEASE$ (TLE), we investigated the changes in microRNA (miRNA) expression profiles of chronic TLE rat models.	0
Genistein Suppresses @DISEASE$ Growth through Inhibition of Oncogenic @MiRNA$.	1
@MiRNA$ Expression Correlates with Response to Neoadjuvant Therapy and Survival in Pancreatic Ductal @DISEASE$.	1
@MiRNA$ is a microRNA (miRNA) that we reported previously to have decreased expression in the temporal cortical gray matter early in the progression of Alzheimer's disease (@DISEASE$ ).	1
These findings support a causal link between let-7 and high-mobility group A2 whereby loss of @MiRNA$ expression induces @DISEASE$ upregulation that represents an important mechanism in pituitary tumorigenesis and progression.	1
Our research revealed that 136 miRNAs were expressing at 6 h post injury, in which 13 miRNAs were more than 2-fold up-regulated, and 14 miRNAs were more than 2-fold down-regulated; 118 miRNAs were expressing at 24 h post injury, in which 4 miRNAs were more than 2-fold up-regulated, and 23 miRNAs were more than 2-fold down-regulated; 149 @MiRNA$ were expressing at 48 h post injury, in which 16 miRNAs were more than 2-fold up-regulated, and 11 miRNAs were more than 2-fold down-regulated; and 203 miRNAs were expressing at 72 h post @DISEASE$, in which 19 miRNAs were more than 2-fold up-regulated, and 5 miRNAs were more than 2-fold down-regulated.	0
One remarkable hit was the argonaute 1 (@MiRNA$ ) gene, a central element of the @DISEASE$ (miRNA) translational silencing machinery.	0
Restoration of @MiRNA$ expression suppresses cell proliferation, migration and invasion in @DISEASE$ by targeting FSCN1.	1
@MiRNA$ sensitizes a multidrug-resistant @DISEASE$ cell line K562/A02 to daunorubicin by targeting BCL-2.	1
@MiRNA$ expression affects invasion potential of human @DISEASE$ cell lines by targeting DVL2.	1
@MiRNA$ enhances angiogenic activity of endothelial cells in @DISEASE$ by promoting PDGFRA expression.	1
Taken together, our findings indicate that @MiRNA$ regulates cell cycle progression in @DISEASE$ cells by targeting cell cycle-related molecules.	0
Thus, plasma concentration of @MiRNA$ provides a promising candidate biomarker for early detection of @DISEASE$.	0
@MiRNA$ 30A promotes autophagy in response to @DISEASE$ therapy.	1
Expression of human endogenous retrovirus-K coincides with that of @MiRNA$ 663 and -638 in @DISEASE$ cell.	1
@MiRNA$ promotes the development of bladder @DISEASE$ via direct repression of Caspase-.	1
These data suggest a significantly independent regulation of IRAK-1 and IRAK-2 in @MiRNA$ and in IL-1β+Aβ42 peptide-stressed HAG cells and that an inducible, NF-κB-sensitive, @DISEASE$ -mediated down-regulation of IRAK-1 coupled to an NF-κB-induced up-regulation of IRAK-2 expression drives an extensively sustained inflammatory response.	0
The authors found a significantly increased @DISEASE$ risk with the @MiRNA$ C (rs11614913) genotype compared with the TT/CT genotype (AOR?=?1.50; 95% CI?=?1.11-2.04; P?=?0.01; FDR-P?=?0.04) in Korean population.	1
In 66 control and AD samples we note a significant up-regulation of @MiRNA$ coupled to down-regulation of @DISEASE$ and a compensatory up-regulation of IRAK-2.	1
@MiRNA$ coordinately targets Polycomb Repressor Complexes in @DISEASE$ stem cells.	1
These findings indicated that the @MiRNA$ SRF pathway may offer a novel strategy for treatment with angiogenesis in @DISEASE$ patients.	1
@MiRNA$ expression in PC cells is induced by @DISEASE$ through a HIF-1alpha-dependent pathway, but does not influence PC cell proliferation.	1
This review summarizes the discovery, functions, and clinical relevance of these @MiRNA$ in cancer, particularly @DISEASE$.	0
We used @MiRNA$ profiling with 1,145 probes to study miRNA expression in normal anterior pituitary (6 cases), adrenocorticotropin (@DISEASE$ )-producing adenomas (8 cases), and ACTH-producing pituitary carcinomas (two cases).	0
These findings suggested that bcl2 is an important functional target for @MiRNA$, and the abnormal expression of miR-34a may contribute to the pathogenesis of Alzheimer's disease, at least in part by affecting the expression of @DISEASE$.	0
@MiRNA$ suppresses proliferation and induces apoptosis in @DISEASE$.	1
Decreased @MiRNA$ Levels In @DISEASE$ Cells Coincides with Increased Cell Proliferation, Invasion, and Accumulation of the Polycomb Ezh2 Methyltransferase.	1
These findings suggested that @MiRNA$ is an important functional target for miR-34a, and the abnormal expression of @DISEASE$ may contribute to the pathogenesis of Alzheimer's disease, at least in part by affecting the expression of bcl2.	0
The @MiRNA$ -regulating @DISEASE$ miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo.	0
@MiRNA$ inhibition normalizes HuR over-expression and aberrant AU-rich mRNA stability in invasive @DISEASE$.	1
However, our knowledge of the role of @MiRNA$ in the microRNA (@DISEASE$ ) synthesis pathway is limited to the association mentioned above.	0
Myc-associated zinc finger protein (MAZ) is regulated by @MiRNA$ and mediates VEGF-induced angiogenesis in @DISEASE$.	1
Differential regulation of interleukin-1 receptor-associated kinase-1 (IRAK-1) and @MiRNA$ by @DISEASE$ and NF-kappaB in stressed human astroglial cells and in Alzheimer disease.	1
These findings suggest that abnormal expression of @MiRNA$ may contribute to the pathogenesis of SCI and are potential targets for therapeutic interventions following @DISEASE$.	1
@MiRNA$ Blocks @DISEASE$ Development and Nicotine-Augmented Expansion.	1
Serum expression level of @MiRNA$ was down-regulated in @DISEASE$ patients.	1
Here we show that @MiRNA$ interacts with the microRNA (@DISEASE$ ) pathway to regulate protein synthesis.	0
Let-7a: Let-7a @MiRNA$ suppresses therapeutics-induced @DISEASE$ cell death by targeting caspase-.	1
@MiRNA$ miR-371-3 in serum as diagnostic tools in the management of testicular @DISEASE$.	1
The @MiRNA$ -regulating microRNA @DISEASE$ is amplified in high-grade glioma and facilitates gliomagenesis in vivo.	0
BACKGROUND: Through negative regulation of gene expression, microRNAs (@MiRNA$ ) can function in @DISEASE$ as oncosuppressors, and they can show altered expression in various tumor types.	0
@MiRNA$ is a putative predictor marker of Imatinib therapy response in @DISEASE$.	1
Down-regulation of @MiRNA$ -214 in cutaneous @DISEASE$ mediates abnormal cell proliferation via the induction of ERK.	1
The most interesting results came from @MiRNA$, strongly up-regulated in glioblastoma and from a set of brain-enriched miRNAs, miR-128, miR-181a, miR-181b, and miR-181c, which are down-regulated in @DISEASE$.	0
In this commentary, we discuss the known functions of @MiRNA$ in @DISEASE$ and stem cells, their therapeutic potential and how the findings of Silber et al provide insight into the role of miR-124/miR-137 dysregulation in glioblastomas.	0
Downregulated plasma @MiRNA$ levels have clinical impact on @DISEASE$ and related disorders.	1
Novel genetic variants in @MiRNA$ gene and familial @DISEASE$.	1
Using transiently transfected murine neuronal N2a cells in culture, in parallel to a mouse model of AD, we were able to demonstrate a role for two @MiRNA$ (miR-298 and miR-328) in the regulation of beta-amyloid (Abeta) precursor protein (APP)-converting enzyme (BACE) messenger RNA (mRNA) translation, thereby providing key insights into the molecular basis underlying BACE deregulation in @DISEASE$.	0
@MiRNA$ was identified as a potential biomarker for malignant @DISEASE$.	1
Many @MiRNA$ changed more than 1.5-fold in brain and blood after each experimental manipulation, and several miRNAs were upregulated or downregulated in both brain and blood after a given @DISEASE$.	0
@MiRNA$ loss is associated with tau exon 10 inclusion in @DISEASE$.	1
A specific subset of five miRNAs revealed by in silico target prediction was significantly overexpressed in NFA samples; three miRs (@MiRNA$, miR-155, and miR-516a-3p) targeted the 3'-untranslated region of the @DISEASE$ transcript, and exogenous overexpression of these miRs inhibited Wee1 protein expression and HeLa cell proliferation.	1
Because microRNAs regulate numerous aspects of cellular physiology and development, we reasoned that alterations in @MiRNA$ expression might contribute to @DISEASE$.	0
The results suggest (a) that unless specifically stabilized, certain brain-enriched miRNAs represent a rapidly executed signaling system employing highly transient effectors of CNS gene expression, and (b) that in AD temporal lobe neocortex specific brain @MiRNA$ are significantly up-regulated in abundance and strongly correlate with the presence of @DISEASE$ -type neuropatholgical change.	1
@MiRNA$ were overexpressed in @DISEASE$ samples, whereas miRNA 181b was downregulated compared with normal brain tissue.	1
Using transiently transfected murine neuronal N2a cells in culture, in parallel to a mouse model of AD, we were able to demonstrate a role for two miRNAs (@MiRNA$ and miR-328) in the regulation of beta-amyloid (Abeta) precursor protein (APP)-converting enzyme (BACE) messenger RNA (mRNA) translation, thereby providing key insights into the molecular basis underlying BACE deregulation in @DISEASE$.	0
CONCLUSION: We investigated gene and microRNA Expression in @MiRNA$ and gave a comprehensive function study of differential expressed gene and @DISEASE$ in glioblastoma patients.	0
We confirm that downregulation of a set of @MiRNA$ in GM (including several miR-15/107 genes and miR-29 paralogs) correlated strongly with the density of diffuse @DISEASE$ detected in adjacent tissue.	0
However, our knowledge of the role of @MiRNA$ in the @DISEASE$ (miRNA) synthesis pathway is limited to the association mentioned above.	0
Regulation of minichromosome maintenance gene family by @MiRNA$ and genistein in @DISEASE$.	1
@MiRNA$, a microRNA up-regulated in a double transgenic mouse model of @DISEASE$, inhibits bcl2 translation.	1
@MiRNA$ regulates the proliferation, invasion and apoptosis of ovarian epithelial @DISEASE$ cells in vitr.	1
The levels of primary miR-21 gene transcripts, precursor miR-21, and mature @MiRNA$ decreased 6 hours after the addition of @DISEASE$, indicating that the reduction in miR-21 levels was due to transcriptional suppression.	1
@MiRNA$ controls proliferation, migration and invasive potential @DISEASE$ cell lines.	1
However, the lack of knowledge about @MiRNA$ target genes postpones full understanding of the biological functions of down-regulated or up-regulated miRNAs in @DISEASE$.	0
@MiRNA$ Is Frequently Down-Regulated in @DISEASE$ and Is a Negative Regulator of Cdc42.	1
@MiRNA$ Is Downregulated in Human @DISEASE$ and Regulates Cell Proliferation and Migration.	1
We used miRNA profiling with 1,145 probes to study @MiRNA$ expression in normal anterior pituitary (6 cases), adrenocorticotropin (@DISEASE$ )-producing adenomas (8 cases), and ACTH-producing pituitary carcinomas (two cases).	0
@MiRNA$ inhibits human CD133-positive @DISEASE$ stem cells through negative regulation of the transcription factor c-Myb.	1
Here we provide evidence in AD brains of a specific up-regulation of an NF-kappaB-sensitive @MiRNA$ highly complementary to the 3'-untranslated region of @DISEASE$ (CFH), an important repressor of the inflammatory response of the brain.	1
@MiRNA$ regulates biological behavior through the PTEN/PI-3 K/Akt signaling pathway in human @DISEASE$ cell.	1
Downregulation of HMGA2 by the pan-deacetylase inhibitor panobinostat is dependent on hsa-@MiRNA$ expression in @DISEASE$ cell lines.	1
@MiRNA$ Down-Regulation Plays a Role in Thyroid Follicular @DISEASE$ through CDK6 Targeting.	1
Using luciferase reporter assays with 3'-UTRs of TBP, over-expression and inhibition of @MiRNA$, we showed that miR-146a targets @DISEASE$.	0
A Ten-@MiRNA$ Expression Signature Predicts Survival in @DISEASE$.	0
@MiRNA$ Suppresses Cell Proliferation and Induces Apoptosis in U87 @DISEASE$ Stem Cells.	1
@MiRNA$ up-regulates E-cadherin through inhibition of NF-kB1-Snail1 pathway in @DISEASE$.	1
However, at present, the pathological implications of deregulated @MiRNA$ expression in @DISEASE$ remain largely unknown.	0
@MiRNA$ have a role in several complex diseases including cancer as well as some neurological diseases such as Tourette's syndrome and @DISEASE$.	0
The Putative Tumor Suppressor @MiRNA$ Directly Targets Jagged-1 and Hes-1 in @DISEASE$.	1
In this study, the time course of @MiRNA$ expression may be related to inflammatory responses after @DISEASE$, and the time course of decreased miR-124a expression may reflect cell death.	0
@MiRNA$ promotes a hypoxic phenotype and increases radioresistance in human @DISEASE$ cell line.	1
@MiRNA$ Regulates Vascular Endothelial Growth Factor-Mediated Alterations in @DISEASE$.	1
@MiRNA$ may be potential biomarker for prediction the prognosis in patients with @DISEASE$.	1
Targeting of the Tumor Suppressor GRHL3 by a @MiRNA$ Dependent Proto-Oncogenic Network Results in PTEN Loss and @DISEASE$.	1
Like other types of cancer, the brain tumor @MiRNA$ shows a distinct @DISEASE$ expression signature, and a number of recent studies have linked these miRNA alterations to key hallmarks of glioblastoma including proliferation, survival, invasion, angiogenesis and stem cell-like behavior.	0
During a research for miRNAs that are differentially expressed in cerebral cortex of APPswe/PSDeltaE9 mice (a model for @MiRNA$ ) and age-matched controls, one candidate @DISEASE$ that is relatively highly expressed, miR-34a, was studied further because sequence analysis suggested a likely interaction with the 3'-untranslated region of bcl2 mRNA.	0
Here, we present evidence that, besides @MiRNA$ expression regulation, @DISEASE$ are equally involved in the regulation of neuronal APP mRNA alternative splicing.	1
Thus, mice that do not process @MiRNA$ in SMNs exhibit hallmarks of spinal muscular atrophy (SMA), including @DISEASE$, aberrant end plate architecture, and myofiber atrophy with signs of denervation.	0
@MiRNA$ Down-Regulation Suppresses Cell Growth, Invasion and Induces Cell Apoptosis by Targeting FASL, TIMP3, and RECK Genes in Esophageal @DISEASE$.	1
METHODS AND FINDINGS: To explore the role of miRNAs in @MiRNA$, 59 microRNA genes on the X-chromosome were amplified and sequenced in males with (193) and without (191) schizophrenia spectrum disorders to test the hypothesis that ultra-rare mutations in @DISEASE$ collectively contribute to the risk of schizophrenia.	0
Human brains retain discrete populations of @MiRNA$ (miRNA) species that support homeostatic brain gene expression functions; however, specific miRNA abundance is significantly altered in neurological disorders such as Alzheimer disease (@DISEASE$ ) when compared with age-matched controls.	0
@MiRNA$ displays @DISEASE$ Promoting properties in NSCLC Cells and targets the Hedgehog Pathway Receptor PTCH1.	1
@MiRNA$ targets cyclin-dependent kinase 6 expression, induces cell cycle G1 arrest and inhibits invasion in @DISEASE$ cells.	1
We show new data from cultured H4 @MiRNA$ cells that demonstrate similarities in mRNAs targeted by miR-16 and miR-103 and also support the importance of the mature @DISEASE$ ' 5' seed region in mRNA target recognition.	0
Emerging studies have identified microRNAs (@MiRNA$ ) as possible therapeutic tools for the treatment of @DISEASE$, the most aggressive brain tumor.	0
A number of miRNAs like miR-193a, miR-224/miR-452 cluster, miR-182/miR-183/@MiRNA$ cluster, and miR-148a having potential @DISEASE$ /metastasis suppressive activity were found to be overexpressed in the WNT signaling associated medulloblastomas.	0
Nuclear factor @MiRNA$ can affect selected @DISEASE$ levels.	1
@MiRNA$ directly targets MARCKS and promotes apoptosis resistance and invasion in @DISEASE$ cells.	1
@MiRNA$ induces apoptosis and suppresses tumorigenicity in @DISEASE$ cells.	1
A specific subset of five miRNAs revealed by in silico target prediction was significantly overexpressed in NFA samples; three @MiRNA$ (miR-128a, miR-155, and miR-516a-3p) targeted the 3'-untranslated region of the Wee1 transcript, and exogenous overexpression of these miRs inhibited @DISEASE$ protein expression and HeLa cell proliferation.	0
Consistent with its regulation by Shh, we observed that Shh treatment of primary cerebellar granule neuron precursors (CGNP), proposed cells of origin for the Shh-associated @MiRNA$, resulted in increased @DISEASE$ expression.	1
The modulation of @MiRNA$ by type I IFN through the activation of @DISEASE$ in human glioma.	1
@MiRNA$ targets cAMP-responsive element-binding protein 1 and suppresses cell growth in human gastric @DISEASE$.	1
The family of miR-64 and @MiRNA$ are co-underexpressed in the alpha-synuclein transgenic and cat-1 strains, and members of let-7 family co-underexpressed in the alpha-synuclein and pdr-1 strains; @DISEASE$ and ptc-1 genes are target candidates for miR-64 and miR-65 and are overexpressed in alpha-synuclein transgenic as well as miR-64/65 (tm3711) knockout animals.	0
To search for miRNAs that may be involved in the pathogenesis of Parkinsons disease (PD), we utilized miRNA microarrays to identify potential gene expression changes in 115 annotated @MiRNA$ in @DISEASE$ -associated Caenorhabditis elegans models that either overexpress human A53T alpha-synuclein or have mutations within the vesicular catecholamine transporter (cat-1) or parkin (pdr-1) ortholog.	0
Both the deregulation of genes controlled by miRNAs and the altered @MiRNA$ expression have been linked to many disorders, including @DISEASE$, cardiovascular, metabolic and neurodegenerative diseases.	0
Recent evidence suggest that microRNAs (@MiRNA$ ) participate in the post-transcriptional regulation of @DISEASE$ expression.	1
Loss of @MiRNA$ cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased @DISEASE$ /beta-secretase expression.	1
Despite the small sample available, we can show that this approach permits identification of meaningful structures, in particular two polycistronic @MiRNA$ genes related to transcriptional activity and likely to be relevant in the discrimination between gliosarcomas and other @DISEASE$.	0
METHODOLOGY/PRINCIPAL FINDINGS: In a screening of MB cell lines, the miRNA @MiRNA$ was seen to be a regulator of the Notch pathway through its targeting of the transcription factor @DISEASE$.	1
@MiRNA$ integrates multiple components of differentiation pathways to control the transition from growth to differentiation in @DISEASE$ cells.	1
Objective: The aim of the study was to analyze the differential expression of let-7a, miR-15a, miR-16, miR-21, @MiRNA$, miR-143, miR-145, and miR-150 in @DISEASE$ and normal pituitary tissue and verify whether their profile of expression correlates with tumor size or remission after treatment.	0
Inhibition of cyclin-dependent kinase 1-induced cell death in @DISEASE$ cells through the @MiRNA$ MYCN-survivin pathway.	1
Over-expression of these miRNAs, but not control @MiRNA$, results in translational repression of @DISEASE$ mRNA and significantly reduces APP protein levels.	0
A computational multiscale model of @DISEASE$ growth: Regulation of cell migration and proliferation via @MiRNA$ LKB1 and AMP.	1
Furthermore, a neurofilament heavy subunit previously implicated in @MiRNA$ is specifically up-regulated in @DISEASE$ -deficient SMNs.	0
We demonstrate that the heavy neurofilament subunit is a target of @MiRNA$, a miRNA that is specifically down-regulated in a genetic model of @DISEASE$.	1
The miR-17-92 @MiRNA$ Regulates Multiple Components of the TGF-beta Pathway in @DISEASE$.	1
Down-regulation of these @MiRNA$ has been reported in chronic lymphocytic lymphoma (@DISEASE$ ), pituitary adenomas, and prostate carcinoma.	1
The @MiRNA$ Binding-Site rs8126 T>C Polymorphism in TNFAIP2 Is Associated with Risk of @DISEASE$.	1
The results show the possible use of blood @MiRNA$ as biomarkers for @DISEASE$ ; that selected blood miRNAs may correlate with miRNA changes in the brain; and that many of the mRNAs, previously shown to be regulated in brain and blood after brain injury, are likely accounted for by changes in miRNA expression.	0
We show that miRNAs belonging to the miR-20a family (that is, @MiRNA$, miR-17-5p and miR-106b) could regulate @DISEASE$ expression in vitro and at the endogenous level in neuronal cell lines.	1
@MiRNA$ leads to aggressive phenotype of @DISEASE$ through indirect activation of TrkB pathwa.	1
@MiRNA$ have a role in several complex diseases including @DISEASE$ as well as some neurological diseases such as Tourette's syndrome and Fragile x syndrome.	0
Silencing of @MiRNA$ confers radio-sensitivity through inhibition of the PI3K/AKT pathway and enhancing autophagy in @DISEASE$ cell line.	1
Using @MiRNA$ -, IRAK-1-, or IRAK-2 promoter-luciferase reporter constructs, we observe decreases in IRAK-1 and increases in miRNA-146a and IRAK-2 expression in interleukin-1β (@DISEASE$ ) and amyloid-β-42 (Aβ42) peptide-stressed HAG cells.	0
The use of @MiRNA$, hsa-miR-181b and hsa-miR-106a as prognostic indicators of @DISEASE$.	0
Restoration of @MiRNA$ Expression Suppresses Epithelial-Mesenchymal Transition in @DISEASE$.	1
@MiRNA$ is downregulated in cis-diamminedichloroplatinum treated sinonasal @DISEASE$ patients with poor prognosis.	1
Profiling the expression of 427 mature microRNAs (miRNA) in a series of 90 primary human medulloblastomas revealed that components of the miR-17/92 polycistron are the most highly up-regulated @MiRNA$ in @DISEASE$.	1
Receiver operating characteristic curve analysis indicated that miR-16, miR-92a, and @MiRNA$ were good markers of severe @DISEASE$ (0.89, 0.82, and 0.86 AUC values, respectively).	0
A myriad of @MiRNA$ variants in control and @DISEASE$ brain regions detected by massively parallel sequencing.	0
@MiRNA$ is Downregulated in Patients with @DISEASE$ and Modulates Inflammatory Cytokines Production by Targeting Mitogen-activated Protein Kinase.	1
The @MiRNA$ Regulates Oxidative Apoptosis and Sensitizes Cells to Chemotherapy in @DISEASE$.	1
@MiRNA$ suppresses cell proliferation in @DISEASE$ by targeting PIK3CA.	1
@MiRNA$ modulates radiotherapy response of @DISEASE$ cells through regulation of p38MAPK, apoptosis and senescence.	1
Although @MiRNA$ seems to be strongly linked to environmental factors such as nutrition and lifestyle, studies have shown that genetic factors, such as polymorphisms associated with metabolic genes, imprinting, fetal programming and miRNA (@DISEASE$ ) expression, could also contribute to the development of this disease.	0
Objective: The aim of the study was to analyze the differential expression of let-7a, @MiRNA$, miR-16, miR-21, miR-141, miR-143, miR-145, and miR-150 in corticotropinomas and normal pituitary tissue and verify whether their profile of expression correlates with @DISEASE$ size or remission after treatment.	0
@MiRNA$ was associated with lymph node @DISEASE$.	1
Differential regulation of @MiRNA$ (IRAK-1) and IRAK-2 by @DISEASE$ and NF-kappaB in stressed human astroglial cells and in Alzheimer disease.	1
Our data suggest that in the CBA mouse at least, @MiRNA$ may have a regulatory role in the pathogenesis of severe @DISEASE$.	0
@MiRNA$ regulation of Alzheimer's @DISEASE$ expression.	1
Human brains retain discrete populations of micro RNA (@MiRNA$ ) species that support homeostatic brain gene expression functions; however, specific miRNA abundance is significantly altered in neurological disorders such as Alzheimer disease (@DISEASE$ ) when compared with age-matched controls.	0
Finally, while rolipram and PDE4D deficiency shortened α2 adrenergic receptor-mediated anesthesia, a surrogate measure of @MiRNA$, @DISEASE$ -mediated PDE4D knock-down in the hippocampus did not.	0
@MiRNA$ and Ets-1 gene polymorphisms in ocular Behcet's disease and @DISEASE$.	1
Down-Regulated Plasma @MiRNA$ Levels in @DISEASE$.	1
Conversely, increasing the level of @MiRNA$ or miR-184* attenuated pathogenic @DISEASE$ effects.	1
@MiRNA$ is a regulatory hub in lipid metabolism and is altered in @DISEASE$.	1
We performed a large-scale, genome-wide @MiRNA$ (miRNA) (n=756) expression profiling of 26 @DISEASE$, 13 anaplastic astrocytoma and 7 normal brain samples with an aim to find deregulated miRNA in malignant astrocytoma.	0
@MiRNA$ and miR-16-1 in @DISEASE$ : discovery, function and future perspectives.	0
@MiRNA$ treatment reduced @DISEASE$ expression in glioma cells markedly, and IFN-beta administration suppressed the growth of glioma-initiating cell-derived intracranial tumors.	1
A @MiRNA$ embedded AAV @DISEASE$ gene silencing vector for dopaminergic neurons.	0
Targeting @MiRNA$ mediated autophagy enhances imatinib activity against human @DISEASE$ cells.	1
Responses of @MiRNA$ following @DISEASE$ in mice.	0
@MiRNA$ impairs cancer stem cells through negative regulation of @DISEASE$ in medulloblastoma.	1
Poly(amido amine) is an ideal carrier of @MiRNA$ for enhancing gene silencing effects on the EGFR pathway in U251 @DISEASE$ cell.	1
Anti-@MiRNA$ Upregulates SOCS3 Expression in @DISEASE$ Cells and Enhances Cisplatin Chemosensitivity.	1
In mild @MiRNA$ patients (GCS score > 12), @DISEASE$ levels were unchanged, while the plasma levels of miR-92a and miR-16 were significantly increased within the first 24 h of injury compared to healthy volunteers, and had AUC values of 0.78 and 0.82, respectively.	0
Using BMC as a paradigm for the study of systemic alterations in @MiRNA$, we investigated whether peripheral @DISEASE$ expression is altered in this condition.	0
Both the deregulation of genes controlled by @MiRNA$ and the altered miRNA expression have been linked to many disorders, including @DISEASE$, cardiovascular, metabolic and neurodegenerative diseases.	0
Neuronal @MiRNA$ deregulation in response to Alzheimer's disease @DISEASE$.	1
High expression of serum @MiRNA$ associated with poor prognosis in patients with @DISEASE$.	1
@MiRNA$ is aberrantly expressed in @DISEASE$ in an ethnic-dependent manner and targets ZEBs, VEGFA, TIMP2, and FBLN5.	1
MYCN-regulated @MiRNA$ Inhibits Secretion of the Tumor Suppressor DICKKOPF-3 (DKK3) in @DISEASE$.	1
Downregulated expression of @MiRNA$ in @DISEASE$ patients: implications in TNFα regulation and proliferation of hematopoietic progenitor cells.	1
Bioinformatic analysis predicts that the deregulated @MiRNA$ are likely to affect target genes present in prominent neuronal pathways known to be disrupted in @DISEASE$.	0
Oncolytic adenovirus co-expressing @MiRNA$ and IL-24 induces superior antitumor activity in @DISEASE$ mode.	1
We have recently compared the miRNA expression profiles between normal brain and @MiRNA$ tissues from Chinese patients by @DISEASE$ microarray and identified a panel of differentially expressed miRNAs.	0
We used quantitative RT-PCR to determine if plasma @MiRNA$ could identify @DISEASE$ patients within the first 24 h post-injury.	0
@MiRNA$ : novel therapeutic targets in @DISEASE$.	0
rs4919510 in @MiRNA$ is associated with outcome but not risk of @DISEASE$.	1
CONCLUSION: Expression level of tumor/metastasis suppressive miRNAs in the WNT signaling associated @MiRNA$ is likely to determine their response to treatment, and thus, these @DISEASE$ would be important biomarkers for risk stratification within the WNT signaling associated medulloblastomas.	0
Our research revealed that 136 miRNAs were expressing at 6 h post injury, in which 13 miRNAs were more than 2-fold up-regulated, and 14 miRNAs were more than 2-fold down-regulated; 118 miRNAs were expressing at 24 h post @MiRNA$, in which 4 miRNAs were more than 2-fold up-regulated, and 23 miRNAs were more than 2-fold down-regulated; 149 @DISEASE$ were expressing at 48 h post injury, in which 16 miRNAs were more than 2-fold up-regulated, and 11 miRNAs were more than 2-fold down-regulated; and 203 miRNAs were expressing at 72 h post injury, in which 19 miRNAs were more than 2-fold up-regulated, and 5 miRNAs were more than 2-fold down-regulated.	0
@MiRNA$ is reduced in @DISEASE$ brain neocortex: validation study.	0
Loss of connective tissue growth factor as an unfavorable prognosis factor activates @MiRNA$ by PI3K/AKT/C-Jun and C-Myc and promotes cell growth in @DISEASE$.	1
Since abnormal neuronal splicing of APP affects β-@MiRNA$ production, these results could contribute to the understanding of the implication of @DISEASE$ in brain health and disease.	0
There were more @MiRNA$ up- (188) or down-regulated (160) between adenomas and normal pituitaries compared to carcinomas and normal pituitaries (92 up- and 91 down-regulated) or between carcinomas and @DISEASE$ (46 up- and 52 down-regulated).	0
@MiRNA$ (miRNAs) in @DISEASE$.	0
Using transiently transfected murine neuronal N2a cells in culture, in parallel to a mouse model of @MiRNA$, we were able to demonstrate a role for two @DISEASE$ (miR-298 and miR-328) in the regulation of beta-amyloid (Abeta) precursor protein (APP)-converting enzyme (BACE) messenger RNA (mRNA) translation, thereby providing key insights into the molecular basis underlying BACE deregulation in AD.	0
In addition, components required for miRNA processing and/or function have also been implicated in X-linked mental retardation, neurological and @MiRNA$, pointing to the wide ranging involvement of @DISEASE$ in disease.	0
However, only a few studies to date have focused on the role of @MiRNA$ in @DISEASE$, the most common malignant pediatric brain tumor.	0
Among the @MiRNA$ -related miRNA expression changes, @DISEASE$ was exceptional because miR-107 levels decreased significantly even in patients with the earliest stages of pathology.	0
@MiRNA$ acts as tumor suppressor and induces apoptosis @DISEASE$ cells through E2F1-mediated suppression of Akt phosphorylatio.	1
Increased @MiRNA$ expression in the serum and peripheral monocytes in chronic HCV @DISEASE$.	1
@MiRNA$ suppresses metastatic activity in brain @DISEASE$.	1
Alcohol Facilitates HCV RNA Replication Via Up-Regulation of @MiRNA$ Expression and Inhibition of Cyclin G1 in Human @DISEASE$ Cell.	1
Our findings suggest a functional collaboration between the @MiRNA$ approximately 92 cluster and the SHH signaling pathway in the development of @DISEASE$ in mouse and man.	0
@MiRNA$ Replacement Therapy Sensitizes @DISEASE$ Cells to Ionizing Radiatio.	1
@MiRNA$ in which @DISEASE$ was up-regulated also had elevated levels of MYC/MYCN expression.	1
During a research for @MiRNA$ that are differentially expressed in cerebral cortex of APPswe/PSDeltaE9 mice (a model for Alzheimer's disease) and age-matched controls, one candidate miRNA that is relatively highly expressed, miR-34a, was studied further because sequence analysis suggested a likely interaction with the 3'-untranslated region of @DISEASE$ mRNA.	0
MicroRNA @MiRNA$ is essential for functional recovery after @DISEASE$ in adult zebrafish.	0
Incubation of a protected antisense miRNA-146a was found to inhibit @MiRNA$ and restore @DISEASE$, whereas IRAK-2 remained unaffected.	0
MicroRNA (@MiRNA$ ) expression was assessed in human cerebral cortical gray matter (GM) and white matter (WM) in order to provide the first insights into the difference between GM and WM miRNA repertoires across a range of @DISEASE$ (AD) pathology.	0
The database search on TargetScan, PicTar and miRBase Target identified neurone navigator 3 (NAV3), a regulator of axon guidance, as a principal target of @MiRNA$, and actually NAV3 mRNA levels were elevated in @DISEASE$ brains.	0
Interactions of @MiRNA$ and TP-53 polymorphisms on the risk of @DISEASE$.	1
Through various experimental approaches, we validated computational predictions and demonstrated that miR-298 and @MiRNA$ recognize specific binding sites in the 3'-UTR of BACE1 mRNA and exert regulatory effects on @DISEASE$ protein expression in cultured neuronal cells.	1
We used microarray technology to identify @MiRNA$ that were upregulated by non-small cell lung cancer (@DISEASE$ ) A549 cells in response to cisplatin (CDDP).	0
Association studies using all common variants detected in the 3' UTR of BACE1 and the @MiRNA$ gene cluster did not identify an association with @DISEASE$ risk.	0
Polymorphism rs4919510:C>G in mature sequence of human @MiRNA$ contributes to the risk of HER2-positive @DISEASE$ but not other subtypes.	1
We studied expression of 90 @MiRNA$ in STHdh(Q111)/Hdh(Q111) cells, a model for @DISEASE$ and compared with that obtained in STHdh(Q7)/Hdh(Q7) cells.	0
@MiRNA$ Antisense Oligonucleotide Suppresses @DISEASE$ Cell Growth by Targeting SEPT.	1
Comparison of mouse cerebellar development and @MiRNA$ demonstrates a shared miRNA-mRNA co-expression program for brain-specific neurologic processes such as synaptic transmission and exocytosis, in which miRNA target expression increases with the accumulation of multiple miRNAs in developing cerebellum and decreases with the loss of these @DISEASE$ in brain tumors.	0
@MiRNA$ is an independent prognostic factor in @DISEASE$ and exerts its anti-apoptotic function by targeting SOX.	1
TGF-{beta}/Smad3 Signaling Promotes Renal @DISEASE$ by Inhibiting @MiRNA$.	1
METHODOLOGY/PRINCIPAL FINDINGS: Using a public database of mapped retroviral insertion sites from various mouse models of @MiRNA$ we demonstrate that MLV-derived retroviral inserts are enriched in close proximity to mouse @DISEASE$ loci.	0
@MiRNA$ targets MACC1 to inhibit cell invasion and migration in @DISEASE$.	1
@MiRNA$ binding site in BMPR1B is Associated with @DISEASE$ pathogenesi.	1
@MiRNA$ Promotes hepatic stellate cells proliferation by targeting p27 and is elevated in the serum of @DISEASE$ patients.	1
Profiling the expression of 427 mature microRNAs (miRNA) in a series of 90 primary human @MiRNA$ revealed that components of the miR-17/92 polycistron are the most highly up-regulated @DISEASE$ in medulloblastoma.	0
Genetic deletion of let-7, antagomir-mediated blockage of let-7 and miR-184* action, transgenic expression of dp target protector, or replacement of endogenous dp with a dp transgene non-responsive to @MiRNA$ each had toxic effects similar to those of pathogenic @DISEASE$.	0
In a well-characterized Belgian group of 358 AD patients and 462 controls, we examined whether genetic variability in microRNA (miRNA) binding sites of APP and @MiRNA$ or in associated @DISEASE$ influenced risk for A.	0
@MiRNA$ (miRNA) may play a significant role in @DISEASE$ biology.	0
We propose that loss of specific @MiRNA$ can contribute to increased @DISEASE$ and Abeta levels in sporadic AD.	1
Furthermore, @MiRNA$ and miR-23a/b analysis in rat hippocampus were performed by real-time quantitative polymerase chain reaction at 0h, 1h, 6h, 12h, 24h, 2days, 7days,10days, 30days,50days after induction of status epilepticus (@DISEASE$ ).	0
Down-Regulation of @MiRNA$ Contributes to the Abnormal Angiogenesis via MEK1 and Cyclin E1 in Senile @DISEASE$ Its Implications to Therapy.	1
Recent studies have identified changes of several specific miRNA expression profiles and polymorphisms affecting the interactions between miRNAs and their targets in various @MiRNA$, including addiction: miR-16 causes adaptive changes in production of the serotonin transporter; @DISEASE$ is specifically expressed in midbrain dopaminergic neurons, and regulates the production of tyrosine hydroxylase and the dopamine transporter; miR-212 affects production of striatal brain-derived neurotrophic factor and synaptic plasticity upon cocaine.	0
@MiRNA$ mediated downregulation of mTOR/FGFR3 controls @DISEASE$ growth induced by Src-related oncogenic pathways.	1
Human @MiRNA$ targets radixin and inhibits migration and invasion of @DISEASE$ cells.	1
We have recently compared the miRNA expression profiles between normal brain and @MiRNA$ tissues from Chinese patients by miRNA microarray and identified a panel of differentially expressed @DISEASE$.	0
The family of @MiRNA$ and miR-65 are co-underexpressed in the alpha-synuclein transgenic and cat-1 strains, and members of let-7 family co-underexpressed in the alpha-synuclein and pdr-1 strains; mdl-1 and @DISEASE$ genes are target candidates for miR-64 and miR-65 and are overexpressed in alpha-synuclein transgenic as well as miR-64/65 (tm3711) knockout animals.	0
@MiRNA$ (miRNAs) are very important regulators of biological processes such as development, cellular differentiation, and @DISEASE$ generation.	0
@MiRNA$ Expression is related to particle-induced @DISEASE$ pathogenesis.	1
Correlation was observed between decreased @MiRNA$ expression and increased @DISEASE$ counts (P< 0.05) and neurofibrillary tangle counts (P< 0.02) in adjacent brain tissue.	0
The levels of primary miR-21 gene transcripts, precursor @MiRNA$, and mature miR-21 decreased 6 hours after the addition of @DISEASE$, indicating that the reduction in miR-21 levels was due to transcriptional suppression.	1
These findings indicate the role of @MiRNA$ in @DISEASE$ progression may be closely associated with p53 mutation and inversely correlated to Bcl-2 expressio.	1
These data suggest a role for HSV-1-induced @MiRNA$ in the evasion of HSV-1 from the complement system, and the activation of key elements of the arachidonic acid cascade known to contribute to @DISEASE$ -type neuropathological change.	0
@MiRNA$ inhibits proliferation @DISEASE$ cells by targeting SLC7A5.	1
By incorporating @MiRNA$ target sequences into a @DISEASE$ -expressing vector, we suppressed GALC expression in HSCs while maintaining robust expression in mature hematopoietic cells.	0
Oncogenic @MiRNA$ Targets Smad4 and RECK in Human @DISEASE$.	1
CONCLUSIONS/SIGNIFICANCE: Sufficient information exists within a set of @MiRNA$ samples to detect endogenous correlations between @DISEASE$ and mRNA levels.	0
Over-expression of these miRNAs, but not control @MiRNA$, results in translational repression of APP mRNA and significantly reduces @DISEASE$ protein levels.	0
We further demonstrate that @MiRNA$ belonging to the miR-15 family are potent regulators of @DISEASE$ expression in mouse neuronal cells and co-expressed with ERK1/2 in vivo.	1
We choose several time points post @MiRNA$ : 6 h, 24 h, 48 h and 72 h, respectively, to reveal differential expression of @DISEASE$ in rat brain cortex compared with control groups.	0
Altered @MiRNA$ regulation in @DISEASE$ models.	1
In sum, miR-107 expression tends to be lower relative to other @MiRNA$ as @DISEASE$ progresses.	0
However, most of the @MiRNA$ expression variability that correlated with the presence of early @DISEASE$ -related pathology was seen in GM.	0
@MiRNA$ modulates epithelial-to-mesenchymal transition (EMT) in human colorectal @DISEASE$.	1
Recent studies have identified changes of several specific miRNA expression profiles and polymorphisms affecting the interactions between miRNAs and their targets in various @MiRNA$, including addiction: miR-16 causes adaptive changes in production of the serotonin transporter; miR-133b is specifically expressed in midbrain dopaminergic neurons, and regulates the production of tyrosine hydroxylase and the dopamine transporter; @DISEASE$ affects production of striatal brain-derived neurotrophic factor and synaptic plasticity upon cocaine.	0
Overexpression of @MiRNA$ induces apoptosis of @DISEASE$ cells through down regulating Mcl-1.	1
@MiRNA$ may be a new therapeutic target for proliferative vascular diseases such as atherosclerosis, postangioplasty restenosis, transplantation @DISEASE$, and stroke.	1
These data support the hypothesis that patterns of @MiRNA$ expression in cortical GM may contribute to @DISEASE$ pathogenetically, because the aggregate change in miRNA expression observed early in the disease would be predicted to cause profound changes in gene expression.	0
@MiRNA$ suppresses IGF2 and inhibits breast @DISEASE$ by interfering with proliferation and survival signaling.	1
Through various experimental approaches, we validated computational predictions and demonstrated that @MiRNA$ and miR-328 recognize specific binding sites in the 3'-UTR of @DISEASE$ mRNA and exert regulatory effects on BACE1 protein expression in cultured neuronal cells.	1
The expression of @MiRNA$ is increased in @DISEASE$.	1
Using transiently transfected murine neuronal N2a cells in culture, in parallel to a mouse model of AD, we were able to demonstrate a role for two miRNAs (miR-298 and @MiRNA$ ) in the regulation of @DISEASE$ (BACE) messenger RNA (mRNA) translation, thereby providing key insights into the molecular basis underlying BACE deregulation in AD.	1
@MiRNA$ inhibits CDKN1C/p57 expression in human @DISEASE$.	1
In this study, we used microarrays for the first joint profiling and analysis of @MiRNA$ and mRNAs expression in brain cortex from @DISEASE$ and age-matched control subjects.	0
Using @MiRNA$ -, IRAK-1-, or IRAK-2 promoter-luciferase reporter constructs, we observe decreases in IRAK-1 and increases in miRNA-146a and @DISEASE$ expression in interleukin-1β (IL-1β) and amyloid-β-42 (Aβ42) peptide-stressed HAG cells.	0
In a well-characterized Belgian group of 358 AD patients and 462 controls, we examined whether genetic variability in @MiRNA$ (miRNA) binding sites of @DISEASE$ and BACE1 or in associated miRNAs influenced risk for A.	0
Analysis of genes that @MiRNA$ interacts with included @DISEASE$ and RUNX2 ( http://microrna.sanger.ac.uk ) both of which have been shown to have roles in pituitary tumor cell growth.	0
Because gene dosage effects of the @MiRNA$ gene can cause genetic AD, dysregulation of the @DISEASE$ network could contribute significantly to disease.	0
These data showing the down-regulation of @MiRNA$ in metastatic @DISEASE$ suggest a potential silencing mechanism through epigenetic or genetic alterations.	1
BACKGROUND: MicroRNAs (@MiRNA$ ) are short non-coding RNAs that regulate differentiation and development in many organisms and play an important role in @DISEASE$.	0
However, it has not yet been determined whether @MiRNA$ expression is altered after @DISEASE$.	0
@MiRNA$ is Methylated and Functions as A Tumor Suppressor by Regulating the ETS1 proto-oncogene in Human Invasive @DISEASE$.	1
In addition to the established role of @MiRNA$ as developmental regulators of normal cellular function, they have recently been shown to be important players in pathological states such as @DISEASE$.	0
@MiRNA$ abundance and stability in human brain: specific alterations in @DISEASE$ temporal lobe neocortex.	0
IFN-beta treatment reduced @MiRNA$ expression in glioma cells markedly, and IFN-beta administration suppressed the growth of glioma-initiating cell-derived @DISEASE$.	0
The results suggest (a) that unless specifically stabilized, certain brain-enriched @MiRNA$ represent a rapidly executed signaling system employing highly transient effectors of CNS gene expression, and (b) that in AD temporal lobe neocortex specific brain miRNAs are significantly up-regulated in abundance and strongly correlate with the presence of @DISEASE$ -type neuropatholgical change.	0
In vivo regulation of @MiRNA$ neuronal splicing by @DISEASE$.	1
While histone modifications and DNA methylation are two classical means to regulate gene expression, @MiRNA$ has also recently been documented to govern gene expression in normal as well as @DISEASE$ cells.	0
Our research revealed that 136 miRNAs were expressing at 6 h post @MiRNA$, in which 13 miRNAs were more than 2-fold up-regulated, and 14 miRNAs were more than 2-fold down-regulated; 118 miRNAs were expressing at 24 h post injury, in which 4 miRNAs were more than 2-fold up-regulated, and 23 miRNAs were more than 2-fold down-regulated; 149 @DISEASE$ were expressing at 48 h post injury, in which 16 miRNAs were more than 2-fold up-regulated, and 11 miRNAs were more than 2-fold down-regulated; and 203 miRNAs were expressing at 72 h post injury, in which 19 miRNAs were more than 2-fold up-regulated, and 5 miRNAs were more than 2-fold down-regulated.	0
Loss of @MiRNA$ contributes to @DISEASE$ development by dysregulating TACSTD2 and MAPK pathwa.	1
@MiRNA$ regulates the longevity-associated protein, SIRT1, in @DISEASE$.	1
Comparative analysis with independent @MiRNA$ datasets showed that such @DISEASE$ -mRNA expression correlations are not static, but rather context-dependent.	0
To understand their functional significance in ischemic pathophysiology, we profiled @MiRNA$ in adult rat brain as a function of reperfusion time after transient @DISEASE$.	0
In addition, pre-@MiRNA$ blocked early manifestations of the DNA damage response, including the phosphorylation of the ataxia-telangiectasia mutated (ATM) kinase and of two ATM substrates, histone H2AX and @DISEASE$.	1
@MiRNA$ induces @DISEASE$ cell apoptosis through suppression of Bcl-2 expression.	1
@MiRNA$ regulates LKB1/AMPK signaling and allows adaptation to metabolic stress in @DISEASE$ cell.	1
We studied the expression of selected @MiRNA$ following @DISEASE$ of CBA mice with Plasmodium berghei ANKA (PbA), which causes cerebral malaria (CM), or Plasmodium berghei K173 (PbK), which causes severe malaria but without cerebral complications, termed non-CM.	0
@MiRNA$ Modulates the expression of c-myc in human @DISEASE$ cells.	1
More importantly, we identified a most discriminatory 23-@MiRNA$ expression signature, by using PAM, which precisely distinguished @DISEASE$ from anaplastic astrocytoma with an accuracy of 95%.	0
Down-regulation of @MiRNA$ promotes migration and invasion of @DISEASE$ by targeting Ezrin.	1
Inhibition of two glioblastoma-upregulated miRNAs (miR-21 and miR-23a) and exogenous overexpression of two @MiRNA$ -downregulated miRNAs (@DISEASE$ and miR-219-5p) resulted in reduced soft agar colony formation but showed varying effects on cell proliferation and chemosensitivity.	1
Expression pattern of miR-146a, an @MiRNA$ -associated @DISEASE$, in experimental and human temporal lobe epilepsy.	0
@MiRNA$ expression in the blood and brain of rats subjected to transient focal @DISEASE$ by middle cerebral artery occlusion.	0
@MiRNA$ functions as a potential tumor suppressor in endometrial serous @DISEASE$.	1
The most interesting results came from miR-221, strongly up-regulated in glioblastoma and from a set of brain-enriched @MiRNA$, miR-128, miR-181a, miR-181b, and miR-181c, which are down-regulated in @DISEASE$.	1
RESULTS: We found underexpression of miR-145 (2.0-fold; P = 0.04), miR-21 (2.4-fold; P = 0.004), miR-141 (2.6-fold; P = 0.02), let-7a (3.3-fold; P = 0.003), miR-150 (3.8-fold; P = 0.04), @MiRNA$ (4.5-fold; P = 0.03), miR-16 (5.0-fold; P = 0.004), and miR-143 (6.4-fold; P = 0.004) in @DISEASE$ when compared to normal pituitary tissues.	1
@MiRNA$ can be induced in neurons by prolonged N-methyl-D-aspartic acid receptor stimulation, an excitotoxic process active in HIV and other @DISEASE$.	0
Mutant p53 drives invasion in @DISEASE$ through up-regulation of @MiRNA$.	1
@MiRNA$ was hyperexpressed in all @DISEASE$ samples whereas higher levels of miRNA-221 were found in high-grade gliomas.	0
OBJECTIVE: To analyze the interaction between the @MiRNA$ and its targeting proteins during the cerebral ischemia and @DISEASE$.	0
We conclude that @MiRNA$ is a positive effector of Shh-mediated proliferation and that aberrant expression/amplification of this miR confers a growth advantage to @DISEASE$.	1
@MiRNA$ of human brain cells induces @DISEASE$ and Alzheimer-type inflammatory signaling.	0
the @MiRNA$ (8, 9) synergizes with MYC to induce @DISEASE$.	1
@MiRNA$ expressed in @DISEASE$ cells suppresses growth factor induced cellular proliferation and downregulates the oncogene BCL9.	1
@MiRNA$ suppresses uveal @DISEASE$ cell proliferation and migration through multiple targets.	1
@MiRNA$ promotes cell invasion through RhoC-AKT signaling pathway by targeting HOXD10 in @DISEASE$.	1
One of the most active fields of miRNA research is miR@MiRNA$ gulation of apoptosis, a programmed cell death implicated in many human diseases, such as can@DISEASE$ lzheimer's disease, hypertrophy and heart failur.	0
Increased @MiRNA$ expression sensitizes esophageal @DISEASE$ to irradiatio.	1
The expression of several BMC @MiRNA$ was found to increase in @DISEASE$ relative to NEC levels, and may differ between AD subjects bearing one or two APOE4 alleles.	0
To identify a @MiRNA$ (miRNA) expression signature that can predict GBM patient survival, we analyzed the miRNA expression data of @DISEASE$ patients (n = 222) derived from The Cancer Genome Atlas (TCGA) dataset.	0
@MiRNA$ targets TRAIL death Receptor-4 and promotes apoptosis resistance in @DISEASE$.	1
Analysis of human MBs demonstrated that 3 miR-17 approximately 92 cluster @MiRNA$ (miR-92, miR-19a, and miR-20) were also overexpressed in human @DISEASE$ with a constitutively activated Sonic Hedgehog (SHH) signaling pathway, but not in other forms of the disease.	0
Connective tissue growth factor modulates oral @DISEASE$ invasion by activating a @MiRNA$ FOXP1 signalling.	1
Recent study demonstrated that the expression of @MiRNA$ was significantly reduced while the expression of RAS was dramatically increased in @DISEASE$ tissues.	1
@MiRNA$ overexpression contributes to cell proliferation by targeting PTEN in endometrioid @DISEASE$.	1
Here we expand the role of GRN in @MiRNA$ and demonstrate that a common genetic variant (rs5848), located in the 3'-untranslated region (UTR) of GRN in a binding-site for @DISEASE$, is a major susceptibility factor for FTLD-U.	0
@MiRNA$ is a potential prognostic marker in human @DISEASE$ and functions as a tumor suppressor by targeting the insulin-like growth factor 1 recepto.	1
Several identified @MiRNA$ may be involved in cell proliferation, apoptosis, @DISEASE$ development and progression.	0
The most interesting results came from miR-221, strongly up-regulated in glioblastoma and from a set of brain-enriched miRNAs, miR-128, miR-181a, miR-181b, and @MiRNA$, which are down-regulated in @DISEASE$.	1
Identification of differentially expressed @MiRNA$ by microarray: a possible role for microRNA genes in @DISEASE$.	0
Truncation in CCND1 mRNA alters @MiRNA$ regulation in @DISEASE$.	1
@MiRNA$ promotes cell migration and invasion in esophageal @DISEASE$.	1
@MiRNA$ inhibitors alone or in combination with perifosine suppress the growth of @DISEASE$ cell.	1
The @MiRNA$ group has also been implicated in human @DISEASE$, cardiovascular disease and neurodegenerative disease, including Alzheimer's disease.	0
@MiRNA$ was found to directly target beta-catenin mRNA, thereby inhibiting its translation and blocking Wnt/beta-catenin signaling, which is frequently involved in @DISEASE$.	0
Searching for MIND: @MiRNA$ in @DISEASE$.	0
Silencing of @MiRNA$ by locked nucleic acid-lipid nanocapsule complexes sensitize human @DISEASE$ cells to radiation-induced cell death.	1
GATA4 expression is primarily regulated via a @MiRNA$ dependent post-transcriptional mechanism during @DISEASE$.	1
Silencing of @MiRNA$ promotes migration and invasion @DISEASE$ via Slit2-Robo1 pathway.	1
Here, we analyzed the miRNA expression and @MiRNA$ regulators in two transgenic models of @DISEASE$, YAC128 and R6/2 mice, and in a 3-nitropropionic acid (3NP)-induced striatal degeneration rat model.	0
@MiRNA$ regulation of Ad6 significantly improves its safety profile after systemic administration, which allows increasing therapeutic doses leading to improved anticancer efficacy of systemic treatment for castration-resistant @DISEASE$.	1
Evaluation of single nucleotide polymorphisms in @MiRNA$ (hsa-miR-196a2 rs11614913 C/T) from Brazilian women with @DISEASE$.	1
To determine whether @MiRNA$ expression is altered in pituitary adenomas, we analyzed the entire miRNAome in 32 @DISEASE$ and in 6 normal pituitary samples by microarray and by Real-Time PCR.	0
Our research revealed that 136 miRNAs were expressing at 6 h post injury, in which 13 miRNAs were more than 2-fold up-regulated, and 14 miRNAs were more than 2-fold down-regulated; 118 miRNAs were expressing at 24 h post injury, in which 4 miRNAs were more than 2-fold up-regulated, and 23 miRNAs were more than 2-fold down-regulated; 149 miRNAs were expressing at 48 h post @MiRNA$, in which 16 miRNAs were more than 2-fold up-regulated, and 11 @DISEASE$ were more than 2-fold down-regulated; and 203 miRNAs were expressing at 72 h post injury, in which 19 miRNAs were more than 2-fold up-regulated, and 5 miRNAs were more than 2-fold down-regulated.	1
Therefore, we hypothesized that @MiRNA$ are also regulated in response to human @DISEASE$.	0
@MiRNA$ regulates EMT phenotype and HIF-1α expression in third-sphereforming @DISEASE$ stem cell-like cells.	1
Emerging studies have identified microRNAs (@MiRNA$ ) as possible therapeutic tools for the treatment of glioma, the most aggressive brain @DISEASE$.	0
Brain cells maintain distinct populations of miRNAs that support physiologically normal patterns of expression, however, certain @MiRNA$ abundances are significantly altered in neurodegenerative disorders such as @DISEASE$ (AD).	1
Reduced expression of @MiRNA$ confers unfavorable prognosis in patients with @DISEASE$.	1
Mutual regulation between @MiRNA$ and methyl-CpG-binding domain protein 2 in @DISEASE$.	1
@MiRNA$ regulates cell cycle progression by targeting cyclins in @DISEASE$ cells.	1
Adrenaline promotes cell proliferation and increases chemoresistance in @DISEASE$ HT29 cells through induction of @MiRNA$.	1
Differential expression of @MiRNA$ in GH-secreting @DISEASE$.	1
@MiRNA$ is upregulated in @DISEASE$ and influences apoptosis of melanocytic cells.	1
Here we provide evidence in human neural (HN) cells of an aluminum-sulfate- and reactive oxygen species (ROS)-mediated up-regulation of an NF-kappaB-sensitive @MiRNA$ that down-regulates the expression of @DISEASE$ (CFH), an important repressor of inflammation.	1
@MiRNA$ has initially been linked to @DISEASE$.	1
Further analyses revealed that platelets contain the Dicer and @MiRNA$ (Ago2) complexes, which function in the processing of exogenous @DISEASE$ precursors and the control of specific reporter transcripts, respectively.	0
Expression of @MiRNA$ was highest in the subgroup of medulloblastomas associated with activation of the @DISEASE$ (Shh) signaling pathway compared with other subgroups of medulloblastoma.	1
The bifunctional @MiRNA$ miR-9/miR-9* regulates REST and CoREST and is downregulated in @DISEASE$.	1
Strikingly, cells with high levels of @MiRNA$ expressed lower levels of miR-326, suggestive of endogenous regulation of PKM2 by @DISEASE$.	0
@MiRNA$ (miRNAs) are posttranscriptional regulatory molecules that have been implicated in the regulation of immune responses, but their role in the immune response to @DISEASE$ is unknown.	0
@MiRNA$ regulation of @DISEASE$ Amyloid precursor protein expression.	1
@MiRNA$ promotes @DISEASE$ cell proliferation and invasion through targeting HOXA5.	1
The Oncogenic Role of @MiRNA$ in Human @DISEASE$ via Targeting Smad4 Expressio.	1
@MiRNA$ appear to be dysregulated in a number of @DISEASE$, developmental disorders, and as a result of stroke.	1
Regulation of microtubule-associated protein tau (MAPT) by @MiRNA$ determines the chemosensitivity of @DISEASE$ to paclitaxe.	1
@MiRNA$ is down-regulated in @DISEASE$ resulting in EZH2-induced proliferation, migration, and angiogenesis.	1
Downregulation of @MiRNA$ induces angiogenesis and lymphangiogenesis by activation of VEGF-A in @DISEASE$.	1
There were more @MiRNA$ up- (188) or down-regulated (160) between adenomas and normal pituitaries compared to @DISEASE$ and normal pituitaries (92 up- and 91 down-regulated) or between carcinomas and adenomas (46 up- and 52 down-regulated).	0
The different expression pattern observed in @MiRNA$ at different stages of malignancy is probably dependent on the cell-specific repertoire of target genes of tumors sharing different molecular pathways activity and suggests @DISEASE$ may have also a place in diagnosis and staging of brain tumors.	0
We further demonstrate that @MiRNA$ belonging to the miR-15 family are potent regulators of ERK1 expression in mouse neuronal cells and co-expressed with @DISEASE$ in vivo.	1
Our research revealed that 136 miRNAs were expressing at 6 h post injury, in which 13 miRNAs were more than 2-fold up-regulated, and 14 @MiRNA$ were more than 2-fold down-regulated; 118 miRNAs were expressing at 24 h post @DISEASE$, in which 4 miRNAs were more than 2-fold up-regulated, and 23 miRNAs were more than 2-fold down-regulated; 149 miRNAs were expressing at 48 h post injury, in which 16 miRNAs were more than 2-fold up-regulated, and 11 miRNAs were more than 2-fold down-regulated; and 203 miRNAs were expressing at 72 h post injury, in which 19 miRNAs were more than 2-fold up-regulated, and 5 miRNAs were more than 2-fold down-regulated.	0
These data provided the unique opportunity to study the relationship between @MiRNA$ and mRNA expression in normal and @DISEASE$ brains.	0
MicroRNAs (@MiRNA$ ) are posttranscriptional regulatory molecules that have been implicated in the regulation of immune responses, but their role in the immune response to @DISEASE$ is unknown.	0
@MiRNA$ Targets the DNA Methyltransferases 1 and Regulates Global DNA Methylation in human @DISEASE$.	1
Our research revealed that 136 miRNAs were expressing at 6 h post injury, in which 13 miRNAs were more than 2-fold up-regulated, and 14 @MiRNA$ were more than 2-fold down-regulated; 118 miRNAs were expressing at 24 h post injury, in which 4 miRNAs were more than 2-fold up-regulated, and 23 miRNAs were more than 2-fold down-regulated; 149 miRNAs were expressing at 48 h post injury, in which 16 miRNAs were more than 2-fold up-regulated, and 11 miRNAs were more than 2-fold down-regulated; and 203 miRNAs were expressing at 72 h post @DISEASE$, in which 19 miRNAs were more than 2-fold up-regulated, and 5 miRNAs were more than 2-fold down-regulated.	0
@MiRNA$ inhibits cell proliferation of human lung @DISEASE$ by targeting EGFR and NUDT1.	1
Expression of @MiRNA$ was studied using real-time quantitative reverse transcriptase polymerase chain reaction and northern blotting for human @DISEASE$ with different grade of malignancy.	0
The family of @MiRNA$ and miR-65 are co-underexpressed in the @DISEASE$ transgenic and cat-1 strains, and members of let-7 family co-underexpressed in the alpha-synuclein and pdr-1 strains; mdl-1 and ptc-1 genes are target candidates for miR-64 and miR-65 and are overexpressed in alpha-synuclein transgenic as well as miR-64/65 (tm3711) knockout animals.	1
Our research revealed that 136 miRNAs were expressing at 6 h post injury, in which 13 miRNAs were more than 2-fold up-regulated, and 14 miRNAs were more than 2-fold down-regulated; 118 miRNAs were expressing at 24 h post injury, in which 4 @MiRNA$ were more than 2-fold up-regulated, and 23 miRNAs were more than 2-fold down-regulated; 149 miRNAs were expressing at 48 h post @DISEASE$, in which 16 miRNAs were more than 2-fold up-regulated, and 11 miRNAs were more than 2-fold down-regulated; and 203 miRNAs were expressing at 72 h post injury, in which 19 miRNAs were more than 2-fold up-regulated, and 5 miRNAs were more than 2-fold down-regulated.	0
Recent studies have shown that the expression of many @MiRNA$ is altered in various human @DISEASE$ and some miRNAs may function as oncogenes or tumor suppressor genes.	0
One remarkable hit was the @MiRNA$ (ago1) gene, a central element of the @DISEASE$ (miRNA) translational silencing machinery.	0
The expression of certain @MiRNA$ correlates with other miRNAs across different cases, and particular subsets of miRNAs are coordinately expressed in relation to @DISEASE$ -related pathology.	0
@MiRNA$ down-regulates Hexokinase 2 in @DISEASE$ cells.	1
Differential expression of 9 @MiRNA$ was observed between micro- and @DISEASE$.	0
Control of mitogenic and motogenic pathways by @MiRNA$ diminishing @DISEASE$ cell growth and migratio.	1
To investigate the involvement of let-7i, miR-27a, and @MiRNA$ in CM-resistant mice, we assessed the expression levels in gamma interferon knockout (@DISEASE$ -γ(-/-)) mice on a C57BL/6 genetic background.	0
Time-course assays of neuronal Abeta treatments show that @MiRNA$ is in fact a powerful regulator of miRNA levels as the response of certain mature @DISEASE$ is extremely rapid.	0
As compared to NEC, @MiRNA$ significantly upregulated in @DISEASE$ subjects and confirmed by qPCR were miR-34a and 181b.	1
The @MiRNA$ -23b/-27b Cluster Suppresses the Metastatic Phenotype of Castration-Resistant @DISEASE$ Cell.	1
A Functional Polymorphism (rs2910164) in @MiRNA$ Is Associated with Susceptibility to @DISEASE$ in a Chinese Population.	1
Anti-oncogenic @MiRNA$ Induces Senescence by Targeting E2F3 in Human @DISEASE$ Cells.	1
To search for @MiRNA$ that may be involved in the pathogenesis of @DISEASE$ (PD), we utilized miRNA microarrays to identify potential gene expression changes in 115 annotated miRNAs in PD-associated Caenorhabditis elegans models that either overexpress human A53T alpha-synuclein or have mutations within the vesicular catecholamine transporter (cat-1) or parkin (pdr-1) ortholog.	0
Epigenetic silencing of @MiRNA$ contributes to leukemogenesis in t(8;21)@DISEASE$ by activating the PTEN/PI3K signal pathwa.	1
The @MiRNA$ is up-regulated in whole blood @DISEASE$ patient.	1
Interestingly the gene locus of one @MiRNA$, miR-175, is a candidate region for two neurologic diseases: early-onset parkinsonism (Waisman syndrome) and X-linked mental retardation (@DISEASE$ ).	1
Global @MiRNA$ expression profiling of Caenorhabditis elegans @DISEASE$ models.	0
The @MiRNA$ is also overexpressed in human @DISEASE$.	1
In CGNPs, the Shh effector N-myc, but not @MiRNA$, induced @DISEASE$ expression.	0
MicroRNAs (@MiRNA$ ) are short RNA molecules regulating gene expression, and are implicated in a variety of diseases including @DISEASE$.	0
In human @MiRNA$ with hippocampal sclerosis, increased astroglial expression of @DISEASE$ was observed mainly in regions where neuronal cell loss and reactive gliosis occurred.	1
cMyc/@MiRNA$ Signalling Determines Sensitivity to Bortezomib in Preclinical Model of @DISEASE$.	1
@MiRNA$ was consistently overexpressed in nearly all @DISEASE$ tested (30-60 fold, P<0.001), regardless of mutations in N-ras or B-raf.	1
@MiRNA$ and their therapeutic potential for human diseases: aberrant microRNA expression in @DISEASE$ brains.	0
Serum expression level of @MiRNA$ was up-regulated in @DISEASE$ patients.	1
Here, we analyzed the @MiRNA$ expression and miRNA regulators in two transgenic models of @DISEASE$, YAC128 and R6/2 mice, and in a 3-nitropropionic acid (3NP)-induced striatal degeneration rat model.	0
In mild TBI patients (GCS score > 12), @MiRNA$ levels were unchanged, while the plasma levels of miR-92a and miR-16 were significantly increased within the first 24 h of @DISEASE$ compared to healthy volunteers, and had AUC values of 0.78 and 0.82, respectively.	0
We used @MiRNA$ expression microarrays on RNA extracted from human brain tissue from the University of Kentucky @DISEASE$ Center Brain Bank with near-optimal clinicopathological correlation.	0
An inverse correlation between @MiRNA$ and @DISEASE$ expression was evident (R=-0.33, P<0.05).	1
The NF-κB inhibitors curcumin, pyrrolidine dithiocarbamate or CAY10512 abrogated both IRAK-2 and @MiRNA$ expression, whereas @DISEASE$ was up-regulated.	0
The use of hsa-miR-21, @MiRNA$ and hsa-miR-106a as prognostic indicators of @DISEASE$.	0
BACKGROUND: The purpose of this study was to (1) identify specific @MiRNA$ in growth hormones (GH)-secreting @DISEASE$ ; (2) determine the relationship between the expression of these miRNAs and tumor size, somatostatin analogs treatment, and responsiveness to somatostatin analogs (SSA).	0
The @MiRNA$ cluster was significantly (and @DISEASE$ -dementia-specific) decreased in AD patients displaying abnormally high BACE1 protein.	0
Exogenous expression of @MiRNA$ and miR-224, two miRNAs that have the highest WNT pathway specific upregulation, was found to inhibit proliferation, increase radiation sensitivity and reduce anchorage-independent growth of @DISEASE$ cells.	1
This region encodes @MiRNA$ (19p13.2), whose expression levels are lower in HCC compared to nontumor liver [59] and is deleted in several other @DISEASE$ types.	1
In human TLE with hippocampal sclerosis, increased astroglial expression of @MiRNA$ was observed mainly in regions where neuronal cell loss and reactive @DISEASE$ occurred.	0
@MiRNA$ may be a new therapeutic target for proliferative vascular diseases such as atherosclerosis, postangioplasty restenosis, transplantation arteriopathy, and @DISEASE$.	1
@MiRNA$ regulation of @DISEASE$ protein expression: rapid and sensitive modulation of the innate immune response.	1
We did reporter assays to elucidate the IFN-beta-mediated suppression of miR-21; the addition of signal transducers and activators of transcription 3 (@MiRNA$ )-expressing vectors induced the IFN-beta-mediated suppression of miR-21, whereas STAT3-inhibiting agents inhibited the @DISEASE$ suppression.	0
@MiRNA$ represses ID1 and is deregulated in lung @DISEASE$.	1
Aberrant gene expression is the main mechanism of miRNAs dysfunction in cancer, with abnormal expression levels of mature and/or precursor @MiRNA$ expression in @DISEASE$ samples versus normal.	0
Recently, the lack of miRNA processing has been shown to promote neurodegeneration and deregulation of several @MiRNA$ has been reported to be associated with @DISEASE$ in mice.	1
In mild TBI patients (GCS score > 12), miR-765 levels were unchanged, while the plasma levels of miR-92a and @MiRNA$ were significantly increased within the first 24 h of @DISEASE$ compared to healthy volunteers, and had AUC values of 0.78 and 0.82, respectively.	1
The most interesting results came from miR-221, strongly up-regulated in @MiRNA$ and from a set of brain-enriched @DISEASE$, miR-128, miR-181a, miR-181b, and miR-181c, which are down-regulated in glioblastoma.	0
We analyzed the @MiRNA$ in 21 GH-secreting @DISEASE$ and 6 normal pituitaries by miRCURY™ LNA array and some differentially expressed miRNAs were validated by quantitative real-time PCR.	0
@DISEASE$ associated genes CSMD1, C10orf26, CACNA1C and TCF4 are @MiRNA$ targets.	1
@MiRNA$ suppresses @DISEASE$ cell invasion and migration in vitro by targeting FAS.	1
Allele variants in functional @MiRNA$ target sites of the neurotrophin-3 receptor gene (NTRK3) as susceptibility factors for @DISEASE$.	1
Downregulation of @MiRNA$ by promoter methylation contributes to @DISEASE$ development.	1
@MiRNA$ was up-regulated during lobular @DISEASE$ progression compared to normal epithelium.	1
The down-regulation of @MiRNA$ in @DISEASE$ was shown to be associated with advanced clinical stages of this disease.	1
@MiRNA$ 181a Influences the Expression of HMGB1 and CD4 in Acute @DISEASE$.	1
Loss of @MiRNA$ 126 and 130a in Angiogenic Early Outgrowth Cells From Patients With @DISEASE$ Role for Impaired In Vivo Neovascularization and Cardiac Repair Capacit.	1
@MiRNA$ enhances the sensitivity of @DISEASE$ cells to anticancer agents by targeting vascular endothelial growth factor A.	1
Our analysis found 50 @MiRNA$ exhibited decreased expression levels and 35 miRNAs exhibited increased expression levels in the hippocampus after @DISEASE$.	0
In silico analysis showed sequence complementarity of eight @MiRNA$ induced after @DISEASE$ to 877 promoters indicating the possibility of noncoding RNA-induced activation of gene expression.	0
Identification of miRs targeting the @MiRNA$ 3'-untranslated region was performed by miR array followed by expression analysis of identified @DISEASE$ using qRT-PCR.	0
However, no studies have investigated the clinical significance of high-mobility group A2 and its relationship to the @MiRNA$ miRNA family in human @DISEASE$.	0
METHODS AND FINDINGS: To explore the role of miRNAs in schizophrenia, 59 @MiRNA$ genes on the X-chromosome were amplified and sequenced in males with (193) and without (191) schizophrenia spectrum disorders to test the hypothesis that ultra-rare mutations in microRNA collectively contribute to the risk of @DISEASE$.	0
Epigenetic-induced repression of @MiRNA$ is associated with MED1 activation and a poorer prognosis in localized @DISEASE$.	1
Correlation of @MiRNA$ downregulation with unfavorable clinical outcome of patients with @DISEASE$.	1
We found that the expression of BACE1-antisense as well as @MiRNA$ are dysregulated in RNA samples from @DISEASE$ subjects compared to control individuals.	1
A few miRNAs were differentially expressed in WM, including @MiRNA$ that is downregulated in AD and miR-424 which is upregulated in @DISEASE$.	0
The Induction of @MiRNA$ in @DISEASE$ Cells by Protein Arginine Deiminase Inhibition Causes a p53-Dependent Cell Cycle Arres.	1
miRs -100, -125b, and -195 were significantly down-regulated, whereas @MiRNA$ was significantly up-regulated in malignant as compared with @DISEASE$.	1
While miR-1, miR-22* and miR-29 expression levels allowed to distinguish non-treated @MiRNA$ from healthy subjects, @DISEASE$ *, miR-26a2* and miR30a differentiated treated from untreated patients.	1
The different expression pattern observed in tumors at different stages of malignancy is probably dependent on the cell-specific repertoire of target genes of @MiRNA$ sharing different molecular pathways activity and suggests @DISEASE$ may have also a place in diagnosis and staging of brain tumors.	0
Joint genome-wide profiling of miRNA and mRNA expression in @MiRNA$ cortex reveals altered @DISEASE$ regulation.	0
Consistent with its regulation by Shh, we observed that Shh treatment of primary cerebellar granule neuron precursors (CGNP), proposed cells of origin for the @MiRNA$ -associated medulloblastomas, resulted in increased @DISEASE$ expression.	0
@MiRNA$ regulates lipid metabolism and inhibits hepatitis C virus replication in human @DISEASE$ cell.	1
@MiRNA$ regulates cardiomyocyte @DISEASE$ in diabete.	1
While the exact role of the patient-specific @MiRNA$ variants within the 3' UTR region of APP and BACE1 demands further analyses, this study does not support a major contribution of miRNA genetic variability to @DISEASE$ pathogenesis.	0
The expression of let-7i, miR-27a, and @MiRNA$ was unchanged in both wild-type (WT) and @DISEASE$ -γ(-/-) mice following infection.	0
Aberrant expression of @MiRNA$ 155 may accelerate cell proliferation by targeting sex-determining region Y box 6 in @DISEASE$.	1
The @MiRNA$ has a role in colorectal liver @DISEASE$.	1
The analysis of the upstream regulatory regions in co-regulated miRNAs suggests a role for RE1-Silencing Transcription Factor (REST) and @MiRNA$ in @DISEASE$ downregulation in HD.	1
@MiRNA$ was hyperexpressed in all tumor samples whereas higher levels of miRNA-221 were found in @DISEASE$.	0
The relative expression of @MiRNA$ was measured by real-time PCR using RNU44 and @DISEASE$ as endogenous controls.	0
While @MiRNA$ has been studied as a therapeutic target in spinal cord injury, this is the first demonstration of endogenous regulation of RhoA by a @DISEASE$ that is required for spinal cord regeneration in zebrafish.	0
@MiRNA$ is down-regulated in human pancreatic ductal @DISEASE$ and regulates cell survival by targeting CDC25B.	1
This effect was abolished by deleting the @MiRNA$ seed site in the 3'UTR of @DISEASE$.	0
The bifunctional @MiRNA$ miR-9/miR-9* regulates REST and @DISEASE$ and is downregulated in Huntington's disease.	1
@MiRNA$ expression of which was repressed by p63, was activated by proapoptotic p73 isoforms in both normal cells and @DISEASE$ cells in vivo.	1
Activin and TGFʇ regulate expression of the @MiRNA$ to promote cell migration and invasion in @DISEASE$ cell.	1
@MiRNA$ contributes to DNA hypomethylation of CD4+ T cells in @DISEASE$ by indirectly targeting DNA methyltransferase.	1
Furthermore, new therapeutic strategies involving miRNA silencing or @MiRNA$ mimics could be proposed based on the roles of these small non-coding RNAs as oncogenes and tumor suppressors in @DISEASE$.	0
@MiRNA$ modulates proliferation, migration, and invasion of @DISEASE$ cells.	1
plasma;Clinical relevance of plasma @MiRNA$ levels in patients with @DISEASE$.	1
Inhibition of two @MiRNA$ -upregulated @DISEASE$ (miR-21 and miR-23a) and exogenous overexpression of two glioblastoma-downregulated miRNAs (miR-218 and miR-219-5p) resulted in reduced soft agar colony formation but showed varying effects on cell proliferation and chemosensitivity.	1
Potential role of @MiRNA$ and their inhibitors in @DISEASE$ treatment.	0
Increased Risk @DISEASE$ Associated with CC Genotype of Has-@MiRNA$ Rs2910164 Polymorphism in Europeans.	1
Both @MiRNA$ and hsa-miR-181b have several predicted gene targets involved in @DISEASE$ and T-cell activation pathways.	0
Our study dissects the complexity of human @MiRNA$ pathology, and addresses the hypothesis that amyloid-beta (Abeta) itself, a known causative factor of AD, causes neuronal @DISEASE$ deregulation, which could contribute to the pathomechanisms of AD.	0
@MiRNA$ Inhibits the Growth of @DISEASE$ by Targeting the Epidermal Growth Factor Receptor.	1
This review summarizes the recent @MiRNA$ literature in both @DISEASE$ and normal brain development.	0
@MiRNA$ enhances the radiosensitivity of @DISEASE$ cells by promoting radiation-induced apoptosis.	1
@MiRNA$ inhibition enhances in vitro chemosensitivity of temozolomide-resistant @DISEASE$ cells.	1
This is a rapidly evolving field and it is likely that we have only begun to appreciate the involvement of @MiRNA$ in relation to @DISEASE$ formation, and the therapeutic potential of microRNAs to improve outcome for glioma patients.	0
Tamoxifen downregulation of @MiRNA$ increases 14-3-3 and promotes @DISEASE$ cell survival and endocrine resistance.	1
@MiRNA$ seed family regulates p21 in @DISEASE$.	1
Thus, the results of our study show that the downregulation of miR-21 contributes to the antitumor effects of IFN-beta and that @MiRNA$ expression is negatively regulated by @DISEASE$ activation.	1
@MiRNA$ regulates @DISEASE$ cell invasion via targeting focal adhesion kinase expression.	1
We propose that loss of specific @MiRNA$ can contribute to increased BACE1 and @DISEASE$ levels in sporadic AD.	1
@MiRNA$ show abnormal expression in human renal @DISEASE$.	1
Human brains retain discrete populations of micro RNA (@MiRNA$ ) species that support homeostatic brain gene expression functions; however, specific miRNA abundance is significantly altered in @DISEASE$ such as Alzheimer disease (AD) when compared with age-matched controls.	0
Our results demonstrate that circulating @MiRNA$ levels are altered after @DISEASE$, providing a rich new source of potential molecular biomarkers.	1
Down-regulation of @MiRNA$ kinase by a specific subset of @DISEASE$ in human sporadic pituitary adenomas.	1
Exogenous expression of miR-193a and miR-224, two @MiRNA$ that have the highest WNT pathway specific upregulation, was found to inhibit proliferation, increase radiation sensitivity and reduce anchorage-independent growth of @DISEASE$ cells.	1
Circulating @MiRNA$ is a potential predictors and therapeutic targets for non-@DISEASE$.	1
Brain cells maintain distinct populations of @MiRNA$ that support physiologically normal patterns of expression, however, certain miRNA abundances are significantly altered in neurodegenerative disorders such as Alzheimer's disease (@DISEASE$ ).	0
Finally, we demonstrate that @MiRNA$ -mediated @DISEASE$ repression in a murine glioma model both enhances de novo tumor formation and precludes loss of heterozygosity and the PTEN locus.	1
@MiRNA$ inhibits @DISEASE$ cell migration and invasion by targeting MMPs.	1
Recently, the lack of @MiRNA$ processing has been shown to promote neurodegeneration and deregulation of several miRNAs has been reported to be associated with @DISEASE$ in mice.	0
@DISEASE$ induced overexpression of @MiRNA$ inhibits insulin-stimulated AKT activation and impairs glucose metabolism.	1
@MiRNA$ down-regulated in estrogen receptor alpha-positive human @DISEASE$.	1
In order to get a better understanding of @MiRNA$ biology, @DISEASE$ profiling of medulloblastomas was carried out in parallel with expression profiling of protein-coding genes.	0
@MiRNA$ regulates migration of human @DISEASE$ cells.	1
@MiRNA$ regulated TCTP as a novel plasma biomarker for @DISEASE$ From quantitative proteomics to post-transcriptional study.	1
@MiRNA$ regulates the proliferation, apoptosis and cell cycle progression of @DISEASE$ cells by targeting Survivin.	1
With respect to the reported regulation of this @MiRNA$ in Scrapie-infected mice, we propose that upregulation of hsa-miR-342-3p may be a general phenomenon in late stage prion disease and might be used as a novel marker for animal and human @DISEASE$.	0
MicroRNAs (@MiRNA$ ) are abundantly expressed in the brain and play an important role in disorders of the brain, including Alzheimer's diseases (@DISEASE$ ).	0
@MiRNA$ Regulates Cell Proliferation, Invasion, and Migration by Directly Targeting ZEB2 in @DISEASE$.	1
To validate the finding, we reversed the analysis and compared each non-autism control to a single mean value for each @MiRNA$ across all @DISEASE$ cases.	0
Sequence analysis revealed two putative binding sites for @MiRNA$ in the 3' UTR of the @DISEASE$ mRNA.	1
This review discusses three aspects of the use of oncolytic adenoviruses to treat cancer: (i) the induction of autophagy and autophagic cell death during adenoviral replication; (ii) the opportunities and strategies involved in the exploitation of @MiRNA$ specificity to generate tissue- and @DISEASE$ -selective oncolytic viruses; and (iii) the rationale for combining oncolytic adenoviruses with chemotherapeutic agents.	0
@MiRNA$ mediated FOXC2 regulation is critical for inhibition @DISEASE$ progression by resveratrol.	1
In short PMI Alzheimer's disease (AD)-affected temporal lobe neocortex, @MiRNA$, miRNA-125b and miRNA-146a were found to be significantly up-regulated, an effect that was not seen in several related @DISEASE$.	0
Brain cells maintain distinct populations of @MiRNA$ that support physiologically normal patterns of expression, however, certain miRNA abundances are significantly altered in @DISEASE$ such as Alzheimer's disease (AD).	0
@MiRNA$ Suppresses Tumorigenicity @DISEASE$ by Inhibiting Mitochondrial Antioxidant Enzymes.	1
Increased expression of P-glycoprotein and doxorubicin chemoresistance of metastatic @DISEASE$ is regulated by @MiRNA$.	1
@MiRNA$ Modulates hTERT Through a STAT3-Dependent Manner on @DISEASE$ Cell Growth.	1
@MiRNA$ promotes migration and invasion through CADM1 in human @DISEASE$ cells.	1
There were more @MiRNA$ up- (188) or down-regulated (160) between adenomas and normal pituitaries compared to carcinomas and normal pituitaries (92 up- and 91 down-regulated) or between @DISEASE$ and adenomas (46 up- and 52 down-regulated).	0
De-regulation of a unique subset of miRNAs suggests a conserved, disease-specific pattern of differentially expressed @MiRNA$ is associated with @DISEASE$ -induced neurodegeneration.	1
@MiRNA$ 100 Regulated beta-tubulin isotypes in MCF7 @DISEASE$ cells.	1
In neurodegenerative disorders such as Alzheimer's disease (@MiRNA$ ), brain miRNA profiles are altered; thus @DISEASE$ dysfunction could be both a cause and a consequence of disease.	0
@MiRNA$ as a plasma prognostic marker in patients with @DISEASE$.	1
RESULTS: Fifty-two @MiRNA$ were differentially expressed between GH-secreting @DISEASE$ and normal pituitaries.	1
Our research revealed that 136 miRNAs were expressing at 6 h post injury, in which 13 miRNAs were more than 2-fold up-regulated, and 14 miRNAs were more than 2-fold down-regulated; 118 miRNAs were expressing at 24 h post injury, in which 4 miRNAs were more than 2-fold up-regulated, and 23 miRNAs were more than 2-fold down-regulated; 149 miRNAs were expressing at 48 h post @MiRNA$, in which 16 @DISEASE$ were more than 2-fold up-regulated, and 11 miRNAs were more than 2-fold down-regulated; and 203 miRNAs were expressing at 72 h post injury, in which 19 miRNAs were more than 2-fold up-regulated, and 5 miRNAs were more than 2-fold down-regulated.	1
@MiRNA$ is frequently down-regulated in @DISEASE$ and is involved in migration and invasion.	1
Furthermore, @MiRNA$ and miR-23a/b analysis in rat hippocampus were performed by real-time quantitative polymerase chain reaction at 0h, 1h, 6h, 12h, 24h, 2days, 7days,10days, 30days,50days after induction of @DISEASE$ (SE).	0
Upregulation of @MiRNA$ is negatively associated with recurrent/newly formed @DISEASE$.	1
The detection of @MiRNA$ expression yielded 78.80% sensitivity and 100.00% specificity in the diagnosis @DISEASE$.	1
Because of its known connection to @MiRNA$ biology, we focused on @DISEASE$ among seven miRNAs influenced by IFN-beta.	0
@MiRNA$ functions as a tumor suppressor modulating EGFR in @DISEASE$.	1
@MiRNA$ inhibits proliferation of @DISEASE$ cells by targeting survivin.	1
Interestingly the gene locus of one miRNA, @MiRNA$, is a candidate region for two neurologic diseases: early-onset parkinsonism (Waisman syndrome) and X-linked mental retardation (@DISEASE$ ).	1
B cell differentiation in EBV-positive @DISEASE$ is impaired at post-transcriptional level by @MiRNA$ altered expression.	1
Our study dissects the complexity of human AD pathology, and addresses the hypothesis that amyloid-beta (Abeta) itself, a known causative factor of AD, causes neuronal @MiRNA$ deregulation, which could contribute to the pathomechanisms of @DISEASE$.	1
@MiRNA$ and NFATc3 regulate myocardin in @DISEASE$.	1
PROCEDURE: @MiRNA$ expression in pediatric @DISEASE$ and normal tissue controls was examined by microarray.	0
@MiRNA$ in PBMCs modulates Th1 function in patients with @DISEASE$.	1
@MiRNA$ 21 regulates the sensitivity to cisplatin in human @DISEASE$ cell.	1
We uncovered a previously unknown alteration in temporal expression of a large set of @MiRNA$ following a contusive @DISEASE$ (SCI) in adult rats using microarray analysis.	1
Let-7b and @MiRNA$ inhibit the proliferation of B16F10 @DISEASE$ cell.	1
These studies have opened the door to the possibility of utilizing @MiRNA$ or miRNA antagonists as therapeutic agents for the treatment of @DISEASE$.	0
@MiRNA$ expression profiling of human @DISEASE$ has led to the identification of signatures correlated with the tumor diagnosis, staging, progression, prognosis and response to treatment.	0
Analysis of human MBs demonstrated that 3 miR-17 approximately 92 cluster miRNAs (miR-92, @MiRNA$, and miR-20) were also overexpressed in human MBs with a constitutively activated @DISEASE$ (SHH) signaling pathway, but not in other forms of the disease.	0
@MiRNA$ (miRNAs) are known to influence many important cellular processes, including proliferation, apoptosis, neurogenesis, angiogenesis, and morphogenesis, all processes that are involved in @DISEASE$ pathophysiology.	0
@MiRNA$ functions as an oncogene in human @DISEASE$ by targeting FBXW7/hCdc4.	1
@MiRNA$ interplays with its host gene BAALC and independently affects outcome of patients with cytogenetically normal @DISEASE$.	1
Using @MiRNA$ -, IRAK-1-, or IRAK-2 promoter-luciferase reporter constructs, we observe decreases in IRAK-1 and increases in miRNA-146a and IRAK-2 expression in @DISEASE$ (IL-1β) and amyloid-β-42 (Aβ42) peptide-stressed HAG cells.	0
Human brains retain discrete populations of @MiRNA$ (miRNA) species that support homeostatic brain gene expression functions; however, specific miRNA abundance is significantly altered in @DISEASE$ such as Alzheimer disease (AD) when compared with age-matched controls.	0
@MiRNA$ 126* Restored Expressions Play a Tumor Suppressor Role by Directly Regulating ADAM9 and MMP7 in @DISEASE$.	1
These data suggest a significantly independent regulation of IRAK-1 and IRAK-2 in AD and in IL-1β+@MiRNA$ peptide-stressed HAG cells and that an inducible, NF-κB-sensitive, @DISEASE$ -mediated down-regulation of IRAK-1 coupled to an NF-κB-induced up-regulation of IRAK-2 expression drives an extensively sustained inflammatory response.	0
@MiRNA$ promoter methylation is associated with poorer overall survival in patients with squamous cell @DISEASE$.	1
@MiRNA$ 223 is Up-regulated in the Multistep Progression of @DISEASE$ and Modulates Sensitivity to Chemotherapy by Targeting PARP1.	1
While mice with control implants expressing a scrambled @MiRNA$ sequence or sham treated control animals were characterized by KA-induced status epilepticus and subsequent CA3 neuronal cell loss, animals with therapeutic ADK knockdown implants displayed a 35% reduction in @DISEASE$ duration and 65% reduction in CA3 neuronal cell loss, when analyzed 24 h after KA-injection.	0
Upregulation of @MiRNA$ confers a poor prognosis in @DISEASE$ patients via inducing a proliferative phenotype.	1
@MiRNA$ promotes @DISEASE$ cell migration and invasion by targeting HOXA10.	1
@MiRNA$ expression promotes cell proliferation and migration of human @DISEASE$ cell.	1
METHODS AND FINDINGS: To explore the role of @MiRNA$ in schizophrenia, 59 microRNA genes on the X-chromosome were amplified and sequenced in males with (193) and without (191) @DISEASE$ spectrum disorders to test the hypothesis that ultra-rare mutations in microRNA collectively contribute to the risk of schizophrenia.	0
Circulating @MiRNA$ levels in patients with @DISEASE$ spectrum disorde.	1
In this report, we describe the @MiRNA$ expression level in rat cerebral cortex after @DISEASE$ using microarray method.	0
@MiRNA$ down-regulated in @DISEASE$ compared with endometrium.	1
@MiRNA$ biomarkers improved the ability to distinguish between healthy tissue, PDAC, and @DISEASE$.	1
Analysis of human MBs demonstrated that 3 miR-17 approximately 92 cluster miRNAs (miR-92, miR-19a, and @MiRNA$ ) were also overexpressed in human @DISEASE$ with a constitutively activated Sonic Hedgehog (SHH) signaling pathway, but not in other forms of the disease.	1
Using transiently transfected murine neuronal N2a cells in culture, in parallel to a mouse model of AD, we were able to demonstrate a role for two miRNAs (miR-298 and @MiRNA$ ) in the regulation of beta-amyloid (Abeta) precursor protein (APP)-converting enzyme (BACE) messenger RNA (mRNA) translation, thereby providing key insights into the molecular basis underlying @DISEASE$ deregulation in AD.	0
@MiRNA$ Functions as a Tumor Suppressor in @DISEASE$ Cells.	1
CONCLUSION: This study is the first to find altered @MiRNA$ profiles in postmortem prefrontal cortex from @DISEASE$ patients.	1
P53-induced @MiRNA$ inhibits proliferation of @DISEASE$ cells and down-regulates the expression of CDK6 and Notch-.	1
@MiRNA$ suppresses epithelial-mesenchymal transition in @DISEASE$ cell lines.	1
Variation in the @MiRNA$ binding site of FGF20 confers risk for @DISEASE$ by overexpression of alpha-synuclein.	1
@MiRNA$ expression in ACTH-producing @DISEASE$ : up-regulation of microRNA-122 and -493 in pituitary carcinomas.	0
Pre-@MiRNA$ arrested A549 cells in the G0-G1 phase of the cell cycle, correlating with increased levels of the cell cycle inhibitor p27(@DISEASE$ ) as well as with reduced proliferation rates and resulting in greatly diminished sensitivity of A549 cells to the late S-G2-M cell cycle arrest mediated by CDDP.	1
MicroRNAs (@MiRNA$ ) are abundantly expressed in the brain and play an important role in disorders of the brain, including @DISEASE$ (AD).	1
@MiRNA$ down-regulated in malignant @DISEASE$ than non-malignant on.	1
CONCLUSION: Expression level of tumor/metastasis suppressive miRNAs in the WNT signaling associated medulloblastomas is likely to determine their response to treatment, and thus, these @MiRNA$ would be important biomarkers for risk stratification within the WNT signaling associated @DISEASE$.	0
We did reporter assays to elucidate the IFN-beta-mediated suppression of miR-21; the addition of @MiRNA$ (STAT3)-expressing vectors induced the IFN-beta-mediated suppression of @DISEASE$, whereas STAT3-inhibiting agents inhibited the miR-21 suppression.	0
Serum Overexpression of @MiRNA$ in Patients with Bone Metastatic Primary @DISEASE$.	1
@MiRNA$ Regulates the PI3K-AKT pathway in @DISEASE$.	1
@MiRNA$ is upregulated by demethylation of an upstream genomic region that occurs during the process of @DISEASE$ cell differentiation induced by all-trans retinoic acid (ATRA).	1
@MiRNA$ profiling reveals new aspects of HIV neurodegeneration: @DISEASE$ regulates astrocyte survival.	0
@MiRNA$ targets DNA methyltransferases 3A in @DISEASE$.	1
Downregulation of the tumor-suppressor @MiRNA$ via progestin-mediated oncogenic signaling contributes to @DISEASE$ development.	1
Altered expression of @MiRNA$ and its targets in the hippocampus after @DISEASE$.	1
A number of miRNAs like miR-193a, @MiRNA$ /miR-452 cluster, miR-182/miR-183/miR-96 cluster, and miR-148a having potential tumor/metastasis suppressive activity were found to be overexpressed in the WNT signaling associated @DISEASE$.	1
Lentivirus-Mediated Overexpression of @MiRNA$ Inhibits Cell Proliferation of Human @DISEASE$.	1
Although @MiRNA$ are being extensively studied for their involvement in cancer and development, little is known about their roles in Alzheimer's disease (@DISEASE$ ).	0
@MiRNA$ Inhibits the Invasion of @DISEASE$ Cells through Downregulation of Multiple Oncogenic Target Gene.	1
@MiRNA$ downregulated in six solid @DISEASE$ types by SAM (Volinia et al., 2006).	1
In a well-characterized Belgian group of 358 AD patients and 462 controls, we examined whether genetic variability in @MiRNA$ (miRNA) binding sites of APP and @DISEASE$ or in associated miRNAs influenced risk for A.	0
Adjusted @MiRNA$ and @DISEASE$ mRNA levels tended to correlate negatively (trend with regression P< 0.07).	1
@MiRNA$ slows ALS progression by sensing motor neuron @DISEASE$ and promoting the compensatory regeneration of neuromuscular synapse.	1
While most @MiRNA$ levels showed little variation across all samples suggesting that @DISEASE$ does not induce global dysfunction of miRNA expression, some miRNAs among the autistic samples were expressed at significantly different levels compared to the mean control value.	0
@MiRNA$ modulates cell cycle by targeting human mutL homolog 1 in human @DISEASE$ cell.	1
Circulating @MiRNA$ is a novel biomarker for screening @DISEASE$ and predicts poor prognosis.	1
@MiRNA$ inhibits epithelial-to-mesenchymal transition by targeting Snai1 and is downregulated in @DISEASE$.	1
Detection of the receptor P2Y(12) mRNA in @MiRNA$ immunoprecipitates suggests that P2Y(12) expression may be subjected to @DISEASE$ control in human platelets.	0
A high expression of @MiRNA$ has been suggested to be significantly associated with unfavorable prognosis in lung @DISEASE$ patients.	1
@MiRNA$ targets RKIP to control cell invasion and expression of metastasis genes in human @DISEASE$ cells.	1
@MiRNA$ Is frequently upregulated in @DISEASE$ and inhibits the extrinsic apoptotic pathway by targeting FAS.	1
Analysis of human MBs demonstrated that 3 @MiRNA$ approximately 92 cluster miRNAs (miR-92, miR-19a, and miR-20) were also overexpressed in human @DISEASE$ with a constitutively activated Sonic Hedgehog (SHH) signaling pathway, but not in other forms of the disease.	1
@MiRNA$ with MB cells in an induced xenograft model in the mouse cerebellum and the use of an adenovirus carrying @DISEASE$ indicate a clinical benefit through this negative influence of miR-199b-5p on tumor growth and on the subset of MB stem-cell-like cells, providing further proof of concept.	0
Targeting @MiRNA$ inhibits in vitro and in vivo @DISEASE$ cell growt.	1
The @MiRNA$ was downregulated in cis-platin resistant (A2780/CP70) vs. cis-platin sensitive (A2780) @DISEASE$ cell lines.	1
The down-regulated expression of @MiRNA$ in @DISEASE$ patients is associated with recurrence after radical operatio.	1
Epigenetic silencing of @MiRNA$ plays an important role in regulating cell proliferation in @DISEASE$.	1
Interestingly, both @MiRNA$ are capable of binding directly to @DISEASE$ in different positions: within the miRNA sequence itself (let-7b) or in the hairpin precursor (miR-663).	1
PDCD4 expression inversely correlated with @MiRNA$ levels in @DISEASE$.	1
Recent evidence has shown that @MiRNA$ plays a pivotal role in the development of many cancers including glioma, a lethal @DISEASE$.	0
@MiRNA$ Regulates HOXA10 Expression in @DISEASE$.	1
RESULTS: MicroRNA-129, miR-142-5p, and @MiRNA$ were differentially expressed in every pediatric @DISEASE$ type compared to normal tissue controls as measured by microarray.	1
@MiRNA$ silencing inhibits proliferation and migration and induces apoptosis by upregulating BACH1 in @DISEASE$ cells.	1
The @MiRNA$ polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in @DISEASE$ -treated cerebellar neural precursors.	0
@MiRNA$ inhibits proliferation and invasion of @DISEASE$ cells via blockade of AKT1 signalin.	1
Comparison of mouse cerebellar development and medulloblastoma demonstrates a shared miRNA-mRNA co-expression program for brain-specific neurologic processes such as synaptic transmission and exocytosis, in which miRNA target expression increases with the accumulation of multiple @MiRNA$ in developing cerebellum and decreases with the loss of these miRNAs in @DISEASE$.	0
The significantly altered @MiRNA$ were validated in another independent sample set consisting of 40 @DISEASE$ samples and 40 NAT samples.	0
To address whether @MiRNA$ pathways play a role in neurodegeneration, we tested whether genes critical for miRNA processing modulated toxicity induced by the @DISEASE$.	0
These data suggest a significantly independent regulation of IRAK-1 and IRAK-2 in AD and in IL-1β+Aβ42 peptide-stressed HAG cells and that an inducible, NF-κB-sensitive, @MiRNA$ -mediated down-regulation of IRAK-1 coupled to an NF-κB-induced up-regulation of @DISEASE$ expression drives an extensively sustained inflammatory response.	1
Epigenetic modulation of the @MiRNA$ is associated with transition to a @DISEASE$ stem cell-like stat.	1
@MiRNA$ Plays an Important Role in Cell Cycle Regulation in @DISEASE$ by Modulating Protein Kinase.	1
Finally, we show that @MiRNA$ is specifically downregulated in @DISEASE$ brain.	1
@MiRNA$ increased expression in c-Myc induced mouse mammary @DISEASE$.	1
MYB transcriptionally regulates the @MiRNA$ host gene in @DISEASE$.	1
These data suggest that (1) as in @MiRNA$ brain, NF-kappaB-sensitive, @DISEASE$ -mediated, modulation of CFH gene expression may contribute to inflammatory responses in aluminum-stressed HN cells, and (2) underscores the potential of nanomolar aluminum to drive genotoxic mechanisms characteristic of neurodegenerative disease processes.	0
In this commentary, we discuss the known functions of miRNAs in cancer and stem cells, their therapeutic potential and how the findings of Silber et al provide insight into the role of miR-124/@MiRNA$ dysregulation in @DISEASE$.	1
Circulating @MiRNA$ as a diagnostic marker for @DISEASE$.	1
@MiRNA$ overexpressed in malignant @DISEASE$ than non-malignant on.	1
Common variation in the @MiRNA$ binding-site of GRN is a major risk factor for TDP43-positive @DISEASE$.	0
@MiRNA$ as a circulating biomarker for @DISEASE$.	1
Histone deacetylase inhibition in @DISEASE$ cells reveals competing roles for members of the oncogenic @MiRNA$.	1
Here, we present an overview of the current progress in @MiRNA$ research related to @DISEASE$ and also highlight the utility of LNA (locked nucleic acid)-modified oligonucleotides in the detection and modulation of miRNA activity.	0
Histone Deacetylases Activate Hepatocyte Growth Factor Signaling by Repressing @MiRNA$ in @DISEASE$ Cells.	1
We further show that in a xenograft model, MB tumor burden can be reduced, indicating the use of @MiRNA$ as an adjuvant therapy after surgery, in combination with radiation and chemotherapy, for the improvement of anti-cancer @DISEASE$ therapies and patient quality of life.	0
OBJECTIVE: Our objective was to examine the expression of @MiRNA$ in pituitary tumors and to identify microRNAs (@DISEASE$ ) that can regulate its expression.	0
Our research revealed that 136 miRNAs were expressing at 6 h post @MiRNA$, in which 13 miRNAs were more than 2-fold up-regulated, and 14 miRNAs were more than 2-fold down-regulated; 118 miRNAs were expressing at 24 h post injury, in which 4 miRNAs were more than 2-fold up-regulated, and 23 @DISEASE$ were more than 2-fold down-regulated; 149 miRNAs were expressing at 48 h post injury, in which 16 miRNAs were more than 2-fold up-regulated, and 11 miRNAs were more than 2-fold down-regulated; and 203 miRNAs were expressing at 72 h post injury, in which 19 miRNAs were more than 2-fold up-regulated, and 5 miRNAs were more than 2-fold down-regulated.	0
Analysis of human MBs demonstrated that 3 miR-17 approximately 92 cluster miRNAs (miR-92, miR-19a, and @MiRNA$ ) were also overexpressed in human MBs with a constitutively activated Sonic Hedgehog (@DISEASE$ ) signaling pathway, but not in other forms of the disease.	0
To investigate the involvement of let-7i, miR-27a, and @MiRNA$ in @DISEASE$ -resistant mice, we assessed the expression levels in gamma interferon knockout (IFN-γ(-/-)) mice on a C57BL/6 genetic background.	0
Patterns of @MiRNA$ expression in normal and early @DISEASE$ human temporal cortex: white matter versus gray matter.	0
Loss of brain-enriched @MiRNA$ enhances the stem-like traits and invasiveness of @DISEASE$ cells.	1
Isoflavone and BR-DIM down-regulated the expression of @MiRNA$ which is known to be associated with RANKL signaling, EMT and @DISEASE$ progression.	1
Regulation of TBP by @MiRNA$ may contribute to @DISEASE$ pathogenesis.	0
These findings suggested that bcl2 is an important functional target for miR-34a, and the abnormal expression of @MiRNA$ may contribute to the pathogenesis of @DISEASE$, at least in part by affecting the expression of bcl2.	1
In monocytes, increased expression of an NF-κB-regulated @MiRNA$ down-regulates expression of the @DISEASE$ (IRAK-1), an essential component of Toll-like/IL-1 receptor signaling.	1
Expression profiling has unveiled @MiRNA$ signatures that not only distinguish @DISEASE$ from normal tissues, but can also differentiate histotypes or molecular subtypes with altered genetic pathways.	0
We investigated the expression and cellular distribution of @MiRNA$ (miR-146a) in a rat model of TLE as well as in human @DISEASE$.	0
The RNA-binding protein HuR opposes the repression of ERBB-2 expression by @MiRNA$ in @DISEASE$ cells.	1
@MiRNA$ significantly enhances drug sensitivity in @DISEASE$ cells via targeting multiple anti-apoptosis genes.	1
We confirm that downregulation of a set of miRNAs in GM (including several @MiRNA$ genes and miR-29 paralogs) correlated strongly with the density of diffuse @DISEASE$ detected in adjacent tissue.	0
@MiRNA$ decreased expression in c-Myc induced mouse mammary @DISEASE$.	1
The @MiRNA$ polycistron is up-regulated in @DISEASE$ -driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors.	0
@MiRNA$ targets LRRFIP1 and contributes to VM-26 resistance in @DISEASE$.	1
The family of miR-64 and miR-65 are co-underexpressed in the @MiRNA$ transgenic and cat-1 strains, and members of let-7 family co-underexpressed in the alpha-synuclein and pdr-1 strains; mdl-1 and ptc-1 genes are target candidates for miR-64 and miR-65 and are overexpressed in alpha-synuclein transgenic as well as @DISEASE$ (tm3711) knockout animals.	0
These results, for the first time, demonstrate that expression of human @MiRNA$ is regulated in part by a specific @DISEASE$, leading to decreased tumor cell migration.	1
@MiRNA$ have a role in several complex diseases including cancer as well as some @DISEASE$ such as Tourette's syndrome and Fragile x syndrome.	0
We identified a miRNA, @MiRNA$, that is specifically expressed in midbrain DNs and is deficient in midbrain tissue from patients with @DISEASE$.	1
@MiRNA$ was upregulated in human and mouse livers in a @DISEASE$ progression-dependent manner.	1
@MiRNA$ Targeting of Trichorhinophalangeal 1 (TRPS1) Promotes Epithelial-to-Mesenchymal Transition in @DISEASE$.	1
Furthermore, we show that @MiRNA$ specifically targets the mRNA of myocyte enhancer factor 2C (@DISEASE$ ), a transcription factor crucial for neuronal function, and reduces its expression.	1
RESULTS: @MiRNA$, miR-142-5p, and miR-25 were differentially expressed in every pediatric @DISEASE$ type compared to normal tissue controls as measured by microarray.	1
Bioinformatics analysis indicated a correlation between @MiRNA$ altered to several mRNAs known to mediate @DISEASE$, transcription, neuroprotection, receptors function, and ionic homeostasis.	0
@MiRNA$ represents an invasion suppressor gene in @DISEASE$ by targeting Bcl-w.	1
@MiRNA$ downregulates peroxiredoxin III in human @DISEASE$.	1
If present in somatic cells, @MiRNA$ alterations may play a role in tumor initiation, while if present in germ line cells they could constitute a @DISEASE$ predisposing event.	0
Prognostic Implications of MicoRNA @MiRNA$ Expression in Human Tongue @DISEASE$.	1
Elevated @MiRNA$ is associated with high vascular endothelial growth factor receptor 2 expression levels and high microvessel density in @DISEASE$.	1
@MiRNA$ 210 as a Biomarker for @DISEASE$.	1
Pre-@MiRNA$ and pre-miR-630 consistently modulated mitochondrial/postmitochondrial steps of the intrinsic pathway of apoptosis, including Bax oligomerization, mitochondrial transmembrane potential dissipation, and the proteolytic maturation of caspase-9 and @DISEASE$.	1
To date, this is the first report that expression of a @MiRNA$ can deplete the @DISEASE$ stem cells, indicating an interesting therapeutic approach for the targeting of these cells in brain tumors.	0
The expression of @MiRNA$ miR-107 decreases early in @DISEASE$ and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1.	1
@MiRNA$ microarray analysis results showed that 125 miRNAs were detected in the hippocampus of lithium-pilocarpine-induced @DISEASE$ rats and normal rats.	0
CONCLUSION: Our results indicate a time-dependent expression pattern of @MiRNA$ and miR-124a in a mouse model of @DISEASE$.	0
@MiRNA$ is restrictedly expressed in cirrhotic and cancerous liver tissues and its overexpression alleviates the tumorigenic effects in @DISEASE$.	1
RESULTS: We report here that BACE1-antisense prevents miRNA-induced repression of @MiRNA$ mRNA by masking the binding site for @DISEASE$.	0
@MiRNA$ 632 downregulates DNAJB6 in @DISEASE$.	1
In a well-characterized Belgian group of 358 AD patients and 462 controls, we examined whether genetic variability in microRNA (miRNA) binding sites of APP and BACE1 or in associated @MiRNA$ influenced risk for @DISEASE$.	0
We used a highly sensitive quantitative PCR assay to measure specific miRNAs (miR-122, miR-133a, and @MiRNA$ ) in plasma samples from rats treated with liver or muscle toxicants and from a rat surgical model of @DISEASE$.	0
The cellular processing of shRNAs shares common features with the biogenesis of naturally occurring @MiRNA$ such as cleavage by nuclear RNase @DISEASE$, export from the nucleus, processing by a cytoplasmic RNase Dicer, and incorporation into the RNA-induced silencing complex (RISC).	0
@MiRNA$ Up-regulated in the blook serum of patients with @DISEASE$ compared to healthy controls.	1
@MiRNA$ targets JAK2 and inhibits @DISEASE$ cell proliferation.	1
@MiRNA$ regulates migration and invasion by targeting Artemin in human esophageal @DISEASE$.	1
The CREB-@MiRNA$ negative feedback minicircuitry coordinates the migration and proliferation of @DISEASE$ cell.	1
Variant rs928883, near @MiRNA$ showed an association (OR per A-allele: 2.80 [95% CI: 1.63-4.82]; p(F)?=?0.027) with marginal zone @DISEASE$ that is significant after correction for multiple testing.	1
The bifunctional microRNA miR-9/@MiRNA$ * regulates REST and @DISEASE$ and is downregulated in Huntington's disease.	1
We did reporter assays to elucidate the IFN-beta-mediated suppression of miR-21; the addition of @MiRNA$ (STAT3)-expressing vectors induced the IFN-beta-mediated suppression of miR-21, whereas STAT3-inhibiting agents inhibited the @DISEASE$ suppression.	0
@MiRNA$ dependent and -independent replication of Hepatitis C Virus in Hep3B human @DISEASE$ cell.	1
Down-regulation of @MiRNA$ might inhibit proliferation and drug resistance of @DISEASE$ cells.	1
@MiRNA$ Feedback Suppresses T Cell Immune Function by Targeting Stat1 in Patients with @DISEASE$.	1
@MiRNA$ Promotes Renal @DISEASE$ and Is a Target of ACE Inhibition.	1
Discovered over a decade ago, @MiRNA$ is fast becoming recognized as crucial in regulating gene expression in @DISEASE$.	0
CDA-2 induces cell differentiation through suppressing Twist/SLUG signaling via @MiRNA$ in @DISEASE$.	1
miRNA-21 was hyperexpressed in all @MiRNA$ samples whereas higher levels of @DISEASE$ were found in high-grade gliomas.	0
However, little is understood about the role(s) of @MiRNA$ in Alzheimer's disease (@DISEASE$ ).	0
Genistein Up-Regulates Tumor Suppressor @MiRNA$ in @DISEASE$.	1
@MiRNA$ expression could differentiate micro- from macro-@DISEASE$ and treated from non-treated patient samples.	0
The serum level of @MiRNA$ strongly correlates with serum ALT activity and with necroinflammatory activity in patients with CHC and elevated ALT levels, but not with @DISEASE$ stage and functional capacity of the live.	1
@MiRNA$ promotes cell proliferation, migration and invasion in @DISEASE$ through repression of PTE.	1
Our research revealed that 136 miRNAs were expressing at 6 h post @MiRNA$, in which 13 miRNAs were more than 2-fold up-regulated, and 14 miRNAs were more than 2-fold down-regulated; 118 miRNAs were expressing at 24 h post injury, in which 4 @DISEASE$ were more than 2-fold up-regulated, and 23 miRNAs were more than 2-fold down-regulated; 149 miRNAs were expressing at 48 h post injury, in which 16 miRNAs were more than 2-fold up-regulated, and 11 miRNAs were more than 2-fold down-regulated; and 203 miRNAs were expressing at 72 h post injury, in which 19 miRNAs were more than 2-fold up-regulated, and 5 miRNAs were more than 2-fold down-regulated.	0
Furthermore, we show that @MiRNA$ specifically targets the mRNA of @DISEASE$ (MEF2C), a transcription factor crucial for neuronal function, and reduces its expression.	1
Taken together, induction of @MiRNA$ expression in BMC may contribute to the aberrant systemic decline in mRNA levels in @DISEASE$.	0
Thus repression of miRNAs constitutes a second, indirect mechanism by which REST can alter the neuronal transcriptome in H@MiRNA$.	0
These results indicate that @MiRNA$ are differentially expressed in C. elegans @DISEASE$ models and suggest a role for these molecules in disease pathogenesis.	1
To investigate this possibility we compared the expression of 264 human @MiRNA$ from postmortem prefrontal cortex tissue of individuals with schizophrenia (n = 13) or @DISEASE$ (n = 2) to tissue of 21 psychiatrically unaffected individuals using a custom miRNA microarray.	0
We used a highly sensitive quantitative PCR assay to measure specific miRNAs (@MiRNA$, miR-133a, and miR-124) in plasma samples from rats treated with liver or muscle toxicants and from a rat surgical model of @DISEASE$.	0
The mRNA expression of the RNases @MiRNA$ and Dicer, cofactor Pasha, and the pre-@DISEASE$ transporter exportin-5, which modulate miRNA biogenesis, were not altered after transient middle cerebral artery occlusion.	0
Delta-tocotrienol suppresses Notch-1 pathway by up-regulating @MiRNA$ in @DISEASE$ cells.	1
@MiRNA$ up to five-fold down-regulated in @DISEASE$ compared to normal liver parenchym.	1
The results show the possible use of blood miRNAs as biomarkers for brain injury; that selected blood @MiRNA$ may correlate with miRNA changes in the brain; and that many of the mRNAs, previously shown to be regulated in brain and blood after @DISEASE$, are likely accounted for by changes in miRNA expression.	0
We hypothesized that @MiRNA$ and TFs might play combinatory regulatory roles for schizophrenia genes and, thus, explored miRNA-TF regulatory networks in @DISEASE$.	0
It has been demonstrated that in @MiRNA$ multiforme miR-21 and 221 are upregulated whereas @DISEASE$ are downregulated.	1
@MiRNA$ inhibits cell proliferation and is down-regulated in @DISEASE$.	1
The analysis of both glioblastoma tissues and glioblastoma cell lines allowed us to identify a group of @MiRNA$ whose expression is significantly altered in this @DISEASE$.	1
Of the 108 @MiRNA$ identified in healthy volunteer plasma, 52 were altered after severe @DISEASE$, including 33 with decreased and 19 with increased relative abundance.	0
@MiRNA$ may serve as an efficient biomarker for diagnosis and novel prognostic indicator in @DISEASE$.	1
A specific subset of five @MiRNA$ revealed by in silico target prediction was significantly overexpressed in NFA samples; three miRs (miR-128a, miR-155, and miR-516a-3p) targeted the 3'-untranslated region of the @DISEASE$ transcript, and exogenous overexpression of these miRs inhibited Wee1 protein expression and HeLa cell proliferation.	0
While the exact role of the patient-specific miRNA variants within the 3' UTR region of APP and @MiRNA$ demands further analyses, this study does not support a major contribution of @DISEASE$ genetic variability to AD pathogenesis.	0
Lin28 Mediates Paclitaxel Resistance by Modulating p21, Rb and Let-7a @MiRNA$ in @DISEASE$ Cells.	1
@MiRNA$ aberrantly expressed in a double transgenic mouse model for @DISEASE$ targets TGF-β type II receptor.	1
The present study demonstrates that blood samples can be used as a source of @MiRNA$ identification associated to Parkinson's disease (@DISEASE$ ).	0
@MiRNA$ negatively regulates expression of the @DISEASE$ associated calmodulin and Mef2a gene.	1
This reveals a previously unrecognized signaling cascade involved in @MiRNA$ development and highlights a novel molecular interaction between @DISEASE$ and Wnt signaling, thereby providing insights into novel therapies for meningiomas.	0
Plasma @MiRNA$ 499 as a biomarker of acute @DISEASE$.	1
Overall, these data point to previously unrecognized alterations in @MiRNA$ profile in the brain during @DISEASE$, which contribute to cell death through dysregulation of cell death machinery.	0
@MiRNA$ promotes @DISEASE$ proliferation by negatively regulating the pro-apoptotic gene EGR.	1
Taken together, our findings suggest that neuronal @MiRNA$ deregulation in response to an insult by Abeta may be an important factor contributing to the cascade of events leading to @DISEASE$.	1
Brain cells maintain distinct populations of miRNAs that support physiologically normal patterns of expression, however, certain @MiRNA$ abundances are significantly altered in @DISEASE$ such as Alzheimer's disease (AD).	1
Knockdown of @MiRNA$ in cultured @DISEASE$ cells triggers activation of caspases and leads to increased apoptotic cell death.	0
@MiRNA$ sensitizes HCC @DISEASE$ cells to adriamycin and vincristine through modulating expression of MDR and inducing cell cycle arrest.	1
Unsupervised clustering analysis further revealed the great potential of the 7-@MiRNA$ profile to differentiate between @DISEASE$ and normal brain tissues.	0
Attenuated adenosine-to-inosine editing of @MiRNA$ promotes invasiveness of @DISEASE$ cell.	1
Serum @MiRNA$ as a novel biomarker for molecular diagnosis of @DISEASE$.	1
@MiRNA$ Represses Cell Proliferationand Regulates Cyclin D1 in @DISEASE$.	1
Recent evidence suggest that microRNA (miRNA) pathways, implicated in gene transcriptional control, could b@MiRNA$ ed in the development of sporadic Alzheimer's disease (AD@DISEASE$.	0
@MiRNA$ downregulated in @DISEASE$ (Iorio et al., 2005).	1
These data provide evidence for miRNA function in @MiRNA$ and emphasize the potential role of @DISEASE$ -based regulatory mechanisms in adult neurons and neurodegenerative states.	0
Camptothecin Induces Apoptosis in @DISEASE$ Cells via @MiRNA$ Mediated Mitochondrial Pathways.	1
@MiRNA$ Inhibits @DISEASE$ Cells EMT by Targeting FOXM1.	1
The specific modulation of several @MiRNA$ has been recently associated to some forms of human @DISEASE$, suggesting that these short molecules may represent a new class of genes involved in oncogenesis.	0
Recent studies have identified changes of several specific miRNA expression profiles and polymorphisms affecting the interactions between @MiRNA$ and their targets in various @DISEASE$, including addiction: miR-16 causes adaptive changes in production of the serotonin transporter; miR-133b is specifically expressed in midbrain dopaminergic neurons, and regulates the production of tyrosine hydroxylase and the dopamine transporter; miR-212 affects production of striatal brain-derived neurotrophic factor and synaptic plasticity upon cocaine.	0
The mRNA expression of the RNases @MiRNA$ and Dicer, cofactor Pasha, and the pre-miRNA transporter exportin-5, which modulate @DISEASE$ biogenesis, were not altered after transient middle cerebral artery occlusion.	1
@MiRNA$ suppresses uveal @DISEASE$ cell migration and invasion through the NF-kB1 pathway.	1
Distinctive @MiRNA$ signature of @DISEASE$ associated with the WNT signaling pathway.	0
We show new data from cultured H4 @MiRNA$ cells that demonstrate similarities in mRNAs targeted by @DISEASE$ and miR-103 and also support the importance of the mature miRNAs' 5' seed region in mRNA target recognition.	0
Re-expression of @MiRNA$ contributes to migration and invasion by inducing epithelial-mesenchymal transition consistent with @DISEASE$ stem cell characteristics in MCF-7 cells.	1
Interaction of @MiRNA$ and glioma suppressor LRRC4 is involved in @DISEASE$ growth.	1
@MiRNA$ downregulates @DISEASE$ amyloid-beta production by targeting BACE1.	1
The bifunctional microRNA miR-9/@MiRNA$ * regulates REST and CoREST and is downregulated in @DISEASE$.	1
@MiRNA$ controls migration and invasive potential by targeting TGFϫ in @DISEASE$ cell line.	1
Downregulation of @MiRNA$ is an independent prognostic factor in patients with @DISEASE$.	1
@MiRNA$ is frequently down-regulated in @DISEASE$ (DCIS) of breast and acts as a tumor suppressor by inhibiting cell proliferatio.	1
@MiRNA$ downregulation has in vivo significance in @DISEASE$ and improves disease risk stratificatio.	1
METHODS: We screened the expression profile of 200 @MiRNA$ in a training sample set consisting of 84 @DISEASE$ samples and 20 normal adjacent tissue (NAT) samples using the method of stem-loop quantitative RT-PCR.	0
Pathogenic LRRK2 antagonizes these @MiRNA$, leading to the overproduction of @DISEASE$ /DP, previously implicated in cell cycle and survival control and shown here to be critical for LRRK2 pathogenesis.	0
The mRNA expression of the RNases Drosha and @MiRNA$, cofactor Pasha, and the pre-miRNA transporter exportin-5, which modulate @DISEASE$ biogenesis, were not altered after transient middle cerebral artery occlusion.	1
Joint genome-wide profiling of @MiRNA$ and mRNA expression in @DISEASE$ cortex reveals altered miRNA regulation.	1
CONCLUSIONS: @MiRNA$ are differentially expressed between pediatric CNS @DISEASE$ and normal tissue suggesting that they may play a significant role in oncogenesis.	0
CAMTA1 is a novel tumour suppressor regulated by @MiRNA$ *) in @DISEASE$ stem cells.	1
To understand the role of miRNAs in the molecular mechanisms of temporal lobe epilepsy (@MiRNA$ ), we investigated the changes in microRNA (@DISEASE$ ) expression profiles of chronic TLE rat models.	0
Using transiently transfected murine neuronal N2a cells in culture, in parallel to a mouse model of AD, we were able to demonstrate a role for two miRNAs (miR-298 and @MiRNA$ ) in the regulation of beta-amyloid (Abeta) precursor protein (APP)-converting enzyme (BACE) messenger RNA (mRNA) translation, thereby providing key insights into the molecular basis underlying BACE deregulation in @DISEASE$.	0
@MiRNA$ modulates multidrug resistance in human @DISEASE$ by down-regulating ADAM-17.	1
Attenuation of dexamethasone-induced cell death in @DISEASE$ is mediated by @MiRNA$ expression.	1
@MiRNA$ is processed from the keratin 19 gene and up-regulated in metastatic @DISEASE$.	1
@MiRNA$ targets the p300/CBP-associated factor and modulates androgen receptor transcriptional activity in cultured @DISEASE$ cell.	1
We show that miRNAs belonging to the miR-20a family (that is, miR-20a, miR-17-5p and @MiRNA$ ) could regulate @DISEASE$ expression in vitro and at the endogenous level in neuronal cell lines.	1
Epigenetic Changes Mediated by @MiRNA$ Activate Cyclooxygenase-2 and Interferon-λ1 Production during @DISEASE$.	1
OBJECTIVE: To analyze the interaction between the @MiRNA$ and its targeting proteins during the @DISEASE$ and reperfusion injury.	0
@MiRNA$ inhibits cell migration and invasion by targeting matrix metalloproteinase 13 in @DISEASE$.	1
@MiRNA$ enhances @DISEASE$ progression via down regulation of neurofibromin.	1
Since its identification 3 years ago as the miRNA most commonly and strongly up-regulated in human @MiRNA$ [1], miR-21 has attracted the attention of researchers in various fields, such as development, oncology, stem cell biology and aging, becoming one of the most studied miRNAs, along with let-7, miR-17-92 cluster ('oncomir-1'), @DISEASE$ and a few others.	0
Since its identification 3 years ago as the miRNA most commonly and strongly up-regulated in human @MiRNA$ [1], miR-21 has attracted the attention of researchers in various fields, such as development, oncology, stem cell biology and aging, becoming one of the most studied miRNAs, along with let-7, @DISEASE$ cluster ('oncomir-1'), miR-155 and a few others.	0
BACKGROUND: Through negative regulation of gene expression, @MiRNA$ (miRNAs) can function in @DISEASE$ as oncosuppressors, and they can show altered expression in various tumor types.	0
KDM5B histone demethylase controls epithelial-mesenchymal transition of @DISEASE$ cells by regulating the expression of the @MiRNA$.	1
In addition, components required for miRNA processing and/or function have also been implicated in @MiRNA$, neurological and neoplastic diseases, pointing to the wide ranging involvement of @DISEASE$ in disease.	0
Analysis of human MBs demonstrated that 3 miR-17 approximately 92 cluster miRNAs (miR-92, miR-19a, and @MiRNA$ ) were also overexpressed in human MBs with a constitutively activated @DISEASE$ (SHH) signaling pathway, but not in other forms of the disease.	0
Aberrant @MiRNA$ expression in the brains of neurodegenerative diseases: miR-29a decreased in @DISEASE$ brains targets neurone navigator.	0
Reduced @MiRNA$ in @DISEASE$ initiating cells induces chemotherapeutic resistance via Bmi-1 and ABCC5.	1
SP1 mediates the link between methylation of the tumour suppressor @MiRNA$ and outcome in @DISEASE$.	1
@MiRNA$ overexpression might confer @DISEASE$ stem cells resistance to TMZ.	1
APP and BACE1 @MiRNA$ genetic variability has no major role in risk for @DISEASE$.	0
Time-course assays of neuronal @MiRNA$ treatments show that Abeta is in fact a powerful regulator of @DISEASE$ levels as the response of certain mature miRNAs is extremely rapid.	0
The family of @MiRNA$ and miR-65 are co-underexpressed in the alpha-synuclein transgenic and cat-1 strains, and members of let-7 family co-underexpressed in the alpha-synuclein and pdr-1 strains; @DISEASE$ and ptc-1 genes are target candidates for miR-64 and miR-65 and are overexpressed in alpha-synuclein transgenic as well as miR-64/65 (tm3711) knockout animals.	0
Synergistic induction of @MiRNA$ by @DISEASE$ and HDAC inhibitors in cardiac myocyte.	1
@MiRNA$ Susceptibility @DISEASE$ in Chines.	1
@MiRNA$ dysregulates the expression of @DISEASE$ in neurons in monkey and human SIV/HIV neurological disease.	1
A few @MiRNA$ were differentially expressed in WM, including miR-212 that is downregulated in AD and miR-424 which is upregulated in @DISEASE$.	0
The results show the possible use of blood miRNAs as biomarkers for brain injury; that selected blood miRNAs may correlate with miRNA changes in the brain; and that many of the mRNAs, previously shown to be regulated in brain and blood after @MiRNA$, are likely accounted for by changes in @DISEASE$ expression.	0
Circulatory @MiRNA$ expression is increased in @DISEASE$.	1
@MiRNA$ Is a Candidate Oncogene that Targets the Homeobox Gene Gax in Human @DISEASE$.	1
@MiRNA$ was also up-regulated in @DISEASE$ compared to ACTH adenomas.	0
Epigenetic Silencing of @MiRNA$ Regulates PDK1 Expression in @DISEASE$.	1
@MiRNA$ associated with aggressiveness of lymph node-negative, estrogen receptor-positive human @DISEASE$.	1
The noncoding RNA, @MiRNA$ suppresses the growth of neoplastic cells by targeting phosphatidylinositol 3-kinase signaling and is frequently lost in @DISEASE$.	1
Identification of @MiRNA$ as a novel prognostic maker @DISEASE$.	1
In a well-characterized Belgian group of 358 AD patients and 462 controls, we examined whether genetic variability in @MiRNA$ (miRNA) binding sites of APP and BACE1 or in associated miRNAs influenced risk for @DISEASE$.	0
We examined whether plasma concentrations of brain-specific @MiRNA$ can serve as a biomarker for cerebral infarction, where the @DISEASE$ was modeled by middle cerebral artery occlusion (MCAO) in the rat.	0
RESULT: @MiRNA$ was the most likely potential targeting protein of @DISEASE$.	1
MicroRNA expression signature and antisense-mediated depletion reveal an essential role of @MiRNA$ in @DISEASE$ formation.	0
We found that 26 miRNAs showed increased expression and 24 @MiRNA$ showed decreased expression in proliferating mouse GNPs and @DISEASE$ relative to mature mouse cerebellum, regardless of genotype.	1
Epithelial-mesenchymal transition, a novel target of sulforaphane via COX-2/MMP2,9/Snail, ZEB1 and @MiRNA$ ZEB1 pathways in human @DISEASE$ cell.	1
The potential biologic significance of this regulation is supported by evidence of an apparent negative feedback loop, with increased expression of three @MiRNA$ -regulating @DISEASE$ by primate macrophages exposed to recombinant IFN-beta or stimulated to produce IFN-beta.	1
To test whether the miR-17 approximately 92 cluster could promote @MiRNA$ formation, we enforced expression of these @DISEASE$ in GNPs isolated from cerebella of postnatal (P) day P6 Ink4c-/-; Ptch1+/- mice.	0
@MiRNA$ in circulating monocytes is a potential biomarker for @DISEASE$.	1
We used microarray technology to identify @MiRNA$ that were upregulated by @DISEASE$ (NSCLC) A549 cells in response to cisplatin (CDDP).	0
Arsenic trioxide induced apoptosis in @DISEASE$ cells by abnormal expression of @MiRNA$.	1
@MiRNA$ regulates p53/Akt signalling and the chemotherapy-induced apoptosis in @DISEASE$.	1
Increased anti-leukemic activity of decitabine via AR-42-induced upregulation of @MiRNA$ a novel epigenetic-targeting approach in @DISEASE$.	1
@MiRNA$ suppresses proliferation and cell cycle progression of endometrioid ndometrial @DISEASE$ via negatively regulating cyclin D1.	1
These data suggest a significantly independent regulation of IRAK-1 and IRAK-2 in AD and in @MiRNA$ β+Aβ42 peptide-stressed HAG cells and that an inducible, NF-κB-sensitive, @DISEASE$ -mediated down-regulation of IRAK-1 coupled to an NF-κB-induced up-regulation of IRAK-2 expression drives an extensively sustained inflammatory response.	0
There were no differences between miRNA expression and @MiRNA$ size as well as miRNA expression and ratio of remission after surgery, except in patients presenting lower @DISEASE$ expression who showed a better chance of remission.	0
MiR-107 is a microRNA (@MiRNA$ ) that we reported previously to have decreased expression in the temporal cortical gray matter early in the progression of Alzheimer's disease (@DISEASE$ ).	1
@MiRNA$ has a critical role in promoting growth and survival of bona fide @DISEASE$ initiating cells with self-renewal potential.	1
@DISEASE$ cell invasiveness is regulated by @MiRNA$ suppression of the BRN2 transcription factor.	1
@MiRNA$ suppresses the invasive-metastatic cascade in @DISEASE$.	1
Like other types of cancer, the brain tumor @MiRNA$ shows a distinct miRNA expression signature, and a number of recent studies have linked these @DISEASE$ alterations to key hallmarks of glioblastoma including proliferation, survival, invasion, angiogenesis and stem cell-like behavior.	0
These results show that TβR II is a functional target of miR-106b and that @MiRNA$ may influence @DISEASE$ signaling, thereby contributing to the pathogenesis of AD.	0
Signal Transducer and Activator of Transcription-3 Induces @MiRNA$ Expression in @DISEASE$.	1
@MiRNA$ and miRPlus-E1245 observed to be specific to XMRV @DISEASE$ in all 4 cell types (Two prostate cell lines (LNCaP and DU145) and two primary cells).	1
BACKGROUND: The purpose of this study was to (1) identify specific @MiRNA$ in growth hormones (GH)-secreting pituitary adenomas; (2) determine the relationship between the expression of these miRNAs and @DISEASE$ size, somatostatin analogs treatment, and responsiveness to somatostatin analogs (SSA).	0
Our results showed that the expression of miR-106b was inversely correlated with TβR II protein levels and @MiRNA$ can directly inhibit the @DISEASE$ translation in vitro.	1
Here, we investigated the possibility that IFN-beta may induce or downregulate cellular microRNAs (@MiRNA$ ) in human @DISEASE$ and thereby use the RNA interference system to show antitumor effects.	0
Loss of @MiRNA$ expression is associated with @DISEASE$ progression.	1
Lipid-based Nanoparticle Delivery of @MiRNA$ Inhibits the Tumorigenicity of Head and Neck @DISEASE$.	1
@MiRNA$ negatively regulates survivin protein expression and inhibits the proliferation and invasion @DISEASE$ cell.	1
The present study provides an initial survey of @MiRNA$ expression in pediatric central nervous system (CNS) malignancies including atypical teratoid/rhabdoid tumor, ependymoma, glioblastoma, @DISEASE$, and pilocytic astrocytoma.	0
@MiRNA$ over-expression blocks expression of several cancer stem-cell genes, impairs the engrafting potential of @DISEASE$ cells in the cerebellum of athymic/nude mice, and of particular interest, decreases the MB stem-cell-like (CD133+) subpopulation of cells.	0
rs1434536 in the 3'UTR of BMPR1B gene affects the binding ability of @MiRNA$ to BMPR1B mRNA and contributes to the genetic hspredisposition to localized @DISEASE$ and patients aged >70years.	1
The @MiRNA$ expression in @DISEASE$ cells could be a prognostic factor in ALL patient.	1
Increased circulating @MiRNA$ is a potential biomarker for patients with malignant pleural @DISEASE$.	1
Since abnormal neuronal splicing of @MiRNA$ affects β-amyloid peptide production, these results could contribute to the understanding of the implication of @DISEASE$ in brain health and disease.	0
To address whether miRNA pathways play a role in neurodegeneration, we tested whether genes critical for @MiRNA$ processing modulated toxicity induced by the spinocerebellar ataxia type 3 (@DISEASE$ ) protein.	0
Infection with @MiRNA$ cells in an induced xenograft model in the mouse cerebellum and the use of an adenovirus carrying @DISEASE$ indicate a clinical benefit through this negative influence of miR-199b-5p on tumor growth and on the subset of MB stem-cell-like cells, providing further proof of concept.	0
Analysis of genes that @MiRNA$ interacts with included LGALS3 and RUNX2 ( http://microrna.sanger.ac.uk ) both of which have been shown to have roles in @DISEASE$ cell growth.	0
@MiRNA$ was also up-regulated in carcinomas compared to @DISEASE$ adenomas.	0
In addition, pre-@MiRNA$ blocked early manifestations of the DNA damage response, including the phosphorylation of the ataxia-telangiectasia mutated (ATM) kinase and of two ATM substrates, histone @DISEASE$ and p53.	1
Elevated levels of circulating @MiRNA$ members correlate with serous epithelial @DISEASE$.	1
Similar results were obtained by depletion of endogenous polypyrimidine tract binding protein 1 (@MiRNA$ ) in cells, a recognized @DISEASE$ target gene.	1
Downregulated @MiRNA$ in @DISEASE$ promotes tumor growth by reducing E-cadherin and activating the Wnt/beta-catenin signaling pathway.	1
Deregulated expression of @MiRNA$ predicts survival in human @DISEASE$ patients.	1
MicroRNA (@MiRNA$ ), an endogenously expressed form of siRNA, not only presents an alternate method to induce RNAi in a given diseased tissue or organ, but also exposes a unique set of diagnostic markers that can be used to identify, and then differentiate between @DISEASE$ grades.	0
@MiRNA$ SNP rs2910164 contribute to @DISEASE$.	1
PATIENTS AND METHODS We profiled the mRNA transcriptome of 194 @MiRNA$ and performed high-density single nucleotide polymorphism array and @DISEASE$ analysis on 115 and 98 of these, respectively.	0
Subsequently, we identified a large set of @MiRNA$ -mRNA associations that are changed in @DISEASE$ versus control, highlighting AD-specific changes in the miRNA regulatory system.	0
@MiRNA$ is an oncogene targeting Dkk-3 and SMAD4 in @DISEASE$.	1
Here, we transformed rat 9L @MiRNA$ cells to express @DISEASE$, a miRNA that lacks homology in rat.	0
Moreover, LPS stimulation decreased expression of microRNAs (miRNA)--@MiRNA$, miR-20a, and miR-93--which target @DISEASE$, implicating a novel role for miRNAs in NKG2D ligand expression.	1
Both real-time RT-PCR and in situ hybridization showed significant up-regulation of @MiRNA$ between @DISEASE$ and adenomas.	1
Activation of the two @MiRNA$ C19MC and miR-371-3 does not play prominent role in @DISEASE$.	1
Epstein-Barr virus latent membrane protein-1 protects @DISEASE$ from rituximab-induced apoptosis through @MiRNA$ mediated Akt activation and up-regulation of Mcl-1.	1
MicroRNAs (@MiRNA$ ) are known to influence many important cellular processes, including proliferation, apoptosis, neurogenesis, angiogenesis, and morphogenesis, all processes that are involved in @DISEASE$ pathophysiology.	0
G-A variant in @MiRNA$ binding site of EFNA1 alters susceptibility to @DISEASE$.	1
serum;An elevated serum @MiRNA$ level in patients with bone-metastatic @DISEASE$ is correlated with more bone lesion.	1
The downregulation of @MiRNA$ in @DISEASE$ leads to metabolic adaptation of cells to a transformed state.	1
Silvestrol exhibits significant in vivo and in vitro antileukemic activities and inhibits FLT3 and @MiRNA$ expressions in @DISEASE$.	1
Exogenous expression of miR-193a and @MiRNA$, two miRNAs that have the highest WNT pathway specific upregulation, was found to inhibit proliferation, increase radiation sensitivity and reduce anchorage-independent growth of @DISEASE$ cells.	1
Through various experimental approaches, we validated computational predictions and demonstrated that miR-298 and @MiRNA$ recognize specific binding sites in the 3'-UTR of @DISEASE$ mRNA and exert regulatory effects on BACE1 protein expression in cultured neuronal cells.	1
The family of miR-64 and miR-65 are co-underexpressed in the alpha-synuclein transgenic and cat-1 strains, and members of @MiRNA$ family co-underexpressed in the alpha-synuclein and pdr-1 strains; mdl-1 and ptc-1 genes are target candidates for miR-64 and miR-65 and are overexpressed in @DISEASE$ transgenic as well as miR-64/65 (tm3711) knockout animals.	0
@MiRNA$ impairs cancer stem cells through negative regulation of HES1 in @DISEASE$.	1
Perturbation of @MiRNA$ LIN28A-NF-ǊB regulatory circuit contributes to the development of @DISEASE$.	1
@MiRNA$ is down-regulated by the @DISEASE$ B virus x protein and induces aberrant DNA methylation by targeting DNA methyltransferase 3.	1
In this paper, we present for the first time evidence that @MiRNA$ (miRNAs), including miR-26a, -34a, -145, and let-7b, may directly regulate @DISEASE$ in human and macaque cells.	1
@MiRNA$ downregulates NF{kappa}B activity via targeting TRAF6, and functions as a tumor suppressor having strong prognostic implications in NK/@DISEASE$.	1
@MiRNA$ targets a NF-kB up-regulated TrkB/NTF3 autocrine signaling loop to enhance anoikis sensitivity in @DISEASE$.	1
@MiRNA$ miR-133b is essential for functional recovery after @DISEASE$ in adult zebrafish.	0
Our research revealed that 136 miRNAs were expressing at 6 h post injury, in which 13 miRNAs were more than 2-fold up-regulated, and 14 miRNAs were more than 2-fold down-regulated; 118 miRNAs were expressing at 24 h post injury, in which 4 miRNAs were more than 2-fold up-regulated, and 23 miRNAs were more than 2-fold down-regulated; 149 miRNAs were expressing at 48 h post injury, in which 16 miRNAs were more than 2-fold up-regulated, and 11 miRNAs were more than 2-fold down-regulated; and 203 @MiRNA$ were expressing at 72 h post @DISEASE$, in which 19 miRNAs were more than 2-fold up-regulated, and 5 miRNAs were more than 2-fold down-regulated.	0
@MiRNA$ increases the sensitivity @DISEASE$ cells to doxorubicin through the suppression of E-cadherin-mediated PTEN/Akt signalin.	1
Interestingly, one of these, the bifunctional brain enriched miR-9/miR-9*, targets two components of the REST complex: miR-9 targets REST and @MiRNA$ * targets @DISEASE$.	1
@MiRNA$ inhibits migration and invasion of @DISEASE$ cells by targeting the HGF/c-MET pathway.	1
@MiRNA$ (small non-coding RNAs) have been recently reported as useful biomarkers in diseases such as @DISEASE$ and diabetes.	0
@MiRNA$ is a target of the tumor-suppressive @DISEASE$ and regulates the survival of glioma cells.	1
Generated by the @MiRNA$, microRNAs (@DISEASE$ ) are predicted to regulate up to 90% of the genes in humans, suggesting that they may control every cellular processes in all cells and tissues of the human body.	0
@MiRNA$ is down-regulated in @DISEASE$ and regulates cell proliferation and apoptosis.	1
EVI1 oncogene promotes KRAS pathway through suppression of @MiRNA$ in pancreatic @DISEASE$.	1
circulating;The circulating @MiRNA$ may serve as a potential for predictive biomarker in HCV mediated @DISEASE$.	1
@MiRNA$ was significantly over-expressed in psoriatic lesional skin p<0.001) but not in @DISEASE$ lesions when compared with healthy skin.	1
Silencing of @MiRNA$ induces @DISEASE$ SK-N-SH cell differentiation, cell cycle arrest and apoptosis through promoting AHR.	1
The combinatorial use of NF-κB inhibitors with @MiRNA$ or antisense miRNA-146a may have potential as a bi-pronged therapeutic strategy directed against @DISEASE$ -driven pathogenic signaling.	0
@MiRNA$ inhibits @DISEASE$ angiogenesis and growth by N-RAS and VEGF.	1
The bifunctional microRNA miR-9/@MiRNA$ * regulates @DISEASE$ and CoREST and is downregulated in Huntington's disease.	1
miR-181a and @MiRNA$ regulate cisplatin-induced @DISEASE$ cell death.	1
We reveal the relative contribution of each subgroup to clinical outcome as a whole and show that a previously unidentified molecular subgroup, characterized genetically by c-@MiRNA$ copy number gains and transcriptionally by enrichment of photoreceptor pathways and increased @DISEASE$ expression, is associated with significantly lower rates of event-free and overall survivals.	0
@MiRNA$ acts as a tumor suppressor in @DISEASE$ by targeting K-ras and Bcl-2.	1
The ZEB1/@MiRNA$ feedback loop controls Notch signalling in @DISEASE$ cells.	1
The expression of @MiRNA$ in @DISEASE$ has not been previously examined.	0
The family of miR-64 and @MiRNA$ -65 are co-underexpressed in the alpha-synuclein transgenic and cat-1 strains, and members of let-7 family co-underexpressed in the alpha-synuclein and pdr-1 strains; mdl-1 and @DISEASE$ genes are target candidates for miR-64 and miR-65 and are overexpressed in alpha-synuclein transgenic as well as miR-64/65 (tm3711) knockout animals.	0
Antisense Inhibition of @MiRNA$ or -221 Arrests Cell Cycle, Induces Apoptosis, and Sensitizes the Effects of Gemcitabine in Pancreatic @DISEASE$.	1
@MiRNA$ 145 targets the insulin receptor substrate-1 and inhibits the growth @DISEASE$ cells.	1
@MiRNA$ inhibits the proliferation @DISEASE$ cells by targeting Cdc42 and Cdk.	1
Methyl-CpG binding protein MBD2 is implicated in methylation-mediated suppression of @MiRNA$ in @DISEASE$.	1
@MiRNA$ suppresses glucose uptake and proliferation of human @DISEASE$ T24 cells by regulating GLUT3 expression.	1
METHODS AND FINDINGS: To explore the role of miRNAs in @MiRNA$, 59 @DISEASE$ genes on the X-chromosome were amplified and sequenced in males with (193) and without (191) schizophrenia spectrum disorders to test the hypothesis that ultra-rare mutations in microRNA collectively contribute to the risk of schizophrenia.	0
Furthermore, we revealed global up-regulation of @MiRNA$ expression within all the four time points post @DISEASE$.	0
@MiRNA$ inhibits cell proliferation, migration and invasion by targeting epidermal growth factor receptor and its downstream effector proteins in @DISEASE$.	1
Epigenetic silencing of @MiRNA$ and its host gene MEST in @DISEASE$.	1
Moreover, the performance of three algorithms (PicTar, TargetScan and DIANA-microT) is both demonstrated and evaluated by performing an in-depth analysis of @MiRNA$ interactions with mRNAs derived from genes triggering hereditary @DISEASE$ known as trinucleotide repeat expansion diseases (TREDs), such as Huntington's disease (HD), a number of spinocerebellar ataxias (SCAs), and myotonic dystrophy type 1 (DM1).	0
miR-15a and @MiRNA$ in @DISEASE$ : discovery, function and future perspectives.	0
Furthermore, let-7e and @MiRNA$ analysis in rat hippocampus were performed by real-time quantitative polymerase chain reaction at 0h, 1h, 6h, 12h, 24h, 2days, 7days,10days, 30days,50days after induction of @DISEASE$ (SE).	0
@MiRNA$ upregulates HIF-1a by targeting isocitrate dehydrogenase 2 (IDH2) in @DISEASE$ cell.	1
Here, we discuss some of the limitations associated to the interpretation and applicability of @MiRNA$ data, based on our recent study on the etiology of @DISEASE$ (AD).	0
Our study dissects the complexity of human AD pathology, and addresses the hypothesis that amyloid-beta (Abeta) itself, a known causative factor of @MiRNA$, causes neuronal @DISEASE$ deregulation, which could contribute to the pathomechanisms of AD.	0
Altogether, these results identify miR-181a and @MiRNA$ as novel modulators of the CDDP response in @DISEASE$.	1
@MiRNA$ promotes @DISEASE$ in vitro through the modulation of p27 expression.	1
@MiRNA$ : overexpressed in malignant @DISEASE$ than non-malignant on.	1
Utilizing human cell lines, we demonstrate that @MiRNA$ hsa-mir-106a and hsa-mir-520c bind to their predicted target sequences in the @DISEASE$ 3'UTR and negatively regulate reporter gene expression.	1
@MiRNA$ modulates chemosensitivity @DISEASE$ cells to adriamycin by targeting Notch.	1
Inhibition of @MiRNA$ expression reduces cell proliferation and clonogenicity of HepG2 @DISEASE$ cell.	1
@MiRNA$ functions downstream of NFATc3 to regulate @DISEASE$.	1
Using transiently transfected murine neuronal N2a cells in culture, in parallel to a mouse model of @MiRNA$, we were able to demonstrate a role for two miRNAs (miR-298 and @DISEASE$ ) in the regulation of beta-amyloid (Abeta) precursor protein (APP)-converting enzyme (BACE) messenger RNA (mRNA) translation, thereby providing key insights into the molecular basis underlying BACE deregulation in AD.	0
Expression of @MiRNA$ in @DISEASE$ is upregulated by Epstein-Barr virus latent membrane protein 1.	1
@MiRNA$ and BACE1 @DISEASE$ genetic variability has no major role in risk for Alzheimer disease.	0
The family of miR-64 and miR-65 are co-underexpressed in the alpha-synuclein transgenic and cat-1 strains, and members of @MiRNA$ family co-underexpressed in the @DISEASE$ and pdr-1 strains; mdl-1 and ptc-1 genes are target candidates for miR-64 and miR-65 and are overexpressed in alpha-synuclein transgenic as well as miR-64/65 (tm3711) knockout animals.	1
@MiRNA$ is a key promoter of cervical @DISEASE$ development through the activation of the ERK and AKT1 pathways.	1
OVER EXPRESSION OF @MiRNA$ 155 AND 21 TARGETING MISMATCH REPAIR PROTEINS IN @DISEASE$.	1
Decreased @MiRNA$ Expression in Ocular Behcet's Disease but Not in @DISEASE$.	1
De-repression of CTGF via the @MiRNA$ upon differentiation of human @DISEASE$ spheroid culture.	1
We therefore investigated changes in microRNA (@MiRNA$ ) expression profiles of sporadic AD patients and found that several miRNAs potentially involved in the regulation of APP and @DISEASE$ expression appeared to be decreased in diseased brain.	0
We did reporter assays to elucidate the IFN-beta-mediated suppression of @MiRNA$ ; the addition of signal transducers and activators of transcription 3 (@DISEASE$ )-expressing vectors induced the IFN-beta-mediated suppression of miR-21, whereas STAT3-inhibiting agents inhibited the miR-21 suppression.	0
Here we provide the first association of @MiRNA$ gene dysfunction with @DISEASE$.	0
Moreover, the performance of three algorithms (PicTar, TargetScan and DIANA-microT) is both demonstrated and evaluated by performing an in-depth analysis of @MiRNA$ interactions with mRNAs derived from genes triggering hereditary neurological disorders known as trinucleotide repeat expansion diseases (TREDs), such as Huntington's disease (HD), a number of spinocerebellar ataxias (@DISEASE$ ), and myotonic dystrophy type 1 (DM1).	0
This novel, cell type-specific in vivo system for reducing gene expression uses a bacterial artificial chromosome (BAC) containing the @MiRNA$ promoter-enhancer elements, the reporter molecule (eGFP) and a modified intron containing a synthetic @DISEASE$ (miRNA) targeted to GAD1.	0
@MiRNA$ expression is decreased inTPA-induced differentiation of human promyelocytic @DISEASE$ cells.	1
To search for miRNAs that may be involved in the pathogenesis of Parkinsons disease (PD), we utilized miRNA microarrays to identify potential gene expression changes in 115 annotated @MiRNA$ in PD-associated Caenorhabditis elegans models that either overexpress human @DISEASE$ or have mutations within the vesicular catecholamine transporter (cat-1) or parkin (pdr-1) ortholog.	0
However, with the exception of @MiRNA$, the expression of @DISEASE$ in brain tumors is unknown.	0
A strong positive correlation between @MiRNA$ abundance and the glial cell markers glial fibrillary acidic protein (@DISEASE$ ) and vimentin, and CDKN2A down-regulation was noted in advanced Alzheimer's disease (AD) and in Down's syndrome (DS) brain, chronic neurological disorders associated with astrogliosis.	1
This review reports the current knowledge of @MiRNA$ (miRNA) expression in @DISEASE$, focusing on recent microarray data.	0
Loss of @MiRNA$ Expression Enhances @DISEASE$ Migration and Stem Cell-like Phenotyp.	1
Subsequently, we identified a large set of @MiRNA$ -mRNA associations that are changed in AD versus control, highlighting @DISEASE$ -specific changes in the miRNA regulatory system.	0
These findings suggested that @MiRNA$ is an important functional target for @DISEASE$, and the abnormal expression of miR-34a may contribute to the pathogenesis of Alzheimer's disease, at least in part by affecting the expression of bcl2.	1
In a well-characterized Belgian group of 358 AD patients and 462 controls, we examined whether genetic variability in microRNA (@MiRNA$ ) binding sites of @DISEASE$ and BACE1 or in associated miRNAs influenced risk for A.	0
@MiRNA$ directly regulates the tumor suppressor, interleukin-24, in human KB @DISEASE$ cell.	1
Involvement of IGF-1R regulation by @MiRNA$ modifies @DISEASE$ risk among BRCA1 carrier.	1
Here we found that @MiRNA$ and @DISEASE$ (TβR II) were aberrantly expressed in APPswe/PS∆E9 mice (a double transgenic mouse model for AD).	1
Our research revealed that 136 miRNAs were expressing at 6 h post @MiRNA$, in which 13 miRNAs were more than 2-fold up-regulated, and 14 miRNAs were more than 2-fold down-regulated; 118 miRNAs were expressing at 24 h post injury, in which 4 miRNAs were more than 2-fold up-regulated, and 23 miRNAs were more than 2-fold down-regulated; 149 miRNAs were expressing at 48 h post injury, in which 16 miRNAs were more than 2-fold up-regulated, and 11 miRNAs were more than 2-fold down-regulated; and 203 @DISEASE$ were expressing at 72 h post injury, in which 19 miRNAs were more than 2-fold up-regulated, and 5 miRNAs were more than 2-fold down-regulated.	0
@MiRNA$ inhibits proliferation by targeting PTGS2 in @DISEASE$.	1
Genome-wide screening revealed that @MiRNA$ targets the TNF-alpha/NF-kB pathway by downregulating IKK and TAB3 in @DISEASE$.	1
Detection of the expression level of @MiRNA$ using realtime fluorescent quantitative PCR in knee synovial fluid of @DISEASE$ patient.	1
@MiRNA$ suppresses proliferation, invasion, migration, and tumorigenicity of human @DISEASE$ cells through targeting androgen recepto.	1
Novel animal models for studying complex @MiRNA$ : BAC-driven @DISEASE$ -mediated in vivo silencing of gene expression.	0
Moreover, 24 miRNAs were identified as a predictive signature of pituitary adenoma and 29 @MiRNA$ were able to predict @DISEASE$ histotype.	0
Decreased serum @MiRNA$ is a potential new tool for @DISEASE$ screening.	1
A tight correlation between these @MiRNA$ and @DISEASE$ was found during brain development and in differentiating neurons.	0
The mRNA expression of the RNases Drosha and Dicer, cofactor Pasha, and the pre-miRNA transporter exportin-5, which modulate @MiRNA$ biogenesis, were not altered after transient middle @DISEASE$.	0
@MiRNA$ (small non-coding RNAs) have been recently reported as useful biomarkers in diseases such as cancer and @DISEASE$.	0
A strong positive correlation between @MiRNA$ abundance and the glial cell markers glial fibrillary acidic protein (GFAP) and @DISEASE$, and CDKN2A down-regulation was noted in advanced Alzheimer's disease (AD) and in Down's syndrome (DS) brain, chronic neurological disorders associated with astrogliosis.	1
Utilizing human cell lines, we demonstrate that miRNAs @MiRNA$ and hsa-mir-520c bind to their predicted target sequences in the @DISEASE$ 3'UTR and negatively regulate reporter gene expression.	1
@MiRNA$ modulates androgen receptor transcriptional activity in human @DISEASE$ cells through targeting the small heterodimer partner protein.	1
@MiRNA$ induces stemness by downregulating transforming growth factor beta receptor 2 (TGFbetaR2) in @DISEASE$ cells.	1
@MiRNA$ Regulates Vascular Smooth Muscle Cell Function via Targeting Tropomyosin 1 in @DISEASE$ of Lower Extremities.	1
We further demonstrate that @MiRNA$ can regulate @DISEASE$ expression in vitro, with miR-659 binding more efficiently to the high risk T-allele of rs5848 resulting in augmented translational inhibition of GRN.	1
Aberrant gene expression is the main mechanism of miRNAs dysfunction in @MiRNA$, with abnormal expression levels of mature and/or precursor @DISEASE$ expression in tumor samples versus normal.	0
@MiRNA$ ablates expression of the HIF regulatory factor FIH to activate the HIF pathway in @DISEASE$.	1
The PTEN-regulating microRNA @MiRNA$ is amplified in high-grade @DISEASE$ and facilitates gliomagenesis in vivo.	1
Recently, differential expression of endogenous regulatory small RNAs, known as '@MiRNA$ ' (miRNAs), in patients of Alzheimer's disease, Parkinson's disease and models of @DISEASE$ suggest that they might have key regulatory roles in neurodegeneration.	0
Infection with MB cells in an induced xenograft model in the mouse cerebellum and the use of an adenovirus carrying @MiRNA$ indicate a clinical benefit through this negative influence of miR-199b-5p on tumor growth and on the subset of @DISEASE$ stem-cell-like cells, providing further proof of concept.	0
We demonstrate that the heavy neurofilament subunit is a target of miR-9, a @MiRNA$ that is specifically down-regulated in a genetic model of @DISEASE$.	1
Increased serum levels of @MiRNA$ in patients with @DISEASE$ vulgaris.	1
@MiRNA$ inhibition @DISEASE$ cell migration and invasion through targeting of oncoprotein c-Me.	1
Compared with normal rats (control group), 23 of the 125 @MiRNA$ were expressed differentially in @DISEASE$ rats including 5 down-regulated miRNAs (let-7e included) and 18 up-regulated miRNAs (miR-23a/b included).	1
@MiRNA$ inhibits the growth of human @DISEASE$ A549 cells through targeting BCL-2.	1
Blockade of @MiRNA$ maturation by MLL-fusion/MYC/LIN-28 is required for MLL-associated @DISEASE$.	1
Down-regulation of KRAS-interacting @MiRNA$ predicts poor prognosis but not response to EGFR-targeted agents in @DISEASE$.	1
tissue-specific @MiRNA$ may serve as diagnostically sensitive plasma biomarkers of tissue @DISEASE$.	1
To search for miRNAs that may be involved in the pathogenesis of Parkinsons disease (@MiRNA$ ), we utilized @DISEASE$ microarrays to identify potential gene expression changes in 115 annotated miRNAs in PD-associated Caenorhabditis elegans models that either overexpress human A53T alpha-synuclein or have mutations within the vesicular catecholamine transporter (cat-1) or parkin (pdr-1) ortholog.	0
@MiRNA$ Inhibits Peritoneal Dissemination of @DISEASE$ Cells by Inhibiting Integrin ϫ5 Expression.	1
Abnormal @MiRNA$ Expression Promotes Aberrant Glycosylation of IgA1 in @DISEASE$.	1
@MiRNA$ downregulates CDX2 expression in @DISEASE$ cells.	1
@MiRNA$ -mediated down-regulation of @DISEASE$ was verified by the luciferase reporter assay.	1
Regulation of expression of deoxyhypusine hydroxylase (DOHH), the enzyme that catalyzes the activation of eIF5A, by @MiRNA$ and miR-642-5p in @DISEASE$ cells.	1
@MiRNA$ is a direct calcineurin/NFAT target gene that increases in expression in mouse and human @DISEASE$ and targets the nuclear NFAT kinase dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1a (Dyrk1a.	1
Our research revealed that 136 miRNAs were expressing at 6 h post @MiRNA$, in which 13 miRNAs were more than 2-fold up-regulated, and 14 miRNAs were more than 2-fold down-regulated; 118 miRNAs were expressing at 24 h post injury, in which 4 miRNAs were more than 2-fold up-regulated, and 23 miRNAs were more than 2-fold down-regulated; 149 miRNAs were expressing at 48 h post injury, in which 16 miRNAs were more than 2-fold up-regulated, and 11 miRNAs were more than 2-fold down-regulated; and 203 miRNAs were expressing at 72 h post injury, in which 19 miRNAs were more than 2-fold up-regulated, and 5 @DISEASE$ were more than 2-fold down-regulated.	0
Methylation of @MiRNA$ is a specific and sensitive biomarker for oral and oropharyngeal @DISEASE$.	1
Increased @MiRNA$ expression in @DISEASE$ tissues and its role in enhancing cell growth and inhibiting apoptosis in vitr.	1
However, only a few studies to date have focused on the role of @MiRNA$ in medulloblastoma, the most common malignant pediatric @DISEASE$.	0
Genetic deletion of @MiRNA$, antagomir-mediated blockage of let-7 and miR-184* action, transgenic expression of dp target protector, or replacement of endogenous dp with a dp transgene non-responsive to let-7 each had toxic effects similar to those of pathogenic @DISEASE$.	0
@MiRNA$ acts as a tumor suppressor in human @DISEASE$ cells.	1
Aberrant microRNA expression in the brains of neurodegenerative diseases: @MiRNA$ decreased in @DISEASE$ brains targets neurone navigator.	0
The plasma concentration of @MiRNA$ was negatively correlated with age and NYHA class, and could be a useful biomarker for @DISEASE$.	1
@MiRNA$ has recently been identified as a candidate biomarker of early pancreatic @DISEASE$.	1
@MiRNA$ enhances ruthenium-derived compound Rawq01 induced cell death in human @DISEASE$.	1
socs7, a target gene of @MiRNA$ regulates interferon-alpha induction through STAT3 nuclear translocation in @DISEASE$ cell.	1
In short PMI Alzheimer's disease (AD)-affected temporal lobe neocortex, miRNA-9, @MiRNA$ and miRNA-146a were found to be significantly up-regulated, an effect that was not seen in several related @DISEASE$.	0
Overexpression of @MiRNA$ reverses paclitaxel-induced chemoresistance through activation of PTEN signaling in p53-mutated @DISEASE$ cells.	1
@MiRNA$ is Involved in the Self-Renewal, Tumorigenicity and Chemoresistance of @DISEASE$ Stem Cells.	1
@MiRNA$ promotes epithelial-mesenchymal transition and invasion in @DISEASE$ cells.	1
@MiRNA$ mediated regulation of Sprouty2 protein expression enhances the cytotoxic effect of 5-fluorouracil and metformin in @DISEASE$ cells.	1
In a well-characterized Belgian group of 358 AD patients and 462 controls, we examined whether genetic variability in microRNA (@MiRNA$ ) binding sites of APP and @DISEASE$ or in associated miRNAs influenced risk for A.	0
Using miRNA-146a-, IRAK-1-, or IRAK-2 promoter-luciferase reporter constructs, we observe decreases in @MiRNA$ and increases in @DISEASE$ and IRAK-2 expression in interleukin-1β (IL-1β) and amyloid-β-42 (Aβ42) peptide-stressed HAG cells.	0
Interestingly, @MiRNA$ that are involved in @DISEASE$ conditions have also been found in our miRNA profiles.	0
With respect to the reported regulation of this miRNA in Scrapie-infected mice, we propose that upregulation of @MiRNA$ may be a general phenomenon in late stage prion disease and might be used as a novel marker for animal and human @DISEASE$.	0
@MiRNA$ acts as a tumor suppressor in human @DISEASE$ through the regulation of pocket proteins.	1
Interestingly, orthotopic mouse tumors ectopically expressing @MiRNA$ approximately 92 lost expression of the wild-type @DISEASE$ allele.	1
A number of miRNAs like @MiRNA$, miR-224/miR-452 cluster, miR-182/miR-183/miR-96 cluster, and miR-148a having potential tumor/metastasis suppressive activity were found to be overexpressed in the WNT signaling associated @DISEASE$.	1
Novel oncogenic function of mesoderm development candidate 1 and its regulation by @MiRNA$ in @DISEASE$ cell lines.	1
@MiRNA$ (miRNA) expression was assessed in human cerebral cortical gray matter (GM) and white matter (WM) in order to provide the first insights into the difference between GM and WM miRNA repertoires across a range of @DISEASE$ (AD) pathology.	0
The @MiRNA$ regulates the expression of BACE1/-secretase correlated with cell death in @DISEASE$.	1
Recent studies have shown that the expression of many miRNAs is altered in various human @MiRNA$ and some @DISEASE$ may function as oncogenes or tumor suppressor genes.	0
We performed a large-scale, genome-wide @MiRNA$ (miRNA) (n=756) expression profiling of 26 glioblastoma, 13 anaplastic astrocytoma and 7 normal brain samples with an aim to find deregulated miRNA in malignant @DISEASE$.	0
In human TLE with @MiRNA$, increased astroglial expression of @DISEASE$ was observed mainly in regions where neuronal cell loss and reactive gliosis occurred.	0
This study will pave a way for selection of potential @MiRNA$ candidates for @DISEASE$ -related genes for quick therapeutic applications and diagnosis.	0
@MiRNA$ targets EGFR and inhibited the growth of human @DISEASE$ cells.	1
Our research revealed that 136 miRNAs were expressing at 6 h post injury, in which 13 miRNAs were more than 2-fold up-regulated, and 14 miRNAs were more than 2-fold down-regulated; 118 miRNAs were expressing at 24 h post injury, in which 4 @MiRNA$ were more than 2-fold up-regulated, and 23 miRNAs were more than 2-fold down-regulated; 149 miRNAs were expressing at 48 h post injury, in which 16 miRNAs were more than 2-fold up-regulated, and 11 miRNAs were more than 2-fold down-regulated; and 203 miRNAs were expressing at 72 h post @DISEASE$, in which 19 miRNAs were more than 2-fold up-regulated, and 5 miRNAs were more than 2-fold down-regulated.	0
The cellular processing of shRNAs shares common features with the biogenesis of naturally occurring @MiRNA$ such as cleavage by nuclear RNase Drosha, export from the nucleus, processing by a cytoplasmic RNase @DISEASE$, and incorporation into the RNA-induced silencing complex (RISC).	0
@MiRNA$ expression is downregulated upon neoplastic progression of @DISEASE$.	1
@MiRNA$ a new regulator of RAC1, suppresses the migration and invasion of @DISEASE$ cells.	1
Our research revealed that 136 miRNAs were expressing at 6 h post injury, in which 13 miRNAs were more than 2-fold up-regulated, and 14 miRNAs were more than 2-fold down-regulated; 118 miRNAs were expressing at 24 h post injury, in which 4 miRNAs were more than 2-fold up-regulated, and 23 miRNAs were more than 2-fold down-regulated; 149 miRNAs were expressing at 48 h post injury, in which 16 miRNAs were more than 2-fold up-regulated, and 11 miRNAs were more than 2-fold down-regulated; and 203 miRNAs were expressing at 72 h post @MiRNA$, in which 19 miRNAs were more than 2-fold up-regulated, and 5 @DISEASE$ were more than 2-fold down-regulated.	1
A number of miRNAs like miR-193a, miR-224/miR-452 cluster, miR-182/@MiRNA$ /miR-96 cluster, and miR-148a having potential @DISEASE$ /metastasis suppressive activity were found to be overexpressed in the WNT signaling associated medulloblastomas.	0
Medulloblastomas in which @MiRNA$ was up-regulated also had elevated levels of @DISEASE$ /MYCN expression.	1
@MiRNA$ upregulation indicates the activation of stellate cells and the progression of @DISEASE$.	1
Interestingly, orthotopic mouse @MiRNA$ ectopically expressing @DISEASE$ approximately 92 lost expression of the wild-type Ptch1 allele.	1
In humans, some of these @MiRNA$ have been found to regulate (patho)physiologic conditions such as @DISEASE$ /regression, cholesterol and glucose homeostasis, etc.	0
This review will briefly summarize recent studies that focus attention on aberrant @MiRNA$ expression in @DISEASE$ brains.	0
A polymorphism (rs16917496) at the @MiRNA$ binding site in the 3' untranslated region of the SET8 gene is associated with the risk of epithelial @DISEASE$.	1
@MiRNA$ Inhibits U87 @DISEASE$ Stem Cells Growth and Invasio.	1
Subsequently, we identified a large set of miRNA-mRNA associations that are changed in @MiRNA$ versus control, highlighting AD-specific changes in the @DISEASE$ regulatory system.	0
Thus we have identified a @MiRNA$ expression signature that can predict @DISEASE$ patient survival.	0
p53 downregulates @DISEASE$ associated DYRK1A through @MiRNA$.	1
Down-regulation of @MiRNA$ and its host gene SLIT3 cooperate to promote invasion and progression @DISEASE$.	1
CONCLUSION: @MiRNA$ can recognize the 3'UTR of eiF4E3 while it has no significant effect on the expression of @DISEASE$.	0
These results show that TβR II is a functional target of @MiRNA$ and that miR-106b may influence @DISEASE$ signaling, thereby contributing to the pathogenesis of AD.	0
Comparison of mouse cerebellar development and @MiRNA$ demonstrates a shared miRNA-mRNA co-expression program for brain-specific neurologic processes such as synaptic transmission and exocytosis, in which @DISEASE$ target expression increases with the accumulation of multiple miRNAs in developing cerebellum and decreases with the loss of these miRNAs in brain tumors.	0
Downregulation of @MiRNA$ promotes @DISEASE$ cell invasion by targeting insulin-like growth factor 1 recepto.	1
The @MiRNA$ polycistron is up-regulated in sonic hedgehog-driven @DISEASE$ and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors.	1
One of the most active fields of miR@MiRNA$ search is miRNA regulation of apoptosis, a programmed cell death implicated in many human diseases, such as cancer, Alz@DISEASE$ ypertrophy and heart failur.	0
However, we did observe statistical interaction between rs535860 (@MiRNA$ 3' UTR) and rs34772568 (near @DISEASE$ ; odds ratio [OR](interaction), 0.4; 95% confidence interval [CI], 0.17-0.96; P=0.033).	0
Using miRNA-146a-, @MiRNA$ -, or IRAK-2 promoter-luciferase reporter constructs, we observe decreases in IRAK-1 and increases in @DISEASE$ and IRAK-2 expression in interleukin-1β (IL-1β) and amyloid-β-42 (Aβ42) peptide-stressed HAG cells.	0
@MiRNA$ upregulation by 1,25-dihydroxyvitamin D3 in human @DISEASE$ cells leads to Bim targeting and inhibition of AraC-induced apoptosis.	1
Reduced @MiRNA$ is Associated with Poor Survival in Pulmonary Arterial @DISEASE$.	1
Infection with MB cells in an induced xenograft model in the mouse cerebellum and the use of an adenovirus carrying miR-199b-5p indicate a clinical benefit through this negative influence of @MiRNA$ on tumor growth and on the subset of @DISEASE$ stem-cell-like cells, providing further proof of concept.	0
Serum: @MiRNA$ is associated with early relapse in operable lung @DISEASE$ patient.	1
@MiRNA$ functions as a tumor suppressor by direct targeting oncogenic SIRT1 in @DISEASE$.	1
@MiRNA$ Targets the SKI Gene in Human @DISEASE$ Cell Line.	1
RPS2 control @MiRNA$ expression in human @DISEASE$.	1
HIV Tat Induces Expression of ICAM-1 in HUVECs: Implications for @MiRNA$ -222 in HIV-Associated @DISEASE$.	1
Our results implicate deregulated synthesis of E2F1/@MiRNA$ caused by the miRNA pathway impairment as a key event in LRRK2 pathogenesis and suggest novel @DISEASE$ -based therapeutic strategies.	0
Overexpressed @MiRNA$ promotes cell proliferation and invasion by targeting RUNX3 in @DISEASE$.	1
BACKGROUND: @MiRNA$ (miRNAs) are short non-coding RNAs that regulate differentiation and development in many organisms and play an important role in @DISEASE$.	0
Expression of these @MiRNA$ inhibits cell proliferation, promotes apoptosis of @DISEASE$ cells, and suppresses tumorigenicity both in vitro and in vivo.	0
@MiRNA$ suppresses invasion @DISEASE$ cell by targeting smoothened.	1
Cigarette smoke mediates epigenetic repression of @MiRNA$ during pulmonary @DISEASE$.	1
Sequential analysis of multistage hepatocarcinogenesis reveals that @MiRNA$ and PLK1 dysregulation is an early event maintained along @DISEASE$ progression.	1
@MiRNA$ regulates proliferation and invasion in human @DISEASE$ cells by targeting TGF-beta RII.	1
Like other types of cancer, the brain tumor glioblastoma shows a distinct miRNA expression signature, and a number of recent studies have linked these @MiRNA$ alterations to key hallmarks of @DISEASE$ including proliferation, survival, invasion, angiogenesis and stem cell-like behavior.	0
Loss of @MiRNA$ cluster miR-29a/b-1 in @DISEASE$ correlates with increased BACE1/beta-secretase expression.	1
Thus we have identified the @MiRNA$ expression signature for malignant @DISEASE$, in particular glioblastoma, and showed the miRNA involvement and their importance in astrocytoma development.	0
@MiRNA$ targets cyclic AMP-responsive element binding protein in @DISEASE$.	1
@MiRNA$ inhibits @DISEASE$ cell migration through down-regulating the expression of the LDL receptor-related protein.	0
@MiRNA$ expression profiling and oligonucleotide microarray were carried out, and the data were validated by quantitative real-time polymerase chain reaction and correlated with published data on protein and gene expression in @DISEASE$ rats.	0
Inhibition of two glioblastoma-upregulated miRNAs (@MiRNA$ and miR-23a) and exogenous overexpression of two @DISEASE$ -downregulated miRNAs (miR-218 and miR-219-5p) resulted in reduced soft agar colony formation but showed varying effects on cell proliferation and chemosensitivity.	0
@MiRNA$ suppresses the proliferation and migration of @DISEASE$ cells through down-regulation of STAT3.	1
To address the broader role for miRNAs in neuroprotection, we also showed that loss of all @MiRNA$, by @DISEASE$ mutation, dramatically enhances pathogenic polyQ protein toxicity in flies and in human HeLa cells.	0
The present study provides an initial survey of @MiRNA$ expression in pediatric central nervous system (CNS) malignancies including atypical teratoid/rhabdoid tumor, ependymoma, @DISEASE$, medulloblastoma, and pilocytic astrocytoma.	0
Aberrant microRNA expression in the brains of neurodegenerative diseases: @MiRNA$ decreased in Alzheimer disease brains targets @DISEASE$.	1
@MiRNA$ promotes human @DISEASE$ cell invasiveness in an orthotopic xenotransplantation model by disrupting the NF-κB/IκBα negative feedback loop.	1
A specific subset of five miRNAs revealed by in silico target prediction was significantly overexpressed in NFA samples; three @MiRNA$ (miR-128a, miR-155, and miR-516a-3p) targeted the 3'-untranslated region of the @DISEASE$ transcript, and exogenous overexpression of these miRs inhibited Wee1 protein expression and HeLa cell proliferation.	0
These findings suggested that bcl2 is an important functional target for @MiRNA$, and the abnormal expression of miR-34a may contribute to the pathogenesis of @DISEASE$, at least in part by affecting the expression of bcl2.	0
Coordinated effects of @MiRNA$ induce G/M arrest in human @DISEASE$.	1
Genetic deletion of let-7, antagomir-mediated blockage of @MiRNA$ and miR-184* action, transgenic expression of dp target protector, or replacement of endogenous dp with a dp transgene non-responsive to let-7 each had toxic effects similar to those of pathogenic @DISEASE$.	0
OxLDL up-regulates @MiRNA$ leading to epigenetic modifications of MMP-2/MMP-9 genes: a novel mechanism for @DISEASE$.	1
In this work, we found that levels of several @MiRNA$ (miRNAs) with upstream RE1 sites are decreased in @DISEASE$ patient cortices relative to healthy controls.	1
@MiRNA$ regulates the maturation and function of midbrain DNs within a negative feedback circuit that includes the paired-like homeodomain transcription factor @DISEASE$.	1
Interestingly, one of these, the bifunctional brain enriched miR-9/@MiRNA$ *, targets two components of the REST complex: miR-9 targets REST and miR-9* targets @DISEASE$.	0
We show new data from cultured H4 @MiRNA$ cells that demonstrate similarities in mRNAs targeted by miR-16 and @DISEASE$ and also support the importance of the mature miRNAs' 5' seed region in mRNA target recognition.	0
DNA damage induces NF-kB-dependent @MiRNA$ upregulation and promotes @DISEASE$ cell invasion.	1
To identify a microRNA (@MiRNA$ ) expression signature that can predict GBM patient survival, we analyzed the miRNA expression data of @DISEASE$ patients (n = 222) derived from The Cancer Genome Atlas (TCGA) dataset.	0
@MiRNA$ expression in ACTH-producing pituitary tumors: up-regulation of microRNA-122 and -493 in @DISEASE$.	0
In human cell lines, we found that @MiRNA$ down-regulates the expression of LRP1 by targeting sequences in the 3'UTR of @DISEASE$ mRNA.	1
@MiRNA$ is responsible for the maturation and function of @DISEASE$ (miRNA) molecules in the cell.	0
RESULTS: We hypothesized that @MiRNA$ might be associated with altered @DISEASE$ profiles.	0
CONCLUSIONS: Our results indicate that altered @MiRNA$ expression is involved in GH-secreting @DISEASE$ transformation, which will shed light on the mechanisms for the treatment of acromegaly by SSA.	1
Characterization of an NF-kappaB-regulated, @MiRNA$ -mediated down-regulation of complement factor H (@DISEASE$ ) in metal-sulfate-stressed human brain cells.	1
The family of miR-64 and miR-65 are co-underexpressed in the alpha-synuclein transgenic and cat-1 strains, and members of let-7 family co-underexpressed in the alpha-synuclein and pdr-1 strains; mdl-1 and ptc-1 genes are target candidates for miR-64 and @MiRNA$ and are overexpressed in @DISEASE$ transgenic as well as miR-64/65 (tm3711) knockout animals.	1
@MiRNA$ functions as a tumor suppressor in human @DISEASE$ by targeting ras-related protein 14 (RAB14).	1
Analysis of @MiRNA$ demonstrated that 3 miR-17 approximately 92 cluster miRNAs (miR-92, miR-19a, and @DISEASE$ ) were also overexpressed in human MBs with a constitutively activated Sonic Hedgehog (SHH) signaling pathway, but not in other forms of the disease.	0
@MiRNA$ inhibit cell migration and invasion of invasive urothelial bladder @DISEASE$ by targeting Notch1.	1
We report that @MiRNA$ of human primary neural cells with a high phenotypic reactivator HSV-1 (17syn+) induces upregulation of a brain-enriched @DISEASE$ that is associated with proinflammatory signaling in stressed brain cells and Alzheimer's disease.	1
Our research revealed that 136 @MiRNA$ were expressing at 6 h post injury, in which 13 miRNAs were more than 2-fold up-regulated, and 14 miRNAs were more than 2-fold down-regulated; 118 miRNAs were expressing at 24 h post injury, in which 4 miRNAs were more than 2-fold up-regulated, and 23 miRNAs were more than 2-fold down-regulated; 149 miRNAs were expressing at 48 h post injury, in which 16 miRNAs were more than 2-fold up-regulated, and 11 miRNAs were more than 2-fold down-regulated; and 203 miRNAs were expressing at 72 h post @DISEASE$, in which 19 miRNAs were more than 2-fold up-regulated, and 5 miRNAs were more than 2-fold down-regulated.	0
To identify a @MiRNA$ (miRNA) expression signature that can predict @DISEASE$ patient survival, we analyzed the miRNA expression data of GBM patients (n = 222) derived from The Cancer Genome Atlas (TCGA) dataset.	0
Expression and significance of PTEN and @MiRNA$ in @DISEASE$.	1
The predicted targets of these @MiRNA$ include those with known or suspected roles in oligodendrocyte development and myelination including C11Orf9, CLDN11, MYTL1, MBOP, MPZL2, and @DISEASE$.	0
HEF1 promotes epithelial mesenchymal transition and bone invasion in @DISEASE$ under the regulation of @MiRNA$.	1
While the exact role of the patient-specific @MiRNA$ variants within the 3' UTR region of APP and @DISEASE$ demands further analyses, this study does not support a major contribution of miRNA genetic variability to AD pathogenesis.	0
@MiRNA$ is a novel inhibitor of YY1 contributing to colorectal @DISEASE$.	1
Expression of @MiRNA$ in ovarian epithelial @DISEASE$ and its clinical significanc.	1
The p63 isoform deltaNp63α inhibits epithelial-mesenchymal transition in human @DISEASE$ cells: Role of @MiRNA$.	1
Our research revealed that 136 miRNAs were expressing at 6 h post @MiRNA$, in which 13 miRNAs were more than 2-fold up-regulated, and 14 miRNAs were more than 2-fold down-regulated; 118 miRNAs were expressing at 24 h post injury, in which 4 miRNAs were more than 2-fold up-regulated, and 23 miRNAs were more than 2-fold down-regulated; 149 miRNAs were expressing at 48 h post injury, in which 16 miRNAs were more than 2-fold up-regulated, and 11 @DISEASE$ were more than 2-fold down-regulated; and 203 miRNAs were expressing at 72 h post injury, in which 19 miRNAs were more than 2-fold up-regulated, and 5 miRNAs were more than 2-fold down-regulated.	0
A specific subset of five @MiRNA$ revealed by in silico target prediction was significantly overexpressed in NFA samples; three miRs (miR-128a, miR-155, and miR-516a-3p) targeted the 3'-untranslated region of the Wee1 transcript, and exogenous overexpression of these miRs inhibited @DISEASE$ protein expression and HeLa cell proliferation.	0
@MiRNA$ is a novel regulator contributing to impaired IL-2 production in T cells from patients with @DISEASE$.	1
In situ hybridization with cross-comparison to neuropathology demonstrated that particular cerebral cortical laminas involved by @MiRNA$ pathology exhibit diminished neuronal @DISEASE$ expression.	1
@MiRNA$ Inhibits Human @DISEASE$ Proliferation by Downregulating Ether go-go 1 Expressio.	1
MicroRNA (@MiRNA$ ) expression was assessed in human cerebral cortical gray matter (GM) and white matter (WM) in order to provide the first insights into the difference between GM and WM miRNA repertoires across a range of Alzheimer's disease (@DISEASE$ ) pathology.	0
A catalogue of porcine and viral @MiRNA$, expressed eight hours post-@DISEASE$, was established by deep sequencing.	0
Estrogen Mediated-Activation of @MiRNA$ Modulates Tumorigenicity @DISEASE$ Cells Depending on Estrogen Receptor Statu.	1
Through various experimental approaches, we validated computational predictions and demonstrated that @MiRNA$ and miR-328 recognize specific binding sites in the 3'-UTR of BACE1 mRNA and exert regulatory effects on @DISEASE$ protein expression in cultured neuronal cells.	1
A strong positive correlation between @MiRNA$ abundance and the glial cell markers glial fibrillary acidic protein (GFAP) and vimentin, and CDKN2A down-regulation was noted in advanced @DISEASE$ (AD) and in Down's syndrome (DS) brain, chronic neurological disorders associated with astrogliosis.	0
Up-regulation of @MiRNA$ by beta-catenin in @DISEASE$ increases tumorigenicity and invasiveness by targeting the matrix metalloproteinase inhibitor REC.	1
DNA methylation silences @MiRNA$ in @DISEASE$.	1
Moreover, LPS stimulation decreased expression of @MiRNA$ (miRNA)--miR-17-5, miR-20a, and miR-93--which target @DISEASE$, implicating a novel role for miRNAs in NKG2D ligand expression.	1
Several deregulated @MiRNA$ uncovered in @DISEASE$ and medulloblastomas have their gene targets and the associated genetic pathways identified.	1
Analysis of human MBs demonstrated that 3 miR-17 approximately 92 cluster miRNAs (miR-92, @MiRNA$, and miR-20) were also overexpressed in human MBs with a constitutively activated Sonic Hedgehog (@DISEASE$ ) signaling pathway, but not in other forms of the disease.	0
Finally, we show that @MiRNA$ is down-regulated in @DISEASE$ brain.	1
@MiRNA$ regulates @DISEASE$ and developmental gene thyroid transcription factor 1.	1
In this work, we found that levels of several microRNAs (@MiRNA$ ) with upstream RE1 sites are decreased in @DISEASE$ patient cortices relative to healthy controls.	1
Plasma @MiRNA$ as sensitive and specific biomarkers of @DISEASE$.	0
To search for @MiRNA$ that may be involved in the pathogenesis of Parkinsons disease (@DISEASE$ ), we utilized miRNA microarrays to identify potential gene expression changes in 115 annotated miRNAs in PD-associated Caenorhabditis elegans models that either overexpress human A53T alpha-synuclein or have mutations within the vesicular catecholamine transporter (cat-1) or parkin (pdr-1) ortholog.	0
Objective: The aim of the study was to analyze the differential expression of let-7a, miR-15a, miR-16, miR-21, miR-141, miR-143, @MiRNA$, and miR-150 in @DISEASE$ and normal pituitary tissue and verify whether their profile of expression correlates with tumor size or remission after treatment.	0
In contrast, no @MiRNA$ changes were detected in the heart, an organ with no known pathology during @DISEASE$.	0
These results show that TβR II is a functional target of @MiRNA$ and that miR-106b may influence TGF-β signaling, thereby contributing to the pathogenesis of @DISEASE$.	0
Analysis of @MiRNA$ demonstrated that 3 miR-17 approximately 92 cluster miRNAs (miR-92, @DISEASE$, and miR-20) were also overexpressed in human MBs with a constitutively activated Sonic Hedgehog (SHH) signaling pathway, but not in other forms of the disease.	0
This study finds that altered miRNA expression levels are observed in postmortem cerebellar cortex from @MiRNA$ patients, a finding which suggests that dysregulation of @DISEASE$ may contribute to autism spectrum phenotype.	0
MTA1 promotes the invasion and migration of @DISEASE$ cells by downregulating @MiRNA$.	1
@MiRNA$ Mediates Proliferation of Vascular Smooth Muscle Cells in @DISEASE$.	1
We therefore investigated changes in @MiRNA$ (miRNA) expression profiles of @DISEASE$ patients and found that several miRNAs potentially involved in the regulation of APP and BACE1 expression appeared to be decreased in diseased brain.	0
These studies provide the foundation to define the @MiRNA$ involved in @DISEASE$, and the biological pathways affected.	0
Here we report that the levels of a human brain-enriched @MiRNA$ are up-regulated in interleukin-6 (@DISEASE$ )-stressed normal human astrocytes (NHA), a treatment known to induce astrogliosis.	1
Using multiplex quantitative polymerase chain reaction (PCR), we compared the expression of 466 human @MiRNA$ from postmortem cerebellar cortex tissue of individuals with @DISEASE$ (n = 13) and a control set of non-autistic cerebellar samples (n = 13).	0
@MiRNA$ expression profiling of both mouse and human medulloblastomas has led to the identification of signatures correlating with the molecular subgroups of @DISEASE$, tumor diagnosis and response to treatment, as well as novel targets of potential clinical relevance.	0
@MiRNA$ regulates cell proliferation and apoptosis by targeting PHF10 in @DISEASE$.	1
Profiling the expression of 427 mature microRNAs (miRNA) in a series of 90 primary human medulloblastomas revealed that components of the @MiRNA$ polycistron are the most highly up-regulated miRNAs in @DISEASE$.	1
Both the deregulation of genes controlled by @MiRNA$ and the altered miRNA expression have been linked to many disorders, including cancer, cardiovascular, metabolic and @DISEASE$.	0
Notably, these same @MiRNA$ are up-regulated in @DISEASE$ brain.	1
The putative tumour suppressor @MiRNA$ modulates @DISEASE$ cell aggressiveness by repressing ROCK2 and EZH2.	1
While miR-1, miR-22* and miR-29 expression levels allowed to distinguish non-treated @MiRNA$ from healthy subjects, miR-16-2*, @DISEASE$ * and miR30a differentiated treated from untreated patients.	1
@MiRNA$ in @DISEASE$ : small regulators of a big problem.	0
We used @MiRNA$ profiling with 1,145 probes to study miRNA expression in normal anterior pituitary (6 cases), adrenocorticotropin (ACTH)-producing @DISEASE$ (8 cases), and ACTH-producing pituitary carcinomas (two cases).	0
RESULTS: By microarray analysis, we identified up-regulation of miR-29a, miR-29b and @MiRNA$ in @DISEASE$ brains, but due to a great interindividual variation, we could not validate these results by quantitative RT-PCR.	1
A mutation in the 3'UTR of the SLITRK1 gene which is associated with @DISEASE$ was found to enhance repression of the SLITRK mRNA by @MiRNA$ presumably preventing SLITRK1's promotion of dendritic growth.	1
@MiRNA$ as a prognostic marker of relapse in surgically resected @DISEASE$.	1
@MiRNA$ profiling was performed using brain tissue from patients with @DISEASE$ (HIVE), a neuroinflammatory/degenerative disorder caused by HIV infection of the brain.	0
@MiRNA$ is epigeneticlly silenced in @DISEASE$.	1
To investigate the involvement of @MiRNA$, miR-27a, and miR-150 in @DISEASE$ -resistant mice, we assessed the expression levels in gamma interferon knockout (IFN-γ(-/-)) mice on a C57BL/6 genetic background.	0
While most miRNAs levels showed little variation across all samples suggesting that @MiRNA$ does not induce global dysfunction of @DISEASE$ expression, some miRNAs among the autistic samples were expressed at significantly different levels compared to the mean control value.	0
Up-regulated @MiRNA$ expression was associated with lymph node positivity (P=0.034), higher proliferation index (Ki-67 >10%) (P=0.019) and advanced @DISEASE$ TNM clinical stage (P=0.002).	1
Recent studies have identified a molecular and ultimately pathogenic role for a subset of @MiRNA$ in @DISEASE$ and schizophrenia, including the characterization of their downstream CNS mRNA targets, such as beta-secretase (BACE1) and calmodulin-dependent protein kinase II (CaMKII).	0
The @MiRNA$ ZBTB10-specificity protein pathway is involved in follicle stimulating hormone-induced VEGF, Cox2 and survivin expression in ovarian @DISEASE$ cell.	1
MicroRNAs (miRNAs) are @MiRNA$ in the brain and play an important role in disorders of the brain, including @DISEASE$ (AD).	1
The @MiRNA$ group has also been implicated in human cancers, cardiovascular disease and neurodegenerative disease, including @DISEASE$.	0
Human brains retain discrete populations of micro RNA (@MiRNA$ ) species that support homeostatic brain gene expression functions; however, specific miRNA abundance is significantly altered in neurological disorders such as @DISEASE$ (AD) when compared with age-matched controls.	0
@MiRNA$ regulates cell survival, growth and chemosensitivity by targeting FOXO3a in @DISEASE$.	1
To investigate this possibility we compared the expression of 264 human miRNAs from postmortem prefrontal cortex tissue of individuals with schizophrenia (n = 13) or @MiRNA$ (n = 2) to tissue of 21 psychiatrically unaffected individuals using a custom @DISEASE$ microarray.	0
The @MiRNA$ cluster collaborates with the Sonic Hedgehog pathway in @DISEASE$.	0
@MiRNA$ suppresses proliferation and migration of esophageal @DISEASE$ cells through downregulation of SOX4 expression.	1
Recent studies have identified changes of several specific miRNA expression profiles and polymorphisms affecting the interactions between miRNAs and their targets in various @MiRNA$, including addiction: @DISEASE$ causes adaptive changes in production of the serotonin transporter; miR-133b is specifically expressed in midbrain dopaminergic neurons, and regulates the production of tyrosine hydroxylase and the dopamine transporter; miR-212 affects production of striatal brain-derived neurotrophic factor and synaptic plasticity upon cocaine.	0
Objective: The aim of the study was to analyze the differential expression of let-7a, miR-15a, @MiRNA$, miR-21, miR-141, miR-143, miR-145, and miR-150 in corticotropinomas and normal pituitary tissue and verify whether their profile of expression correlates with @DISEASE$ size or remission after treatment.	0
The results show the possible use of blood miRNAs as biomarkers for brain injury; that selected blood miRNAs may correlate with @MiRNA$ changes in the brain; and that many of the mRNAs, previously shown to be regulated in brain and blood after @DISEASE$, are likely accounted for by changes in miRNA expression.	0
@MiRNA$ is overexpressed in T-lymphocytes of early @DISEASE$ patients.	1
@MiRNA$ facilitates @DISEASE$ cell growth by promoting cell cycle progression through the negative regulation of RBL.	1
Objective: The aim of the study was to analyze the differential expression of @MiRNA$, miR-15a, miR-16, miR-21, miR-141, miR-143, miR-145, and miR-150 in corticotropinomas and normal pituitary tissue and verify whether their profile of expression correlates with @DISEASE$ size or remission after treatment.	0
The decreased expression level of @MiRNA$ is correlated to @DISEASE$ disease severity.	1
Comparison of mouse cerebellar development and medulloblastoma demonstrates a shared miRNA-mRNA co-expression program for brain-specific neurologic processes such as synaptic transmission and exocytosis, in which @MiRNA$ target expression increases with the accumulation of multiple miRNAs in developing cerebellum and decreases with the loss of these miRNAs in @DISEASE$.	0
Consistent with its regulation by Shh, we observed that @MiRNA$ treatment of primary cerebellar granule neuron precursors (CGNP), proposed cells of origin for the Shh-associated medulloblastomas, resulted in increased @DISEASE$ expression.	0
@MiRNA$ enhances the sensitivities of human @DISEASE$ to cisplatin-based chemotherapy and radiotherap.	1
We used @MiRNA$ profiling with 1,145 probes to study miRNA expression in normal anterior pituitary (6 cases), adrenocorticotropin (ACTH)-producing adenomas (8 cases), and @DISEASE$ -producing pituitary carcinomas (two cases).	0
@MiRNA$ expression signature and antisense-mediated depletion reveal an essential role of MicroRNA in @DISEASE$ formation.	0
Our research revealed that 136 miRNAs were expressing at 6 h post @MiRNA$, in which 13 miRNAs were more than 2-fold up-regulated, and 14 miRNAs were more than 2-fold down-regulated; 118 miRNAs were expressing at 24 h post injury, in which 4 miRNAs were more than 2-fold up-regulated, and 23 miRNAs were more than 2-fold down-regulated; 149 miRNAs were expressing at 48 h post injury, in which 16 @DISEASE$ were more than 2-fold up-regulated, and 11 miRNAs were more than 2-fold down-regulated; and 203 miRNAs were expressing at 72 h post injury, in which 19 miRNAs were more than 2-fold up-regulated, and 5 miRNAs were more than 2-fold down-regulated.	0
One of the most active fields of miRNA research is miR@MiRNA$ gulation of apoptosis, a programmed cell death implicated in many human diseases, such as cancer, Alzheimer's disease, hypertrophy and hea@DISEASE$.	0
Interestingly the gene locus of one miRNA, @MiRNA$, is a candidate region for two neurologic diseases: @DISEASE$ (Waisman syndrome) and X-linked mental retardation (MRX3).	1
SnoN/SKIL modulates proliferation through control of @MiRNA$ transcription in @DISEASE$ cell.	1
Targeting @MiRNA$ in @DISEASE$.	0
Our studies show markedly elevated @MiRNA$ levels in human glioblastoma tumor tissues, @DISEASE$ cultures, and in six established glioblastoma cell lines (A172, U87, U373, LN229, LN428, and LN308) compared with nonneoplastic fetal and adult brain tissues and compared with cultured nonneoplastic glial cells.	1
Overexpression of @MiRNA$ induces mesenchymal-to-epithelial transition (MET) in metastatic @DISEASE$ cells.	1
A few miRNAs (e.g., miR-298, miR-155, and @MiRNA$ ) were upregulated or downregulated more than twofold in both brain and blood after several different @DISEASE$.	0
The putative targets of deregulated @MiRNA$ and seed-region IsomiRs strongly suggest that their altered expression contributes to the aberrant gene expression in @DISEASE$.	1
Our research revealed that 136 miRNAs were expressing at 6 h post injury, in which 13 miRNAs were more than 2-fold up-regulated, and 14 miRNAs were more than 2-fold down-regulated; 118 miRNAs were expressing at 24 h post @MiRNA$, in which 4 miRNAs were more than 2-fold up-regulated, and 23 miRNAs were more than 2-fold down-regulated; 149 miRNAs were expressing at 48 h post injury, in which 16 miRNAs were more than 2-fold up-regulated, and 11 @DISEASE$ were more than 2-fold down-regulated; and 203 miRNAs were expressing at 72 h post injury, in which 19 miRNAs were more than 2-fold up-regulated, and 5 miRNAs were more than 2-fold down-regulated.	0
Overexpression of @MiRNA$ regulates the ubiquitin ligase FBXW7 in oesophageal @DISEASE$.	1
Epigenetic Regulation of @MiRNA$ by MMP-9 Governs @DISEASE$ Cell Apoptosis,Chemosensitivity and Radiosensitivit.	1
Levels of @MiRNA$ in serum, and its levels in patients' serum in association with a specific marker of MPM, SMRPs, correlate with subjects at high risk to develop malignant pleural @DISEASE$ (MPM).	1
Recent evidence has shown that @MiRNA$ plays a pivotal role in the development of many cancers including @DISEASE$, a lethal brain cancer.	0
In this study, miRNA array analysis in various tissues showed that @MiRNA$ is almost exclusively expressed in the central nervous system and neuronal cells, suggesting that it might be useful as a potential biomarker for @DISEASE$.	0
@MiRNA$ acts as a metastasis suppressor in @DISEASE$ by targeting Bcl-w and specificity protein 1.	1
Here we expand the role of GRN in FTLD-U and demonstrate that a common genetic variant (rs5848), located in the 3'-untranslated region (UTR) of @MiRNA$ in a binding-site for @DISEASE$, is a major susceptibility factor for FTLD-U.	1
@MiRNA$ downregulates the stress-induced cell surface molecule MICB, a critical ligand for @DISEASE$ cell recognition by natural killer cells.	1
One of the most active fields of miRNA research is miR@MiRNA$ gulation of apoptosis, a programmed cell death implicated in many human diseases, such as cancer, Alz@DISEASE$ ypertrophy and heart failur.	0
However, it is unclear whether @MiRNA$ involved in AD pathogenesis by regulating @DISEASE$ signaling.	0
Our results showed that the expression of @MiRNA$ was inversely correlated with TβR II protein levels and miR-106b can directly inhibit the @DISEASE$ translation in vitro.	0
@MiRNA$ promotes the transition from indolent to invasive @DISEASE$.	1
